[
    {
        "text": "in the present study , we tested whether the highly specific metabotropic glutamate receptor # antagonist , HD00906 , reduces dopaminergic and noradrenergic neuronal loss in monkeys rendered parkinsonian by chronic treatment with low doses of HD00907 .",
        "label": "NA"
    },
    {
        "text": "weekly intramuscular HD00907 injections { # # mg/kg body weight } , in combination with daily administration of HD00906 or vehicle , were performed until the development of parkinsonian motor symptoms in either of the two experimental groups { ddrug2 / ddrug3 versus ddrug4 / vehicle } .",
        "label": "NA"
    },
    {
        "text": "weekly intramuscular HD00907 injections { # # mg/kg body weight } , in combination with daily administration of ddrug1 or vehicle , were performed until the development of parkinsonian motor symptoms in either of the two experimental groups { ddrug2 / HD00906 versus ddrug4 / vehicle } .",
        "label": "NA"
    },
    {
        "text": "weekly intramuscular ddrug0 injections { # # mg/kg body weight } , in combination with daily administration of HD00906 or vehicle , were performed until the development of parkinsonian motor symptoms in either of the two experimental groups { HD00907 / ddrug3 versus ddrug4 / vehicle } .",
        "label": "NA"
    },
    {
        "text": "after # weeks of HD00907 treatment , all ddrug1 / vehicle-treated animals displayed parkinsonian symptoms , whereas none of the ddrug2 / HD00906 - treated monkeys were significantly affected .",
        "label": "NA"
    },
    {
        "text": "after # weeks of ddrug0 treatment , all HD00907 / vehicle-treated animals displayed parkinsonian symptoms , whereas none of the ddrug2 / HD00906 - treated monkeys were significantly affected .",
        "label": "NA"
    },
    {
        "text": "after # weeks of ddrug0 treatment , all ddrug1 / vehicle-treated animals displayed parkinsonian symptoms , whereas none of the HD00907 / HD00906 - treated monkeys were significantly affected .",
        "label": "effect"
    },
    {
        "text": "these behavioural observations were consistent with in vivo positron emission tomography dopamine transporter imaging data , and with post-mortem stereological counts of midbrain dopaminergic neurons , as well as striatal intensity measurements of dopamine transporter and tyrosine hydroxylase immunoreactivity , which were all significantly higher in HD00907 / HD00906 - treated animals than in ddrug2 / vehicle-treated monkeys .",
        "label": "effect"
    },
    {
        "text": "these behavioural observations were consistent with in vivo positron emission tomography dopamine transporter imaging data , and with post-mortem stereological counts of midbrain dopaminergic neurons , as well as striatal intensity measurements of dopamine transporter and tyrosine hydroxylase immunoreactivity , which were all significantly higher in ddrug0 / HD00906 - treated animals than in HD00907 / vehicle-treated monkeys .",
        "label": "NA"
    },
    {
        "text": "the HD00906 treatment also had a significant effect on the HD00907 - induced loss of norepinephrine neurons in the locus coeruleus and adjoining a5 and a7 noradrenaline cell groups .",
        "label": "effect"
    },
    {
        "text": "in HD00907 / vehicle-treated animals , almost 40 % loss of tyrosine hydroxylase-positive norepinephrine neurons was found in locus coeruleus/a5/a7 noradrenaline cell groups , whereas the extent of neuronal loss was lower than 15 % of control values in ddrug1 / HD00906 - treated monkeys .",
        "label": "NA"
    },
    {
        "text": "in ddrug0 / vehicle-treated animals , almost 40 % loss of tyrosine hydroxylase-positive norepinephrine neurons was found in locus coeruleus/a5/a7 noradrenaline cell groups , whereas the extent of neuronal loss was lower than 15 % of control values in HD00907 / HD00906 - treated monkeys .",
        "label": "effect"
    },
    {
        "text": "our data demonstrate that chronic treatment with the metabotropic glutamate receptor # antagonist , HD00906 , significantly reduces HD00907 toxicity towards dopaminergic and noradrenergic cell groups in non-human primates .",
        "label": "effect"
    },
    {
        "text": "effect of DB01026 - mediated cyp3a4 inhibition on clinical pharmacokinetics of DB06603 { ddrug2 } , an orally active ddrug3 .",
        "label": "NA"
    },
    {
        "text": "effect of DB01026 - mediated cyp3a4 inhibition on clinical pharmacokinetics of ddrug1 { HD00908 } , an orally active ddrug3 .",
        "label": "NA"
    },
    {
        "text": "effect of DB01026 - mediated cyp3a4 inhibition on clinical pharmacokinetics of ddrug1 { ddrug2 } , an orally active HD00909 .",
        "label": "NA"
    },
    {
        "text": "effect of ddrug0 - mediated cyp3a4 inhibition on clinical pharmacokinetics of DB06603 { ddrug2 } , an orally active HD00909 .",
        "label": "NA"
    },
    {
        "text": "effect of ddrug0 - mediated cyp3a4 inhibition on clinical pharmacokinetics of ddrug1 { HD00908 } , an orally active HD00909 .",
        "label": "NA"
    },
    {
        "text": "this study evaluated the effect of a potent cyp3a inhibitor , DB01026 , on the pharmacokinetics and safety of DB06603 .",
        "label": "NA"
    },
    {
        "text": "on day 8 , a single DB06603 dose was co-administered with DB01026 .",
        "label": "NA"
    },
    {
        "text": "in the presence of DB01026 , there was # - and # - fold increase in c { max } and auc of DB06603 , respectively .",
        "label": "mechanism"
    },
    {
        "text": "interaction study of DB00218 and DB00978 with co-administered drugs .",
        "label": "NA"
    },
    {
        "text": "DB00218 and DB00978 are ddrug2 used in treating urinary and respiratory tract infections .",
        "label": "NA"
    },
    {
        "text": "DB00218 and ddrug1 are HD00910 used in treating urinary and respiratory tract infections .",
        "label": "NA"
    },
    {
        "text": "ddrug0 and DB00978 are HD00910 used in treating urinary and respiratory tract infections .",
        "label": "NA"
    },
    {
        "text": "being DB00218 and lomefloxacin HD00001 the interaction study of was carried out with ddrug2 , ddrug3 , ddrug4 and ddrug5 .",
        "label": "NA"
    },
    {
        "text": "being DB00218 and lomefloxacin ddrug1 the interaction study of was carried out with DB00364 , ddrug3 , ddrug4 and ddrug5 .",
        "label": "NA"
    },
    {
        "text": "being DB00218 and lomefloxacin ddrug1 the interaction study of was carried out with ddrug2 , DB06723 , ddrug4 and ddrug5 .",
        "label": "NA"
    },
    {
        "text": "being DB00218 and lomefloxacin ddrug1 the interaction study of was carried out with ddrug2 , ddrug3 , DB00199 and ddrug5 .",
        "label": "NA"
    },
    {
        "text": "being DB00218 and lomefloxacin ddrug1 the interaction study of was carried out with ddrug2 , ddrug3 , ddrug4 and HD00911 .",
        "label": "NA"
    },
    {
        "text": "being ddrug0 and lomefloxacin HD00001 the interaction study of was carried out with DB00364 , ddrug3 , ddrug4 and ddrug5 .",
        "label": "NA"
    },
    {
        "text": "being ddrug0 and lomefloxacin HD00001 the interaction study of was carried out with ddrug2 , DB06723 , ddrug4 and ddrug5 .",
        "label": "NA"
    },
    {
        "text": "being ddrug0 and lomefloxacin HD00001 the interaction study of was carried out with ddrug2 , ddrug3 , DB00199 and ddrug5 .",
        "label": "NA"
    },
    {
        "text": "being ddrug0 and lomefloxacin HD00001 the interaction study of was carried out with ddrug2 , ddrug3 , ddrug4 and HD00911 .",
        "label": "NA"
    },
    {
        "text": "the response of DB00218 and DB00978 after interaction with co-administered drugs at different conditions and temperature were noted using a shimadzu hplc system with pda detector .",
        "label": "NA"
    },
    {
        "text": "DB00218 and DB00978 reacts faster with ddrug2 and ddrug3 in acidic media whereas with ddrug4 in basic media and ddrug5 in neutral media .",
        "label": "NA"
    },
    {
        "text": "DB00218 and ddrug1 reacts faster with DB00364 and ddrug3 in acidic media whereas with ddrug4 in basic media and ddrug5 in neutral media .",
        "label": "mechanism"
    },
    {
        "text": "DB00218 and ddrug1 reacts faster with ddrug2 and DB06723 in acidic media whereas with ddrug4 in basic media and ddrug5 in neutral media .",
        "label": "mechanism"
    },
    {
        "text": "DB00218 and ddrug1 reacts faster with ddrug2 and ddrug3 in acidic media whereas with DB00199 in basic media and ddrug5 in neutral media .",
        "label": "mechanism"
    },
    {
        "text": "DB00218 and ddrug1 reacts faster with ddrug2 and ddrug3 in acidic media whereas with ddrug4 in basic media and HD00912 in neutral media .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 and DB00978 reacts faster with DB00364 and ddrug3 in acidic media whereas with ddrug4 in basic media and ddrug5 in neutral media .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 and DB00978 reacts faster with ddrug2 and DB06723 in acidic media whereas with ddrug4 in basic media and ddrug5 in neutral media .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 and DB00978 reacts faster with ddrug2 and ddrug3 in acidic media whereas with DB00199 in basic media and ddrug5 in neutral media .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 and DB00978 reacts faster with ddrug2 and ddrug3 in acidic media whereas with ddrug4 in basic media and HD00912 in neutral media .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 and ddrug1 reacts faster with DB00364 and DB06723 in acidic media whereas with ddrug4 in basic media and ddrug5 in neutral media .",
        "label": "NA"
    },
    {
        "text": "ddrug0 and ddrug1 reacts faster with DB00364 and ddrug3 in acidic media whereas with DB00199 in basic media and ddrug5 in neutral media .",
        "label": "NA"
    },
    {
        "text": "ddrug0 and ddrug1 reacts faster with DB00364 and ddrug3 in acidic media whereas with ddrug4 in basic media and HD00912 in neutral media .",
        "label": "NA"
    },
    {
        "text": "ddrug0 and ddrug1 reacts faster with ddrug2 and DB06723 in acidic media whereas with DB00199 in basic media and ddrug5 in neutral media .",
        "label": "NA"
    },
    {
        "text": "ddrug0 and ddrug1 reacts faster with ddrug2 and DB06723 in acidic media whereas with ddrug4 in basic media and HD00912 in neutral media .",
        "label": "NA"
    },
    {
        "text": "ddrug0 and ddrug1 reacts faster with ddrug2 and ddrug3 in acidic media whereas with DB00199 in basic media and HD00912 in neutral media .",
        "label": "NA"
    },
    {
        "text": "exposure to oral DB11823 is unaffected by DB01167 but greatly increased by ddrug2 .",
        "label": "NA"
    },
    {
        "text": "exposure to oral DB11823 is unaffected by ddrug1 but greatly increased by DB00208 .",
        "label": "effect"
    },
    {
        "text": "exposure to oral ddrug0 is unaffected by DB01167 but greatly increased by DB00208 .",
        "label": "NA"
    },
    {
        "text": "this study examined drug-drug interactions of oral DB11823 with the cytochrome cyp2b6 { cyp } 2b6 inhibitor DB00208 and the cytochrome_p450_family_3_subfamily_a inhibitor ddrug2 .",
        "label": "NA"
    },
    {
        "text": "this study examined drug-drug interactions of oral DB11823 with the cytochrome cyp2b6 { cyp } 2b6 inhibitor ddrug1 and the cytochrome_p450_family_3_subfamily_a inhibitor DB01167 .",
        "label": "NA"
    },
    {
        "text": "this study examined drug-drug interactions of oral ddrug0 with the cytochrome cyp2b6 { cyp } 2b6 inhibitor DB00208 and the cytochrome_p450_family_3_subfamily_a inhibitor DB01167 .",
        "label": "NA"
    },
    {
        "text": "in this randomized , blinded , crossover study , # healthy volunteers ingested # mg/kg DB11823 after pretreatments with oral DB00208 { 250 mg twice daily } , ddrug2 { 200 mg once daily } , or placebo in 6-day treatment periods at intervals of # weeks .",
        "label": "NA"
    },
    {
        "text": "in this randomized , blinded , crossover study , # healthy volunteers ingested # mg/kg DB11823 after pretreatments with oral ddrug1 { 250 mg twice daily } , DB01167 { 200 mg once daily } , or placebo in 6-day treatment periods at intervals of # weeks .",
        "label": "NA"
    },
    {
        "text": "DB00208 treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity { auc { 0 - } } of oral DB01221 by # - fold , whereas ddrug2 treatment did not increase the exposure to ddrug3 .",
        "label": "mechanism"
    },
    {
        "text": "DB00208 treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity { auc { 0 - } } of oral ddrug1 by # - fold , whereas DB01167 treatment did not increase the exposure to ddrug3 .",
        "label": "NA"
    },
    {
        "text": "DB00208 treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity { auc { 0 - } } of oral ddrug1 by # - fold , whereas ddrug2 treatment did not increase the exposure to DB11823 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity { auc { 0 - } } of oral DB01221 by # - fold , whereas DB01167 treatment did not increase the exposure to ddrug3 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity { auc { 0 - } } of oral ddrug1 by # - fold , whereas DB01167 treatment did not increase the exposure to DB11823 .",
        "label": "NA"
    },
    {
        "text": "the ratio of HD00913 auc { 0 - } to ddrug1 auc { 0 - } was significantly decreased in the DB00208 { p < # } and ddrug3 phases { p = # } as compared to placebo .",
        "label": "NA"
    },
    {
        "text": "the ratio of HD00913 auc { 0 - } to ddrug1 auc { 0 - } was significantly decreased in the ddrug2 { p < # } and DB01167 phases { p = # } as compared to placebo .",
        "label": "NA"
    },
    {
        "text": "the ratio of ddrug0 auc { 0 - } to DB01221 auc { 0 - } was significantly decreased in the DB00208 { p < # } and ddrug3 phases { p = # } as compared to placebo .",
        "label": "NA"
    },
    {
        "text": "the ratio of ddrug0 auc { 0 - } to DB01221 auc { 0 - } was significantly decreased in the ddrug2 { p < # } and DB01167 phases { p = # } as compared to placebo .",
        "label": "NA"
    },
    {
        "text": "the ratio of ddrug0 auc { 0 - } to ddrug1 auc { 0 - } was significantly decreased in the DB00208 { p < # } and DB01167 phases { p = # } as compared to placebo .",
        "label": "NA"
    },
    {
        "text": "in the DB00208 and DB01167 phases , the areas under the effect-time curves { self-reported drowsiness and performance } were significantly higher than those in the placebo phase { p < # } .",
        "label": "NA"
    },
    {
        "text": "the findings suggest that the dosage of DB11823 should be reduced in patients receiving DB00208 .",
        "label": "advise"
    },
    {
        "text": "we also found that bcl-2 was overexpressed in HD00914 insensitive cells , and cotreatment with ddrug1 and HD00915 , a bcl2 family inhibitor , synergistically inhibited growth and induced apoptosis of ddrug3 insensitive mm cells .",
        "label": "NA"
    },
    {
        "text": "we also found that bcl-2 was overexpressed in ddrug0 insensitive cells , and cotreatment with HD00914 and HD00915 , a bcl2 family inhibitor , synergistically inhibited growth and induced apoptosis of ddrug3 insensitive mm cells .",
        "label": "effect"
    },
    {
        "text": "we also found that bcl-2 was overexpressed in ddrug0 insensitive cells , and cotreatment with ddrug1 and HD00915 , a bcl2 family inhibitor , synergistically inhibited growth and induced apoptosis of HD00914 insensitive mm cells .",
        "label": "NA"
    },
    {
        "text": "in addition , HD00914 insensitivity might be associated with overexpression of bcl-2 , and the combination of HD00915 and ddrug2 could synergistically induced apoptosis .",
        "label": "NA"
    },
    {
        "text": "in addition , ddrug0 insensitivity might be associated with overexpression of bcl-2 , and the combination of HD00915 and HD00914 could synergistically induced apoptosis .",
        "label": "effect"
    },
    {
        "text": "DB00294 failure in an hiv-positive woman on HD00056 therapy resulting in two ectopic pregnancies .",
        "label": "effect"
    },
    {
        "text": "we present an interesting case of an hiv-positive woman on HD00056 therapy having tubal pregnancies on two separate occasions with DB00294 in place .",
        "label": "effect"
    },
    {
        "text": "we sought to evaluate whether initiation of an HD00711 increases the risk of hospitalization for gastrointestinal bleeding in DB00682 users .",
        "label": "NA"
    },
    {
        "text": "DB00682 users had an increased odds ratio of gastrointestinal bleeding upon initiation of DB00215 { or = # -lsb- 95 % ci , # # -rsb- } , ddrug2 { or = # -lsb- 95 % ci , # # -rsb- } , ddrug3 { or = # -lsb- 95 % ci , # # -rsb- } , ddrug4 { or = # -lsb- 95 % ci , # # -rsb- } .",
        "label": "effect"
    },
    {
        "text": "DB00682 users had an increased odds ratio of gastrointestinal bleeding upon initiation of ddrug1 { or = # -lsb- 95 % ci , # # -rsb- } , DB00472 { or = # -lsb- 95 % ci , # # -rsb- } , ddrug3 { or = # -lsb- 95 % ci , # # -rsb- } , ddrug4 { or = # -lsb- 95 % ci , # # -rsb- } .",
        "label": "effect"
    },
    {
        "text": "DB00682 users had an increased odds ratio of gastrointestinal bleeding upon initiation of ddrug1 { or = # -lsb- 95 % ci , # # -rsb- } , ddrug2 { or = # -lsb- 95 % ci , # # -rsb- } , DB00715 { or = # -lsb- 95 % ci , # # -rsb- } , ddrug4 { or = # -lsb- 95 % ci , # # -rsb- } .",
        "label": "effect"
    },
    {
        "text": "DB00682 users had an increased odds ratio of gastrointestinal bleeding upon initiation of ddrug1 { or = # -lsb- 95 % ci , # # -rsb- } , ddrug2 { or = # -lsb- 95 % ci , # # -rsb- } , ddrug3 { or = # -lsb- 95 % ci , # # -rsb- } , DB00321 { or = # -lsb- 95 % ci , # # -rsb- } .",
        "label": "effect"
    },
    {
        "text": "also DB00370 , which is not believed to interact with DB00682 , increased the risk of gi bleeding { or = # -lsb- 95 % ci , # # -rsb- } .",
        "label": "effect"
    },
    {
        "text": "DB00682 users who initiated DB00215 , ddrug2 , ddrug3 , ddrug4 , or ddrug5 had an increased risk of hospitalization for gastrointestinal bleeding .",
        "label": "effect"
    },
    {
        "text": "DB00682 users who initiated ddrug1 , DB00472 , ddrug3 , ddrug4 , or ddrug5 had an increased risk of hospitalization for gastrointestinal bleeding .",
        "label": "effect"
    },
    {
        "text": "DB00682 users who initiated ddrug1 , ddrug2 , DB00715 , ddrug4 , or ddrug5 had an increased risk of hospitalization for gastrointestinal bleeding .",
        "label": "effect"
    },
    {
        "text": "DB00682 users who initiated ddrug1 , ddrug2 , ddrug3 , DB00321 , or ddrug5 had an increased risk of hospitalization for gastrointestinal bleeding .",
        "label": "effect"
    },
    {
        "text": "DB00682 users who initiated ddrug1 , ddrug2 , ddrug3 , ddrug4 , or DB00370 had an increased risk of hospitalization for gastrointestinal bleeding .",
        "label": "effect"
    },
    {
        "text": "HD00916 decreased the toxicity of HD00917 , increased exposure to parent compound , and decreased metabolite levels in a dose-dependent manner .",
        "label": "effect"
    },
    {
        "text": "of the isoform-specific cyp inhibitors tested for an effect on the HD00917 metabolite profile , only DB00752 was noticeably effective , indicating a role of ppig 2a6 , 2c9 , 2cl9 , and 2e1 .",
        "label": "NA"
    },
    {
        "text": "with respect to toxicity , the order of cyp inhibitor effectiveness was HD00916 > DB02520 ~ ddrug2 > ddrug3 .",
        "label": "NA"
    },
    {
        "text": "with respect to toxicity , the order of cyp inhibitor effectiveness was HD00916 > ddrug1 ~ DB00752 > ddrug3 .",
        "label": "NA"
    },
    {
        "text": "with respect to toxicity , the order of cyp inhibitor effectiveness was HD00916 > ddrug1 ~ ddrug2 > DB01026 .",
        "label": "NA"
    },
    {
        "text": "with respect to toxicity , the order of cyp inhibitor effectiveness was ddrug0 > DB02520 ~ DB00752 > ddrug3 .",
        "label": "NA"
    },
    {
        "text": "with respect to toxicity , the order of cyp inhibitor effectiveness was ddrug0 > DB02520 ~ ddrug2 > DB01026 .",
        "label": "NA"
    },
    {
        "text": "with respect to toxicity , the order of cyp inhibitor effectiveness was ddrug0 > ddrug1 ~ DB00752 > DB01026 .",
        "label": "NA"
    },
    {
        "text": "DB14029 and DB06729 had no effect , while ddrug2 appeared to augment ddrug3 toxicity .",
        "label": "NA"
    },
    {
        "text": "DB14029 and ddrug1 had no effect , while DB00908 appeared to augment ddrug3 toxicity .",
        "label": "NA"
    },
    {
        "text": "DB14029 and ddrug1 had no effect , while ddrug2 appeared to augment HD00917 toxicity .",
        "label": "NA"
    },
    {
        "text": "ddrug0 and DB06729 had no effect , while DB00908 appeared to augment ddrug3 toxicity .",
        "label": "NA"
    },
    {
        "text": "ddrug0 and DB06729 had no effect , while ddrug2 appeared to augment HD00917 toxicity .",
        "label": "NA"
    },
    {
        "text": "ddrug0 and ddrug1 had no effect , while DB00908 appeared to augment HD00917 toxicity .",
        "label": "effect"
    },
    {
        "text": "HD00918 containing cdna encoding enhanced green fluorescent protein { gfp } , under the control of a chicken - actin promoter , was delivered by intravitreal injection to adult mice in conjunction with enzymes including DB00048 , ddrug2 , ddrug3 , or ddrug4 .",
        "label": "NA"
    },
    {
        "text": "HD00918 containing cdna encoding enhanced green fluorescent protein { gfp } , under the control of a chicken - actin promoter , was delivered by intravitreal injection to adult mice in conjunction with enzymes including ddrug1 , HD00919 , ddrug3 , or ddrug4 .",
        "label": "NA"
    },
    {
        "text": "HD00918 containing cdna encoding enhanced green fluorescent protein { gfp } , under the control of a chicken - actin promoter , was delivered by intravitreal injection to adult mice in conjunction with enzymes including ddrug1 , ddrug2 , HD00920 , or ddrug4 .",
        "label": "NA"
    },
    {
        "text": "HD00918 containing cdna encoding enhanced green fluorescent protein { gfp } , under the control of a chicken - actin promoter , was delivered by intravitreal injection to adult mice in conjunction with enzymes including ddrug1 , ddrug2 , ddrug3 , or HD00921 .",
        "label": "NA"
    },
    {
        "text": "the addition of HD00920 or HD00921 greatly enhanced transduction of the retinal ganglion cell layer and increased the depth of transduction into the outer retina .",
        "label": "NA"
    },
    {
        "text": "HD00919 had a limited effect and DB00048 was ineffective .",
        "label": "NA"
    },
    {
        "text": "electroretinograms survived with higher concentrations of HD00920 and HD00921 than were required for optimal retinal transduction .",
        "label": "NA"
    },
    {
        "text": "HD00918 - mediated retinal transduction is improved by co-injection of HD00920 or ddrug2 .",
        "label": "effect"
    },
    {
        "text": "HD00918 - mediated retinal transduction is improved by co-injection of ddrug1 or HD00921 .",
        "label": "effect"
    },
    {
        "text": "ddrug0 - mediated retinal transduction is improved by co-injection of HD00920 or HD00921 .",
        "label": "NA"
    },
    {
        "text": "prevention of emergence agitation in seven children receiving low-dose DB01221 and DB00818 total intravenous anesthesia .",
        "label": "NA"
    },
    {
        "text": "we retrospectively reviewed the records of # pediatric oncology patients who received low-dose DB01221 in conjunction with DB00818 for total intravenous anesthesia { tiva } repeatedly for radiation therapy .",
        "label": "NA"
    },
    {
        "text": "ea signs were observed in all # patients in association with DB00818 tiva but did not recur in any of # subsequent anesthetics sessions during which low-dose DB01221 was added to ddrug2 .",
        "label": "NA"
    },
    {
        "text": "ea signs were observed in all # patients in association with ddrug0 tiva but did not recur in any of # subsequent anesthetics sessions during which low-dose DB01221 was added to DB00818 .",
        "label": "NA"
    },
    {
        "text": "based on this experience , we suggest that low-dose DB01221 added to DB00818 may be associated with prevention of ea in children with a history of ea with ddrug2 tiva .",
        "label": "effect"
    },
    {
        "text": "based on this experience , we suggest that low-dose DB01221 added to ddrug1 may be associated with prevention of ea in children with a history of ea with DB00818 tiva .",
        "label": "NA"
    },
    {
        "text": "DB00675 , an HD00922 , is the standard hormone treatment for breast cancer .",
        "label": "NA"
    },
    {
        "text": "DB00715 and DB00472 reduce the plasma concentration of ddrug2 by about 50 % .",
        "label": "NA"
    },
    {
        "text": "DB00715 and ddrug1 reduce the plasma concentration of HD00923 by about 50 % .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 and DB00472 reduce the plasma concentration of HD00923 by about 50 % .",
        "label": "mechanism"
    },
    {
        "text": "it is better to avoid prescribing isoenzyme cyp 2d6 inhibitors to women treated with DB00675 for breast cancer , especially HD00924 such as ddrug2 and ddrug3 .",
        "label": "advise"
    },
    {
        "text": "it is better to avoid prescribing isoenzyme cyp 2d6 inhibitors to women treated with DB00675 for breast cancer , especially ddrug1 such as DB00715 and ddrug3 .",
        "label": "advise"
    },
    {
        "text": "it is better to avoid prescribing isoenzyme cyp 2d6 inhibitors to women treated with DB00675 for breast cancer , especially ddrug1 such as ddrug2 and DB00472 .",
        "label": "advise"
    },
    {
        "text": "it is better to avoid prescribing isoenzyme cyp 2d6 inhibitors to women treated with ddrug0 for breast cancer , especially HD00924 such as DB00715 and ddrug3 .",
        "label": "NA"
    },
    {
        "text": "it is better to avoid prescribing isoenzyme cyp 2d6 inhibitors to women treated with ddrug0 for breast cancer , especially HD00924 such as ddrug2 and DB00472 .",
        "label": "NA"
    },
    {
        "text": "it is better to avoid prescribing isoenzyme cyp 2d6 inhibitors to women treated with ddrug0 for breast cancer , especially ddrug1 such as DB00715 and DB00472 .",
        "label": "NA"
    },
    {
        "text": "depression does not always require HD00925 therapy , and HD00216 have no proven preventive impact on hot flushes linked to the menopause .",
        "label": "NA"
    },
    {
        "text": "if in certain cases , an HD00711 is considered necessary , it may be advisable to replace DB00675 with ddrug2 .",
        "label": "advise"
    },
    {
        "text": "if in certain cases , an HD00711 is considered necessary , it may be advisable to replace ddrug1 with DB01217 .",
        "label": "NA"
    },
    {
        "text": "if in certain cases , an ddrug0 is considered necessary , it may be advisable to replace DB00675 with DB01217 .",
        "label": "NA"
    },
    {
        "text": "DB00182 locomotor sensitization and conditioned place preference in adolescent male and female rats neonatally treated with HD00926 .",
        "label": "NA"
    },
    {
        "text": "the objective was to analyze the effects of neonatal HD00926 treatment on effects of DB00182 in adolescent rats using locomotor sensitization and conditioned place preference procedures .",
        "label": "NA"
    },
    {
        "text": "in female rats , neonatal HD00926 treatment enhanced DB00182 locomotor sensitization compared with ddrug2 - free controls sensitized to ddrug3 .",
        "label": "effect"
    },
    {
        "text": "in female rats , neonatal HD00926 treatment enhanced ddrug1 locomotor sensitization compared with ddrug2 - free controls sensitized to DB00182 .",
        "label": "NA"
    },
    {
        "text": "in female rats , neonatal ddrug0 treatment enhanced DB00182 locomotor sensitization compared with HD00926 - free controls sensitized to ddrug3 .",
        "label": "NA"
    },
    {
        "text": "in female rats , neonatal ddrug0 treatment enhanced ddrug1 locomotor sensitization compared with HD00926 - free controls sensitized to DB00182 .",
        "label": "NA"
    },
    {
        "text": "male rats demonstrated sensitization to DB00182 , although this was muted compared with female rats , and were unaffected by neonatal HD00926 .",
        "label": "NA"
    },
    {
        "text": "rats treated with neonatal HD00926 enhanced time spent in the DB00182 - paired context compared with ddrug2 - free controls conditioned with ddrug3 , but only female controls conditioned with ddrug4 spent more time in the drug-paired context compared with saline-treated controls .",
        "label": "NA"
    },
    {
        "text": "rats treated with neonatal HD00926 enhanced time spent in the ddrug1 - paired context compared with ddrug2 - free controls conditioned with DB00182 , but only female controls conditioned with ddrug4 spent more time in the drug-paired context compared with saline-treated controls .",
        "label": "NA"
    },
    {
        "text": "rats treated with neonatal HD00926 enhanced time spent in the ddrug1 - paired context compared with ddrug2 - free controls conditioned with ddrug3 , but only female controls conditioned with DB00182 spent more time in the drug-paired context compared with saline-treated controls .",
        "label": "NA"
    },
    {
        "text": "rats treated with neonatal ddrug0 enhanced time spent in the DB00182 - paired context compared with HD00926 - free controls conditioned with ddrug3 , but only female controls conditioned with ddrug4 spent more time in the drug-paired context compared with saline-treated controls .",
        "label": "NA"
    },
    {
        "text": "rats treated with neonatal ddrug0 enhanced time spent in the ddrug1 - paired context compared with HD00926 - free controls conditioned with DB00182 , but only female controls conditioned with ddrug4 spent more time in the drug-paired context compared with saline-treated controls .",
        "label": "NA"
    },
    {
        "text": "rats treated with neonatal ddrug0 enhanced time spent in the ddrug1 - paired context compared with HD00926 - free controls conditioned with ddrug3 , but only female controls conditioned with DB00182 spent more time in the drug-paired context compared with saline-treated controls .",
        "label": "NA"
    },
    {
        "text": "in vivo cyp3a activity is significantly lower in DB00091 - treated as compared with DB00864 - treated renal allograft recipients .",
        "label": "NA"
    },
    {
        "text": "in vitro studies have identified DB00091 and DB00864 as cytochrome_p450_family_3_subfamily_a inhibitors .",
        "label": "NA"
    },
    {
        "text": "systemic and apparent oral DB00683 clearance were 24 % { 269 # vs , # # ml/min , p = # } and 31 % { 479 # vs , # # ml/min , p = # } , respectively , lower in DB00091 - treated patients { n = 20 } than in matched ddrug2 - treated patients { n = 20 } .",
        "label": "mechanism"
    },
    {
        "text": "systemic and apparent oral DB00683 clearance were 24 % { 269 # vs , # # ml/min , p = # } and 31 % { 479 # vs , # # ml/min , p = # } , respectively , lower in ddrug1 - treated patients { n = 20 } than in matched DB00864 - treated patients { n = 20 } .",
        "label": "NA"
    },
    {
        "text": "systemic and apparent oral ddrug0 clearance were 24 % { 269 # vs , # # ml/min , p = # } and 31 % { 479 # vs , # # ml/min , p = # } , respectively , lower in DB00091 - treated patients { n = 20 } than in matched DB00864 - treated patients { n = 20 } .",
        "label": "NA"
    },
    {
        "text": "the latter displayed DB00683 clearances similar to those in two larger cohorts of nonmatched DB00864 - treated patients { n = # and n = 80 } and to those receiving a ddrug2 - free regimen { n = 6 } .",
        "label": "NA"
    },
    {
        "text": "the latter displayed DB00683 clearances similar to those in two larger cohorts of nonmatched ddrug1 - treated patients { n = # and n = 80 } and to those receiving a HD00927 - free regimen { n = 6 } .",
        "label": "NA"
    },
    {
        "text": "the latter displayed ddrug0 clearances similar to those in two larger cohorts of nonmatched DB00864 - treated patients { n = # and n = 80 } and to those receiving a HD00927 - free regimen { n = 6 } .",
        "label": "NA"
    },
    {
        "text": "this implies that in vivo hepatic and first-pass cyp3a activities are significantly lower in patients receiving DB00091 than in those receiving DB00864 , indicating that , at the doses generally used in clinical practice , ddrug2 is the stronger of the two with respect to cytochrome_p450_family_3_subfamily_a inhibition .",
        "label": "NA"
    },
    {
        "text": "this implies that in vivo hepatic and first-pass cyp3a activities are significantly lower in patients receiving ddrug0 than in those receiving DB00864 , indicating that , at the doses generally used in clinical practice , DB00091 is the stronger of the two with respect to cytochrome_p450_family_3_subfamily_a inhibition .",
        "label": "NA"
    },
    {
        "text": "improved parathyroid hormone control by DB01012 is associated with reduction in DB00012 requirement in patients with end-stage renal disease .",
        "label": "NA"
    },
    {
        "text": "medical treatment with DB01012 is effective in reducing plasma pth { pth } levels , but its effect on DB00012 dosing is unknown .",
        "label": "NA"
    },
    {
        "text": "the primary objective of the study was to ascertain the difference in DB00012 responsiveness before and after # months of DB01012 therapy .",
        "label": "NA"
    },
    {
        "text": "reduction of pth by DB01012 is associated with a decrease in DB00012 requirement .",
        "label": "effect"
    },
    {
        "text": "interaction of DB00482 with different HD00928 is antagonistic in breast but not in other cancer cells .",
        "label": "effect"
    },
    {
        "text": "this study investigates the ability of HD00929 to sensitize cells from different origins to several HD00646 .",
        "label": "NA"
    },
    {
        "text": "we found antagonism between DB00482 and the four drugs in the breast_cancer cells mcf7 following all incubation schedules and between ddrug1 and DB00997 in all cell_line except for two combinations in hct116 cells .",
        "label": "NA"
    },
    {
        "text": "we found antagonism between ddrug0 and the four drugs in the breast_cancer cells mcf7 following all incubation schedules and between DB00482 and DB00997 in all cell_line except for two combinations in hct116 cells .",
        "label": "effect"
    },
    {
        "text": "these results , if confirmed in-vivo , indicate that DB00482 is not a suitable chemosensitizer for breast_cancer or with DB00997 for other cancers .",
        "label": "NA"
    },
    {
        "text": "the drug interaction between HD00587 and DB00758 has been the subject of much study in recent years .",
        "label": "NA"
    },
    {
        "text": "contradictory results regarding the effect of HD00587 on platelet reactivity and on clinical outcome in DB00758 - treated patients have been reported in literature .",
        "label": "NA"
    },
    {
        "text": "concomitant use of DB00338 and DB00758 was found to decrease the exposure { auc } to clopidogrel 's active metabolite by 50 % and to sharply increase platelet reactivity , as a result of inhibition by ddrug2 of cyp2c19 , a cytochrome cyp2b6 { cyp } enzyme .",
        "label": "mechanism"
    },
    {
        "text": "concomitant use of ddrug0 and DB00758 was found to decrease the exposure { auc } to clopidogrel 's active metabolite by 50 % and to sharply increase platelet reactivity , as a result of inhibition by DB00338 of cyp2c19 , a cytochrome cyp2b6 { cyp } enzyme .",
        "label": "NA"
    },
    {
        "text": "DB00213 has a much weaker effect on DB00758 's pharmacokinetics and on platelet reactivity during concomitant use .",
        "label": "mechanism"
    },
    {
        "text": "the influence of the other HD00587 when used simultaneously with DB00758 has not yet been investigated in adequately randomized studies .",
        "label": "NA"
    },
    {
        "text": "regulatory agencies state that the combination of DB00758 and the cyp2c19 inhibitors DB00338 and ddrug2 should be avoided .",
        "label": "advise"
    },
    {
        "text": "regulatory agencies state that the combination of DB00758 and the cyp2c19 inhibitors ddrug1 and DB00736 should be avoided .",
        "label": "advise"
    },
    {
        "text": "to date , there is no conclusive evidence of a clinically-relevant interaction between any of the HD00587 and DB00758 .",
        "label": "NA"
    },
    {
        "text": "in vitro activity of DB01017 combined with DB00828 against clinical isolates of ddrug2 - resistant staphylococcus aureus .",
        "label": "NA"
    },
    {
        "text": "in vitro activity of DB01017 combined with ddrug1 against clinical isolates of DB01603 - resistant staphylococcus aureus .",
        "label": "NA"
    },
    {
        "text": "in vitro activity of ddrug0 combined with DB00828 against clinical isolates of DB01603 - resistant staphylococcus aureus .",
        "label": "NA"
    },
    {
        "text": "this study aimed to evaluate the in vitro activity of DB01017 combined with DB00828 against isolates of ddrug2 - resistant staphylococcus aureus { mrsa } .",
        "label": "NA"
    },
    {
        "text": "this study aimed to evaluate the in vitro activity of DB01017 combined with ddrug1 against isolates of DB01603 - resistant staphylococcus aureus { mrsa } .",
        "label": "NA"
    },
    {
        "text": "this study aimed to evaluate the in vitro activity of ddrug0 combined with DB00828 against isolates of DB01603 - resistant staphylococcus aureus { mrsa } .",
        "label": "NA"
    },
    {
        "text": "the susceptibility results for DB01017 and DB00828 were interpreted according to the most relevant criteria .",
        "label": "NA"
    },
    {
        "text": "the combination of DB01017 and DB00828 can be synergistic against mrsa .",
        "label": "effect"
    },
    {
        "text": "the authors report the case of an infant with confirmed congenital hypothyroidism on DB00451 who experienced a possible drug interaction with DB09512 .",
        "label": "int"
    },
    {
        "text": "questioning revealed the child was taking DB09512 drops before feeds while on DB00451 .",
        "label": "NA"
    },
    {
        "text": "drug interaction of HD00525 with DB09512 has not been reported previously and is not listed in the british national formulary for children .",
        "label": "NA"
    },
    {
        "text": "DB01373 does not inhibit the absorption of # milligrams of HD00930 or ddrug2 at doses less than # milligrams in nonpregnant women .",
        "label": "NA"
    },
    {
        "text": "DB01373 does not inhibit the absorption of # milligrams of ddrug1 or HD00931 at doses less than # milligrams in nonpregnant women .",
        "label": "NA"
    },
    {
        "text": "DB01373 is the only known component in the diet that may affect absorption of both HD00930 and ddrug2 .",
        "label": "mechanism"
    },
    {
        "text": "DB01373 is the only known component in the diet that may affect absorption of both ddrug1 and HD00931 .",
        "label": "mechanism"
    },
    {
        "text": "however , the evidence for a DB01373 effect on DB01592 absorption mainly comes from studies that did not isolate the effect of ddrug2 from that of other dietary components , because it was detected in single-meal studies .",
        "label": "mechanism"
    },
    {
        "text": "however , the evidence for a ddrug0 effect on DB01592 absorption mainly comes from studies that did not isolate the effect of DB01373 from that of other dietary components , because it was detected in single-meal studies .",
        "label": "NA"
    },
    {
        "text": "our objective was to establish potential effects of DB01373 on absorption of HD00930 and ddrug2 n and the dose response for this effect in the absence of a meal .",
        "label": "NA"
    },
    {
        "text": "our objective was to establish potential effects of DB01373 on absorption of ddrug1 and HD00931 n and the dose response for this effect in the absence of a meal .",
        "label": "NA"
    },
    {
        "text": "we evaluated the effects of DB01373 doses between # and # mg on absorption of # mg HD00930 { as ddrug2 } .",
        "label": "NA"
    },
    {
        "text": "we evaluated the effects of DB01373 doses between # and # mg on absorption of # mg ddrug1 { as DB01373 } .",
        "label": "NA"
    },
    {
        "text": "we also evaluated the effects of DB01373 doses between # and # mg on absorption of # mg HD00931 -lsb- as concentrated rbc { crbc } -rsb- .",
        "label": "NA"
    },
    {
        "text": "DB01373 was administered as ddrug1 in all studies and HD00932 were ingested on an empty stomach .",
        "label": "NA"
    },
    {
        "text": "ddrug0 was administered as DB01164 in all studies and HD00932 were ingested on an empty stomach .",
        "label": "NA"
    },
    {
        "text": "DB01373 doses # mg diminished HD00930 absorption by an average of # % .",
        "label": "mechanism"
    },
    {
        "text": "a DB01373 dose of # mg diminished absorption of # mg HD00931 by # % .",
        "label": "mechanism"
    },
    {
        "text": "in conclusion , we demonstrated an isolated effect of DB01373 { as chloride } on absorption of # mg of iron provided as HD00930 { as sulfate } and ddrug2 { as crbc } .",
        "label": "mechanism"
    },
    {
        "text": "in conclusion , we demonstrated an isolated effect of DB01373 { as chloride } on absorption of # mg of iron provided as ddrug1 { as sulfate } and HD00931 { as crbc } .",
        "label": "mechanism"
    },
    {
        "text": "synergistic interaction between DB01268 and DB01248 is sequence dependent in human non-small lung_cancer with egfr tkis-resistant mutation .",
        "label": "int"
    },
    {
        "text": "this study was aimed to investigate the efficacy of single use of DB01268 and that of concurrent or sequential administration of ddrug1 and DB01248 in non-small_cell_lung_cancer cell lines that are resistant to egfr tkis .",
        "label": "NA"
    },
    {
        "text": "this study was aimed to investigate the efficacy of single use of ddrug0 and that of concurrent or sequential administration of DB01268 and DB01248 in non-small_cell_lung_cancer cell lines that are resistant to egfr tkis .",
        "label": "NA"
    },
    {
        "text": "DB01268 exhibited dose-dependent growth inhibition in non-small_cell_lung_cancer cell lines and arrested cell cycle at g1 phase , whereas DB01248 arrested at s phase .",
        "label": "NA"
    },
    {
        "text": "although single or concurrent use of DB01268 and DB01248 has some anti-proliferative effects , the sequential administrations of both drugs remarkably enhanced anti-tumor activity .",
        "label": "effect"
    },
    {
        "text": "when cells were exposed to DB01248 followed by DB01268 , synergism was observed .",
        "label": "effect"
    },
    {
        "text": "the molecular basis of this synergism is that the signaling pathways that were initially activated by DB01248 exposure were efficiently suppressed by the subsequent exposure to DB01268 .",
        "label": "effect"
    },
    {
        "text": "DB01268 as a single agent exhibits anti-proliferative effects in vitro in non-small_cell_lung_cancer cell lines with egfr t790 m and k-ras mutations but the sequential administration of DB01248 followed by ddrug2 is superior to ddrug3 followed by ddrug4 and concurrent administration .",
        "label": "NA"
    },
    {
        "text": "DB01268 as a single agent exhibits anti-proliferative effects in vitro in non-small_cell_lung_cancer cell lines with egfr t790 m and k-ras mutations but the sequential administration of ddrug1 followed by ddrug2 is superior to ddrug3 followed by DB01248 and concurrent administration .",
        "label": "NA"
    },
    {
        "text": "ddrug0 as a single agent exhibits anti-proliferative effects in vitro in non-small_cell_lung_cancer cell lines with egfr t790 m and k-ras mutations but the sequential administration of DB01248 followed by DB01268 is superior to ddrug3 followed by ddrug4 and concurrent administration .",
        "label": "effect"
    },
    {
        "text": "ddrug0 as a single agent exhibits anti-proliferative effects in vitro in non-small_cell_lung_cancer cell lines with egfr t790 m and k-ras mutations but the sequential administration of DB01248 followed by ddrug2 is superior to DB01268 followed by ddrug4 and concurrent administration .",
        "label": "NA"
    },
    {
        "text": "ddrug0 as a single agent exhibits anti-proliferative effects in vitro in non-small_cell_lung_cancer cell lines with egfr t790 m and k-ras mutations but the sequential administration of ddrug1 followed by DB01268 is superior to ddrug3 followed by DB01248 and concurrent administration .",
        "label": "NA"
    },
    {
        "text": "ddrug0 as a single agent exhibits anti-proliferative effects in vitro in non-small_cell_lung_cancer cell lines with egfr t790 m and k-ras mutations but the sequential administration of ddrug1 followed by ddrug2 is superior to DB01268 followed by DB01248 and concurrent administration .",
        "label": "NA"
    },
    {
        "text": "distinct synergistic action of DB00319 and DB03587 against pseudomonas aeruginosa .",
        "label": "NA"
    },
    {
        "text": "distinct and statistically significant synergism was observed between DB03587 and DB00319 by disc diffusion tests when compared with their individual effects .",
        "label": "effect"
    },
    {
        "text": "synergism was also noted when DB03587 was combined with DB00578 and ddrug2 .",
        "label": "effect"
    },
    {
        "text": "synergism was also noted when DB03587 was combined with ddrug1 and DB00479 .",
        "label": "effect"
    },
    {
        "text": "synergism was also noted when ddrug0 was combined with DB00578 and DB00479 .",
        "label": "NA"
    },
    {
        "text": "protective effect of DB08842 and DB00166 against the acute toxicity of diepoxybutane to human lymphocytes .",
        "label": "NA"
    },
    {
        "text": "{ ii } DB08842 elicits a significant protective effect on deb induced toxicity , which was potentiated by DB00166 .",
        "label": "effect"
    },
    {
        "text": "-lsb- influence of HD00933 and DB00254 on mptp-evoked behavior violations in c57bl/6 mice -rsb- .",
        "label": "NA"
    },
    {
        "text": "the effects of HD00934 HD00933 -lsb- ddrug2 -rsb- { 10 mg/kg , p , o.",
        "label": "NA"
    },
    {
        "text": "the effects of HD00934 ddrug1 -lsb- HD00935 -rsb- { 10 mg/kg , p , o.",
        "label": "NA"
    },
    {
        "text": "the effects of ddrug0 HD00933 -lsb- HD00935 -rsb- { 10 mg/kg , p , o.",
        "label": "NA"
    },
    {
        "text": "and/or HD00936 DB00254 { 100 mg/kg , p , o , } , as well as that of neurotoxin ddrug2 { ddrug3 } { 4 x # mg/kg , i , p.",
        "label": "NA"
    },
    {
        "text": "and/or HD00936 ddrug1 { 100 mg/kg , p , o , } , as well as that of neurotoxin HD00937 { ddrug3 } { 4 x # mg/kg , i , p.",
        "label": "NA"
    },
    {
        "text": "and/or HD00936 ddrug1 { 100 mg/kg , p , o , } , as well as that of neurotoxin ddrug2 { HD00146 } { 4 x # mg/kg , i , p.",
        "label": "NA"
    },
    {
        "text": "and/or ddrug0 DB00254 { 100 mg/kg , p , o , } , as well as that of neurotoxin HD00937 { ddrug3 } { 4 x # mg/kg , i , p.",
        "label": "NA"
    },
    {
        "text": "and/or ddrug0 DB00254 { 100 mg/kg , p , o , } , as well as that of neurotoxin ddrug2 { HD00146 } { 4 x # mg/kg , i , p.",
        "label": "NA"
    },
    {
        "text": "acute administration of HD00933 or DB00254 failed to influence locomotion in mice , while their combination normalized motor activity .",
        "label": "effect"
    },
    {
        "text": "the role of p27 { kip1 } in DB01254 - enhanced DB01229 cytotoxicity in human ovarian_cancer cells .",
        "label": "effect"
    },
    {
        "text": "the effect of DB01254 , an inhibitor of src and abl1 kinases , on DB01229 sensitivity was measured in ovarian_cancer cells and hey xenografts .",
        "label": "NA"
    },
    {
        "text": "the roles of p27 { kip1 } , bcl-2 , and cdk1 in apoptosis induced by DB01254 and DB01229 were assessed using a terminal deoxynucleotidyl transferase-mediated dutp nick-end labeling { tunel } assay , sirna knockdown of gene expression , transfection with bcl-2 and cdk1 expression vectors , and flow cytometry .",
        "label": "NA"
    },
    {
        "text": "hey cells treated with DB01254 plus DB01229 formed fewer colonies than did cells treated with either agent alone .",
        "label": "effect"
    },
    {
        "text": "treatment of hey xenograft-bearing mice with DB01254 plus DB01229 inhibited tumor growth more than treatment with either agent alone { average tumor volume per mouse , ddrug2 + ddrug3 vs ddrug4 : # vs , # cm3 , difference = # cm3 , 95 % confidence interval -lsb- ci -rsb- = # to # cm3 , p = # } ;",
        "label": "effect"
    },
    {
        "text": "treatment of hey xenograft-bearing mice with DB01254 plus ddrug1 inhibited tumor growth more than treatment with either agent alone { average tumor volume per mouse , ddrug2 + DB01229 vs ddrug4 : # vs , # cm3 , difference = # cm3 , 95 % confidence interval -lsb- ci -rsb- = # to # cm3 , p = # } ;",
        "label": "NA"
    },
    {
        "text": "treatment of hey xenograft-bearing mice with DB01254 plus ddrug1 inhibited tumor growth more than treatment with either agent alone { average tumor volume per mouse , ddrug2 + ddrug3 vs DB01229 : # vs , # cm3 , difference = # cm3 , 95 % confidence interval -lsb- ci -rsb- = # to # cm3 , p = # } ;",
        "label": "NA"
    },
    {
        "text": "treatment of hey xenograft-bearing mice with ddrug0 plus DB01229 inhibited tumor growth more than treatment with either agent alone { average tumor volume per mouse , DB01254 + ddrug3 vs ddrug4 : # vs , # cm3 , difference = # cm3 , 95 % confidence interval -lsb- ci -rsb- = # to # cm3 , p = # } ;",
        "label": "NA"
    },
    {
        "text": "treatment of hey xenograft-bearing mice with ddrug0 plus ddrug1 inhibited tumor growth more than treatment with either agent alone { average tumor volume per mouse , DB01254 + DB01229 vs ddrug4 : # vs , # cm3 , difference = # cm3 , 95 % confidence interval -lsb- ci -rsb- = # to # cm3 , p = # } ;",
        "label": "NA"
    },
    {
        "text": "treatment of hey xenograft-bearing mice with ddrug0 plus ddrug1 inhibited tumor growth more than treatment with either agent alone { average tumor volume per mouse , DB01254 + ddrug3 vs DB01229 : # vs , # cm3 , difference = # cm3 , 95 % confidence interval -lsb- ci -rsb- = # to # cm3 , p = # } ;",
        "label": "NA"
    },
    {
        "text": "DB01254 + DB01229 vs.",
        "label": "NA"
    },
    {
        "text": "the sirna knockdown of p27 { kip1 } decreased DB01254 - and DB01229 - induced apoptosis compared with a negative control sirna { sub-g1 fraction , control sirna vs , p27 { kip1 } sirna : # % vs , # % , difference = # % , 95 % ci = # % to # % , p = # } .",
        "label": "NA"
    },
    {
        "text": "studies with forced expression and sirna knockdown of bcl-2 and cdk1 suggest that DB01254 - mediated induction of p27 { kip1 } enhanced DB01229 - induced apoptosis by negatively regulating bcl2 and cdk1 expression .",
        "label": "effect"
    },
    {
        "text": "inhibition of src family and abl kinases with either sirnas or DB01254 enhances DB01229 sensitivity of ovarian_cancer cells through p27 { kip1 } - mediated suppression of bcl-2 and cdk1 expression .",
        "label": "effect"
    },
    {
        "text": "phase i trial of DB00480 and HD00938 in patients with relapsed multiple myeloma : evidence for ddrug2 - ddrug3 interaction via p-glycoprotein .",
        "label": "NA"
    },
    {
        "text": "phase i trial of DB00480 and ddrug1 in patients with relapsed multiple myeloma : evidence for ddrug2 - HD00938 interaction via p-glycoprotein .",
        "label": "NA"
    },
    {
        "text": "phase i trial of ddrug0 and HD00938 in patients with relapsed multiple myeloma : evidence for DB00480 - ddrug3 interaction via p-glycoprotein .",
        "label": "NA"
    },
    {
        "text": "phase i trial of ddrug0 and ddrug1 in patients with relapsed multiple myeloma : evidence for DB00480 - HD00938 interaction via p-glycoprotein .",
        "label": "NA"
    },
    {
        "text": "the preclinical combination of DB00480 with the mtor_inhibitor HD00938 has displayed synergy in vitro and represents a novel combination in mm .",
        "label": "effect"
    },
    {
        "text": "enhancement of humoral immune responses to inactivated newcastle disease and HD00939 by oral administration of HD00940 in chickens .",
        "label": "NA"
    },
    {
        "text": "the objective of this study was to evaluate the effect of oral administration of HD00940 { ddrug1 } on the humoral immune responses of chickens to HD00941 and ddrug3 .",
        "label": "NA"
    },
    {
        "text": "the objective of this study was to evaluate the effect of oral administration of HD00940 { ddrug1 } on the humoral immune responses of chickens to ddrug2 and HD00942 .",
        "label": "NA"
    },
    {
        "text": "the objective of this study was to evaluate the effect of oral administration of ddrug0 { HD00943 } on the humoral immune responses of chickens to HD00941 and ddrug3 .",
        "label": "NA"
    },
    {
        "text": "the objective of this study was to evaluate the effect of oral administration of ddrug0 { HD00943 } on the humoral immune responses of chickens to ddrug2 and HD00942 .",
        "label": "NA"
    },
    {
        "text": "in experiment 1 , oral administration of HD00943 at a dose of # mg/kg of bw for # d on the immune response in chickens intramuscularly injected with HD00944 was evaluated .",
        "label": "NA"
    },
    {
        "text": "in experiment 2 , the same regimen of HD00943 was administered to chickens inoculated with HD00942 , and an enhanced serum antibody response to ai vaccination was also observed .",
        "label": "effect"
    },
    {
        "text": "interaction of DB00851 and DB05003 , in vitro and in vivo , in human a-375 melanoma cells .",
        "label": "NA"
    },
    {
        "text": "we evaluated mechanisms of interaction between the alkyating agent DB00851 { ddrug1 } and the pro-oxidant , DB05003 , in the human a-375 melanoma cell line .",
        "label": "NA"
    },
    {
        "text": "we evaluated mechanisms of interaction between the alkyating agent ddrug0 { DB00851 } and the pro-oxidant , DB05003 , in the human a-375 melanoma cell line .",
        "label": "NA"
    },
    {
        "text": "the effect of DB00851 and DB05003 , alone and in combination , was evaluated for growth inhibition { mtt } , radiolabeled drug uptake , cellular thiol content { hplc } , and dna strand breaks { comet assay } .",
        "label": "NA"
    },
    {
        "text": "there was a > 75 % reduction in cellular glutathione and cysteine with DB05003 but not DB00851 .",
        "label": "NA"
    },
    {
        "text": "DB05003 and DB00851 show additive effects in vitro but not in vivo in human a-375 melanoma cells .",
        "label": "effect"
    },
    {
        "text": "DB01259 enhances DB00072 - mediated antibody-dependent cellular cytotoxicity by up-regulation of cell surface erbb2 expression .",
        "label": "effect"
    },
    {
        "text": "although it was previously reported that DB01259 combined with DB00072 improved the progression-free survival rate compared with ddrug2 alone for patients with ddrug3 - refractory her2-positive metastatic breast cancer , the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents .",
        "label": "effect"
    },
    {
        "text": "although it was previously reported that DB01259 combined with ddrug1 improved the progression-free survival rate compared with ddrug2 alone for patients with DB00072 - refractory her2-positive metastatic breast cancer , the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents .",
        "label": "NA"
    },
    {
        "text": "although it was previously reported that ddrug0 combined with DB00072 improved the progression-free survival rate compared with DB01259 alone for patients with ddrug3 - refractory her2-positive metastatic breast cancer , the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents .",
        "label": "NA"
    },
    {
        "text": "although it was previously reported that ddrug0 combined with ddrug1 improved the progression-free survival rate compared with DB01259 alone for patients with DB00072 - refractory her2-positive metastatic breast cancer , the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents .",
        "label": "NA"
    },
    {
        "text": "we evaluated how DB01259 interacts with DB00072 in her2-positive breast cancer , with a particular focus on ddrug2 - mediated antibody-dependent cellular cytotoxicity { adcc } .",
        "label": "NA"
    },
    {
        "text": "we evaluated how DB01259 interacts with ddrug1 in her2-positive breast cancer , with a particular focus on DB00072 - mediated antibody-dependent cellular cytotoxicity { adcc } .",
        "label": "NA"
    },
    {
        "text": "in an in vitro assay , DB01259 induced erbb2 expression at the cell surface of her2-positive breast cancer cell lines , leading to the enhancement of DB00072 - mediated adcc .",
        "label": "effect"
    },
    {
        "text": "furthermore , we present a case report in which a second DB00072 treatment following DB01259 resulted in the marked shrinkage of multiple metastatic tumors in her2-positive breast cancer .",
        "label": "effect"
    },
    {
        "text": "DB01259 may have the potential to convert DB00072 - refractory to ddrug2 - sensitive tumors in her2-positive breast_cancer by up-regulation of the cell surface expression of her2 .",
        "label": "NA"
    },
    {
        "text": "DB01259 may have the potential to convert ddrug1 - refractory to DB00072 - sensitive tumors in her2-positive breast_cancer by up-regulation of the cell surface expression of her2 .",
        "label": "NA"
    },
    {
        "text": "we elucidated the expression of hb-egf in t-all cell lines , and evaluated the effect of HD00945 on these cells alone or in combination with HD00946 .",
        "label": "NA"
    },
    {
        "text": "HD00945 induced apoptosis , and furthermore , the combination of ddrug1 plus DB00997 enhanced cytotoxicity in a t-all cell line .",
        "label": "NA"
    },
    {
        "text": "ddrug0 induced apoptosis , and furthermore , the combination of HD00945 plus DB00997 enhanced cytotoxicity in a t-all cell line .",
        "label": "effect"
    },
    {
        "text": "DB01364 enhances the antinociceptive effect of DB00633 in mice .",
        "label": "effect"
    },
    {
        "text": "the purpose of this study was to evaluate whether the psychostimulant drug DB01364 has any effect on DB00633 - induced antinociception and locomotor inhibitor activity in mice in acute application .",
        "label": "NA"
    },
    {
        "text": "saline + saline , DB01364 { 10 mg/kg } + saline , saline + DB00633 { 15 g/kg } and ddrug2 { 10 mg/kg } + ddrug3 { 15 g/kg } , intraperitoneally , # min before hot plate or holed open field tests .",
        "label": "NA"
    },
    {
        "text": "saline + saline , DB01364 { 10 mg/kg } + saline , saline + ddrug1 { 15 g/kg } and ddrug2 { 10 mg/kg } + DB00633 { 15 g/kg } , intraperitoneally , # min before hot plate or holed open field tests .",
        "label": "NA"
    },
    {
        "text": "saline + saline , ddrug0 { 10 mg/kg } + saline , saline + DB00633 { 15 g/kg } and DB01364 { 10 mg/kg } + ddrug3 { 15 g/kg } , intraperitoneally , # min before hot plate or holed open field tests .",
        "label": "NA"
    },
    {
        "text": "saline + saline , ddrug0 { 10 mg/kg } + saline , saline + ddrug1 { 15 g/kg } and DB01364 { 10 mg/kg } + DB00633 { 15 g/kg } , intraperitoneally , # min before hot plate or holed open field tests .",
        "label": "NA"
    },
    {
        "text": "in the hot plate test in mice , co-administration of # g/kg DB00633 with # mg/kg DB01364 intraperitoneally not only enhanced , but also prolonged the duration of antinociception induced by ddrug2 .",
        "label": "effect"
    },
    {
        "text": "in the hot plate test in mice , co-administration of # g/kg ddrug0 with # mg/kg DB01364 intraperitoneally not only enhanced , but also prolonged the duration of antinociception induced by DB00633 .",
        "label": "NA"
    },
    {
        "text": "at the same time , the locomotor inhibitory effect of DB00633 was counteracted by DB01364 .",
        "label": "effect"
    },
    {
        "text": "we concluded that the combined administration of DB00633 with DB01364 may have beneficial effects in the treatment of pain without causing sedation , which limits the use of ddrug2 as an ddrug3 in humans .",
        "label": "effect"
    },
    {
        "text": "we concluded that the combined administration of DB00633 with ddrug1 may have beneficial effects in the treatment of pain without causing sedation , which limits the use of ddrug2 as an DB00825 in humans .",
        "label": "NA"
    },
    {
        "text": "we concluded that the combined administration of ddrug0 with DB01364 may have beneficial effects in the treatment of pain without causing sedation , which limits the use of DB00633 as an ddrug3 in humans .",
        "label": "NA"
    },
    {
        "text": "we concluded that the combined administration of ddrug0 with DB01364 may have beneficial effects in the treatment of pain without causing sedation , which limits the use of ddrug2 as an DB00825 in humans .",
        "label": "NA"
    },
    {
        "text": "we concluded that the combined administration of ddrug0 with ddrug1 may have beneficial effects in the treatment of pain without causing sedation , which limits the use of DB00633 as an DB00825 in humans .",
        "label": "NA"
    },
    {
        "text": "but the use of fixed combination DB00381 / ddrug1 compared with traditional therapy was associated with lower clinical and self measured bp , quicker achievement of target bp { # + / # and # + / # days , respectively , # } , lesser number of HD00448 { # + / # and # + / # days , respectively } , lower rate of concealed inefficacy of treatment { 12 and 31 % , respectively , # } .",
        "label": "NA"
    },
    {
        "text": "but the use of fixed combination ddrug0 / DB00177 compared with traditional therapy was associated with lower clinical and self measured bp , quicker achievement of target bp { # + / # and # + / # days , respectively , # } , lesser number of HD00448 { # + / # and # + / # days , respectively } , lower rate of concealed inefficacy of treatment { 12 and 31 % , respectively , # } .",
        "label": "NA"
    },
    {
        "text": "we have demonstrated appropriateness of inhospital administration of fixed DB00381 / ddrug1 combination as an approach allowing to achieve target bp in shorter time , with the use of fewer HD00448 , and diminishing concealed inefficacy of treatment .",
        "label": "NA"
    },
    {
        "text": "we have demonstrated appropriateness of inhospital administration of fixed ddrug0 / DB00177 combination as an approach allowing to achieve target bp in shorter time , with the use of fewer HD00448 , and diminishing concealed inefficacy of treatment .",
        "label": "NA"
    },
    {
        "text": "DB08816 { ddrug1 } -- better than DB00758 { ddrug3 }",
        "label": "NA"
    },
    {
        "text": "DB08816 { ddrug1 } -- better than ddrug2 { DB00758 }",
        "label": "NA"
    },
    {
        "text": "ddrug0 { DB08816 } -- better than DB00758 { ddrug3 }",
        "label": "NA"
    },
    {
        "text": "ddrug0 { DB08816 } -- better than ddrug2 { DB00758 }",
        "label": "NA"
    },
    {
        "text": "the fda has approved DB08816 { ddrug1 - astrazeneca } , an oral HD00947 , for use with low-dose ddrug3 to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome { acs } .",
        "label": "NA"
    },
    {
        "text": "the fda has approved DB08816 { ddrug1 - astrazeneca } , an oral ddrug2 , for use with low-dose DB00945 to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome { acs } .",
        "label": "effect"
    },
    {
        "text": "the fda has approved ddrug0 { DB08816 - astrazeneca } , an oral HD00947 , for use with low-dose ddrug3 to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome { acs } .",
        "label": "NA"
    },
    {
        "text": "the fda has approved ddrug0 { DB08816 - astrazeneca } , an oral ddrug2 , for use with low-dose DB00945 to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome { acs } .",
        "label": "effect"
    },
    {
        "text": "the fda has approved ddrug0 { ddrug1 - astrazeneca } , an oral HD00947 , for use with low-dose DB00945 to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome { acs } .",
        "label": "NA"
    },
    {
        "text": "it will compete with DB00758 { ddrug1 } and DB06209 { ddrug3 } for such use .",
        "label": "NA"
    },
    {
        "text": "it will compete with DB00758 { ddrug1 } and ddrug2 { DB06209 } for such use .",
        "label": "NA"
    },
    {
        "text": "it will compete with ddrug0 { DB00758 } and DB06209 { ddrug3 } for such use .",
        "label": "NA"
    },
    {
        "text": "it will compete with ddrug0 { DB00758 } and ddrug2 { DB06209 } for such use .",
        "label": "NA"
    },
    {
        "text": "influence of DB12582 on DB01050 induced antinociception and its pharmacokinetics .",
        "label": "NA"
    },
    {
        "text": "in the present study DB12582 { 10 mg/kg } significantly increased the dose-dependent antinociceptive activity of DB01050 evaluated by both ddrug2 writhing and formalin test , when it was administered with ddrug3 .",
        "label": "effect"
    },
    {
        "text": "in the present study DB12582 { 10 mg/kg } significantly increased the dose-dependent antinociceptive activity of ddrug1 evaluated by both DB03166 writhing and formalin test , when it was administered with ddrug3 .",
        "label": "NA"
    },
    {
        "text": "in the present study DB12582 { 10 mg/kg } significantly increased the dose-dependent antinociceptive activity of ddrug1 evaluated by both ddrug2 writhing and formalin test , when it was administered with DB01050 .",
        "label": "NA"
    },
    {
        "text": "in the present study ddrug0 { 10 mg/kg } significantly increased the dose-dependent antinociceptive activity of DB01050 evaluated by both DB03166 writhing and formalin test , when it was administered with ddrug3 .",
        "label": "NA"
    },
    {
        "text": "in the present study ddrug0 { 10 mg/kg } significantly increased the dose-dependent antinociceptive activity of ddrug1 evaluated by both DB03166 writhing and formalin test , when it was administered with DB01050 .",
        "label": "NA"
    },
    {
        "text": "DB01050 plasma concentration was also increased when it was administered with DB12582 .",
        "label": "mechanism"
    },
    {
        "text": "the synergistic antinociception activity of DB01050 when administered with DB12582 can be attributed to increased plasma concentration of ddrug2 .",
        "label": "mechanism"
    },
    {
        "text": "the synergistic antinociception activity of ddrug0 when administered with DB12582 can be attributed to increased plasma concentration of DB01050 .",
        "label": "NA"
    },
    {
        "text": "pharmacokinetic properties of DB01048 were not altered by the addition of either DB00709 or ddrug2 or the combination of ddrug3 and ddrug4 .",
        "label": "NA"
    },
    {
        "text": "pharmacokinetic properties of DB01048 were not altered by the addition of either ddrug1 or DB00495 or the combination of ddrug3 and ddrug4 .",
        "label": "NA"
    },
    {
        "text": "pharmacokinetic properties of DB01048 were not altered by the addition of either ddrug1 or ddrug2 or the combination of DB00709 and ddrug4 .",
        "label": "NA"
    },
    {
        "text": "pharmacokinetic properties of DB01048 were not altered by the addition of either ddrug1 or ddrug2 or the combination of ddrug3 and DB00495 .",
        "label": "NA"
    },
    {
        "text": "pharmacokinetic properties of ddrug0 were not altered by the addition of either DB00709 or DB00495 or the combination of ddrug3 and ddrug4 .",
        "label": "NA"
    },
    {
        "text": "pharmacokinetic properties of ddrug0 were not altered by the addition of either DB00709 or ddrug2 or the combination of ddrug3 and DB00495 .",
        "label": "NA"
    },
    {
        "text": "pharmacokinetic properties of ddrug0 were not altered by the addition of either ddrug1 or DB00495 or the combination of DB00709 and ddrug4 .",
        "label": "NA"
    },
    {
        "text": "pharmacokinetic properties of ddrug0 were not altered by the addition of either ddrug1 or ddrug2 or the combination of DB00709 and DB00495 .",
        "label": "NA"
    },
    {
        "text": "no clinically significant changes to DB00709 or DB00495 pharmacokinetics were observed following concomitant administration of ddrug2 .",
        "label": "NA"
    },
    {
        "text": "no clinically significant changes to DB00709 or ddrug1 pharmacokinetics were observed following concomitant administration of DB01048 .",
        "label": "NA"
    },
    {
        "text": "no clinically significant changes to ddrug0 or DB00495 pharmacokinetics were observed following concomitant administration of DB01048 .",
        "label": "NA"
    },
    {
        "text": "DB01048 has no effect on the pharmacokinetic properties of DB00898 .",
        "label": "NA"
    },
    {
        "text": "DB00898 decreases the elimination of DB01048 causing an increase in overall exposure , the addition of ddrug2 has no clinically significant effect on the pharmacokinetic properties of ddrug3 .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 decreases the elimination of ddrug1 causing an increase in overall exposure , the addition of DB00333 has no clinically significant effect on the pharmacokinetic properties of DB01048 .",
        "label": "NA"
    },
    {
        "text": "in a study of # hiv-infected patients receiving DB00333 - maintenance therapy { 40 mg and # mg daily } with # mg of DB01048 twice daily { twice the currently recommended dose } , oral ddrug2 clearance increased 22 % { 90 % ci 6 % to 42 % } .",
        "label": "mechanism"
    },
    {
        "text": "in a study of # hiv-infected patients receiving ddrug0 - maintenance therapy { 40 mg and # mg daily } with # mg of DB01048 twice daily { twice the currently recommended dose } , oral DB00333 clearance increased 22 % { 90 % ci 6 % to 42 % } .",
        "label": "NA"
    },
    {
        "text": "DB01432 : concomitant ddrug1 administration decreased the mean auc of total DB00973 approximately 55 % .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : concomitant DB01432 administration decreased the mean auc of total DB00973 approximately 55 % .",
        "label": "mechanism"
    },
    {
        "text": "the incremental ldl-c reduction due to adding DB00973 to DB01432 may be reduced by this interaction .",
        "label": "effect"
    },
    {
        "text": "ddrug0 : the safety and effectiveness of DB00973 administered with HD00550 have not been established .",
        "label": "NA"
    },
    {
        "text": "co-administration of DB00973 with HD00550 is not recommended until use in patients is studied .",
        "label": "advise"
    },
    {
        "text": "DB01039 : in a pharmacokinetic study , concomitant ddrug1 administration increased total DB00973 concentrations approximately # - fold .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : in a pharmacokinetic study , concomitant DB01039 administration increased total DB00973 concentrations approximately # - fold .",
        "label": "mechanism"
    },
    {
        "text": "DB01241 : in a pharmacokinetic study , concomitant ddrug1 administration increased total DB00973 concentrations approximately # - fold .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : in a pharmacokinetic study , concomitant DB01241 administration increased total DB00973 concentrations approximately # - fold .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : no clinically significant pharmacokinetic interactions were seen when DB00973 was co-administered with DB01076 , ddrug3 , ddrug4 , ddrug5 , or ddrug6 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : no clinically significant pharmacokinetic interactions were seen when DB00973 was co-administered with ddrug2 , DB00641 , ddrug4 , ddrug5 , or ddrug6 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : no clinically significant pharmacokinetic interactions were seen when DB00973 was co-administered with ddrug2 , ddrug3 , DB00175 , ddrug5 , or ddrug6 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : no clinically significant pharmacokinetic interactions were seen when DB00973 was co-administered with ddrug2 , ddrug3 , ddrug4 , DB00227 , or ddrug6 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : no clinically significant pharmacokinetic interactions were seen when DB00973 was co-administered with ddrug2 , ddrug3 , ddrug4 , ddrug5 , or DB01095 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : the total DB00973 level increased 12-fold in one renal transplant patient receiving multiple medications , including DB00091 .",
        "label": "mechanism"
    },
    {
        "text": "patients who take both DB00973 and DB00091 should be carefully monitored .",
        "label": "advise"
    },
    {
        "text": "multiple dose studies of DB00973 given in combination with HD00095 { ddrug2 } in rats and rabbits during organogenesis result in higher ddrug3 and staticor exposures .",
        "label": "NA"
    },
    {
        "text": "multiple dose studies of DB00973 given in combination with ddrug1 { HD00434 } in rats and rabbits during organogenesis result in higher ddrug3 and staticor exposures .",
        "label": "NA"
    },
    {
        "text": "multiple dose studies of ddrug0 given in combination with HD00095 { ddrug2 } in rats and rabbits during organogenesis result in higher DB00973 and staticor exposures .",
        "label": "NA"
    },
    {
        "text": "multiple dose studies of ddrug0 given in combination with ddrug1 { HD00434 } in rats and rabbits during organogenesis result in higher DB00973 and staticor exposures .",
        "label": "NA"
    },
    {
        "text": "when DB00973 is administered with an HD00383 in a woman of childbearing potential , refer to the pregnancy category and package labeling for the ddrug2 .",
        "label": "NA"
    },
    {
        "text": "when DB00973 is administered with an ddrug1 in a woman of childbearing potential , refer to the pregnancy category and package labeling for the HD00383 .",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral HD00484 , HD00724 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral HD00484 , ddrug1 , DB00252 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral HD00484 , ddrug1 , ddrug2 , DB00091 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral HD00484 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB00342 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral HD00484 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , DB00604 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral HD00484 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , DB00637 , ddrug9 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral HD00484 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , DB00615 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral HD00484 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , DB00864 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral HD00484 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , HD00736 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , HD00724 , DB00252 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , HD00724 , ddrug2 , DB00091 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , HD00724 , ddrug2 , ddrug3 , DB01045 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , HD00724 , ddrug2 , ddrug3 , ddrug4 , DB00277 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , HD00724 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB00342 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , HD00724 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , DB00604 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , HD00724 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , DB00637 , ddrug9 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , HD00724 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , DB00615 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , HD00724 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , DB00864 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , HD00724 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , HD00736 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , HD00724 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , oral HD00484 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , DB00252 , DB00091 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , DB00252 , ddrug3 , ddrug4 , ddrug5 , DB00342 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , DB00252 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , DB00604 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , DB00252 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , DB00637 , ddrug9 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , DB00252 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , DB00615 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , DB00252 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , DB00864 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , DB00252 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , HD00736 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , DB00252 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , oral HD00484 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , DB00091 , ddrug4 , ddrug5 , DB00342 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , DB00091 , ddrug4 , ddrug5 , ddrug6 , DB00604 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , DB00091 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , DB00637 , ddrug9 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , DB00091 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , DB00615 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , DB00091 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , DB00864 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , DB00091 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , HD00736 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , DB00091 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , oral HD00484 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , ddrug3 , DB01045 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , DB00615 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , ddrug3 , DB01045 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , DB00864 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , ddrug3 , DB01045 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , HD00736 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00277 , ddrug6 , ddrug7 , ddrug8 , DB00615 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00277 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , DB00864 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00277 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , HD00736 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB00342 , ddrug7 , ddrug8 , DB00615 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB00342 , ddrug7 , ddrug8 , ddrug9 , DB00864 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB00342 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , HD00736 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , DB00604 , ddrug8 , DB00615 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , DB00604 , ddrug8 , ddrug9 , DB00864 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , DB00604 , ddrug8 , ddrug9 , ddrug10 , HD00736 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , DB00637 , DB00615 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , DB00637 , ddrug9 , DB00864 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , DB00637 , ddrug9 , ddrug10 , HD00736 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , DB00615 , DB00864 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , DB00615 , ddrug10 , HD00736 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , DB00615 , ddrug10 , ddrug11 , oral HD00484 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , DB00864 , HD00736 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , DB00864 , ddrug11 , oral HD00484 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , HD00736 , oral HD00484 : clinically significant hypoglycemia may be precipitated by the use of ddrug13 with oral ddrug14 ;",
        "label": "NA"
    },
    {
        "text": "these are described in greater detail below : oral ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , oral ddrug12 : clinically significant hypoglycemia may be precipitated by the use of DB00196 with oral HD00062 ;",
        "label": "effect"
    },
    {
        "text": "one fatality has been reported from hypoglycemia in association with combined DB00196 and DB01016 use .",
        "label": "effect"
    },
    {
        "text": "DB00196 reduces the metabolism of DB01124 , ddrug2 , and ddrug3 and increases the plasma concentration of these agents .",
        "label": "mechanism"
    },
    {
        "text": "DB00196 reduces the metabolism of ddrug1 , DB01016 , and ddrug3 and increases the plasma concentration of these agents .",
        "label": "mechanism"
    },
    {
        "text": "DB00196 reduces the metabolism of ddrug1 , ddrug2 , and DB01067 and increases the plasma concentration of these agents .",
        "label": "mechanism"
    },
    {
        "text": "when DB00196 is used concomitantly with these or other HD00948 , blood glucose concentrations should be carefully monitored and the dose of the ddrug2 should be adjusted as necessary .",
        "label": "advise"
    },
    {
        "text": "when DB00196 is used concomitantly with these or other ddrug1 , blood glucose concentrations should be carefully monitored and the dose of the HD00226 should be adjusted as necessary .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : prothrombin time may be increased in patients receiving concomitant DB00196 and HD00724 .",
        "label": "effect"
    },
    {
        "text": "in post-marketing experience , as with other HD00270 , bleeding events { bruising , epistaxis , gastrointestinal bleeding , hematuria , and melena } have been reported in association with increases in prothrombin time in patients receiving DB00196 concurrently with ddrug2 .",
        "label": "NA"
    },
    {
        "text": "in post-marketing experience , as with other HD00270 , bleeding events { bruising , epistaxis , gastrointestinal bleeding , hematuria , and melena } have been reported in association with increases in prothrombin time in patients receiving ddrug1 concurrently with DB00682 .",
        "label": "NA"
    },
    {
        "text": "in post-marketing experience , as with other ddrug0 , bleeding events { bruising , epistaxis , gastrointestinal bleeding , hematuria , and melena } have been reported in association with increases in prothrombin time in patients receiving DB00196 concurrently with DB00682 .",
        "label": "effect"
    },
    {
        "text": "careful monitoring of prothrombin time in patients receiving DB00196 and HD00724 is recommended .",
        "label": "advise"
    },
    {
        "text": "ddrug0 : DB00196 increases the plasma concentrations of DB00252 .",
        "label": "mechanism"
    },
    {
        "text": "careful monitoring of DB00252 concentrations in patients receiving DB00196 and ddrug2 is recommended .",
        "label": "NA"
    },
    {
        "text": "careful monitoring of ddrug0 concentrations in patients receiving DB00196 and DB00252 is recommended .",
        "label": "advise"
    },
    {
        "text": "ddrug0 : DB00196 may significantly increase DB00091 levels in renal transplant patients with or without renal impairment .",
        "label": "mechanism"
    },
    {
        "text": "careful monitoring of DB00091 concentrations and serum creatinine is recommended in patients receiving DB00196 and ddrug2 .",
        "label": "NA"
    },
    {
        "text": "careful monitoring of ddrug0 concentrations and serum creatinine is recommended in patients receiving DB00196 and DB00091 .",
        "label": "advise"
    },
    {
        "text": "ddrug0 : DB01045 enhances the metabolism of concurrently administered DB00196 .",
        "label": "mechanism"
    },
    {
        "text": "depending on clinical circumstances , consideration should be given to increasing the dose of DB00196 when it is administered with DB01045 .",
        "label": "advise"
    },
    {
        "text": "ddrug0 : DB00196 increases the serum concentrations of DB00277 .",
        "label": "mechanism"
    },
    {
        "text": "careful monitoring of serum DB00277 concentrations in patients receiving DB00196 and ddrug2 is recommended .",
        "label": "NA"
    },
    {
        "text": "careful monitoring of serum ddrug0 concentrations in patients receiving DB00196 and DB00277 is recommended .",
        "label": "advise"
    },
    {
        "text": "ddrug0 : because of the occurrence of serious cardiac dysrhythmias secondary to prolongation of the qtc interval in patients receiving HD00270 in conjunction with DB00342 , interaction studies have been performed .",
        "label": "effect"
    },
    {
        "text": "another study at a 400-mg and 800-mg daily dose of DB00196 demonstrated that DB00196 taken in doses of # mg per day or greater significantly increases plasma levels of ddrug2 when taken concomitantly .",
        "label": "NA"
    },
    {
        "text": "another study at a 400-mg and 800-mg daily dose of DB00196 demonstrated that ddrug1 taken in doses of # mg per day or greater significantly increases plasma levels of DB00342 when taken concomitantly .",
        "label": "NA"
    },
    {
        "text": "another study at a 400-mg and 800-mg daily dose of ddrug0 demonstrated that DB00196 taken in doses of # mg per day or greater significantly increases plasma levels of DB00342 when taken concomitantly .",
        "label": "mechanism"
    },
    {
        "text": "the combined use of DB00196 at doses of # mg or greater with DB00342 is contraindicated .",
        "label": "advise"
    },
    {
        "text": "the coadministration of DB00196 at doses lower than # mg/day with DB00342 should be carefully monitored .",
        "label": "advise"
    },
    {
        "text": "ddrug0 : there have been reports of cardiac events , including torsade de pointes in patients to whom DB00196 and DB00604 were coadministered .",
        "label": "effect"
    },
    {
        "text": "a controlled study found that concomitant DB00196 # mg once daily and DB00604 # mg four times a day yielded a significant increase in ddrug2 plasma levels and prolongation of qtc interval .",
        "label": "mechanism"
    },
    {
        "text": "a controlled study found that concomitant DB00196 # mg once daily and ddrug1 # mg four times a day yielded a significant increase in DB00604 plasma levels and prolongation of qtc interval .",
        "label": "NA"
    },
    {
        "text": "the combined use of DB00196 with DB00604 is contraindicated .",
        "label": "advise"
    },
    {
        "text": "ddrug0 : the use of DB00196 in patients concurrently taking DB00637 or other drugs metabolized by the cytochrome cyp2b6 system may be associated with elevations in serum levels of these drugs .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 : there have been reports of uveitis in patients to whom DB00196 and DB00615 were coadministered .",
        "label": "effect"
    },
    {
        "text": "patients receiving DB00615 and DB00196 concomitantly should be carefully monitored .",
        "label": "advise"
    },
    {
        "text": "ddrug0 : there have been reports of nephrotoxicity in patients to whom DB00196 and DB00864 were coadministered .",
        "label": "effect"
    },
    {
        "text": "patients receiving DB00864 and DB00196 concomitantly should be carefully monitored .",
        "label": "advise"
    },
    {
        "text": "ddrug0 : following oral administration of DB00683 , DB00196 resulted in substantial increases in ddrug3 concentrations and psychomotor effects .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 : following oral administration of ddrug1 , DB00196 resulted in substantial increases in DB00683 concentrations and psychomotor effects .",
        "label": "NA"
    },
    {
        "text": "this effect on DB00683 appears to be more pronounced following oral administration of DB00196 than with ddrug2 administered intravenously .",
        "label": "effect"
    },
    {
        "text": "this effect on DB00683 appears to be more pronounced following oral administration of ddrug1 than with DB00196 administered intravenously .",
        "label": "NA"
    },
    {
        "text": "if HD00736 , which are metabolized by the cytochrome cyp2b6 system , are concomitantly administered with DB00196 , consideration should be given to decreasing the ddrug2 dosage , and the patients should be appropriately monitored .",
        "label": "advise"
    },
    {
        "text": "if ddrug0 , which are metabolized by the cytochrome cyp2b6 system , are concomitantly administered with DB00196 , consideration should be given to decreasing the DB12537 dosage , and the patients should be appropriately monitored .",
        "label": "NA"
    },
    {
        "text": "DB00196 tablets coadministered with DB00977 - and ddrug2 - containing oral ddrug3 produced an overall mean increase in ddrug4 and ddrug5 levels ;",
        "label": "mechanism"
    },
    {
        "text": "DB00196 tablets coadministered with ddrug1 - and DB00367 - containing oral ddrug3 produced an overall mean increase in ddrug4 and ddrug5 levels ;",
        "label": "mechanism"
    },
    {
        "text": "DB00196 tablets coadministered with ddrug1 - and ddrug2 - containing oral HD00283 produced an overall mean increase in ddrug4 and ddrug5 levels ;",
        "label": "NA"
    },
    {
        "text": "DB00196 tablets coadministered with ddrug1 - and ddrug2 - containing oral ddrug3 produced an overall mean increase in DB00977 and ddrug5 levels ;",
        "label": "NA"
    },
    {
        "text": "DB00196 tablets coadministered with ddrug1 - and ddrug2 - containing oral ddrug3 produced an overall mean increase in ddrug4 and DB00367 levels ;",
        "label": "NA"
    },
    {
        "text": "ddrug0 tablets coadministered with DB00977 - and DB00367 - containing oral ddrug3 produced an overall mean increase in ddrug4 and ddrug5 levels ;",
        "label": "NA"
    },
    {
        "text": "ddrug0 tablets coadministered with DB00977 - and ddrug2 - containing oral HD00283 produced an overall mean increase in ddrug4 and ddrug5 levels ;",
        "label": "NA"
    },
    {
        "text": "ddrug0 tablets coadministered with DB00977 - and ddrug2 - containing oral ddrug3 produced an overall mean increase in ddrug4 and DB00367 levels ;",
        "label": "NA"
    },
    {
        "text": "ddrug0 tablets coadministered with ddrug1 - and DB00367 - containing oral HD00283 produced an overall mean increase in ddrug4 and ddrug5 levels ;",
        "label": "NA"
    },
    {
        "text": "ddrug0 tablets coadministered with ddrug1 - and DB00367 - containing oral ddrug3 produced an overall mean increase in DB00977 and ddrug5 levels ;",
        "label": "NA"
    },
    {
        "text": "ddrug0 tablets coadministered with ddrug1 - and ddrug2 - containing oral HD00283 produced an overall mean increase in DB00977 and ddrug5 levels ;",
        "label": "NA"
    },
    {
        "text": "ddrug0 tablets coadministered with ddrug1 - and ddrug2 - containing oral HD00283 produced an overall mean increase in ddrug4 and DB00367 levels ;",
        "label": "NA"
    },
    {
        "text": "ddrug0 tablets coadministered with ddrug1 - and ddrug2 - containing oral ddrug3 produced an overall mean increase in DB00977 and DB00367 levels ;",
        "label": "NA"
    },
    {
        "text": "however , in some patients there were decreases up to 47 % and 33 % of DB00977 and DB00367 levels .",
        "label": "NA"
    },
    {
        "text": "the data presently available indicate that the decreases in some individual DB00977 and DB00367 auc values with ddrug2 treatment are likely the result of random variation .",
        "label": "NA"
    },
    {
        "text": "the data presently available indicate that the decreases in some individual DB00977 and ddrug1 auc values with DB00196 treatment are likely the result of random variation .",
        "label": "NA"
    },
    {
        "text": "the data presently available indicate that the decreases in some individual ddrug0 and DB00367 auc values with DB00196 treatment are likely the result of random variation .",
        "label": "NA"
    },
    {
        "text": "while there is evidence that DB00196 can inhibit the metabolism of DB00977 and ddrug2 , there is no evidence that ddrug3 is a net inducer of ddrug4 or ddrug5 metabolism .",
        "label": "mechanism"
    },
    {
        "text": "while there is evidence that DB00196 can inhibit the metabolism of ddrug1 and DB00367 , there is no evidence that ddrug3 is a net inducer of ddrug4 or ddrug5 metabolism .",
        "label": "mechanism"
    },
    {
        "text": "while there is evidence that DB00196 can inhibit the metabolism of ddrug1 and ddrug2 , there is no evidence that ddrug3 is a net inducer of DB00977 or ddrug5 metabolism .",
        "label": "NA"
    },
    {
        "text": "while there is evidence that DB00196 can inhibit the metabolism of ddrug1 and ddrug2 , there is no evidence that ddrug3 is a net inducer of ddrug4 or DB00367 metabolism .",
        "label": "NA"
    },
    {
        "text": "while there is evidence that ddrug0 can inhibit the metabolism of DB00977 and DB00367 , there is no evidence that ddrug3 is a net inducer of ddrug4 or ddrug5 metabolism .",
        "label": "NA"
    },
    {
        "text": "while there is evidence that ddrug0 can inhibit the metabolism of DB00977 and ddrug2 , there is no evidence that DB00196 is a net inducer of ddrug4 or ddrug5 metabolism .",
        "label": "NA"
    },
    {
        "text": "while there is evidence that ddrug0 can inhibit the metabolism of DB00977 and ddrug2 , there is no evidence that ddrug3 is a net inducer of ddrug4 or DB00367 metabolism .",
        "label": "NA"
    },
    {
        "text": "while there is evidence that ddrug0 can inhibit the metabolism of ddrug1 and DB00367 , there is no evidence that DB00196 is a net inducer of ddrug4 or ddrug5 metabolism .",
        "label": "NA"
    },
    {
        "text": "while there is evidence that ddrug0 can inhibit the metabolism of ddrug1 and DB00367 , there is no evidence that ddrug3 is a net inducer of DB00977 or ddrug5 metabolism .",
        "label": "NA"
    },
    {
        "text": "while there is evidence that ddrug0 can inhibit the metabolism of ddrug1 and ddrug2 , there is no evidence that DB00196 is a net inducer of DB00977 or ddrug5 metabolism .",
        "label": "NA"
    },
    {
        "text": "while there is evidence that ddrug0 can inhibit the metabolism of ddrug1 and ddrug2 , there is no evidence that DB00196 is a net inducer of ddrug4 or DB00367 metabolism .",
        "label": "NA"
    },
    {
        "text": "while there is evidence that ddrug0 can inhibit the metabolism of ddrug1 and ddrug2 , there is no evidence that ddrug3 is a net inducer of DB00977 or DB00367 metabolism .",
        "label": "NA"
    },
    {
        "text": "you can not take DB00579 if you have taken a HD00762 { ddrug2 } such as ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , or ddrug7 { ddrug8 } in the last # days .",
        "label": "advise"
    },
    {
        "text": "you can not take DB00579 if you have taken a ddrug1 { HD00725 } such as ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , or ddrug7 { ddrug8 } in the last # days .",
        "label": "advise"
    },
    {
        "text": "you can not take DB00579 if you have taken a ddrug1 { ddrug2 } such as DB01247 { ddrug4 } , ddrug5 { ddrug6 } , or ddrug7 { ddrug8 } in the last # days .",
        "label": "advise"
    },
    {
        "text": "you can not take DB00579 if you have taken a ddrug1 { ddrug2 } such as ddrug3 { DB01247 } , ddrug5 { ddrug6 } , or ddrug7 { ddrug8 } in the last # days .",
        "label": "advise"
    },
    {
        "text": "you can not take DB00579 if you have taken a ddrug1 { ddrug2 } such as ddrug3 { ddrug4 } , DB00752 { ddrug6 } , or ddrug7 { ddrug8 } in the last # days .",
        "label": "advise"
    },
    {
        "text": "you can not take DB00579 if you have taken a ddrug1 { ddrug2 } such as ddrug3 { ddrug4 } , ddrug5 { DB00752 } , or ddrug7 { ddrug8 } in the last # days .",
        "label": "advise"
    },
    {
        "text": "you can not take DB00579 if you have taken a ddrug1 { ddrug2 } such as ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , or DB00780 { ddrug8 } in the last # days .",
        "label": "advise"
    },
    {
        "text": "you can not take DB00579 if you have taken a ddrug1 { ddrug2 } such as ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , or ddrug7 { DB00780 } in the last # days .",
        "label": "advise"
    },
    {
        "text": "you can not take ddrug0 if you have taken a HD00762 { ddrug2 } such as DB01247 { ddrug4 } , ddrug5 { ddrug6 } , or ddrug7 { ddrug8 } in the last # days .",
        "label": "NA"
    },
    {
        "text": "you can not take ddrug0 if you have taken a HD00762 { ddrug2 } such as ddrug3 { DB01247 } , ddrug5 { ddrug6 } , or ddrug7 { ddrug8 } in the last # days .",
        "label": "NA"
    },
    {
        "text": "you can not take ddrug0 if you have taken a HD00762 { ddrug2 } such as ddrug3 { ddrug4 } , DB00752 { ddrug6 } , or ddrug7 { ddrug8 } in the last # days .",
        "label": "NA"
    },
    {
        "text": "you can not take ddrug0 if you have taken a HD00762 { ddrug2 } such as ddrug3 { ddrug4 } , ddrug5 { DB00752 } , or ddrug7 { ddrug8 } in the last # days .",
        "label": "NA"
    },
    {
        "text": "you can not take ddrug0 if you have taken a HD00762 { ddrug2 } such as ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , or DB00780 { ddrug8 } in the last # days .",
        "label": "NA"
    },
    {
        "text": "you can not take ddrug0 if you have taken a HD00762 { ddrug2 } such as ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , or ddrug7 { DB00780 } in the last # days .",
        "label": "NA"
    },
    {
        "text": "you can not take ddrug0 if you have taken a ddrug1 { HD00725 } such as DB01247 { ddrug4 } , ddrug5 { ddrug6 } , or ddrug7 { ddrug8 } in the last # days .",
        "label": "NA"
    },
    {
        "text": "you can not take ddrug0 if you have taken a ddrug1 { HD00725 } such as ddrug3 { DB01247 } , ddrug5 { ddrug6 } , or ddrug7 { ddrug8 } in the last # days .",
        "label": "NA"
    },
    {
        "text": "you can not take ddrug0 if you have taken a ddrug1 { HD00725 } such as ddrug3 { ddrug4 } , DB00752 { ddrug6 } , or ddrug7 { ddrug8 } in the last # days .",
        "label": "NA"
    },
    {
        "text": "you can not take ddrug0 if you have taken a ddrug1 { HD00725 } such as ddrug3 { ddrug4 } , ddrug5 { DB00752 } , or ddrug7 { ddrug8 } in the last # days .",
        "label": "NA"
    },
    {
        "text": "you can not take ddrug0 if you have taken a ddrug1 { HD00725 } such as ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , or DB00780 { ddrug8 } in the last # days .",
        "label": "NA"
    },
    {
        "text": "you can not take ddrug0 if you have taken a ddrug1 { HD00725 } such as ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , or ddrug7 { DB00780 } in the last # days .",
        "label": "NA"
    },
    {
        "text": "changes in HD00071 and other diabetes drug therapies may be necessary during treatment with DB00579 .",
        "label": "advise"
    },
    {
        "text": "DB00579 may reduce the effects of DB01170 { ddrug2 } .",
        "label": "effect"
    },
    {
        "text": "DB00579 may reduce the effects of ddrug1 { DB01170 } .",
        "label": "effect"
    },
    {
        "text": "before taking this medication , tell your doctor if you are taking a HD00042 such as DB00321 { ddrug2 } , ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , ddrug7 { ddrug8 } , ddrug9 { ddrug10 } , ddrug11 { ddrug12 } , ddrug13 { ddrug14 } , or ddrug15 { ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "before taking this medication , tell your doctor if you are taking a HD00042 such as ddrug1 { DB00321 } , ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , ddrug7 { ddrug8 } , ddrug9 { ddrug10 } , ddrug11 { ddrug12 } , ddrug13 { ddrug14 } , or ddrug15 { ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "before taking this medication , tell your doctor if you are taking a HD00042 such as ddrug1 { ddrug2 } , DB00543 { ddrug4 } , ddrug5 { ddrug6 } , ddrug7 { ddrug8 } , ddrug9 { ddrug10 } , ddrug11 { ddrug12 } , ddrug13 { ddrug14 } , or ddrug15 { ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "before taking this medication , tell your doctor if you are taking a HD00042 such as ddrug1 { ddrug2 } , ddrug3 { HD00949 } , ddrug5 { ddrug6 } , ddrug7 { ddrug8 } , ddrug9 { ddrug10 } , ddrug11 { ddrug12 } , ddrug13 { ddrug14 } , or ddrug15 { ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "before taking this medication , tell your doctor if you are taking a HD00042 such as ddrug1 { ddrug2 } , ddrug3 { ddrug4 } , DB01142 { ddrug6 } , ddrug7 { ddrug8 } , ddrug9 { ddrug10 } , ddrug11 { ddrug12 } , ddrug13 { ddrug14 } , or ddrug15 { ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "before taking this medication , tell your doctor if you are taking a HD00042 such as ddrug1 { ddrug2 } , ddrug3 { ddrug4 } , ddrug5 { DB01142 } , ddrug7 { ddrug8 } , ddrug9 { ddrug10 } , ddrug11 { ddrug12 } , ddrug13 { ddrug14 } , or ddrug15 { ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "before taking this medication , tell your doctor if you are taking a HD00042 such as ddrug1 { ddrug2 } , ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , DB00540 { ddrug8 } , ddrug9 { ddrug10 } , ddrug11 { ddrug12 } , ddrug13 { ddrug14 } , or ddrug15 { ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "before taking this medication , tell your doctor if you are taking a HD00042 such as ddrug1 { ddrug2 } , ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , ddrug7 { DB00540 } , ddrug9 { ddrug10 } , ddrug11 { ddrug12 } , ddrug13 { ddrug14 } , or ddrug15 { ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "before taking this medication , tell your doctor if you are taking a HD00042 such as ddrug1 { ddrug2 } , ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , ddrug7 { ddrug8 } , DB00458 { ddrug10 } , ddrug11 { ddrug12 } , ddrug13 { ddrug14 } , or ddrug15 { ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "before taking this medication , tell your doctor if you are taking a HD00042 such as ddrug1 { ddrug2 } , ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , ddrug7 { ddrug8 } , ddrug9 { DB00458 } , ddrug11 { ddrug12 } , ddrug13 { ddrug14 } , or ddrug15 { ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "before taking this medication , tell your doctor if you are taking a HD00042 such as ddrug1 { ddrug2 } , ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , ddrug7 { ddrug8 } , ddrug9 { ddrug10 } , DB01242 { ddrug12 } , ddrug13 { ddrug14 } , or ddrug15 { ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "before taking this medication , tell your doctor if you are taking a HD00042 such as ddrug1 { ddrug2 } , ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , ddrug7 { ddrug8 } , ddrug9 { ddrug10 } , ddrug11 { DB01242 } , ddrug13 { ddrug14 } , or ddrug15 { ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "before taking this medication , tell your doctor if you are taking a HD00042 such as ddrug1 { ddrug2 } , ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , ddrug7 { ddrug8 } , ddrug9 { ddrug10 } , ddrug11 { ddrug12 } , DB00344 { ddrug14 } , or ddrug15 { ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "before taking this medication , tell your doctor if you are taking a HD00042 such as ddrug1 { ddrug2 } , ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , ddrug7 { ddrug8 } , ddrug9 { ddrug10 } , ddrug11 { ddrug12 } , ddrug13 { DB00344 } , or ddrug15 { ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "before taking this medication , tell your doctor if you are taking a HD00042 such as ddrug1 { ddrug2 } , ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , ddrug7 { ddrug8 } , ddrug9 { ddrug10 } , ddrug11 { ddrug12 } , ddrug13 { ddrug14 } , or DB01151 { ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "before taking this medication , tell your doctor if you are taking a HD00042 such as ddrug1 { ddrug2 } , ddrug3 { ddrug4 } , ddrug5 { ddrug6 } , ddrug7 { ddrug8 } , ddrug9 { ddrug10 } , ddrug11 { ddrug12 } , ddrug13 { ddrug14 } , or ddrug15 { DB01151 } .",
        "label": "NA"
    },
    {
        "text": "preliminary evidence suggests that DB00501 inhibits DB00643 metabolism and may result in an increase in plasma concentrations of ddrug2 .",
        "label": "mechanism"
    },
    {
        "text": "preliminary evidence suggests that DB00501 inhibits ddrug1 metabolism and may result in an increase in plasma concentrations of DB00643 .",
        "label": "NA"
    },
    {
        "text": "patients receiving HD00002 and HD00297 generally should not be treated with ddrug2 .",
        "label": "NA"
    },
    {
        "text": "patients receiving HD00002 and ddrug1 generally should not be treated with HD00950 .",
        "label": "advise"
    },
    {
        "text": "patients receiving ddrug0 and HD00297 generally should not be treated with HD00950 .",
        "label": "advise"
    },
    {
        "text": "the action of DB00657 may be potentiated by anesthesia , other HD00448 and ddrug2 .",
        "label": "effect"
    },
    {
        "text": "the action of DB00657 may be potentiated by anesthesia , other ddrug1 and DB02325 .",
        "label": "effect"
    },
    {
        "text": "DB00357 administered concomitantly with HD00951 may significantly decrease the serum concentrations of ddrug2 .",
        "label": "mechanism"
    },
    {
        "text": "DB00357 administered concomitantly with ddrug1 may significantly decrease the serum concentrations of DB00603 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 administered concomitantly with HD00951 may significantly decrease the serum concentrations of DB00603 .",
        "label": "NA"
    },
    {
        "text": "pharmacokinetic studies show that there are no significant alterations in pharmacokinetic parameters of DB00495 or DB00615 to warrant dosage adjustment when ddrug2 is administered with these drugs .",
        "label": "NA"
    },
    {
        "text": "pharmacokinetic studies show that there are no significant alterations in pharmacokinetic parameters of DB00495 or ddrug1 to warrant dosage adjustment when DB00351 is administered with these drugs .",
        "label": "NA"
    },
    {
        "text": "pharmacokinetic studies show that there are no significant alterations in pharmacokinetic parameters of ddrug0 or DB00615 to warrant dosage adjustment when DB00351 is administered with these drugs .",
        "label": "NA"
    },
    {
        "text": "a pharmacokinetic study demonstrated that coadministration of DB00351 and DB00224 results in a significant decrease in the pharmacokinetic parameters { ~ 36 % for cmax and ~ 28 % for auc } of ddrug2 .",
        "label": "mechanism"
    },
    {
        "text": "a pharmacokinetic study demonstrated that coadministration of DB00351 and ddrug1 results in a significant decrease in the pharmacokinetic parameters { ~ 36 % for cmax and ~ 28 % for auc } of DB00224 .",
        "label": "NA"
    },
    {
        "text": "administration of a higher dose of DB00224 should be considered when coadministering with DB00351 .",
        "label": "advise"
    },
    {
        "text": "the effects of DB00224 , ddrug1 or ddrug2 on the pharmacokinetics of DB00351 were not studied .",
        "label": "NA"
    },
    {
        "text": "the effects of ddrug0 , DB00495 or ddrug2 on the pharmacokinetics of DB00351 were not studied .",
        "label": "NA"
    },
    {
        "text": "the effects of ddrug0 , ddrug1 or DB00615 on the pharmacokinetics of DB00351 were not studied .",
        "label": "NA"
    },
    {
        "text": "DB01065 may interact with the following drugs : DB00945 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "int"
    },
    {
        "text": "DB01065 may interact with the following drugs : ddrug1 and other HD00203 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "int"
    },
    {
        "text": "DB01065 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , DB00176 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "int"
    },
    {
        "text": "DB01065 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , HD00378 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "int"
    },
    {
        "text": "DB01065 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , DB00472 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "int"
    },
    {
        "text": "DB01065 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , HD00237 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "int"
    },
    {
        "text": "DB01065 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with HD00237 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "DB01065 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , HD00952 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "int"
    },
    {
        "text": "DB01065 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and HD00175 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "int"
    },
    {
        "text": "DB01065 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and HD00175 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "DB01065 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the HD00175 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : DB00945 and other HD00203 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : DB00945 and other ddrug2 { may lower DB01065 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : DB00945 and other ddrug2 { may lower ddrug3 levels } , DB00176 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : DB00945 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral DB01065 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : DB00945 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease DB01065 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : DB00945 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , DB00472 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : DB00945 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , HD00237 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : DB00945 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of DB01065 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : DB00945 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with HD00237 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : DB00945 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , HD00952 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : DB00945 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and HD00175 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : DB00945 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of DB01065 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : DB00945 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and HD00175 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : DB00945 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the HD00175 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other HD00203 { may lower DB01065 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other HD00203 { may lower ddrug3 levels } , DB00176 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other HD00203 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral DB01065 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other HD00203 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease DB01065 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other HD00203 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , DB00472 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other HD00203 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , HD00237 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other HD00203 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of DB01065 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other HD00203 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with HD00237 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other HD00203 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , HD00952 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other HD00203 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and HD00175 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other HD00203 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of DB01065 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other HD00203 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and HD00175 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other HD00203 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the HD00175 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower DB01065 levels } , DB00176 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower DB01065 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , HD00378 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower DB01065 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , DB00472 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower DB01065 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , HD00237 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower DB01065 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with HD00237 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower DB01065 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , HD00952 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower DB01065 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and HD00175 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower DB01065 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and HD00175 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower DB01065 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the HD00175 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , DB00176 { bioavailability of oral DB01065 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , DB00176 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease DB01065 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , DB00176 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of DB01065 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , DB00176 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with HD00237 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , DB00176 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and HD00175 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , DB00176 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of DB01065 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , DB00176 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and HD00175 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , DB00176 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the HD00175 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral DB01065 is increased with coadministration } , HD00378 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral DB01065 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , DB00472 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral DB01065 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , HD00237 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral DB01065 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with HD00237 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral DB01065 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , HD00952 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral DB01065 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and HD00175 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral DB01065 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and HD00175 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral DB01065 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the HD00175 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , HD00378 { may decrease DB01065 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , HD00378 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of DB01065 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , HD00378 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with HD00237 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , HD00378 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and HD00175 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , HD00378 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of DB01065 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , HD00378 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and HD00175 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , HD00378 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the HD00175 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease DB01065 levels } , DB00472 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease DB01065 levels } , ddrug8 { reports of psychotic episodes when coadministered } , HD00237 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease DB01065 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with HD00237 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease DB01065 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , HD00952 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease DB01065 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and HD00175 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease DB01065 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and HD00175 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease DB01065 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the HD00175 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , DB00472 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of DB01065 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , DB00472 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with HD00237 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , DB00472 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and HD00175 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , DB00472 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of DB01065 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , DB00472 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and HD00175 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , DB00472 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the HD00175 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , HD00237 { coadministration of DB01065 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , HD00237 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and HD00175 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , HD00237 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of DB01065 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , HD00237 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and HD00175 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , HD00237 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the HD00175 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of DB01065 with HD00237 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "effect"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of DB01065 with ddrug11 can inhibit ovarian function in women } , HD00952 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of DB01065 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and HD00175 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of DB01065 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and HD00175 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of DB01065 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the HD00175 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with HD00237 can inhibit ovarian function in women } , HD00952 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with HD00237 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and HD00175 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with HD00237 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of DB01065 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with HD00237 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and HD00175 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with HD00237 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the HD00175 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , HD00952 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and HD00175 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , HD00952 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of DB01065 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , HD00952 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and HD00175 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , HD00952 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of ddrug14 and ddrug15 may interfere with the efficacy of the HD00175 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and HD00175 { coadministration of DB01065 and ddrug15 may interfere with the efficacy of the ddrug16 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of DB01065 and HD00175 may interfere with the efficacy of the ddrug16 } .",
        "label": "effect"
    },
    {
        "text": "ddrug0 may interact with the following drugs : ddrug1 and other ddrug2 { may lower ddrug3 levels } , ddrug4 { bioavailability of oral ddrug5 is increased with coadministration } , ddrug6 { may decrease ddrug7 levels } , ddrug8 { reports of psychotic episodes when coadministered } , ddrug9 { coadministration of ddrug10 with ddrug11 can inhibit ovarian function in women } , ddrug12 and other sedating drugs { may result in additive sedation and an increased incidence of adverse effects } , and ddrug13 { coadministration of DB01065 and ddrug15 may interfere with the efficacy of the HD00175 } .",
        "label": "NA"
    },
    {
        "text": "HD00106 reports suggest that HD00203 may diminish the antihypertensive effect of ddrug2 .",
        "label": "NA"
    },
    {
        "text": "HD00106 reports suggest that ddrug1 may diminish the antihypertensive effect of HD00730 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 reports suggest that HD00203 may diminish the antihypertensive effect of HD00730 .",
        "label": "effect"
    },
    {
        "text": "this interaction should be given consideration in patients taking HD00203 concomitantly with HD00106 .",
        "label": "advise"
    },
    {
        "text": "DB00945 : concomitant administration of ddrug1 { 1000 mg tid } to healthy volunteers tended to increase the auc { 10 % } and cmax { 24 % } of DB00814 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : concomitant administration of DB00945 { 1000 mg tid } to healthy volunteers tended to increase the auc { 10 % } and cmax { 24 % } of DB00814 .",
        "label": "mechanism"
    },
    {
        "text": "however , as with other HD00203 , concomitant administration of DB00814 and ddrug2 is not generally recommended because of the potential for increased adverse effects .",
        "label": "NA"
    },
    {
        "text": "however , as with other HD00203 , concomitant administration of ddrug1 and DB00945 is not generally recommended because of the potential for increased adverse effects .",
        "label": "advise"
    },
    {
        "text": "however , as with other ddrug0 , concomitant administration of DB00814 and DB00945 is not generally recommended because of the potential for increased adverse effects .",
        "label": "advise"
    },
    {
        "text": "concomitant administration of low-dose DB00945 with DB00814 may result in an increased rate of gi ulceration or other complications , compared to use of ddrug2 alone .",
        "label": "effect"
    },
    {
        "text": "concomitant administration of low-dose DB00945 with ddrug1 may result in an increased rate of gi ulceration or other complications , compared to use of DB00814 alone .",
        "label": "NA"
    },
    {
        "text": "DB00814 is not a substitute for DB00945 for cardiovascular prophylaxis .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : pretreatment for four days with DB01432 significantly increased the clearance of DB00814 by 50 % .",
        "label": "mechanism"
    },
    {
        "text": "DB00501 : concomitant administration of # mg ddrug1 qid did not alter the single-dose pharmacokinetics of # mg DB00814 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : concomitant administration of # mg DB00501 qid did not alter the single-dose pharmacokinetics of # mg DB00814 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : DB00814 # mg once daily for # days did not alter the plasma concentration profile of DB00390 after b-acetyldigoxin administration for # days at clinical doses .",
        "label": "NA"
    },
    {
        "text": "in vitro testing found no protein binding drug interaction between DB00390 and DB00814 .",
        "label": "NA"
    },
    {
        "text": "DB00695 : clinical studies , as well as post-marketing observations , have shown that HD00203 can reduce the natriuretic effect of ddrug2 and ddrug3 in some patients .",
        "label": "NA"
    },
    {
        "text": "DB00695 : clinical studies , as well as post-marketing observations , have shown that ddrug1 can reduce the natriuretic effect of ddrug2 and HD00029 in some patients .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : clinical studies , as well as post-marketing observations , have shown that HD00203 can reduce the natriuretic effect of DB00695 and ddrug3 in some patients .",
        "label": "effect"
    },
    {
        "text": "ddrug0 : clinical studies , as well as post-marketing observations , have shown that HD00203 can reduce the natriuretic effect of ddrug2 and HD00029 in some patients .",
        "label": "effect"
    },
    {
        "text": "ddrug0 : clinical studies , as well as post-marketing observations , have shown that ddrug1 can reduce the natriuretic effect of DB00695 and HD00029 in some patients .",
        "label": "NA"
    },
    {
        "text": "studies with DB00695 agents and DB00814 have not demonstrated a reduction in natriuretic effect .",
        "label": "NA"
    },
    {
        "text": "DB00695 : single and multiple dose pharmacodynamics and pharmacokinetics are not affected by multiple doses of DB00814 .",
        "label": "NA"
    },
    {
        "text": "nevertheless , during concomitant therapy with DB00695 and DB00814 , patients should be observed closely for signs of declining renal function , as well as to assure diuretic efficacy .",
        "label": "advise"
    },
    {
        "text": "DB14507 : in clinical trials , HD00203 have produced an elevation of plasma ddrug2 levels and a reduction in renal ddrug3 clearance .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : in clinical trials , HD00203 have produced an elevation of plasma DB14507 levels and a reduction in renal ddrug3 clearance .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 : in clinical trials , HD00203 have produced an elevation of plasma ddrug2 levels and a reduction in renal DB14507 clearance .",
        "label": "NA"
    },
    {
        "text": "in a study conducted in healthy subjects , mean pre-dose DB14507 concentration and auc were increased by 21 % in subjects receiving ddrug1 doses ranging from # to # mg bid with DB00814 # mg qd as compared to subjects receiving ddrug3 alone .",
        "label": "NA"
    },
    {
        "text": "in a study conducted in healthy subjects , mean pre-dose ddrug0 concentration and auc were increased by 21 % in subjects receiving DB14507 doses ranging from # to # mg bid with DB00814 # mg qd as compared to subjects receiving ddrug3 alone .",
        "label": "mechanism"
    },
    {
        "text": "in a study conducted in healthy subjects , mean pre-dose ddrug0 concentration and auc were increased by 21 % in subjects receiving ddrug1 doses ranging from # to # mg bid with DB00814 # mg qd as compared to subjects receiving DB14507 alone .",
        "label": "NA"
    },
    {
        "text": "patients on DB14507 treatment should be closely monitored when DB00814 is introduced or withdrawn .",
        "label": "advise"
    },
    {
        "text": "ddrug0 : a study in # rheumatoid_arthritis { ra } patients evaluated the effects of multiple doses of DB00814 on the pharmacokinetics of DB00563 taken once weekly .",
        "label": "NA"
    },
    {
        "text": "DB00814 did not have a significant effect on the pharmacokinetics of single doses of DB00563 .",
        "label": "NA"
    },
    {
        "text": "in vitro , DB00563 did not displace DB00814 from its human serum binding sites .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : anticoagulant activity should be monitored , particularly in the first few days after initiating or changing DB00814 therapy in patients receiving DB00682 or similar agents , since these patients are at an increased risk of bleeding .",
        "label": "advise"
    },
    {
        "text": "the effect of DB00814 on the anticoagulant effect of DB00682 was studied in a group of healthy subjects receiving daily doses of ddrug2 that produced an inr { international normalized ratio } between # and # .",
        "label": "NA"
    },
    {
        "text": "the effect of DB00814 on the anticoagulant effect of ddrug1 was studied in a group of healthy subjects receiving daily doses of DB00682 that produced an inr { international normalized ratio } between # and # .",
        "label": "NA"
    },
    {
        "text": "in these subjects , DB00814 did not alter DB00682 pharmacokinetics and the average anticoagulant effect of ddrug2 as determined by prothrombin time .",
        "label": "NA"
    },
    {
        "text": "in these subjects , DB00814 did not alter ddrug1 pharmacokinetics and the average anticoagulant effect of DB00682 as determined by prothrombin time .",
        "label": "NA"
    },
    {
        "text": "caution should be used when administering DB00814 with DB00682 since patients on ddrug2 may experience changes in inr and an increased risk of bleeding complications when a new medication is introduced .",
        "label": "advise"
    },
    {
        "text": "caution should be used when administering DB00814 with ddrug1 since patients on DB00682 may experience changes in inr and an increased risk of bleeding complications when a new medication is introduced .",
        "label": "NA"
    },
    {
        "text": "drug interactions there are no known drug/drug interactions with oral DB01042 vaccinations with HD00953 are not recommended in immunocompromised individuals ddrug2 together with high-dose intravenous ddrug3 has caused deaths in children due to haemorrhagic enterocolitis .",
        "label": "NA"
    },
    {
        "text": "drug interactions there are no known drug/drug interactions with oral DB01042 vaccinations with ddrug1 are not recommended in immunocompromised individuals DB00779 together with high-dose intravenous ddrug3 has caused deaths in children due to haemorrhagic enterocolitis .",
        "label": "NA"
    },
    {
        "text": "drug interactions there are no known drug/drug interactions with oral DB01042 vaccinations with ddrug1 are not recommended in immunocompromised individuals ddrug2 together with high-dose intravenous DB01042 has caused deaths in children due to haemorrhagic enterocolitis .",
        "label": "NA"
    },
    {
        "text": "drug interactions there are no known drug/drug interactions with oral ddrug0 vaccinations with HD00953 are not recommended in immunocompromised individuals DB00779 together with high-dose intravenous ddrug3 has caused deaths in children due to haemorrhagic enterocolitis .",
        "label": "NA"
    },
    {
        "text": "drug interactions there are no known drug/drug interactions with oral ddrug0 vaccinations with HD00953 are not recommended in immunocompromised individuals ddrug2 together with high-dose intravenous DB01042 has caused deaths in children due to haemorrhagic enterocolitis .",
        "label": "NA"
    },
    {
        "text": "drug interactions there are no known drug/drug interactions with oral ddrug0 vaccinations with ddrug1 are not recommended in immunocompromised individuals DB00779 together with high-dose intravenous DB01042 has caused deaths in children due to haemorrhagic enterocolitis .",
        "label": "effect"
    },
    {
        "text": "impaired renal function has been described in bone marrow transplant patients who were conditioned with high-dose intravenous DB01042 and who subsequently received DB00091 to prevent graft-versus-host disease",
        "label": "effect"
    },
    {
        "text": "the following agents may increase certain actions or side effects of HD00522 : DB00915 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "effect"
    },
    {
        "text": "the following agents may increase certain actions or side effects of HD00522 : ddrug1 , HD00954 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "effect"
    },
    {
        "text": "the following agents may increase certain actions or side effects of HD00522 : ddrug1 , ddrug2 { e , g , , DB00908 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "effect"
    },
    {
        "text": "the following agents may increase certain actions or side effects of HD00522 : ddrug1 , ddrug2 { e , g , , ddrug3 } , HD00388 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "effect"
    },
    {
        "text": "the following agents may increase certain actions or side effects of HD00522 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , HD00617 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "effect"
    },
    {
        "text": "the following agents may increase certain actions or side effects of HD00522 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , HD00219 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "effect"
    },
    {
        "text": "the following agents may increase certain actions or side effects of HD00522 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , HD00100 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "effect"
    },
    {
        "text": "the following agents may increase certain actions or side effects of HD00522 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , HD00343 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "effect"
    },
    {
        "text": "the following agents may increase certain actions or side effects of HD00522 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , HD00424 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "effect"
    },
    {
        "text": "the following agents may increase certain actions or side effects of HD00522 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , DB00454 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "effect"
    },
    {
        "text": "the following agents may increase certain actions or side effects of HD00522 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , DB14049 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "effect"
    },
    {
        "text": "the following agents may increase certain actions or side effects of HD00522 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and HD00635 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "effect"
    },
    {
        "text": "the following agents may increase certain actions or side effects of HD00522 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , HD00571 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "effect"
    },
    {
        "text": "the following agents may increase certain actions or side effects of HD00522 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , HD00043 , and other drugs having anticholinergic activity .",
        "label": "effect"
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : DB00915 , HD00954 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "NA"
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : DB00915 , ddrug2 { e , g , , DB00908 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "NA"
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : DB00915 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , HD00343 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "NA"
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : DB00915 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , DB14049 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "NA"
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : DB00915 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and HD00635 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "NA"
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : DB00915 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , HD00571 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "NA"
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : DB00915 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , HD00043 , and other drugs having anticholinergic activity .",
        "label": "NA"
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , HD00954 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , HD00343 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "NA"
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , HD00954 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , DB14049 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "NA"
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , HD00954 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and HD00635 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "NA"
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , HD00954 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , HD00571 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "NA"
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , HD00954 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , HD00043 , and other drugs having anticholinergic activity .",
        "label": "NA"
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , ddrug2 { e , g , , DB00908 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , HD00343 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "NA"
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , ddrug2 { e , g , , DB00908 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , DB14049 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "NA"
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , ddrug2 { e , g , , DB00908 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and HD00635 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "NA"
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , ddrug2 { e , g , , DB00908 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , HD00571 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "NA"
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , ddrug2 { e , g , , DB00908 } , ddrug4 , ddrug5 { e , g , , ddrug6 } , ddrug7 , ddrug8 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , HD00043 , and other drugs having anticholinergic activity .",
        "label": "NA"
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , HD00617 { e , g , , ddrug6 } , ddrug7 , HD00343 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "NA"
    },
    {
        "text": "the following agents may increase certain actions or side effects of ddrug0 : ddrug1 , ddrug2 { e , g , , ddrug3 } , ddrug4 , ddrug5 { e , g , , HD00219 } , ddrug7 , HD00343 , ddrug9 { e , g , , ddrug10 } , ddrug11 and ddrug12 , ddrug13 , ddrug14 , and other drugs having anticholinergic activity .",
        "label": "NA"
    },
    {
        "text": "HD00444 antagonize the effects of HD00618 .",
        "label": "effect"
    },
    {
        "text": "HD00522 in the presence of increased intraocular pressure may be hazardous when taken concurrently with agents such as HD00175 .",
        "label": "effect"
    },
    {
        "text": "HD00352 may affect gastrointestinal absorption of various drugs , such as slowly dissolving dosage forms of DB00390 ;",
        "label": "mechanism"
    },
    {
        "text": "HD00522 may antagonize the effects of drugs that alter gastrointestinal motility , such as DB01233 .",
        "label": "effect"
    },
    {
        "text": "because HD00374 may interfere with the absorption of HD00352 , simultaneous use of these drugs should be avoided .",
        "label": "mechanism"
    },
    {
        "text": "interaction with other ddrug0 : DB00454 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other HD00424 , general ddrug3 , ddrug4 , other ddrug5 , ddrug6 { including ddrug7 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "label": "advise"
    },
    {
        "text": "interaction with other ddrug0 : DB00454 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general HD00264 , ddrug4 , other ddrug5 , ddrug6 { including ddrug7 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "label": "advise"
    },
    {
        "text": "interaction with other ddrug0 : DB00454 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , HD00219 , other ddrug5 , ddrug6 { including ddrug7 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "label": "advise"
    },
    {
        "text": "interaction with other ddrug0 : DB00454 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , ddrug4 , other HD00262 , ddrug6 { including ddrug7 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "label": "advise"
    },
    {
        "text": "interaction with other ddrug0 : DB00454 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , ddrug4 , other ddrug5 , HD00460 { including ddrug7 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "label": "advise"
    },
    {
        "text": "interaction with other ddrug0 : DB00454 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , ddrug4 , other ddrug5 , ddrug6 { including HD00026 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "label": "advise"
    },
    {
        "text": "interaction with other ddrug0 : DB00454 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , ddrug4 , other ddrug5 , ddrug6 { including ddrug7 } , HD00043 and other ddrug9 { including ddrug10 } .",
        "label": "advise"
    },
    {
        "text": "interaction with other ddrug0 : DB00454 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , ddrug4 , other ddrug5 , ddrug6 { including ddrug7 } , ddrug8 and other HD00261 { including ddrug10 } .",
        "label": "advise"
    },
    {
        "text": "interaction with other ddrug0 : DB00454 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , ddrug4 , other ddrug5 , ddrug6 { including ddrug7 } , ddrug8 and other ddrug9 { including DB02325 } .",
        "label": "advise"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other HD00424 , general ddrug3 , HD00219 , other ddrug5 , ddrug6 { including ddrug7 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other HD00424 , general ddrug3 , ddrug4 , other HD00262 , ddrug6 { including ddrug7 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other HD00424 , general ddrug3 , ddrug4 , other ddrug5 , HD00460 { including ddrug7 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other HD00424 , general ddrug3 , ddrug4 , other ddrug5 , ddrug6 { including HD00026 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other HD00424 , general ddrug3 , ddrug4 , other ddrug5 , ddrug6 { including ddrug7 } , HD00043 and other ddrug9 { including ddrug10 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other HD00424 , general ddrug3 , ddrug4 , other ddrug5 , ddrug6 { including ddrug7 } , ddrug8 and other HD00261 { including ddrug10 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other HD00424 , general ddrug3 , ddrug4 , other ddrug5 , ddrug6 { including ddrug7 } , ddrug8 and other ddrug9 { including DB02325 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general HD00264 , HD00219 , other ddrug5 , ddrug6 { including ddrug7 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general HD00264 , ddrug4 , other HD00262 , ddrug6 { including ddrug7 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general HD00264 , ddrug4 , other ddrug5 , ddrug6 { including ddrug7 } , ddrug8 and other HD00261 { including ddrug10 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general HD00264 , ddrug4 , other ddrug5 , ddrug6 { including ddrug7 } , ddrug8 and other ddrug9 { including DB02325 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , HD00219 , other HD00262 , ddrug6 { including ddrug7 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , HD00219 , other ddrug5 , HD00460 { including ddrug7 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , HD00219 , other ddrug5 , ddrug6 { including HD00026 } , ddrug8 and other ddrug9 { including ddrug10 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , HD00219 , other ddrug5 , ddrug6 { including ddrug7 } , HD00043 and other ddrug9 { including ddrug10 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , HD00219 , other ddrug5 , ddrug6 { including ddrug7 } , ddrug8 and other HD00261 { including ddrug10 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , HD00219 , other ddrug5 , ddrug6 { including ddrug7 } , ddrug8 and other ddrug9 { including DB02325 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , ddrug4 , other HD00262 , ddrug6 { including ddrug7 } , ddrug8 and other HD00261 { including ddrug10 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , ddrug4 , other HD00262 , ddrug6 { including ddrug7 } , ddrug8 and other ddrug9 { including DB02325 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , ddrug4 , other ddrug5 , HD00460 { including ddrug7 } , ddrug8 and other HD00261 { including ddrug10 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , ddrug4 , other ddrug5 , HD00460 { including ddrug7 } , ddrug8 and other ddrug9 { including DB02325 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , ddrug4 , other ddrug5 , ddrug6 { including HD00026 } , ddrug8 and other HD00261 { including ddrug10 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , ddrug4 , other ddrug5 , ddrug6 { including HD00026 } , ddrug8 and other ddrug9 { including DB02325 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , ddrug4 , other ddrug5 , ddrug6 { including ddrug7 } , HD00043 and other HD00261 { including ddrug10 } .",
        "label": "NA"
    },
    {
        "text": "interaction with other ddrug0 : ddrug1 should be used with rxfp2 caution and in reduced dosage in patients who are concurrently receiving other ddrug2 , general ddrug3 , ddrug4 , other ddrug5 , ddrug6 { including ddrug7 } , HD00043 and other ddrug9 { including DB02325 } .",
        "label": "NA"
    },
    {
        "text": "some HD00282 may interact with DB00532 .",
        "label": "int"
    },
    {
        "text": "those HD00282 include DB00313 , ddrug2 , and ddrug3 .",
        "label": "NA"
    },
    {
        "text": "those HD00282 include ddrug1 , DB00313 , and ddrug3 .",
        "label": "NA"
    },
    {
        "text": "those HD00282 include ddrug1 , ddrug2 , and DB01174 .",
        "label": "NA"
    },
    {
        "text": "DB00532 may also affect the effects of other drugs , which include some HD00955 , ddrug2 , certain heart medicines , birth control pills , ddrug3 , ddrug4 and ddrug5 please note that ddrug6 may interact with other drugs that are not listed here .",
        "label": "effect"
    },
    {
        "text": "DB00532 may also affect the effects of other drugs , which include some ddrug1 , DB00682 , certain heart medicines , birth control pills , ddrug3 , ddrug4 and ddrug5 please note that ddrug6 may interact with other drugs that are not listed here .",
        "label": "effect"
    },
    {
        "text": "DB00532 may also affect the effects of other drugs , which include some ddrug1 , ddrug2 , certain heart medicines , birth control pills , HD00956 , ddrug4 and ddrug5 please note that ddrug6 may interact with other drugs that are not listed here .",
        "label": "effect"
    },
    {
        "text": "DB00532 may also affect the effects of other drugs , which include some ddrug1 , ddrug2 , certain heart medicines , birth control pills , ddrug3 , DB00695 and ddrug5 please note that ddrug6 may interact with other drugs that are not listed here .",
        "label": "effect"
    },
    {
        "text": "DB00532 may also affect the effects of other drugs , which include some ddrug1 , ddrug2 , certain heart medicines , birth control pills , ddrug3 , ddrug4 and DB00277 please note that ddrug6 may interact with other drugs that are not listed here .",
        "label": "effect"
    },
    {
        "text": "ddrug0 may also affect the effects of other drugs , which include some HD00955 , DB00682 , certain heart medicines , birth control pills , ddrug3 , ddrug4 and ddrug5 please note that ddrug6 may interact with other drugs that are not listed here .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may also affect the effects of other drugs , which include some HD00955 , ddrug2 , certain heart medicines , birth control pills , HD00956 , ddrug4 and ddrug5 please note that ddrug6 may interact with other drugs that are not listed here .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may also affect the effects of other drugs , which include some HD00955 , ddrug2 , certain heart medicines , birth control pills , ddrug3 , DB00695 and ddrug5 please note that ddrug6 may interact with other drugs that are not listed here .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may also affect the effects of other drugs , which include some HD00955 , ddrug2 , certain heart medicines , birth control pills , ddrug3 , ddrug4 and DB00277 please note that ddrug6 may interact with other drugs that are not listed here .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may also affect the effects of other drugs , which include some HD00955 , ddrug2 , certain heart medicines , birth control pills , ddrug3 , ddrug4 and ddrug5 please note that DB00532 may interact with other drugs that are not listed here .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may also affect the effects of other drugs , which include some ddrug1 , DB00682 , certain heart medicines , birth control pills , HD00956 , ddrug4 and ddrug5 please note that ddrug6 may interact with other drugs that are not listed here .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may also affect the effects of other drugs , which include some ddrug1 , DB00682 , certain heart medicines , birth control pills , ddrug3 , DB00695 and ddrug5 please note that ddrug6 may interact with other drugs that are not listed here .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may also affect the effects of other drugs , which include some ddrug1 , DB00682 , certain heart medicines , birth control pills , ddrug3 , ddrug4 and DB00277 please note that ddrug6 may interact with other drugs that are not listed here .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may also affect the effects of other drugs , which include some ddrug1 , DB00682 , certain heart medicines , birth control pills , ddrug3 , ddrug4 and ddrug5 please note that DB00532 may interact with other drugs that are not listed here .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may also affect the effects of other drugs , which include some ddrug1 , ddrug2 , certain heart medicines , birth control pills , HD00956 , DB00695 and ddrug5 please note that ddrug6 may interact with other drugs that are not listed here .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may also affect the effects of other drugs , which include some ddrug1 , ddrug2 , certain heart medicines , birth control pills , HD00956 , ddrug4 and DB00277 please note that ddrug6 may interact with other drugs that are not listed here .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may also affect the effects of other drugs , which include some ddrug1 , ddrug2 , certain heart medicines , birth control pills , HD00956 , ddrug4 and ddrug5 please note that DB00532 may interact with other drugs that are not listed here .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may also affect the effects of other drugs , which include some ddrug1 , ddrug2 , certain heart medicines , birth control pills , ddrug3 , DB00695 and DB00277 please note that ddrug6 may interact with other drugs that are not listed here .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may also affect the effects of other drugs , which include some ddrug1 , ddrug2 , certain heart medicines , birth control pills , ddrug3 , DB00695 and ddrug5 please note that DB00532 may interact with other drugs that are not listed here .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may also affect the effects of other drugs , which include some ddrug1 , ddrug2 , certain heart medicines , birth control pills , ddrug3 , ddrug4 and DB00277 please note that DB00532 may interact with other drugs that are not listed here .",
        "label": "NA"
    },
    {
        "text": "DB01071 can interact with HD00957 , ddrug2 , ddrug3 , ddrug4 , and ddrug5 .",
        "label": "int"
    },
    {
        "text": "DB01071 can interact with ddrug1 , HD00958 , ddrug3 , ddrug4 , and ddrug5 .",
        "label": "int"
    },
    {
        "text": "DB01071 can interact with ddrug1 , ddrug2 , HD00312 , ddrug4 , and ddrug5 .",
        "label": "int"
    },
    {
        "text": "DB01071 can interact with ddrug1 , ddrug2 , ddrug3 , HD00546 , and ddrug5 .",
        "label": "int"
    },
    {
        "text": "DB01071 can interact with ddrug1 , ddrug2 , ddrug3 , ddrug4 , and DB02325 .",
        "label": "int"
    },
    {
        "text": "DB01032 competes with DB00760 for active tubular secretion and thus inhibits the renal excretion of ddrug2 .",
        "label": "mechanism"
    },
    {
        "text": "DB01032 competes with ddrug1 for active tubular secretion and thus inhibits the renal excretion of DB00760 .",
        "label": "NA"
    },
    {
        "text": "therefore , the coadministration of DB01032 with DB00760 is not recommended .",
        "label": "advise"
    },
    {
        "text": "there is evidence that DB00760 may reduce serum levels of DB00313 to subtherapeutic levels { therapeutic range considered to be # to # g/ml total ddrug2 } .",
        "label": "mechanism"
    },
    {
        "text": "there is evidence that DB00760 may reduce serum levels of ddrug1 to subtherapeutic levels { therapeutic range considered to be # to # g/ml total DB00313 } .",
        "label": "NA"
    },
    {
        "text": "there is evidence that ddrug0 may reduce serum levels of DB00313 to subtherapeutic levels { therapeutic range considered to be # to # g/ml total DB00313 } .",
        "label": "NA"
    },
    {
        "text": "HD00959 should be used with caution in digitalized patients , since the combination of HD00118 and ddrug2 may cause ectopic arrhythmias .",
        "label": "NA"
    },
    {
        "text": "HD00959 should be used with caution in digitalized patients , since the combination of ddrug1 and HD00399 may cause ectopic arrhythmias .",
        "label": "NA"
    },
    {
        "text": "ddrug0 should be used with caution in digitalized patients , since the combination of HD00118 and HD00399 may cause ectopic arrhythmias .",
        "label": "effect"
    },
    {
        "text": "HD00275 or HD00043 may potentiate the action of ddrug2 .",
        "label": "NA"
    },
    {
        "text": "HD00275 or ddrug1 may potentiate the action of HD00399 .",
        "label": "effect"
    },
    {
        "text": "ddrug0 or HD00043 may potentiate the action of HD00399 .",
        "label": "effect"
    },
    {
        "text": "DB00660 may enhance the effects of DB02325 , ddrug2 and other ddrug3 .",
        "label": "effect"
    },
    {
        "text": "DB00660 may enhance the effects of ddrug1 , HD00026 and other ddrug3 .",
        "label": "effect"
    },
    {
        "text": "DB00660 may enhance the effects of ddrug1 , ddrug2 and other HD00261 .",
        "label": "effect"
    },
    {
        "text": "caution is advised for patients receiving high-dose DB00945 and DB00703 concomitantly , as anorexia , tachypnea , lethargy , coma and death have been reported with concomitant use of high-dose ddrug2 and ddrug3 .",
        "label": "advise"
    },
    {
        "text": "caution is advised for patients receiving high-dose DB00945 and ddrug1 concomitantly , as anorexia , tachypnea , lethargy , coma and death have been reported with concomitant use of high-dose ddrug2 and HD00442 .",
        "label": "NA"
    },
    {
        "text": "caution is advised for patients receiving high-dose ddrug0 and DB00703 concomitantly , as anorexia , tachypnea , lethargy , coma and death have been reported with concomitant use of high-dose DB00945 and ddrug3 .",
        "label": "NA"
    },
    {
        "text": "caution is advised for patients receiving high-dose ddrug0 and DB00703 concomitantly , as anorexia , tachypnea , lethargy , coma and death have been reported with concomitant use of high-dose ddrug2 and HD00442 .",
        "label": "NA"
    },
    {
        "text": "caution is advised for patients receiving high-dose ddrug0 and ddrug1 concomitantly , as anorexia , tachypnea , lethargy , coma and death have been reported with concomitant use of high-dose DB00945 and HD00442 .",
        "label": "effect"
    },
    {
        "text": "ddrug0 { oral } : the activity of oral HD00326 may be potentiated by anti-vitamin-k activity attributed to DB00763 .",
        "label": "effect"
    },
    {
        "text": "dosages of concomitantly administered HD00263 should be reduced by approximately half , because DB01403 amplifies the therapeutic actions and side-effects of ddrug2 .",
        "label": "effect"
    },
    {
        "text": "dosages of concomitantly administered ddrug0 should be reduced by approximately half , because DB01403 amplifies the therapeutic actions and side-effects of HD00263 .",
        "label": "effect"
    },
    {
        "text": "additive sedative effects and confusional states may emerge if DB01403 is given with HD00100 or ddrug2 .",
        "label": "effect"
    },
    {
        "text": "additive sedative effects and confusional states may emerge if DB01403 is given with ddrug1 or HD00026 .",
        "label": "effect"
    },
    {
        "text": "additive sedative effects and confusional states may emerge if ddrug0 is given with HD00100 or HD00026 .",
        "label": "NA"
    },
    {
        "text": "exert particular caution in combining DB01403 with other HD00522 { ddrug2 and ddrug3 } : particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .",
        "label": "advise"
    },
    {
        "text": "exert particular caution in combining DB01403 with other ddrug1 { HD00043 and ddrug3 } : particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .",
        "label": "advise"
    },
    {
        "text": "exert particular caution in combining DB01403 with other ddrug1 { ddrug2 and HD00960 } : particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .",
        "label": "advise"
    },
    {
        "text": "DB00201 and/or stimulantes of the DB01364 / ddrug2 type may counteract the specific actions of ddrug3 .",
        "label": "NA"
    },
    {
        "text": "DB00201 and/or stimulantes of the ddrug1 / DB00182 type may counteract the specific actions of ddrug3 .",
        "label": "NA"
    },
    {
        "text": "DB00201 and/or stimulantes of the ddrug1 / ddrug2 type may counteract the specific actions of DB01403 .",
        "label": "effect"
    },
    {
        "text": "ddrug0 and/or stimulantes of the DB01364 / ddrug2 type may counteract the specific actions of DB01403 .",
        "label": "effect"
    },
    {
        "text": "ddrug0 and/or stimulantes of the ddrug1 / DB00182 type may counteract the specific actions of DB01403 .",
        "label": "effect"
    },
    {
        "text": "since DB05246 { ddrug1 } may interact with concurrently administered HD00703 , periodic serum level determinations of these drugs may be necessary { eg ddrug3 may increase the plasma concentrations of ddrug4 and ddrug5 } .",
        "label": "advise"
    },
    {
        "text": "since DB05246 { ddrug1 } may interact with concurrently administered ddrug2 , periodic serum level determinations of these drugs may be necessary { eg DB05246 may increase the plasma concentrations of ddrug4 and ddrug5 } .",
        "label": "NA"
    },
    {
        "text": "since DB05246 { ddrug1 } may interact with concurrently administered ddrug2 , periodic serum level determinations of these drugs may be necessary { eg ddrug3 may increase the plasma concentrations of DB00252 and ddrug5 } .",
        "label": "NA"
    },
    {
        "text": "since DB05246 { ddrug1 } may interact with concurrently administered ddrug2 , periodic serum level determinations of these drugs may be necessary { eg ddrug3 may increase the plasma concentrations of ddrug4 and DB01174 } .",
        "label": "NA"
    },
    {
        "text": "since ddrug0 { DB05246 } may interact with concurrently administered HD00703 , periodic serum level determinations of these drugs may be necessary { eg ddrug3 may increase the plasma concentrations of ddrug4 and ddrug5 } .",
        "label": "advise"
    },
    {
        "text": "since ddrug0 { DB05246 } may interact with concurrently administered ddrug2 , periodic serum level determinations of these drugs may be necessary { eg ddrug3 may increase the plasma concentrations of DB00252 and ddrug5 } .",
        "label": "NA"
    },
    {
        "text": "since ddrug0 { DB05246 } may interact with concurrently administered ddrug2 , periodic serum level determinations of these drugs may be necessary { eg ddrug3 may increase the plasma concentrations of ddrug4 and DB01174 } .",
        "label": "NA"
    },
    {
        "text": "since ddrug0 { ddrug1 } may interact with concurrently administered HD00703 , periodic serum level determinations of these drugs may be necessary { eg DB05246 may increase the plasma concentrations of ddrug4 and ddrug5 } .",
        "label": "NA"
    },
    {
        "text": "since ddrug0 { ddrug1 } may interact with concurrently administered HD00703 , periodic serum level determinations of these drugs may be necessary { eg ddrug3 may increase the plasma concentrations of DB00252 and ddrug5 } .",
        "label": "NA"
    },
    {
        "text": "since ddrug0 { ddrug1 } may interact with concurrently administered HD00703 , periodic serum level determinations of these drugs may be necessary { eg ddrug3 may increase the plasma concentrations of ddrug4 and DB01174 } .",
        "label": "NA"
    },
    {
        "text": "since ddrug0 { ddrug1 } may interact with concurrently administered ddrug2 , periodic serum level determinations of these drugs may be necessary { eg DB05246 may increase the plasma concentrations of DB00252 and ddrug5 } .",
        "label": "mechanism"
    },
    {
        "text": "since ddrug0 { ddrug1 } may interact with concurrently administered ddrug2 , periodic serum level determinations of these drugs may be necessary { eg DB05246 may increase the plasma concentrations of ddrug4 and DB01174 } .",
        "label": "mechanism"
    },
    {
        "text": "since ddrug0 { ddrug1 } may interact with concurrently administered ddrug2 , periodic serum level determinations of these drugs may be necessary { eg ddrug3 may increase the plasma concentrations of DB00252 and DB01174 } .",
        "label": "NA"
    },
    {
        "text": "hypokalemia may develop during concomitant use of HD00356 or DB01285 .",
        "label": "NA"
    },
    {
        "text": "HD00217 may decrease arterial responsiveness to DB00368 .",
        "label": "effect"
    },
    {
        "text": "HD00788 may increase the responsiveness of DB01199 .",
        "label": "effect"
    },
    {
        "text": "DB14507 renal clearance is reduced by HD00217 , increasing the risk of ddrug2 toxicity .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 renal clearance is reduced by HD00217 , increasing the risk of DB14507 toxicity .",
        "label": "NA"
    },
    {
        "text": "HD00217 may add to or potentiate the action of other HD00448 .",
        "label": "effect"
    },
    {
        "text": "potentiation occurs with HD00747 or HD00748 .",
        "label": "NA"
    },
    {
        "text": "when DB00968 is used with other HD00448 , potentiation of antihypertensive effect may occur .",
        "label": "effect"
    },
    {
        "text": "patients may require reduced doses of HD00264 when on DB00968 .",
        "label": "advise"
    },
    {
        "text": "when DB00968 and DB14507 are given concomitantly the patient should be carefully monitored for symptoms of ddrug2 toxicity .",
        "label": "advise"
    },
    {
        "text": "when DB00968 and ddrug1 are given concomitantly the patient should be carefully monitored for symptoms of DB14507 toxicity .",
        "label": "NA"
    },
    {
        "text": "several studies demonstrate a decrease in the bioavailability of DB00968 when it is ingested with DB01373 or ddrug2 .",
        "label": "mechanism"
    },
    {
        "text": "several studies demonstrate a decrease in the bioavailability of DB00968 when it is ingested with ddrug1 or DB14488 .",
        "label": "mechanism"
    },
    {
        "text": "several studies demonstrate a decrease in the bioavailability of ddrug0 when it is ingested with DB01373 or DB14488 .",
        "label": "NA"
    },
    {
        "text": "coadministration of DB00968 with DB01373 or ddrug2 is not recommended .",
        "label": "advise"
    },
    {
        "text": "coadministration of DB00968 with ddrug1 or DB14488 is not recommended .",
        "label": "advise"
    },
    {
        "text": "coadministration of ddrug0 with DB01373 or DB14488 is not recommended .",
        "label": "NA"
    },
    {
        "text": "DB00968 does not interfere with measurement of HD00961 { ddrug2 } , a test for pheochromocytoma , by those methods which convert ddrug3 to ddrug4 .",
        "label": "NA"
    },
    {
        "text": "DB00968 does not interfere with measurement of ddrug1 { HD00962 } , a test for pheochromocytoma , by those methods which convert ddrug3 to ddrug4 .",
        "label": "NA"
    },
    {
        "text": "DB00968 does not interfere with measurement of ddrug1 { ddrug2 } , a test for pheochromocytoma , by those methods which convert HD00961 to ddrug4 .",
        "label": "NA"
    },
    {
        "text": "DB00968 does not interfere with measurement of ddrug1 { ddrug2 } , a test for pheochromocytoma , by those methods which convert ddrug3 to HD00963 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 does not interfere with measurement of HD00961 { ddrug2 } , a test for pheochromocytoma , by those methods which convert ddrug3 to HD00963 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 does not interfere with measurement of ddrug1 { HD00962 } , a test for pheochromocytoma , by those methods which convert HD00961 to ddrug4 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 does not interfere with measurement of ddrug1 { HD00962 } , a test for pheochromocytoma , by those methods which convert ddrug3 to HD00963 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 does not interfere with measurement of ddrug1 { ddrug2 } , a test for pheochromocytoma , by those methods which convert HD00961 to HD00963 .",
        "label": "NA"
    },
    {
        "text": "cyp 3a4 inhibitors { e , g , HD00093 and ddrug1 } there have been rare reports of serious adverse events in connection with the coadministration of certain HD00964 { e , g , ddrug3 and ddrug4 } and potent ppig 3a4 inhibitors , resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .",
        "label": "NA"
    },
    {
        "text": "cyp 3a4 inhibitors { e , g , HD00093 and ddrug1 } there have been rare reports of serious adverse events in connection with the coadministration of certain ddrug2 { e , g , DB00320 and ddrug4 } and potent ppig 3a4 inhibitors , resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .",
        "label": "NA"
    },
    {
        "text": "cyp 3a4 inhibitors { e , g , HD00093 and ddrug1 } there have been rare reports of serious adverse events in connection with the coadministration of certain ddrug2 { e , g , ddrug3 and DB00201 } and potent ppig 3a4 inhibitors , resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .",
        "label": "NA"
    },
    {
        "text": "cyp 3a4 inhibitors { e , g , ddrug0 and HD00269 } there have been rare reports of serious adverse events in connection with the coadministration of certain HD00964 { e , g , ddrug3 and ddrug4 } and potent ppig 3a4 inhibitors , resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .",
        "label": "NA"
    },
    {
        "text": "cyp 3a4 inhibitors { e , g , ddrug0 and HD00269 } there have been rare reports of serious adverse events in connection with the coadministration of certain ddrug2 { e , g , DB00320 and ddrug4 } and potent ppig 3a4 inhibitors , resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .",
        "label": "NA"
    },
    {
        "text": "cyp 3a4 inhibitors { e , g , ddrug0 and HD00269 } there have been rare reports of serious adverse events in connection with the coadministration of certain ddrug2 { e , g , ddrug3 and DB00201 } and potent ppig 3a4 inhibitors , resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .",
        "label": "NA"
    },
    {
        "text": "examples of some of the more potent cyp 3a4 inhibitors include ddrug0 { e , g , , ddrug1 , ddrug2 , ddrug3 } , HD00324 or HD00057 { e , g , , ddrug6 , ddrug7 , ddrug8 , ddrug9 } or ddrug10 { e , g , , ddrug11 , ddrug12 , ddrug13 } .",
        "label": "NA"
    },
    {
        "text": "examples of some of the more potent cyp 3a4 inhibitors include ddrug0 { e , g , , ddrug1 , ddrug2 , ddrug3 } , HD00324 or ddrug5 { e , g , , ddrug6 , ddrug7 , ddrug8 , ddrug9 } or HD00270 { e , g , , ddrug11 , ddrug12 , ddrug13 } .",
        "label": "NA"
    },
    {
        "text": "examples of some of the more potent cyp 3a4 inhibitors include ddrug0 { e , g , , ddrug1 , ddrug2 , ddrug3 } , HD00324 or ddrug5 { e , g , , ddrug6 , ddrug7 , ddrug8 , ddrug9 } or ddrug10 { e , g , , DB01026 , ddrug12 , ddrug13 } .",
        "label": "NA"
    },
    {
        "text": "examples of some of the more potent cyp 3a4 inhibitors include ddrug0 { e , g , , ddrug1 , ddrug2 , ddrug3 } , HD00324 or ddrug5 { e , g , , ddrug6 , ddrug7 , ddrug8 , ddrug9 } or ddrug10 { e , g , , ddrug11 , DB01167 , ddrug13 } .",
        "label": "NA"
    },
    {
        "text": "examples of some of the more potent cyp 3a4 inhibitors include ddrug0 { e , g , , ddrug1 , ddrug2 , ddrug3 } , HD00324 or ddrug5 { e , g , , ddrug6 , ddrug7 , ddrug8 , ddrug9 } or ddrug10 { e , g , , ddrug11 , ddrug12 , DB00582 } .",
        "label": "NA"
    },
    {
        "text": "caution should be exercised when DB00353 { ddrug1 } is used concurrently with other HD00622 or ddrug3 .",
        "label": "advise"
    },
    {
        "text": "caution should be exercised when DB00353 { ddrug1 } is used concurrently with other ddrug2 or HD00443 .",
        "label": "advise"
    },
    {
        "text": "caution should be exercised when ddrug0 { DB00353 } is used concurrently with other HD00622 or ddrug3 .",
        "label": "advise"
    },
    {
        "text": "caution should be exercised when ddrug0 { DB00353 } is used concurrently with other ddrug2 or HD00443 .",
        "label": "NA"
    },
    {
        "text": "caution should be exercised when ddrug0 { ddrug1 } is used concurrently with other HD00622 or HD00443 .",
        "label": "NA"
    },
    {
        "text": "DB00422 may decrease the hypotensive effect of DB01170 .",
        "label": "effect"
    },
    {
        "text": "human pharmacologic studies have shown that DB00422 may inhibit the metabolism of HD00423 , ddrug2 { ddrug3 , ddrug4 , ddrug5 } , ddrug6 , and ddrug7 { ddrug8 , ddrug9 , ddrug10 } .",
        "label": "mechanism"
    },
    {
        "text": "human pharmacologic studies have shown that DB00422 may inhibit the metabolism of ddrug1 , HD00282 { ddrug3 , ddrug4 , ddrug5 } , ddrug6 , and ddrug7 { ddrug8 , ddrug9 , ddrug10 } .",
        "label": "mechanism"
    },
    {
        "text": "human pharmacologic studies have shown that DB00422 may inhibit the metabolism of ddrug1 , ddrug2 { DB01174 , ddrug4 , ddrug5 } , ddrug6 , and ddrug7 { ddrug8 , ddrug9 , ddrug10 } .",
        "label": "mechanism"
    },
    {
        "text": "human pharmacologic studies have shown that DB00422 may inhibit the metabolism of ddrug1 , ddrug2 { ddrug3 , DB00252 , ddrug5 } , ddrug6 , and ddrug7 { ddrug8 , ddrug9 , ddrug10 } .",
        "label": "mechanism"
    },
    {
        "text": "human pharmacologic studies have shown that DB00422 may inhibit the metabolism of ddrug1 , ddrug2 { ddrug3 , ddrug4 , DB00794 } , ddrug6 , and ddrug7 { ddrug8 , ddrug9 , ddrug10 } .",
        "label": "mechanism"
    },
    {
        "text": "human pharmacologic studies have shown that DB00422 may inhibit the metabolism of ddrug1 , ddrug2 { ddrug3 , ddrug4 , ddrug5 } , DB00812 , and ddrug7 { ddrug8 , ddrug9 , ddrug10 } .",
        "label": "mechanism"
    },
    {
        "text": "human pharmacologic studies have shown that DB00422 may inhibit the metabolism of ddrug1 , ddrug2 { ddrug3 , ddrug4 , ddrug5 } , ddrug6 , and HD00965 { ddrug8 , ddrug9 , ddrug10 } .",
        "label": "mechanism"
    },
    {
        "text": "human pharmacologic studies have shown that DB00422 may inhibit the metabolism of ddrug1 , ddrug2 { ddrug3 , ddrug4 , ddrug5 } , ddrug6 , and ddrug7 { DB00458 , ddrug9 , ddrug10 } .",
        "label": "mechanism"
    },
    {
        "text": "human pharmacologic studies have shown that DB00422 may inhibit the metabolism of ddrug1 , ddrug2 { ddrug3 , ddrug4 , ddrug5 } , ddrug6 , and ddrug7 { ddrug8 , DB01242 , ddrug10 } .",
        "label": "mechanism"
    },
    {
        "text": "human pharmacologic studies have shown that DB00422 may inhibit the metabolism of ddrug1 , ddrug2 { ddrug3 , ddrug4 , ddrug5 } , ddrug6 , and ddrug7 { ddrug8 , ddrug9 , DB01151 } .",
        "label": "mechanism"
    },
    {
        "text": "the safety of using DB00422 in combination with DB00575 or other centrally acting ddrug2 has not been systemically evaluated .",
        "label": "NA"
    },
    {
        "text": "the safety of using DB00422 in combination with ddrug1 or other centrally acting HD00966 has not been systemically evaluated .",
        "label": "NA"
    },
    {
        "text": "the safety of using ddrug0 in combination with DB00575 or other centrally acting HD00966 has not been systemically evaluated .",
        "label": "NA"
    },
    {
        "text": "mutual inhibition of metabolism occurs with concurrent use of DB00091 and DB00959 ;",
        "label": "mechanism"
    },
    {
        "text": "convulsions have been reported with concurrent use of DB00959 and DB00091 .",
        "label": "effect"
    },
    {
        "text": "drugs that induce hepatic enzymes such as DB01174 , ddrug1 , and ddrug2 may increase the clearance of DB00959 and may require increased in ddrug4 dose to achieve the desired response .",
        "label": "mechanism"
    },
    {
        "text": "drugs that induce hepatic enzymes such as DB01174 , ddrug1 , and ddrug2 may increase the clearance of ddrug3 and may require increased in DB00959 dose to achieve the desired response .",
        "label": "advise"
    },
    {
        "text": "drugs that induce hepatic enzymes such as ddrug0 , DB00252 , and ddrug2 may increase the clearance of DB00959 and may require increased in ddrug4 dose to achieve the desired response .",
        "label": "mechanism"
    },
    {
        "text": "drugs that induce hepatic enzymes such as ddrug0 , DB00252 , and ddrug2 may increase the clearance of ddrug3 and may require increased in DB00959 dose to achieve the desired response .",
        "label": "advise"
    },
    {
        "text": "drugs that induce hepatic enzymes such as ddrug0 , ddrug1 , and DB01045 may increase the clearance of DB00959 and may require increased in ddrug4 dose to achieve the desired response .",
        "label": "mechanism"
    },
    {
        "text": "drugs that induce hepatic enzymes such as ddrug0 , ddrug1 , and DB01045 may increase the clearance of ddrug3 and may require increased in DB00959 dose to achieve the desired response .",
        "label": "advise"
    },
    {
        "text": "drugs such as DB13179 and DB01026 may inhibit the metabolism of ddrug2 and thus decrease its clearance .",
        "label": "NA"
    },
    {
        "text": "drugs such as DB13179 and ddrug1 may inhibit the metabolism of DB00959 and thus decrease its clearance .",
        "label": "mechanism"
    },
    {
        "text": "drugs such as ddrug0 and DB01026 may inhibit the metabolism of DB00959 and thus decrease its clearance .",
        "label": "mechanism"
    },
    {
        "text": "DB00959 may increase the clearance of chronic high dose DB00945 .",
        "label": "mechanism"
    },
    {
        "text": "this could lead to decreased HD00372 serum levels or increase the risk of ddrug1 toxicity when DB00959 is withdrawn .",
        "label": "NA"
    },
    {
        "text": "this could lead to decreased ddrug0 serum levels or increase the risk of HD00372 toxicity when DB00959 is withdrawn .",
        "label": "effect"
    },
    {
        "text": "DB00945 should be used cautiously in conjunction with HD00175 in patients suffering from hypoprothrombinemia .",
        "label": "advise"
    },
    {
        "text": "the effect of DB00959 on oral HD00326 is variable .",
        "label": "NA"
    },
    {
        "text": "there are reports of enhanced as well as diminished effects of HD00025 when given concurrently with HD00175 .",
        "label": "effect"
    },
    {
        "text": "DB11315 may interact with HD00216 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "DB11315 may interact with ddrug1 { HD00351 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "label": "int"
    },
    {
        "text": "DB11315 may interact with ddrug1 { ddrug2 type } , HD00343 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "label": "int"
    },
    {
        "text": "DB11315 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , DB00780 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "label": "int"
    },
    {
        "text": "DB11315 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , DB00601 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "label": "int"
    },
    {
        "text": "DB11315 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , DB00752 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "label": "int"
    },
    {
        "text": "DB11315 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , DB01247 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "label": "int"
    },
    {
        "text": "DB11315 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , DB01037 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "label": "int"
    },
    {
        "text": "DB11315 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , DB00614 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "label": "int"
    },
    {
        "text": "DB11315 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , DB00908 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "label": "int"
    },
    {
        "text": "DB11315 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , DB00915 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "label": "int"
    },
    {
        "text": "DB11315 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , HD00388 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "label": "int"
    },
    {
        "text": "DB11315 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , DB14487 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "label": "int"
    },
    {
        "text": "DB11315 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other HD00444 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "label": "int"
    },
    {
        "text": "DB11315 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , DB00761 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "label": "int"
    },
    {
        "text": "DB11315 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , HD00374 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "label": "int"
    },
    {
        "text": "DB11315 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , HD00967 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "label": "int"
    },
    {
        "text": "DB11315 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , DB01575 - ddrug19 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "label": "int"
    },
    {
        "text": "DB11315 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - DB11158 } , ddrug20 { e , g , , ddrug21 , ddrug22 } .",
        "label": "int"
    },
    {
        "text": "DB11315 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , HD00219 { e , g , , ddrug21 , ddrug22 } .",
        "label": "int"
    },
    {
        "text": "DB11315 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , DB00477 , ddrug22 } .",
        "label": "int"
    },
    {
        "text": "DB11315 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , DB01069 } .",
        "label": "int"
    },
    {
        "text": "ddrug0 may interact with HD00216 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , HD00219 { e , g , , ddrug21 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with HD00216 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , DB00477 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with HD00216 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , DB01069 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { HD00351 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , HD00219 { e , g , , ddrug21 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { HD00351 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , DB00477 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { HD00351 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , DB01069 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , HD00343 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , HD00219 { e , g , , ddrug21 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , HD00343 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , DB00477 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , HD00343 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , DB01069 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , DB00780 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , HD00219 { e , g , , ddrug21 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , DB00780 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , DB00477 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , DB00780 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , DB01069 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , DB00601 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , HD00219 { e , g , , ddrug21 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , DB00601 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , DB00477 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , DB00601 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , DB01069 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , DB00752 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , HD00219 { e , g , , ddrug21 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , DB00752 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , DB00477 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , DB00752 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , DB01069 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , DB01247 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , HD00219 { e , g , , ddrug21 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , DB01247 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , DB00477 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , DB01247 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , DB01069 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , DB01037 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , HD00219 { e , g , , ddrug21 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , DB01037 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , DB00477 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , DB01037 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , DB01069 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , DB00614 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , HD00219 { e , g , , ddrug21 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , DB00614 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , DB00477 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , DB00614 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , DB01069 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , DB00908 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , HD00219 { e , g , , ddrug21 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , DB00908 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , DB00477 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , DB00908 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , DB01069 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , DB00915 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , HD00219 { e , g , , ddrug21 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , DB00915 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , DB00477 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , DB00915 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , DB01069 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , HD00388 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , HD00219 { e , g , , ddrug21 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , HD00388 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , DB00477 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , HD00388 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , DB01069 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , DB14487 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , HD00219 { e , g , , ddrug21 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , DB14487 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , DB00477 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , DB14487 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , DB01069 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other HD00444 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , HD00219 { e , g , , ddrug21 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other HD00444 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , DB00477 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other HD00444 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , DB01069 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , DB00761 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , HD00219 { e , g , , ddrug21 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , DB00761 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , DB00477 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , DB00761 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , DB01069 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , HD00374 , ddrug17 { e , g , , ddrug18 - ddrug19 } , HD00219 { e , g , , ddrug21 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , HD00374 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , DB00477 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , HD00374 , ddrug17 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , DB01069 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , HD00967 { e , g , , ddrug18 - ddrug19 } , HD00219 { e , g , , ddrug21 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , HD00967 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , DB00477 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , HD00967 { e , g , , ddrug18 - ddrug19 } , ddrug20 { e , g , , ddrug21 , DB01069 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , DB01575 - ddrug19 } , HD00219 { e , g , , ddrug21 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , DB01575 - ddrug19 } , ddrug20 { e , g , , DB00477 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , DB01575 - ddrug19 } , ddrug20 { e , g , , ddrug21 , DB01069 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - DB11158 } , HD00219 { e , g , , ddrug21 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - DB11158 } , ddrug20 { e , g , , DB00477 , ddrug22 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may interact with ddrug1 { ddrug2 type } , ddrug3 { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 } , ddrug10 , ddrug11 , ddrug12 { e , g , , ddrug13 } , other ddrug14 , ddrug15 supplements , ddrug16 , ddrug17 { e , g , , ddrug18 - DB11158 } , ddrug20 { e , g , , ddrug21 , DB01069 } .",
        "label": "NA"
    },
    {
        "text": "concurrent use of DB02325 and other HD00968 may increase the cns depressant effects of ddrug2 or these other medications .",
        "label": "NA"
    },
    {
        "text": "concurrent use of DB02325 and other ddrug1 may increase the cns depressant effects of DB01107 or these other medications .",
        "label": "effect"
    },
    {
        "text": "concurrent use of ddrug0 and other HD00968 may increase the cns depressant effects of DB01107 or these other medications .",
        "label": "effect"
    },
    {
        "text": "DB00247 may reverse the analgesic activity of HD00424 .",
        "label": "effect"
    },
    {
        "text": "concurrent use with HD00969 including HD00443 , ddrug2 , and ddrug3 { e , g , smoking } may result in enhanced vasoconstriction .",
        "label": "NA"
    },
    {
        "text": "concurrent use with HD00969 including ddrug1 , DB00669 , and ddrug3 { e , g , smoking } may result in enhanced vasoconstriction .",
        "label": "NA"
    },
    {
        "text": "concurrent use with HD00969 including ddrug1 , ddrug2 , and DB00184 { e , g , smoking } may result in enhanced vasoconstriction .",
        "label": "NA"
    },
    {
        "text": "the effects of DB01233 on gastrointestinal motility are antagonized by HD00522 and ddrug2 .",
        "label": "effect"
    },
    {
        "text": "the effects of DB01233 on gastrointestinal motility are antagonized by ddrug1 and HD00424 .",
        "label": "effect"
    },
    {
        "text": "the effects of ddrug0 on gastrointestinal motility are antagonized by HD00522 and HD00424 .",
        "label": "NA"
    },
    {
        "text": "additive sedative effects can occur when DB01233 is given with DB02325 , ddrug2 , ddrug3 , ddrug4 , or ddrug5 .",
        "label": "effect"
    },
    {
        "text": "additive sedative effects can occur when DB01233 is given with ddrug1 , HD00024 , ddrug3 , ddrug4 , or ddrug5 .",
        "label": "effect"
    },
    {
        "text": "additive sedative effects can occur when DB01233 is given with ddrug1 , ddrug2 , HD00214 , ddrug4 , or ddrug5 .",
        "label": "effect"
    },
    {
        "text": "additive sedative effects can occur when DB01233 is given with ddrug1 , ddrug2 , ddrug3 , HD00543 , or ddrug5 .",
        "label": "effect"
    },
    {
        "text": "additive sedative effects can occur when DB01233 is given with ddrug1 , ddrug2 , ddrug3 , ddrug4 , or HD00262 .",
        "label": "effect"
    },
    {
        "text": "the finding that DB01233 releases catecholamines in patients with essential hypertension suggests that it should be used cautiously , if at all , in patients receiving HD00970 .",
        "label": "advise"
    },
    {
        "text": "absorption of drugs from the stomach may be diminished { e , g , , DB00390 } by DB01233 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased { e , g , , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 } .",
        "label": "mechanism"
    },
    {
        "text": "absorption of drugs from the stomach may be diminished { e , g , , DB00390 } by ddrug1 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased { e , g , , DB00316 , ddrug3 , ddrug4 , ddrug5 , ddrug6 } .",
        "label": "NA"
    },
    {
        "text": "absorption of drugs from the stomach may be diminished { e , g , , DB00390 } by ddrug1 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased { e , g , , ddrug2 , DB00759 , ddrug4 , ddrug5 , ddrug6 } .",
        "label": "NA"
    },
    {
        "text": "absorption of drugs from the stomach may be diminished { e , g , , DB00390 } by ddrug1 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased { e , g , , ddrug2 , ddrug3 , DB01235 , ddrug5 , ddrug6 } .",
        "label": "NA"
    },
    {
        "text": "absorption of drugs from the stomach may be diminished { e , g , , DB00390 } by ddrug1 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased { e , g , , ddrug2 , ddrug3 , ddrug4 , DB00898 , ddrug6 } .",
        "label": "NA"
    },
    {
        "text": "absorption of drugs from the stomach may be diminished { e , g , , DB00390 } by ddrug1 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased { e , g , , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB00091 } .",
        "label": "NA"
    },
    {
        "text": "absorption of drugs from the stomach may be diminished { e , g , , ddrug0 } by DB01233 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased { e , g , , DB00316 , ddrug3 , ddrug4 , ddrug5 , ddrug6 } .",
        "label": "mechanism"
    },
    {
        "text": "absorption of drugs from the stomach may be diminished { e , g , , ddrug0 } by DB01233 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased { e , g , , ddrug2 , DB00759 , ddrug4 , ddrug5 , ddrug6 } .",
        "label": "NA"
    },
    {
        "text": "absorption of drugs from the stomach may be diminished { e , g , , ddrug0 } by DB01233 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased { e , g , , ddrug2 , ddrug3 , DB01235 , ddrug5 , ddrug6 } .",
        "label": "NA"
    },
    {
        "text": "absorption of drugs from the stomach may be diminished { e , g , , ddrug0 } by DB01233 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased { e , g , , ddrug2 , ddrug3 , ddrug4 , DB00898 , ddrug6 } .",
        "label": "NA"
    },
    {
        "text": "absorption of drugs from the stomach may be diminished { e , g , , ddrug0 } by DB01233 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased { e , g , , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB00091 } .",
        "label": "NA"
    },
    {
        "text": "because the action of DB01233 will influence the delivery of food to the intestines and thus the rate of absorption , HD00071 dosage or timing of dosage may require adjustment .",
        "label": "advise"
    },
    {
        "text": "ddrug0 : DB00695 and probably other HD00105 given concomitantly with ddrug3 can cause unusually large or prolonged losses of fluid and electrolytes .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : DB00695 and probably other ddrug2 given concomitantly with DB00524 can cause unusually large or prolonged losses of fluid and electrolytes .",
        "label": "effect"
    },
    {
        "text": "ddrug0 : ddrug1 and probably other HD00105 given concomitantly with DB00524 can cause unusually large or prolonged losses of fluid and electrolytes .",
        "label": "effect"
    },
    {
        "text": "other ddrug0 : when HD00971 tablets are used with other HD00448 , care must be taken , especially during initial therapy .",
        "label": "advise"
    },
    {
        "text": "ddrug0 : HD00295 - induced hypokalemia can increase the sensitivity of the myocardium to HD00118 .",
        "label": "effect"
    },
    {
        "text": "HD00175 or DB01285 : may increase the risk of hypokalemia and increase salt and water retention .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : HD00295 - induced hypokalemia may enhance neuromuscular blocking effects of HD00972 { such as ddrug3 } the most serious effect would be respiratory_failure which could proceed to apnea .",
        "label": "effect"
    },
    {
        "text": "ddrug0 : HD00295 - induced hypokalemia may enhance neuromuscular blocking effects of ddrug2 { such as DB01199 } the most serious effect would be respiratory_failure which could proceed to apnea .",
        "label": "effect"
    },
    {
        "text": "HD00328 and other HD00330 : may decrease the antihypertensive effects of ddrug2 tablets .",
        "label": "NA"
    },
    {
        "text": "HD00328 and other ddrug1 : may decrease the antihypertensive effects of HD00971 tablets .",
        "label": "effect"
    },
    {
        "text": "ddrug0 and other HD00330 : may decrease the antihypertensive effects of HD00971 tablets .",
        "label": "effect"
    },
    {
        "text": "ddrug0 : DB00524 may decrease arterial responsiveness to DB00368 , but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use .",
        "label": "effect"
    },
    {
        "text": "DB06799 : efficacy may be decreased due to urinary alkalizing effect of DB00524 .",
        "label": "effect"
    },
    {
        "text": "HD00326 : DB00524 , as well as other ddrug2 , may affect the hypoprothrombinemic response to ddrug3 ;",
        "label": "NA"
    },
    {
        "text": "HD00326 : ddrug1 , as well as other HD00973 , may affect the hypoprothrombinemic response to ddrug3 ;",
        "label": "NA"
    },
    {
        "text": "ddrug0 : DB00524 , as well as other HD00973 , may affect the hypoprothrombinemic response to ddrug3 ;",
        "label": "NA"
    },
    {
        "text": "ddrug0 : DB00524 , as well as other ddrug2 , may affect the hypoprothrombinemic response to HD00326 ;",
        "label": "effect"
    },
    {
        "text": "ddrug0 : ddrug1 , as well as other HD00973 , may affect the hypoprothrombinemic response to HD00326 ;",
        "label": "NA"
    },
    {
        "text": "catecholamine-depleting drugs { e , g , , DB00206 } may have an additive effect when given with HD00228 .",
        "label": "effect"
    },
    {
        "text": "oral DB00916 has been reported to potentiate the anticoagulant effect of DB04665 and ddrug2 , resulting in a prolongation of prothrombin time .",
        "label": "effect"
    },
    {
        "text": "oral DB00916 has been reported to potentiate the anticoagulant effect of ddrug1 and DB00682 , resulting in a prolongation of prothrombin time .",
        "label": "effect"
    },
    {
        "text": "oral ddrug0 has been reported to potentiate the anticoagulant effect of DB04665 and DB00682 , resulting in a prolongation of prothrombin time .",
        "label": "NA"
    },
    {
        "text": "drug interactions should be kept in mind when DB00916 { ddrug1 gel } , 1 % is prescribed for patients who are receiving anticoagulant treatment , although they are less likely to occur with topical DB00916 administration because of low absorption .",
        "label": "NA"
    },
    {
        "text": "the metabolism of DB01011 is accelerated by DB00252 ;",
        "label": "mechanism"
    },
    {
        "text": "DB01011 inhibits the glucuronidation of DB00316 and could possibly potentiate ddrug2 toxicity .",
        "label": "mechanism"
    },
    {
        "text": "DB01011 inhibits the glucuronidation of ddrug1 and could possibly potentiate DB00316 toxicity .",
        "label": "effect"
    },
    {
        "text": "caution should be observed in administering DB00765 to patients receiving HD00219 or ddrug2 because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis .",
        "label": "advise"
    },
    {
        "text": "caution should be observed in administering DB00765 to patients receiving ddrug1 or DB00502 because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis .",
        "label": "advise"
    },
    {
        "text": "caution should be observed in administering ddrug0 to patients receiving HD00219 or DB00502 because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis .",
        "label": "NA"
    },
    {
        "text": "concurrent use of DB00765 with DB02325 or other ddrug2 can increase their sedative effects .",
        "label": "effect"
    },
    {
        "text": "concurrent use of DB00765 with ddrug1 or other HD00261 can increase their sedative effects .",
        "label": "effect"
    },
    {
        "text": "concurrent use of ddrug0 with DB02325 or other HD00261 can increase their sedative effects .",
        "label": "NA"
    },
    {
        "text": "since DB00379 is a substrate for the metabolic pathways involving cyp2d6 and cyp1a2 enzymes , inhibition or induction of either of these enzymes would be expected to alter DB00379 plasma concentrations .",
        "label": "NA"
    },
    {
        "text": "in a formal , single-dose interaction study { n = # males } the clearance of DB00379 was decreased by 38 % following the coadministration of DB00176 , an inhibitor of cyp1a2 .",
        "label": "mechanism"
    },
    {
        "text": "in another formal study { n = # extensive and n = # poor metabolizers of cyp2d6 } , coadministration of DB01182 did not alter the kinetics of DB00379 in the poor cyp2d6 metabolizer group .",
        "label": "NA"
    },
    {
        "text": "in this crossover steady state study , the pharmacokinetics of DB01182 were unaffected in either phenotype by the coadministration of DB00379 .",
        "label": "NA"
    },
    {
        "text": "addition of DB00379 to DB01182 did not lead to further electrocardiographic parameters changes of qrs , qtc , rr , and pr intervals than ddrug2 alone .",
        "label": "NA"
    },
    {
        "text": "addition of DB00379 to ddrug1 did not lead to further electrocardiographic parameters changes of qrs , qtc , rr , and pr intervals than DB01182 alone .",
        "label": "NA"
    },
    {
        "text": "in a large compassionate use program DB00379 has been used concurrently with commonly employed antianginal , HD00876 , and ddrug2 without observed interactions .",
        "label": "NA"
    },
    {
        "text": "in a large compassionate use program DB00379 has been used concurrently with commonly employed antianginal , ddrug1 , and HD00974 without observed interactions .",
        "label": "NA"
    },
    {
        "text": "in a large compassionate use program ddrug0 has been used concurrently with commonly employed antianginal , HD00876 , and HD00974 without observed interactions .",
        "label": "NA"
    },
    {
        "text": "a variety of HD00303 such as DB00908 or ddrug2 were also added , sometimes with improved control of ventricular ectopy .",
        "label": "NA"
    },
    {
        "text": "a variety of HD00303 such as ddrug1 or DB00571 were also added , sometimes with improved control of ventricular ectopy .",
        "label": "NA"
    },
    {
        "text": "a variety of ddrug0 such as DB00908 or DB00571 were also added , sometimes with improved control of ventricular ectopy .",
        "label": "NA"
    },
    {
        "text": "when DB00252 or other hepatic enzyme inducers such as DB01045 and ddrug2 have been taken concurrently with ddrug3 , lowered ddrug4 plasma levels have been reported .",
        "label": "NA"
    },
    {
        "text": "when DB00252 or other hepatic enzyme inducers such as ddrug1 and DB01174 have been taken concurrently with ddrug3 , lowered ddrug4 plasma levels have been reported .",
        "label": "NA"
    },
    {
        "text": "when DB00252 or other hepatic enzyme inducers such as ddrug1 and ddrug2 have been taken concurrently with DB00379 , lowered ddrug4 plasma levels have been reported .",
        "label": "mechanism"
    },
    {
        "text": "when DB00252 or other hepatic enzyme inducers such as ddrug1 and ddrug2 have been taken concurrently with ddrug3 , lowered DB00379 plasma levels have been reported .",
        "label": "NA"
    },
    {
        "text": "when ddrug0 or other hepatic enzyme inducers such as DB01045 and DB01174 have been taken concurrently with ddrug3 , lowered ddrug4 plasma levels have been reported .",
        "label": "NA"
    },
    {
        "text": "when ddrug0 or other hepatic enzyme inducers such as DB01045 and ddrug2 have been taken concurrently with DB00379 , lowered ddrug4 plasma levels have been reported .",
        "label": "mechanism"
    },
    {
        "text": "when ddrug0 or other hepatic enzyme inducers such as DB01045 and ddrug2 have been taken concurrently with ddrug3 , lowered DB00379 plasma levels have been reported .",
        "label": "NA"
    },
    {
        "text": "when ddrug0 or other hepatic enzyme inducers such as ddrug1 and DB01174 have been taken concurrently with DB00379 , lowered ddrug4 plasma levels have been reported .",
        "label": "mechanism"
    },
    {
        "text": "when ddrug0 or other hepatic enzyme inducers such as ddrug1 and DB01174 have been taken concurrently with ddrug3 , lowered DB00379 plasma levels have been reported .",
        "label": "NA"
    },
    {
        "text": "in a formal study , HD00100 were shown not to affect DB00379 plasma concentrations .",
        "label": "NA"
    },
    {
        "text": "concurrent administration of DB00501 and DB00379 has been reported to increase , decrease , or leave unchanged ddrug2 plasma levels ;",
        "label": "mechanism"
    },
    {
        "text": "concurrent administration of DB00501 and ddrug1 has been reported to increase , decrease , or leave unchanged DB00379 plasma levels ;",
        "label": "NA"
    },
    {
        "text": "DB00379 does not alter serum DB00390 levels but ddrug2 , when used to treat gastrointestinal symptoms due to ddrug3 , has been reported to lower serum ddrug4 levels .",
        "label": "NA"
    },
    {
        "text": "DB00379 does not alter serum ddrug1 levels but HD00975 , when used to treat gastrointestinal symptoms due to ddrug3 , has been reported to lower serum ddrug4 levels .",
        "label": "NA"
    },
    {
        "text": "DB00379 does not alter serum ddrug1 levels but ddrug2 , when used to treat gastrointestinal symptoms due to ddrug3 , has been reported to lower serum DB00390 levels .",
        "label": "NA"
    },
    {
        "text": "ddrug0 does not alter serum DB00390 levels but HD00975 , when used to treat gastrointestinal symptoms due to ddrug3 , has been reported to lower serum ddrug4 levels .",
        "label": "NA"
    },
    {
        "text": "ddrug0 does not alter serum DB00390 levels but ddrug2 , when used to treat gastrointestinal symptoms due to DB00379 , has been reported to lower serum ddrug4 levels .",
        "label": "NA"
    },
    {
        "text": "ddrug0 does not alter serum ddrug1 levels but HD00975 , when used to treat gastrointestinal symptoms due to DB00379 , has been reported to lower serum ddrug4 levels .",
        "label": "NA"
    },
    {
        "text": "ddrug0 does not alter serum ddrug1 levels but HD00975 , when used to treat gastrointestinal symptoms due to ddrug3 , has been reported to lower serum DB00390 levels .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 does not alter serum ddrug1 levels but ddrug2 , when used to treat gastrointestinal symptoms due to DB00379 , has been reported to lower serum DB00390 levels .",
        "label": "NA"
    },
    {
        "text": "concurrent use of DB00379 and DB00277 may lead to increased plasma ddrug2 levels .",
        "label": "mechanism"
    },
    {
        "text": "concurrent use of DB00379 and ddrug1 may lead to increased plasma DB00277 levels .",
        "label": "NA"
    },
    {
        "text": "this increase was observed at the first test point which was the second day after starting ddrug0 , DB00277 plasma levels returned to pre - DB00379 values within # hours after discontinuing ddrug3 , if ddrug4 and ddrug5 are to be used concurrently , ddrug6 blood levels should be monitored , particularly when the ddrug7 dose is changed .",
        "label": "NA"
    },
    {
        "text": "this increase was observed at the first test point which was the second day after starting ddrug0 , DB00277 plasma levels returned to pre - ddrug2 values within # hours after discontinuing DB00379 , if ddrug4 and ddrug5 are to be used concurrently , ddrug6 blood levels should be monitored , particularly when the ddrug7 dose is changed .",
        "label": "mechanism"
    },
    {
        "text": "this increase was observed at the first test point which was the second day after starting ddrug0 , ddrug1 plasma levels returned to pre - ddrug2 values within # hours after discontinuing ddrug3 , if DB00379 and DB00277 are to be used concurrently , ddrug6 blood levels should be monitored , particularly when the ddrug7 dose is changed .",
        "label": "advise"
    },
    {
        "text": "this increase was observed at the first test point which was the second day after starting ddrug0 , ddrug1 plasma levels returned to pre - ddrug2 values within # hours after discontinuing ddrug3 , if DB00379 and ddrug5 are to be used concurrently , DB00277 blood levels should be monitored , particularly when the ddrug7 dose is changed .",
        "label": "NA"
    },
    {
        "text": "this increase was observed at the first test point which was the second day after starting ddrug0 , ddrug1 plasma levels returned to pre - ddrug2 values within # hours after discontinuing ddrug3 , if ddrug4 and DB00277 are to be used concurrently , ddrug6 blood levels should be monitored , particularly when the DB00379 dose is changed .",
        "label": "NA"
    },
    {
        "text": "this increase was observed at the first test point which was the second day after starting ddrug0 , ddrug1 plasma levels returned to pre - ddrug2 values within # hours after discontinuing ddrug3 , if ddrug4 and ddrug5 are to be used concurrently , DB00277 blood levels should be monitored , particularly when the DB00379 dose is changed .",
        "label": "NA"
    },
    {
        "text": "additionally , in one controlled study in five normal subjects and seven patients , the clearance of DB00201 was decreased 50 % following the administration of DB00379 .",
        "label": "mechanism"
    },
    {
        "text": "HD00976 inhibits some of the liver 's ability to metabolize some other drugs - DB00342 , ddrug2 , ddrug3 , ddrug4 , and ddrug5 .",
        "label": "mechanism"
    },
    {
        "text": "HD00976 inhibits some of the liver 's ability to metabolize some other drugs - ddrug1 , DB00637 , ddrug3 , ddrug4 , and ddrug5 .",
        "label": "mechanism"
    },
    {
        "text": "HD00976 inhibits some of the liver 's ability to metabolize some other drugs - ddrug1 , ddrug2 , DB00604 , ddrug4 , and ddrug5 .",
        "label": "mechanism"
    },
    {
        "text": "HD00976 inhibits some of the liver 's ability to metabolize some other drugs - ddrug1 , ddrug2 , ddrug3 , DB00091 , and ddrug5 .",
        "label": "mechanism"
    },
    {
        "text": "HD00976 inhibits some of the liver 's ability to metabolize some other drugs - ddrug1 , ddrug2 , ddrug3 , ddrug4 , and HD00043 .",
        "label": "mechanism"
    },
    {
        "text": "there was no effect of a single dose or multiple doses of DB01141 on DB00688 , ddrug2 , ddrug3 , ddrug4 , and ddrug5 pharmacokinetics .",
        "label": "NA"
    },
    {
        "text": "there was no effect of a single dose or multiple doses of DB01141 on ddrug1 , DB00091 , ddrug3 , ddrug4 , and ddrug5 pharmacokinetics .",
        "label": "NA"
    },
    {
        "text": "there was no effect of a single dose or multiple doses of DB01141 on ddrug1 , ddrug2 , DB00864 , ddrug4 , and ddrug5 pharmacokinetics .",
        "label": "NA"
    },
    {
        "text": "there was no effect of a single dose or multiple doses of DB01141 on ddrug1 , ddrug2 , ddrug3 , DB00860 , and ddrug5 pharmacokinetics .",
        "label": "NA"
    },
    {
        "text": "there was no effect of a single dose or multiple doses of DB01141 on ddrug1 , ddrug2 , ddrug3 , ddrug4 , and DB00196 pharmacokinetics .",
        "label": "NA"
    },
    {
        "text": "there was no effect of a single dose or multiple doses of ddrug0 on DB00688 , ddrug2 , ddrug3 , ddrug4 , and DB00196 pharmacokinetics .",
        "label": "NA"
    },
    {
        "text": "there was no effect of a single dose or multiple doses of ddrug0 on ddrug1 , ddrug2 , DB00864 , ddrug4 , and DB00196 pharmacokinetics .",
        "label": "NA"
    },
    {
        "text": "DB00877 auc was increased by 21 % with no effect on cmax in the presence of steady-state DB01141 compared with ddrug2 alone .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 auc was increased by 21 % with no effect on cmax in the presence of steady-state DB01141 compared with DB00877 alone .",
        "label": "NA"
    },
    {
        "text": "DB01115 auc and cmax were increased by 18 % and 42 % , respectively , in the presence of steady-state DB01141 compared with ddrug2 alone .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 auc and cmax were increased by 18 % and 42 % , respectively , in the presence of steady-state DB01141 compared with DB01115 alone .",
        "label": "NA"
    },
    {
        "text": "patients receiving DB00877 or DB01115 in combination with ddrug2 should be monitored for ddrug3 or ddrug4 toxicity and ddrug5 or ddrug6 dosage should be reduced if necessary .",
        "label": "NA"
    },
    {
        "text": "patients receiving DB00877 or ddrug1 in combination with DB01141 should be monitored for ddrug3 or ddrug4 toxicity and ddrug5 or ddrug6 dosage should be reduced if necessary .",
        "label": "advise"
    },
    {
        "text": "patients receiving DB00877 or ddrug1 in combination with ddrug2 should be monitored for ddrug3 or DB01115 toxicity and ddrug5 or ddrug6 dosage should be reduced if necessary .",
        "label": "NA"
    },
    {
        "text": "patients receiving DB00877 or ddrug1 in combination with ddrug2 should be monitored for ddrug3 or ddrug4 toxicity and ddrug5 or DB01115 dosage should be reduced if necessary .",
        "label": "NA"
    },
    {
        "text": "patients receiving ddrug0 or DB01115 in combination with DB01141 should be monitored for ddrug3 or ddrug4 toxicity and ddrug5 or ddrug6 dosage should be reduced if necessary .",
        "label": "advise"
    },
    {
        "text": "patients receiving ddrug0 or DB01115 in combination with ddrug2 should be monitored for DB00877 or ddrug4 toxicity and ddrug5 or ddrug6 dosage should be reduced if necessary .",
        "label": "NA"
    },
    {
        "text": "patients receiving ddrug0 or DB01115 in combination with ddrug2 should be monitored for ddrug3 or ddrug4 toxicity and DB00877 or ddrug6 dosage should be reduced if necessary .",
        "label": "NA"
    },
    {
        "text": "patients receiving ddrug0 or ddrug1 in combination with DB01141 should be monitored for DB00877 or ddrug4 toxicity and ddrug5 or ddrug6 dosage should be reduced if necessary .",
        "label": "NA"
    },
    {
        "text": "patients receiving ddrug0 or ddrug1 in combination with DB01141 should be monitored for ddrug3 or DB01115 toxicity and ddrug5 or ddrug6 dosage should be reduced if necessary .",
        "label": "NA"
    },
    {
        "text": "patients receiving ddrug0 or ddrug1 in combination with DB01141 should be monitored for ddrug3 or ddrug4 toxicity and DB00877 or ddrug6 dosage should be reduced if necessary .",
        "label": "NA"
    },
    {
        "text": "patients receiving ddrug0 or ddrug1 in combination with DB01141 should be monitored for ddrug3 or ddrug4 toxicity and ddrug5 or DB01115 dosage should be reduced if necessary .",
        "label": "NA"
    },
    {
        "text": "patients receiving ddrug0 or ddrug1 in combination with ddrug2 should be monitored for DB00877 or DB01115 toxicity and ddrug5 or ddrug6 dosage should be reduced if necessary .",
        "label": "NA"
    },
    {
        "text": "patients receiving ddrug0 or ddrug1 in combination with ddrug2 should be monitored for DB00877 or ddrug4 toxicity and ddrug5 or DB01115 dosage should be reduced if necessary .",
        "label": "NA"
    },
    {
        "text": "patients receiving ddrug0 or ddrug1 in combination with ddrug2 should be monitored for ddrug3 or DB01115 toxicity and DB00877 or ddrug6 dosage should be reduced if necessary .",
        "label": "NA"
    },
    {
        "text": "patients receiving ddrug0 or ddrug1 in combination with ddrug2 should be monitored for ddrug3 or ddrug4 toxicity and DB00877 or DB01115 dosage should be reduced if necessary .",
        "label": "NA"
    },
    {
        "text": "drug interactions : inhibitors of cyp3a4 isozymes : caution is advised when DB00683 is administered concomitantly with drugs that are known to inhibit the cyp3a4 enzyme system { ie , some drugs in the drug classes of HD00977 , ddrug2 , ddrug3 , and ddrug4 } .",
        "label": "advise"
    },
    {
        "text": "drug interactions : inhibitors of cyp3a4 isozymes : caution is advised when DB00683 is administered concomitantly with drugs that are known to inhibit the cyp3a4 enzyme system { ie , some drugs in the drug classes of ddrug1 , HD00269 , ddrug3 , and ddrug4 } .",
        "label": "advise"
    },
    {
        "text": "drug interactions : inhibitors of cyp3a4 isozymes : caution is advised when DB00683 is administered concomitantly with drugs that are known to inhibit the cyp3a4 enzyme system { ie , some drugs in the drug classes of ddrug1 , ddrug2 , HD00208 , and ddrug4 } .",
        "label": "advise"
    },
    {
        "text": "drug interactions : inhibitors of cyp3a4 isozymes : caution is advised when DB00683 is administered concomitantly with drugs that are known to inhibit the cyp3a4 enzyme system { ie , some drugs in the drug classes of ddrug1 , ddrug2 , ddrug3 , and HD00093 } .",
        "label": "advise"
    },
    {
        "text": "drugs such as DB00199 , ddrug1 , ddrug2 , ddrug3 , ddrug4 and ddrug5 were shown to significantly increase the c max and auc of orally administered DB00683 .",
        "label": "mechanism"
    },
    {
        "text": "drugs such as ddrug0 , DB00343 , ddrug2 , ddrug3 , ddrug4 and ddrug5 were shown to significantly increase the c max and auc of orally administered DB00683 .",
        "label": "mechanism"
    },
    {
        "text": "drugs such as ddrug0 , ddrug1 , DB00661 , ddrug3 , ddrug4 and ddrug5 were shown to significantly increase the c max and auc of orally administered DB00683 .",
        "label": "mechanism"
    },
    {
        "text": "drugs such as ddrug0 , ddrug1 , ddrug2 , DB01026 , ddrug4 and ddrug5 were shown to significantly increase the c max and auc of orally administered DB00683 .",
        "label": "mechanism"
    },
    {
        "text": "drugs such as ddrug0 , ddrug1 , ddrug2 , ddrug3 , DB00196 and ddrug5 were shown to significantly increase the c max and auc of orally administered DB00683 .",
        "label": "mechanism"
    },
    {
        "text": "drugs such as ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 and DB01167 were shown to significantly increase the c max and auc of orally administered DB00683 .",
        "label": "mechanism"
    },
    {
        "text": "although not studied , the potent cytochrome p450 3a4 inhibitors DB00503 and DB00220 may cause intense and prolonged sedation and respiratory_failure due to a decrease in plasma clearance of ddrug2 .",
        "label": "NA"
    },
    {
        "text": "although not studied , the potent cytochrome p450 3a4 inhibitors DB00503 and ddrug1 may cause intense and prolonged sedation and respiratory_failure due to a decrease in plasma clearance of DB00683 .",
        "label": "mechanism"
    },
    {
        "text": "although not studied , the potent cytochrome p450 3a4 inhibitors ddrug0 and DB00220 may cause intense and prolonged sedation and respiratory_failure due to a decrease in plasma clearance of DB00683 .",
        "label": "mechanism"
    },
    {
        "text": "inducers of cyp3a4 isozymes : cytochrome p450 inducers , such as DB01045 , ddrug1 , and ddrug2 , induce metabolism and caused a markedly decreased c max and auc of oral DB00683 in adult studies .",
        "label": "mechanism"
    },
    {
        "text": "inducers of cyp3a4 isozymes : cytochrome p450 inducers , such as ddrug0 , DB00564 , and ddrug2 , induce metabolism and caused a markedly decreased c max and auc of oral DB00683 in adult studies .",
        "label": "mechanism"
    },
    {
        "text": "inducers of cyp3a4 isozymes : cytochrome p450 inducers , such as ddrug0 , ddrug1 , and DB00252 , induce metabolism and caused a markedly decreased c max and auc of oral DB00683 in adult studies .",
        "label": "mechanism"
    },
    {
        "text": "the difficulty in achieving adequate sedation may have been the result of decreased absorption of the HD00024 due to both the gastrointestinal effects and stimulant effects of DB00422 .",
        "label": "NA"
    },
    {
        "text": "the sedative effect of HD00978 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly HD00543 { eg , ddrug2 , ddrug3 and ddrug4 } , ddrug5 , ddrug6 , ddrug7 , ddrug8 and ddrug9 .",
        "label": "effect"
    },
    {
        "text": "the sedative effect of HD00978 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly ddrug1 { eg , DB00295 , ddrug3 and ddrug4 } , ddrug5 , ddrug6 , ddrug7 , ddrug8 and ddrug9 .",
        "label": "effect"
    },
    {
        "text": "the sedative effect of HD00978 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly ddrug1 { eg , ddrug2 , DB00454 and ddrug4 } , ddrug5 , ddrug6 , ddrug7 , ddrug8 and ddrug9 .",
        "label": "effect"
    },
    {
        "text": "the sedative effect of HD00978 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly ddrug1 { eg , ddrug2 , ddrug3 and DB00813 } , ddrug5 , ddrug6 , ddrug7 , ddrug8 and ddrug9 .",
        "label": "effect"
    },
    {
        "text": "the sedative effect of HD00978 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly ddrug1 { eg , ddrug2 , ddrug3 and ddrug4 } , DB00818 , ddrug6 , ddrug7 , ddrug8 and ddrug9 .",
        "label": "effect"
    },
    {
        "text": "the sedative effect of HD00978 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly ddrug1 { eg , ddrug2 , ddrug3 and ddrug4 } , ddrug5 , DB01221 , ddrug7 , ddrug8 and ddrug9 .",
        "label": "effect"
    },
    {
        "text": "the sedative effect of HD00978 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly ddrug1 { eg , ddrug2 , ddrug3 and ddrug4 } , ddrug5 , ddrug6 , DB06690 , ddrug8 and ddrug9 .",
        "label": "effect"
    },
    {
        "text": "the sedative effect of HD00978 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly ddrug1 { eg , ddrug2 , ddrug3 and ddrug4 } , ddrug5 , ddrug6 , ddrug7 , DB00418 and ddrug9 .",
        "label": "effect"
    },
    {
        "text": "the sedative effect of HD00978 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly ddrug1 { eg , ddrug2 , ddrug3 and ddrug4 } , ddrug5 , ddrug6 , ddrug7 , ddrug8 and DB00450 .",
        "label": "effect"
    },
    {
        "text": "the sedative effect of ddrug0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly ddrug1 { eg , ddrug2 , ddrug3 and ddrug4 } , DB00818 , DB01221 , ddrug7 , ddrug8 and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "the sedative effect of ddrug0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly ddrug1 { eg , ddrug2 , ddrug3 and ddrug4 } , DB00818 , ddrug6 , DB06690 , ddrug8 and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "the sedative effect of ddrug0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly ddrug1 { eg , ddrug2 , ddrug3 and ddrug4 } , DB00818 , ddrug6 , ddrug7 , DB00418 and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "the sedative effect of ddrug0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly ddrug1 { eg , ddrug2 , ddrug3 and ddrug4 } , DB00818 , ddrug6 , ddrug7 , ddrug8 and DB00450 .",
        "label": "NA"
    },
    {
        "text": "no significant adverse interactions with common premedications { such as DB00572 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , and other ddrug5 } or local HD00264 have been observed .",
        "label": "NA"
    },
    {
        "text": "no significant adverse interactions with common premedications { such as ddrug0 , DB00747 , ddrug2 , ddrug3 , ddrug4 , and other ddrug5 } or local HD00264 have been observed .",
        "label": "NA"
    },
    {
        "text": "no significant adverse interactions with common premedications { such as ddrug0 , ddrug1 , DB00986 , ddrug3 , ddrug4 , and other ddrug5 } or local HD00264 have been observed .",
        "label": "NA"
    },
    {
        "text": "no significant adverse interactions with common premedications { such as ddrug0 , ddrug1 , ddrug2 , DB00829 , ddrug4 , and other ddrug5 } or local HD00264 have been observed .",
        "label": "NA"
    },
    {
        "text": "no significant adverse interactions with common premedications { such as ddrug0 , ddrug1 , ddrug2 , ddrug3 , DB00557 , and other ddrug5 } or local HD00264 have been observed .",
        "label": "NA"
    },
    {
        "text": "no significant adverse interactions with common premedications { such as ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , and other HD00542 } or local HD00264 have been observed .",
        "label": "NA"
    },
    {
        "text": "when administered concomitantly with DB00211 , HD00345 may enhance or precipitate bradycardia , a , v.",
        "label": "effect"
    },
    {
        "text": "the use of drugs that stimulate alpha-adrenergic receptors { e , g , , DB00388 , ddrug1 , ddrug2 , ddrug3 or ddrug4 } may enhance or potentiate the pressor effects of DB00211 , therefore , caution should be used when ddrug6 is administered concomitantly with agents that cause vasoconstriction .",
        "label": "effect"
    },
    {
        "text": "the use of drugs that stimulate alpha-adrenergic receptors { e , g , , DB00388 , ddrug1 , ddrug2 , ddrug3 or ddrug4 } may enhance or potentiate the pressor effects of ddrug5 , therefore , caution should be used when DB00211 is administered concomitantly with agents that cause vasoconstriction .",
        "label": "NA"
    },
    {
        "text": "the use of drugs that stimulate alpha-adrenergic receptors { e , g , , ddrug0 , DB00852 , ddrug2 , ddrug3 or ddrug4 } may enhance or potentiate the pressor effects of DB00211 , therefore , caution should be used when ddrug6 is administered concomitantly with agents that cause vasoconstriction .",
        "label": "effect"
    },
    {
        "text": "the use of drugs that stimulate alpha-adrenergic receptors { e , g , , ddrug0 , DB00852 , ddrug2 , ddrug3 or ddrug4 } may enhance or potentiate the pressor effects of ddrug5 , therefore , caution should be used when DB00211 is administered concomitantly with agents that cause vasoconstriction .",
        "label": "NA"
    },
    {
        "text": "the use of drugs that stimulate alpha-adrenergic receptors { e , g , , ddrug0 , ddrug1 , DB01364 , ddrug3 or ddrug4 } may enhance or potentiate the pressor effects of DB00211 , therefore , caution should be used when ddrug6 is administered concomitantly with agents that cause vasoconstriction .",
        "label": "effect"
    },
    {
        "text": "the use of drugs that stimulate alpha-adrenergic receptors { e , g , , ddrug0 , ddrug1 , DB01364 , ddrug3 or ddrug4 } may enhance or potentiate the pressor effects of ddrug5 , therefore , caution should be used when DB00211 is administered concomitantly with agents that cause vasoconstriction .",
        "label": "NA"
    },
    {
        "text": "the use of drugs that stimulate alpha-adrenergic receptors { e , g , , ddrug0 , ddrug1 , ddrug2 , DB00397 or ddrug4 } may enhance or potentiate the pressor effects of DB00211 , therefore , caution should be used when ddrug6 is administered concomitantly with agents that cause vasoconstriction .",
        "label": "effect"
    },
    {
        "text": "the use of drugs that stimulate alpha-adrenergic receptors { e , g , , ddrug0 , ddrug1 , ddrug2 , DB00397 or ddrug4 } may enhance or potentiate the pressor effects of ddrug5 , therefore , caution should be used when DB00211 is administered concomitantly with agents that cause vasoconstriction .",
        "label": "NA"
    },
    {
        "text": "the use of drugs that stimulate alpha-adrenergic receptors { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 or DB00320 } may enhance or potentiate the pressor effects of DB00211 , therefore , caution should be used when ddrug6 is administered concomitantly with agents that cause vasoconstriction .",
        "label": "effect"
    },
    {
        "text": "the use of drugs that stimulate alpha-adrenergic receptors { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 or DB00320 } may enhance or potentiate the pressor effects of ddrug5 , therefore , caution should be used when DB00211 is administered concomitantly with agents that cause vasoconstriction .",
        "label": "NA"
    },
    {
        "text": "DB00211 has been used in patients concomitantly treated with salt-retaining steroid therapy { i , e , , DB00687 } , with or without salt supplementation .",
        "label": "NA"
    },
    {
        "text": "DB00211 , HD00647 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "DB00211 , ddrug1 , such as DB00457 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "DB00211 , ddrug1 , such as ddrug2 , DB01162 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "DB00211 , ddrug1 , such as ddrug2 , ddrug3 , and DB00590 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "DB00211 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of HD00979 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "DB00211 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DB00331 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "DB00211 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , DB00501 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "DB00211 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , DB00863 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "DB00211 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , DB01035 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "DB00211 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , DB00384 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "DB00211 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , DB01195 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "DB00211 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and DB00908 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , HD00647 , such as DB00457 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , HD00647 , such as ddrug2 , DB01162 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , HD00647 , such as ddrug2 , ddrug3 , and DB00590 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , HD00647 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of DB00211 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "effect"
    },
    {
        "text": "ddrug0 , HD00647 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of HD00979 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , HD00647 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DB00331 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , HD00647 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , DB00501 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , HD00647 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , DB00863 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , HD00647 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , DB01035 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , HD00647 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , DB00384 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , HD00647 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , DB01195 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , HD00647 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and DB00908 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as DB00457 , ddrug3 , and ddrug4 , can antagonize the effects of DB00211 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "effect"
    },
    {
        "text": "ddrug0 , ddrug1 , such as DB00457 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of HD00979 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as DB00457 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DB00331 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as DB00457 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , DB00501 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as DB00457 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , DB00863 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as DB00457 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , DB01035 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as DB00457 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , DB00384 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as DB00457 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , DB01195 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as DB00457 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and DB00908 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , DB01162 , and ddrug4 , can antagonize the effects of DB00211 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "effect"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , DB01162 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of HD00979 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , DB01162 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DB00331 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , DB01162 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , DB00501 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , DB01162 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , DB00863 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , DB01162 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , DB01035 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , DB01162 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , DB00384 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , DB01162 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , DB01195 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , DB01162 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and DB00908 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and DB00590 , can antagonize the effects of DB00211 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "effect"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and DB00590 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of HD00979 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and DB00590 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DB00331 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and DB00590 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , DB00501 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and DB00590 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , DB00863 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and DB00590 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , DB01035 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and DB00590 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , DB00384 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and DB00590 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , DB01195 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and DB00590 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and DB00908 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of DB00211 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of HD00979 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of DB00211 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DB00331 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of DB00211 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , DB00501 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of DB00211 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , DB00863 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of DB00211 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , DB01035 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of DB00211 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , DB00384 , ddrug12 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of DB00211 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , DB01195 , and ddrug13 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of DB00211 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of ddrug6 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and DB00908 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of HD00979 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DB00331 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of HD00979 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , DB00501 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of HD00979 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , DB00863 , ddrug10 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of HD00979 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , DB01035 , ddrug11 , ddrug12 , and ddrug13 .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of HD00979 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , DB00384 , ddrug12 , and ddrug13 .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of HD00979 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , DB01195 , and ddrug13 .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 , ddrug1 , such as ddrug2 , ddrug3 , and ddrug4 , can antagonize the effects of ddrug5 , potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of HD00979 { a base } is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , and DB00908 .",
        "label": "mechanism"
    },
    {
        "text": "although specific drug or food interactions with DB00834 have not been studied , on the basis of this drug s metabolism by ppig 3a4 , it is possible that DB01026 , ddrug2 , ddrug3 , and grapefruit juice may inhibit its metabolism { increasing serum levels of ddrug4 } .",
        "label": "NA"
    },
    {
        "text": "although specific drug or food interactions with DB00834 have not been studied , on the basis of this drug s metabolism by ppig 3a4 , it is possible that ddrug1 , DB01167 , ddrug3 , and grapefruit juice may inhibit its metabolism { increasing serum levels of ddrug4 } .",
        "label": "NA"
    },
    {
        "text": "although specific drug or food interactions with DB00834 have not been studied , on the basis of this drug s metabolism by ppig 3a4 , it is possible that ddrug1 , ddrug2 , DB00199 , and grapefruit juice may inhibit its metabolism { increasing serum levels of ddrug4 } .",
        "label": "NA"
    },
    {
        "text": "although specific drug or food interactions with ddrug0 have not been studied , on the basis of this drug s metabolism by ppig 3a4 , it is possible that DB01026 , ddrug2 , ddrug3 , and grapefruit juice may inhibit its metabolism { increasing serum levels of DB00834 } .",
        "label": "mechanism"
    },
    {
        "text": "although specific drug or food interactions with ddrug0 have not been studied , on the basis of this drug s metabolism by ppig 3a4 , it is possible that ddrug1 , DB01167 , ddrug3 , and grapefruit juice may inhibit its metabolism { increasing serum levels of DB00834 } .",
        "label": "mechanism"
    },
    {
        "text": "although specific drug or food interactions with ddrug0 have not been studied , on the basis of this drug s metabolism by ppig 3a4 , it is possible that ddrug1 , ddrug2 , DB00199 , and grapefruit juice may inhibit its metabolism { increasing serum levels of DB00834 } .",
        "label": "mechanism"
    },
    {
        "text": "furthermore , DB01045 , DB01234 , st .",
        "label": "NA"
    },
    {
        "text": "john s wort , and certain HD00282 { ddrug1 , ddrug2 , ddrug3 } may induce DB00834 metabolism { lowering serum levels of ddrug5 } .",
        "label": "mechanism"
    },
    {
        "text": "john s wort , and certain HD00282 { ddrug1 , ddrug2 , ddrug3 } may induce ddrug4 metabolism { lowering serum levels of DB00834 } .",
        "label": "NA"
    },
    {
        "text": "john s wort , and certain ddrug0 { DB00252 , ddrug2 , ddrug3 } may induce DB00834 metabolism { lowering serum levels of ddrug5 } .",
        "label": "mechanism"
    },
    {
        "text": "john s wort , and certain ddrug0 { DB00252 , ddrug2 , ddrug3 } may induce ddrug4 metabolism { lowering serum levels of DB00834 } .",
        "label": "NA"
    },
    {
        "text": "john s wort , and certain ddrug0 { ddrug1 , DB01174 , ddrug3 } may induce DB00834 metabolism { lowering serum levels of ddrug5 } .",
        "label": "mechanism"
    },
    {
        "text": "john s wort , and certain ddrug0 { ddrug1 , DB01174 , ddrug3 } may induce ddrug4 metabolism { lowering serum levels of DB00834 } .",
        "label": "NA"
    },
    {
        "text": "john s wort , and certain ddrug0 { ddrug1 , ddrug2 , DB00564 } may induce DB00834 metabolism { lowering serum levels of ddrug5 } .",
        "label": "mechanism"
    },
    {
        "text": "john s wort , and certain ddrug0 { ddrug1 , ddrug2 , DB00564 } may induce ddrug4 metabolism { lowering serum levels of DB00834 } .",
        "label": "NA"
    },
    {
        "text": "while co-administration of DB00419 appeared to increase the clearance of DB00053 by 70 % , these results are not conclusive because of the small number of subjects studied and because patients took variable doses of ddrug2 .",
        "label": "mechanism"
    },
    {
        "text": "while co-administration of DB00419 appeared to increase the clearance of ddrug1 by 70 % , these results are not conclusive because of the small number of subjects studied and because patients took variable doses of DB00053 .",
        "label": "NA"
    },
    {
        "text": "combination therapy with DB00053 { ddrug1 } and DB00419 is not indicated .",
        "label": "advise"
    },
    {
        "text": "combination therapy with ddrug0 { DB00053 } and DB00419 is not indicated .",
        "label": "advise"
    },
    {
        "text": "because HD00239 have been shown to depress plasma prothrombin activity , patients who are on HD00025 therapy may require downward adjustment of their ddrug2 dosage .",
        "label": "advise"
    },
    {
        "text": "because HD00239 have been shown to depress plasma prothrombin activity , patients who are on ddrug1 therapy may require downward adjustment of their HD00025 dosage .",
        "label": "NA"
    },
    {
        "text": "since bacteriostatic drugs may interfere with the bactericidal action of HD00284 , it is advisable to avoid giving HD00980 in conjunction with ddrug2 .",
        "label": "NA"
    },
    {
        "text": "since bacteriostatic drugs may interfere with the bactericidal action of ddrug0 , it is advisable to avoid giving HD00980 in conjunction with HD00284 .",
        "label": "advise"
    },
    {
        "text": "absorption of HD00239 is impaired by HD00374 containing ddrug2 , ddrug3 or ddrug4 , and ddrug5 - containing preparations .",
        "label": "NA"
    },
    {
        "text": "absorption of HD00239 is impaired by ddrug1 containing DB01370 , ddrug3 or ddrug4 , and ddrug5 - containing preparations .",
        "label": "mechanism"
    },
    {
        "text": "absorption of HD00239 is impaired by ddrug1 containing ddrug2 , DB01373 or ddrug4 , and ddrug5 - containing preparations .",
        "label": "mechanism"
    },
    {
        "text": "absorption of HD00239 is impaired by ddrug1 containing ddrug2 , ddrug3 or DB14513 , and ddrug5 - containing preparations .",
        "label": "mechanism"
    },
    {
        "text": "absorption of HD00239 is impaired by ddrug1 containing ddrug2 , ddrug3 or ddrug4 , and DB01592 - containing preparations .",
        "label": "mechanism"
    },
    {
        "text": "absorption of ddrug0 is impaired by HD00374 containing DB01370 , ddrug3 or ddrug4 , and ddrug5 - containing preparations .",
        "label": "NA"
    },
    {
        "text": "absorption of ddrug0 is impaired by HD00374 containing ddrug2 , DB01373 or ddrug4 , and ddrug5 - containing preparations .",
        "label": "NA"
    },
    {
        "text": "absorption of ddrug0 is impaired by HD00374 containing ddrug2 , ddrug3 or DB14513 , and ddrug5 - containing preparations .",
        "label": "NA"
    },
    {
        "text": "absorption of ddrug0 is impaired by HD00374 containing ddrug2 , ddrug3 or ddrug4 , and DB01592 - containing preparations .",
        "label": "NA"
    },
    {
        "text": "absorption of ddrug0 is impaired by ddrug1 containing DB01370 , ddrug3 or ddrug4 , and DB01592 - containing preparations .",
        "label": "NA"
    },
    {
        "text": "absorption of ddrug0 is impaired by ddrug1 containing ddrug2 , DB01373 or ddrug4 , and DB01592 - containing preparations .",
        "label": "NA"
    },
    {
        "text": "absorption of ddrug0 is impaired by ddrug1 containing ddrug2 , ddrug3 or DB14513 , and DB01592 - containing preparations .",
        "label": "NA"
    },
    {
        "text": "the concurrent use of DB00759 and DB01028 has been reported to result in fatal renal toxicity .",
        "label": "effect"
    },
    {
        "text": "concurrent use of HD00239 with oral HD00283 may render oral ddrug2 less effective .",
        "label": "effect"
    },
    {
        "text": "concurrent use of HD00239 with oral ddrug1 may render oral HD00283 less effective .",
        "label": "NA"
    },
    {
        "text": "interaction with ddrug0 : although DB00350 does not itself cause orthostatic hypotension , its administration to patients already receiving DB01170 can result in profound orthostatic effects .",
        "label": "effect"
    },
    {
        "text": "if at all possible DB01170 should be discontinued well before DB00350 is begun .",
        "label": "advise"
    },
    {
        "text": "while in vitro studies have shown that DB00370 is not a potent inhibitor of any of these enzymes , an indication that ddrug1 is not likely to have a clinically significant inhibitory effect on the metabolism of other drugs that are substrates for these cytochrome cyp2b6 enzymes , the concomitant use of DB00370 with most other drugs metabolized by these enzymes has not been formally studied .",
        "label": "NA"
    },
    {
        "text": "while in vitro studies have shown that ddrug0 is not a potent inhibitor of any of these enzymes , an indication that DB00370 is not likely to have a clinically significant inhibitory effect on the metabolism of other drugs that are substrates for these cytochrome cyp2b6 enzymes , the concomitant use of DB00370 with most other drugs metabolized by these enzymes has not been formally studied .",
        "label": "NA"
    },
    {
        "text": "DB02325 : concomitant administration of ddrug1 { equivalent to # g } had a minimal effect on plasma levels of DB00370 { 15 mg } in # healthy male subjects .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : concomitant administration of DB02325 { equivalent to # g } had a minimal effect on plasma levels of DB00370 { 15 mg } in # healthy male subjects .",
        "label": "mechanism"
    },
    {
        "text": "however , the impairment of cognitive and motor skills produced by DB00370 were shown to be additive with those produced by DB02325 .",
        "label": "effect"
    },
    {
        "text": "accordingly , patients should be advised to avoid DB02325 while taking DB00370 , ddrug2 : concomitant administration of ddrug3 { 15 mg } had a minimal effect on plasma levels of ddrug4 { 15 mg } in # healthy subjects .",
        "label": "advise"
    },
    {
        "text": "accordingly , patients should be advised to avoid DB02325 while taking ddrug1 , DB00829 : concomitant administration of ddrug3 { 15 mg } had a minimal effect on plasma levels of ddrug4 { 15 mg } in # healthy subjects .",
        "label": "NA"
    },
    {
        "text": "accordingly , patients should be advised to avoid DB02325 while taking ddrug1 , ddrug2 : concomitant administration of DB00829 { 15 mg } had a minimal effect on plasma levels of ddrug4 { 15 mg } in # healthy subjects .",
        "label": "NA"
    },
    {
        "text": "accordingly , patients should be advised to avoid DB02325 while taking ddrug1 , ddrug2 : concomitant administration of ddrug3 { 15 mg } had a minimal effect on plasma levels of DB00370 { 15 mg } in # healthy subjects .",
        "label": "NA"
    },
    {
        "text": "accordingly , patients should be advised to avoid ddrug0 while taking DB00370 , DB00829 : concomitant administration of ddrug3 { 15 mg } had a minimal effect on plasma levels of ddrug4 { 15 mg } in # healthy subjects .",
        "label": "NA"
    },
    {
        "text": "accordingly , patients should be advised to avoid ddrug0 while taking DB00370 , ddrug2 : concomitant administration of DB00829 { 15 mg } had a minimal effect on plasma levels of ddrug4 { 15 mg } in # healthy subjects .",
        "label": "NA"
    },
    {
        "text": "accordingly , patients should be advised to avoid ddrug0 while taking DB00370 , ddrug2 : concomitant administration of ddrug3 { 15 mg } had a minimal effect on plasma levels of DB00370 { 15 mg } in # healthy subjects .",
        "label": "NA"
    },
    {
        "text": "accordingly , patients should be advised to avoid ddrug0 while taking ddrug1 , DB00829 : concomitant administration of ddrug3 { 15 mg } had a minimal effect on plasma levels of DB00370 { 15 mg } in # healthy subjects .",
        "label": "NA"
    },
    {
        "text": "accordingly , patients should be advised to avoid ddrug0 while taking ddrug1 , ddrug2 : concomitant administration of DB00829 { 15 mg } had a minimal effect on plasma levels of DB00370 { 15 mg } in # healthy subjects .",
        "label": "mechanism"
    },
    {
        "text": "however , the impairment of motor skills produced by DB00370 has been shown to be additive with those caused by DB00829 .",
        "label": "effect"
    },
    {
        "text": "accordingly , patients should be advised to avoid DB00829 and other similar drugs while taking DB00370 .",
        "label": "advise"
    },
    {
        "text": "DB00648 has been reported to accelerate the metabolism of DB00682 by the mechanism of hepatic microsomal enzyme induction , leading to an increase in dosage requirements for ddrug2 .",
        "label": "mechanism"
    },
    {
        "text": "DB00648 has been reported to accelerate the metabolism of ddrug1 by the mechanism of hepatic microsomal enzyme induction , leading to an increase in dosage requirements for DB00682 .",
        "label": "NA"
    },
    {
        "text": "therefore , physicians should closely monitor patients for a change in HD00025 dosage requirements when administering DB00648 to patients on ddrug2 .",
        "label": "NA"
    },
    {
        "text": "therefore , physicians should closely monitor patients for a change in ddrug0 dosage requirements when administering DB00648 to patients on HD00724 .",
        "label": "advise"
    },
    {
        "text": "although DB01226 { a mixture of three stereoisomers } has been administered safely following succinylcholine-facilitated tracheal intubation , the interaction between ddrug1 and DB00202 has not been systematically studied .",
        "label": "NA"
    },
    {
        "text": "although ddrug0 { a mixture of three stereoisomers } has been administered safely following succinylcholine-facilitated tracheal intubation , the interaction between DB01226 and DB00202 has not been systematically studied .",
        "label": "NA"
    },
    {
        "text": "prior administration of DB00202 can potentiate the neuromuscular blocking effects of HD00539 .",
        "label": "effect"
    },
    {
        "text": "evidence of spontaneous recovery from DB00202 should be observed before the administration of DB01226 .",
        "label": "advise"
    },
    {
        "text": "the use of DB01226 before DB00202 to attenuate some of the side effects of ddrug2 has not been studied .",
        "label": "NA"
    },
    {
        "text": "the use of DB01226 before ddrug1 to attenuate some of the side effects of DB00202 has not been studied .",
        "label": "NA"
    },
    {
        "text": "there are no clinical data on the use of DB01226 with other HD00541 .",
        "label": "NA"
    },
    {
        "text": "DB00753 and DB00228 { administered with ddrug2 / ddrug3 to achieve # m , c.",
        "label": "NA"
    },
    {
        "text": "DB00753 and ddrug1 { administered with DB06690 / ddrug3 to achieve # m , c.",
        "label": "NA"
    },
    {
        "text": "DB00753 and ddrug1 { administered with ddrug2 / DB09140 to achieve # m , c.",
        "label": "NA"
    },
    {
        "text": "ddrug0 and DB00228 { administered with DB06690 / ddrug3 to achieve # m , c.",
        "label": "NA"
    },
    {
        "text": "ddrug0 and DB00228 { administered with ddrug2 / DB09140 to achieve # m , c.",
        "label": "NA"
    },
    {
        "text": "a greater potentiation of the neuromuscular blocking effects of DB01226 may be expected with higher concentrations of DB00228 or ddrug2 .",
        "label": "NA"
    },
    {
        "text": "a greater potentiation of the neuromuscular blocking effects of DB01226 may be expected with higher concentrations of ddrug1 or DB00753 .",
        "label": "NA"
    },
    {
        "text": "a greater potentiation of the neuromuscular blocking effects of ddrug0 may be expected with higher concentrations of DB00228 or DB00753 .",
        "label": "NA"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of HD00539 such as DB01226 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "NA"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of HD00539 such as ddrug1 include certain HD00002 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of HD00539 such as ddrug1 include certain ddrug2 { e , g , , HD00249 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of HD00539 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , HD00239 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of HD00539 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , DB00781 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of HD00539 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , HD00384 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of HD00539 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , DB01627 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of HD00539 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , DB01190 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of HD00539 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , DB00803 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of HD00539 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and HD00652 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of HD00539 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , DB14513 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of HD00539 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , DB14507 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of HD00539 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local HD00264 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of HD00539 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , DB01035 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of HD00539 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and DB00908 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as DB01226 include certain HD00002 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as DB01226 include certain ddrug2 { e , g , , HD00249 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as DB01226 include certain ddrug2 { e , g , , ddrug3 , HD00239 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as DB01226 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , DB00781 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as DB01226 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , HD00384 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as DB01226 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , DB01627 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as DB01226 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , DB01190 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as DB01226 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , DB00803 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as DB01226 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and HD00652 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as DB01226 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , DB14513 salts , ddrug12 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as DB01226 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , DB14507 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as DB01226 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local HD00264 , ddrug14 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as DB01226 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , DB01035 , and ddrug15 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as DB01226 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , ddrug11 salts , ddrug12 , local ddrug13 , ddrug14 , and DB00908 .",
        "label": "int"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , DB14513 salts , DB14507 , local ddrug13 , ddrug14 , and ddrug15 .",
        "label": "NA"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , DB14513 salts , ddrug12 , local HD00264 , ddrug14 , and ddrug15 .",
        "label": "NA"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , DB14513 salts , ddrug12 , local ddrug13 , DB01035 , and ddrug15 .",
        "label": "NA"
    },
    {
        "text": "other drugs which may enhance the neuromuscular blocking action of ddrug0 such as ddrug1 include certain ddrug2 { e , g , , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and ddrug10 } , DB14513 salts , ddrug12 , local ddrug13 , ddrug14 , and DB00908 .",
        "label": "NA"
    },
    {
        "text": "the neuromuscular blocking effect of DB01226 may be enhanced by drugs that reduce plasma bche activity { e , g , , chronically administered oral HD00283 , ddrug2 , or certain ddrug3 } or by drugs that irreversibly inhibit plasma bche , resistance to the neuromuscular blocking action of nondepolarizing ddrug4 has been demonstrated in patients chronically administered ddrug5 or ddrug6 .",
        "label": "effect"
    },
    {
        "text": "the neuromuscular blocking effect of DB01226 may be enhanced by drugs that reduce plasma bche activity { e , g , , chronically administered oral ddrug1 , HD00115 , or certain ddrug3 } or by drugs that irreversibly inhibit plasma bche , resistance to the neuromuscular blocking action of nondepolarizing ddrug4 has been demonstrated in patients chronically administered ddrug5 or ddrug6 .",
        "label": "effect"
    },
    {
        "text": "the neuromuscular blocking effect of DB01226 may be enhanced by drugs that reduce plasma bche activity { e , g , , chronically administered oral ddrug1 , ddrug2 , or certain HD00275 } or by drugs that irreversibly inhibit plasma bche , resistance to the neuromuscular blocking action of nondepolarizing ddrug4 has been demonstrated in patients chronically administered ddrug5 or ddrug6 .",
        "label": "effect"
    },
    {
        "text": "the neuromuscular blocking effect of ddrug0 may be enhanced by drugs that reduce plasma bche activity { e , g , , chronically administered oral ddrug1 , ddrug2 , or certain ddrug3 } or by drugs that irreversibly inhibit plasma bche , resistance to the neuromuscular blocking action of nondepolarizing HD00547 has been demonstrated in patients chronically administered DB00252 or ddrug6 .",
        "label": "effect"
    },
    {
        "text": "the neuromuscular blocking effect of ddrug0 may be enhanced by drugs that reduce plasma bche activity { e , g , , chronically administered oral ddrug1 , ddrug2 , or certain ddrug3 } or by drugs that irreversibly inhibit plasma bche , resistance to the neuromuscular blocking action of nondepolarizing HD00547 has been demonstrated in patients chronically administered ddrug5 or DB00564 .",
        "label": "effect"
    },
    {
        "text": "the neuromuscular blocking effect of ddrug0 may be enhanced by drugs that reduce plasma bche activity { e , g , , chronically administered oral ddrug1 , ddrug2 , or certain ddrug3 } or by drugs that irreversibly inhibit plasma bche , resistance to the neuromuscular blocking action of nondepolarizing ddrug4 has been demonstrated in patients chronically administered DB00252 or DB00564 .",
        "label": "NA"
    },
    {
        "text": "while the effects of chronic DB00252 or DB00564 therapy on the action of ddrug2 are unknown , slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .",
        "label": "NA"
    },
    {
        "text": "while the effects of chronic DB00252 or ddrug1 therapy on the action of DB01226 are unknown , slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .",
        "label": "effect"
    },
    {
        "text": "while the effects of chronic ddrug0 or DB00564 therapy on the action of DB01226 are unknown , slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .",
        "label": "effect"
    },
    {
        "text": "some drug interactions are : - birth control pills - HD00175 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DB00252 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - HD00175 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or DB00564 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - HD00175 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain HD00002 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - HD00175 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - DB00515 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - HD00175 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - DB01010 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - HD00175 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - DB01400 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - HD00175 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - DB00781 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - HD00175 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or DB00781 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - HD00175 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local HD00264 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - HD00175 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as DB00721 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - HD00175 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general HD00264 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - HD00175 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - DB00202 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - HD00175 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other HD00542",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DB00252 or DB00564 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DB00252 or ddrug2 - certain HD00002 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DB00252 or ddrug2 - certain ddrug3 given by injection - DB00515 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DB00252 or ddrug2 - certain ddrug3 given by injection - ddrug4 - DB01010 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DB00252 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - DB01400 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DB00252 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - DB00781 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DB00252 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or DB00781 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DB00252 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local HD00264 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DB00252 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as DB00721 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DB00252 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general HD00264 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DB00252 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - DB00202 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DB00252 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other HD00542",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or DB00564 - certain HD00002 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or DB00564 - certain ddrug3 given by injection - DB00515 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or DB00564 - certain ddrug3 given by injection - ddrug4 - DB01010 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or DB00564 - certain ddrug3 given by injection - ddrug4 - ddrug5 - DB01400 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or DB00564 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - DB00781 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or DB00564 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or DB00781 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or DB00564 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local HD00264 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or DB00564 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as DB00721 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or DB00564 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general HD00264 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or DB00564 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - DB00202 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or DB00564 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other HD00542",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain HD00002 given by injection - DB00515 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain HD00002 given by injection - ddrug4 - DB01010 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain HD00002 given by injection - ddrug4 - ddrug5 - DB01400 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain HD00002 given by injection - ddrug4 - ddrug5 - ddrug6 - DB00781 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain HD00002 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or DB00781 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain HD00002 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local HD00264 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain HD00002 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as DB00721 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain HD00002 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general HD00264 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain HD00002 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - DB00202 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain HD00002 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other HD00542",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - DB00515 - DB01010 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - DB00515 - ddrug5 - DB01400 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - DB00515 - ddrug5 - ddrug6 - DB00781 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - DB00515 - ddrug5 - ddrug6 - ddrug7 or DB00781 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - DB00515 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local HD00264 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - DB00515 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as DB00721 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - DB00515 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general HD00264 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - DB00515 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - DB00202 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - DB00515 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other HD00542",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - DB01010 - DB01400 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - DB01010 - ddrug6 - DB00781 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - DB01010 - ddrug6 - ddrug7 or DB00781 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - DB01010 - ddrug6 - ddrug7 or ddrug8 - local HD00264 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - DB01010 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as DB00721 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - DB01010 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general HD00264 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - DB01010 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - DB00202 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - DB01010 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other HD00542",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - DB01400 - DB00781 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - DB01400 - ddrug7 or DB00781 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - DB01400 - ddrug7 or ddrug8 - local HD00264 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - DB01400 - ddrug7 or ddrug8 - local ddrug9 such as DB00721 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - DB01400 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general HD00264 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - DB01400 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - DB00202 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - DB01400 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other HD00542",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - DB00781 or DB00781 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - DB00781 or ddrug8 - local HD00264 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - DB00781 or ddrug8 - local ddrug9 such as DB00721 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - DB00781 or ddrug8 - local ddrug9 such as ddrug10 - general HD00264 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - DB00781 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - DB00202 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - DB00781 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other HD00542",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or DB00781 - local HD00264 such as ddrug10 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or DB00781 - local ddrug9 such as DB00721 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or DB00781 - local ddrug9 such as ddrug10 - general HD00264 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or DB00781 - local ddrug9 such as ddrug10 - general ddrug11 - DB00202 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or DB00781 - local ddrug9 such as ddrug10 - general ddrug11 - ddrug12 or other HD00542",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local HD00264 such as DB00721 - general ddrug11 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local HD00264 such as ddrug10 - general ddrug11 - DB00202 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local HD00264 such as ddrug10 - general ddrug11 - ddrug12 or other HD00542",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as DB00721 - general HD00264 - ddrug12 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as DB00721 - general ddrug11 - DB00202 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as DB00721 - general ddrug11 - ddrug12 or other HD00542",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general HD00264 - DB00202 or other ddrug13",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general HD00264 - ddrug12 or other HD00542",
        "label": "NA"
    },
    {
        "text": "some drug interactions are : - birth control pills - ddrug0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as ddrug1 or ddrug2 - certain ddrug3 given by injection - ddrug4 - ddrug5 - ddrug6 - ddrug7 or ddrug8 - local ddrug9 such as ddrug10 - general ddrug11 - DB00202 or other HD00542",
        "label": "NA"
    },
    {
        "text": "HD00218 : excessive reductions in blood pressure may occur in patients on diuretic therapy when HD00106 are started .",
        "label": "NA"
    },
    {
        "text": "DB14500 supplements and ddrug1 : DB00691 can increase serum potassium because it decreases aldosterone secretion .",
        "label": "NA"
    },
    {
        "text": "ddrug0 supplements and HD00293 : DB00691 can increase serum potassium because it decreases aldosterone secretion .",
        "label": "NA"
    },
    {
        "text": "use of HD00293 { ddrug1 , ddrug2 , ddrug3 } or ddrug4 supplements concomitantly with HD00106 can increase the risk of hyperkalemia .",
        "label": "effect"
    },
    {
        "text": "use of ddrug0 { DB00421 , ddrug2 , ddrug3 } or DB14500 supplements concomitantly with ddrug5 can increase the risk of hyperkalemia .",
        "label": "NA"
    },
    {
        "text": "use of ddrug0 { DB00421 , ddrug2 , ddrug3 } or ddrug4 supplements concomitantly with HD00106 can increase the risk of hyperkalemia .",
        "label": "effect"
    },
    {
        "text": "use of ddrug0 { ddrug1 , DB00384 , ddrug3 } or DB14500 supplements concomitantly with ddrug5 can increase the risk of hyperkalemia .",
        "label": "NA"
    },
    {
        "text": "use of ddrug0 { ddrug1 , DB00384 , ddrug3 } or ddrug4 supplements concomitantly with HD00106 can increase the risk of hyperkalemia .",
        "label": "effect"
    },
    {
        "text": "use of ddrug0 { ddrug1 , ddrug2 , DB00594 } or DB14500 supplements concomitantly with ddrug5 can increase the risk of hyperkalemia .",
        "label": "NA"
    },
    {
        "text": "use of ddrug0 { ddrug1 , ddrug2 , DB00594 } or ddrug4 supplements concomitantly with HD00106 can increase the risk of hyperkalemia .",
        "label": "effect"
    },
    {
        "text": "use of ddrug0 { ddrug1 , ddrug2 , ddrug3 } or DB14500 supplements concomitantly with HD00106 can increase the risk of hyperkalemia .",
        "label": "effect"
    },
    {
        "text": "oral HD00326 : interaction studies with DB00682 failed to identify any clinically important effect on the serum concentrations of the ddrug2 or on its anticoagulant effect .",
        "label": "NA"
    },
    {
        "text": "oral ddrug0 : interaction studies with DB00682 failed to identify any clinically important effect on the serum concentrations of the HD00025 or on its anticoagulant effect .",
        "label": "NA"
    },
    {
        "text": "DB14507 : increased serum ddrug1 levels and symptoms of ddrug2 toxicity have been reported in patients receiving HD00106 during therapy with ddrug4 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : increased serum DB14507 levels and symptoms of ddrug2 toxicity have been reported in patients receiving HD00106 during therapy with ddrug4 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : increased serum ddrug1 levels and symptoms of DB14507 toxicity have been reported in patients receiving HD00106 during therapy with ddrug4 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : increased serum ddrug1 levels and symptoms of ddrug2 toxicity have been reported in patients receiving HD00106 during therapy with DB14507 .",
        "label": "effect"
    },
    {
        "text": "if a HD00295 is also used , the risk of DB14507 toxicity may be increased .",
        "label": "effect"
    },
    {
        "text": "other agents : no clinically important pharmacokinetic interactions occurred when DB00691 was administered concomitantly with DB00999 , ddrug2 , or ddrug3 .",
        "label": "NA"
    },
    {
        "text": "other agents : no clinically important pharmacokinetic interactions occurred when DB00691 was administered concomitantly with ddrug1 , DB00390 , or ddrug3 .",
        "label": "NA"
    },
    {
        "text": "other agents : no clinically important pharmacokinetic interactions occurred when DB00691 was administered concomitantly with ddrug1 , ddrug2 , or DB00501 .",
        "label": "NA"
    },
    {
        "text": "DB00691 has been used in clinical trials concomitantly with HD00396 , ddrug2 , ddrug3 , ddrug4 , oral ddrug5 , and cholesterol-lowering agents .",
        "label": "NA"
    },
    {
        "text": "DB00691 has been used in clinical trials concomitantly with ddrug1 , HD00218 , ddrug3 , ddrug4 , oral ddrug5 , and cholesterol-lowering agents .",
        "label": "NA"
    },
    {
        "text": "DB00691 has been used in clinical trials concomitantly with ddrug1 , ddrug2 , HD00586 , ddrug4 , oral ddrug5 , and cholesterol-lowering agents .",
        "label": "NA"
    },
    {
        "text": "DB00691 has been used in clinical trials concomitantly with ddrug1 , ddrug2 , ddrug3 , DB00390 , oral ddrug5 , and cholesterol-lowering agents .",
        "label": "NA"
    },
    {
        "text": "DB00691 has been used in clinical trials concomitantly with ddrug1 , ddrug2 , ddrug3 , ddrug4 , oral HD00062 , and cholesterol-lowering agents .",
        "label": "NA"
    },
    {
        "text": "however , DB01026 , a potent inhibitor of cytochrome p450 3a4 , may increase plasma levels of DB14512 during concomitant dosing .",
        "label": "mechanism"
    },
    {
        "text": "DB00471 at a dose of # mg once daily dosed to pharmacokinetic steady state - did not cause clinically significant changes in the kinetics of a single intravenous dose of DB00277 { predominantly a cyp1a2 substrate } .",
        "label": "NA"
    },
    {
        "text": "- did not change the plasma concentration profile of DB00342 { a substrate of cytochrome p450 3a4 } or DB00950 , its carboxylated metabolite , and did not prolong the qtc interval following co-administration with ddrug2 # mg twice daily .",
        "label": "NA"
    },
    {
        "text": "- did not change the plasma concentration profile of ddrug0 { a substrate of cytochrome p450 3a4 } or DB00950 , its carboxylated metabolite , and did not prolong the qtc interval following co-administration with DB00342 # mg twice daily .",
        "label": "NA"
    },
    {
        "text": "DB00471 at doses of # mg daily dosed to pharmacokinetic steady state : - did not significantly alter the plasma concentrations of either component of an oral HD00349 containing ddrug2 # mg/ethinyl ddrug3 # mcg .",
        "label": "NA"
    },
    {
        "text": "DB00471 at doses of # mg daily dosed to pharmacokinetic steady state : - did not significantly alter the plasma concentrations of either component of an oral ddrug1 containing DB00717 # mg/ethinyl ddrug3 # mcg .",
        "label": "NA"
    },
    {
        "text": "DB00471 at doses of # mg daily dosed to pharmacokinetic steady state : - did not significantly alter the plasma concentrations of either component of an oral ddrug1 containing ddrug2 # mg/ethinyl DB00783 # mcg .",
        "label": "NA"
    },
    {
        "text": "ddrug0 at doses of # mg daily dosed to pharmacokinetic steady state : - did not significantly alter the plasma concentrations of either component of an oral HD00349 containing DB00717 # mg/ethinyl ddrug3 # mcg .",
        "label": "NA"
    },
    {
        "text": "ddrug0 at doses of # mg daily dosed to pharmacokinetic steady state : - did not significantly alter the plasma concentrations of either component of an oral HD00349 containing ddrug2 # mg/ethinyl DB00783 # mcg .",
        "label": "NA"
    },
    {
        "text": "ddrug0 at doses of # mg daily dosed to pharmacokinetic steady state : - did not significantly alter the plasma concentrations of either component of an oral ddrug1 containing DB00717 # mg/ethinyl DB00783 # mcg .",
        "label": "NA"
    },
    {
        "text": "- did not cause any clinically significant change in plasma profiles of DB00898 or DB00860 following administration of either oral ddrug2 or intravenous ddrug3 .",
        "label": "NA"
    },
    {
        "text": "- did not cause any clinically significant change in plasma profiles of DB00898 or ddrug1 following administration of either oral ddrug2 or intravenous DB00860 .",
        "label": "NA"
    },
    {
        "text": "- did not cause any clinically significant change in plasma profiles of ddrug0 or DB00860 following administration of either oral DB00898 or intravenous ddrug3 .",
        "label": "NA"
    },
    {
        "text": "- did not cause any clinically significant change in plasma profiles of ddrug0 or ddrug1 following administration of either oral DB00898 or intravenous DB00860 .",
        "label": "NA"
    },
    {
        "text": "DB01174 , which induces hepatic metabolism , decreased the auc of DB00471 approximately 40 % following a single 10-mg dose of ddrug2 .",
        "label": "NA"
    },
    {
        "text": "DB01174 , which induces hepatic metabolism , decreased the auc of ddrug1 approximately 40 % following a single 10-mg dose of DB00471 .",
        "label": "NA"
    },
    {
        "text": "it is reasonable to employ appropriate clinical monitoring when potent cytochrome p450 enzyme inducers , such as DB01174 or DB01045 , are co-administered with ddrug2 .",
        "label": "NA"
    },
    {
        "text": "it is reasonable to employ appropriate clinical monitoring when potent cytochrome p450 enzyme inducers , such as DB01174 or ddrug1 , are co-administered with DB00471 .",
        "label": "advise"
    },
    {
        "text": "it is reasonable to employ appropriate clinical monitoring when potent cytochrome p450 enzyme inducers , such as ddrug0 or DB01045 , are co-administered with DB00471 .",
        "label": "advise"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of DB00471 did not have clinically important effects on the pharmacokinetics of the following drugs : DB00277 , ddrug2 , ddrug3 , oral ddrug4 { ddrug5 # mg / ddrug6 # mcg } , ddrug7 , ddrug8 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of DB00471 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , DB00898 , ddrug3 , oral ddrug4 { ddrug5 # mg / ddrug6 # mcg } , ddrug7 , ddrug8 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of DB00471 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , ddrug2 , DB00860 , oral ddrug4 { ddrug5 # mg / ddrug6 # mcg } , ddrug7 , ddrug8 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of DB00471 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , ddrug2 , ddrug3 , oral HD00283 { ddrug5 # mg / ddrug6 # mcg } , ddrug7 , ddrug8 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of DB00471 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , ddrug2 , ddrug3 , oral ddrug4 { DB00717 # mg / ddrug6 # mcg } , ddrug7 , ddrug8 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of DB00471 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , ddrug2 , ddrug3 , oral ddrug4 { ddrug5 # mg / DB00977 # mcg } , ddrug7 , ddrug8 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of DB00471 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , ddrug2 , ddrug3 , oral ddrug4 { ddrug5 # mg / ddrug6 # mcg } , DB00342 , ddrug8 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of DB00471 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , ddrug2 , ddrug3 , oral ddrug4 { ddrug5 # mg / ddrug6 # mcg } , ddrug7 , DB00390 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of DB00471 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , ddrug2 , ddrug3 , oral ddrug4 { ddrug5 # mg / ddrug6 # mcg } , ddrug7 , ddrug8 , and DB00682 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : DB00277 , DB00898 , ddrug3 , oral ddrug4 { ddrug5 # mg / ddrug6 # mcg } , ddrug7 , ddrug8 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : DB00277 , ddrug2 , DB00860 , oral ddrug4 { ddrug5 # mg / ddrug6 # mcg } , ddrug7 , ddrug8 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : DB00277 , ddrug2 , ddrug3 , oral ddrug4 { DB00717 # mg / ddrug6 # mcg } , ddrug7 , ddrug8 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : DB00277 , ddrug2 , ddrug3 , oral ddrug4 { ddrug5 # mg / DB00977 # mcg } , ddrug7 , ddrug8 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : DB00277 , ddrug2 , ddrug3 , oral ddrug4 { ddrug5 # mg / ddrug6 # mcg } , DB00342 , ddrug8 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : DB00277 , ddrug2 , ddrug3 , oral ddrug4 { ddrug5 # mg / ddrug6 # mcg } , ddrug7 , DB00390 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : DB00277 , ddrug2 , ddrug3 , oral ddrug4 { ddrug5 # mg / ddrug6 # mcg } , ddrug7 , ddrug8 , and DB00682 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , DB00898 , DB00860 , oral ddrug4 { ddrug5 # mg / ddrug6 # mcg } , ddrug7 , ddrug8 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , DB00898 , ddrug3 , oral ddrug4 { DB00717 # mg / ddrug6 # mcg } , ddrug7 , ddrug8 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , DB00898 , ddrug3 , oral ddrug4 { ddrug5 # mg / DB00977 # mcg } , ddrug7 , ddrug8 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , DB00898 , ddrug3 , oral ddrug4 { ddrug5 # mg / ddrug6 # mcg } , DB00342 , ddrug8 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , DB00898 , ddrug3 , oral ddrug4 { ddrug5 # mg / ddrug6 # mcg } , ddrug7 , DB00390 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , DB00898 , ddrug3 , oral ddrug4 { ddrug5 # mg / ddrug6 # mcg } , ddrug7 , ddrug8 , and DB00682 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , ddrug2 , DB00860 , oral ddrug4 { DB00717 # mg / ddrug6 # mcg } , ddrug7 , ddrug8 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , ddrug2 , DB00860 , oral ddrug4 { ddrug5 # mg / DB00977 # mcg } , ddrug7 , ddrug8 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , ddrug2 , ddrug3 , oral HD00283 { DB00717 # mg / ddrug6 # mcg } , ddrug7 , ddrug8 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , ddrug2 , ddrug3 , oral HD00283 { ddrug5 # mg / DB00977 # mcg } , ddrug7 , ddrug8 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , ddrug2 , ddrug3 , oral ddrug4 { DB00717 # mg / DB00977 # mcg } , ddrug7 , ddrug8 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , ddrug2 , ddrug3 , oral ddrug4 { DB00717 # mg / ddrug6 # mcg } , DB00342 , ddrug8 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , ddrug2 , ddrug3 , oral ddrug4 { DB00717 # mg / ddrug6 # mcg } , ddrug7 , DB00390 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , ddrug2 , ddrug3 , oral ddrug4 { DB00717 # mg / ddrug6 # mcg } , ddrug7 , ddrug8 , and DB00682 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , ddrug2 , ddrug3 , oral ddrug4 { ddrug5 # mg / DB00977 # mcg } , DB00342 , ddrug8 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , ddrug2 , ddrug3 , oral ddrug4 { ddrug5 # mg / DB00977 # mcg } , ddrug7 , DB00390 , and ddrug9 .",
        "label": "NA"
    },
    {
        "text": "in drug-interaction studies , the recommended clinical dose of ddrug0 did not have clinically important effects on the pharmacokinetics of the following drugs : ddrug1 , ddrug2 , ddrug3 , oral ddrug4 { ddrug5 # mg / DB00977 # mcg } , ddrug7 , ddrug8 , and DB00682 .",
        "label": "NA"
    },
    {
        "text": "DB01174 , which induces hepatic metabolism , decreased the auc of DB00471 approximately 40 % following a single 10-mg dose of ddrug2 .",
        "label": "NA"
    },
    {
        "text": "DB01174 , which induces hepatic metabolism , decreased the auc of ddrug1 approximately 40 % following a single 10-mg dose of DB00471 .",
        "label": "NA"
    },
    {
        "text": "it is reasonable to employ appropriate clinical monitoring when potent cytochrome p450 enzyme inducers , such as DB01174 or DB01045 , are co-administered with ddrug2 .",
        "label": "NA"
    },
    {
        "text": "it is reasonable to employ appropriate clinical monitoring when potent cytochrome p450 enzyme inducers , such as DB01174 or ddrug1 , are co-administered with DB00471 .",
        "label": "advise"
    },
    {
        "text": "it is reasonable to employ appropriate clinical monitoring when potent cytochrome p450 enzyme inducers , such as ddrug0 or DB01045 , are co-administered with DB00471 .",
        "label": "advise"
    },
    {
        "text": "use with other ddrug0 : the depressant effects of DB00295 are potentiated by the presence of other HD00261 such as ddrug3 , ddrug4 , ddrug5 , or ddrug6 .",
        "label": "effect"
    },
    {
        "text": "use with other ddrug0 : the depressant effects of DB00295 are potentiated by the presence of other ddrug2 such as DB02325 , ddrug4 , ddrug5 , or ddrug6 .",
        "label": "effect"
    },
    {
        "text": "use with other ddrug0 : the depressant effects of DB00295 are potentiated by the presence of other ddrug2 such as ddrug3 , HD00024 , ddrug5 , or ddrug6 .",
        "label": "effect"
    },
    {
        "text": "use with other ddrug0 : the depressant effects of DB00295 are potentiated by the presence of other ddrug2 such as ddrug3 , ddrug4 , HD00130 , or ddrug6 .",
        "label": "effect"
    },
    {
        "text": "use with other ddrug0 : the depressant effects of DB00295 are potentiated by the presence of other ddrug2 such as ddrug3 , ddrug4 , ddrug5 , or HD00456 .",
        "label": "effect"
    },
    {
        "text": "use with other ddrug0 : the depressant effects of ddrug1 are potentiated by the presence of other HD00261 such as DB02325 , ddrug4 , ddrug5 , or ddrug6 .",
        "label": "NA"
    },
    {
        "text": "use with other ddrug0 : the depressant effects of ddrug1 are potentiated by the presence of other HD00261 such as ddrug3 , HD00024 , ddrug5 , or ddrug6 .",
        "label": "NA"
    },
    {
        "text": "use with other ddrug0 : the depressant effects of ddrug1 are potentiated by the presence of other HD00261 such as ddrug3 , ddrug4 , HD00130 , or ddrug6 .",
        "label": "NA"
    },
    {
        "text": "use with other ddrug0 : the depressant effects of ddrug1 are potentiated by the presence of other HD00261 such as ddrug3 , ddrug4 , ddrug5 , or HD00456 .",
        "label": "NA"
    },
    {
        "text": "use of HD00137 in conjunction with oral DB00295 may increase the risk of respiratory depression , hypotension and profound sedation or coma .",
        "label": "effect"
    },
    {
        "text": "interaction with HD00841 : ddrug1 { i , e , , DB00652 , ddrug3 , ddrug4 , or ddrug5 } should not be administered to patients who have received or are receiving a course of therapy with a proof ddrug6 .",
        "label": "NA"
    },
    {
        "text": "interaction with HD00841 : ddrug1 { i , e , , ddrug2 , DB00844 , ddrug4 , or ddrug5 } should not be administered to patients who have received or are receiving a course of therapy with a proof ddrug6 .",
        "label": "NA"
    },
    {
        "text": "interaction with HD00841 : ddrug1 { i , e , , ddrug2 , ddrug3 , DB00611 , or ddrug5 } should not be administered to patients who have received or are receiving a course of therapy with a proof ddrug6 .",
        "label": "NA"
    },
    {
        "text": "interaction with HD00841 : ddrug1 { i , e , , ddrug2 , ddrug3 , ddrug4 , or DB00921 } should not be administered to patients who have received or are receiving a course of therapy with a proof ddrug6 .",
        "label": "NA"
    },
    {
        "text": "interaction with ddrug0 : HD00842 { i , e , , ddrug2 , ddrug3 , ddrug4 , or ddrug5 } should not be administered to patients who have received or are receiving a course of therapy with a proof HD00981 .",
        "label": "advise"
    },
    {
        "text": "interaction with ddrug0 : ddrug1 { i , e , , DB00652 , ddrug3 , ddrug4 , or ddrug5 } should not be administered to patients who have received or are receiving a course of therapy with a proof HD00981 .",
        "label": "advise"
    },
    {
        "text": "interaction with ddrug0 : ddrug1 { i , e , , ddrug2 , DB00844 , ddrug4 , or ddrug5 } should not be administered to patients who have received or are receiving a course of therapy with a proof HD00981 .",
        "label": "advise"
    },
    {
        "text": "interaction with ddrug0 : ddrug1 { i , e , , ddrug2 , ddrug3 , DB00611 , or ddrug5 } should not be administered to patients who have received or are receiving a course of therapy with a proof HD00981 .",
        "label": "advise"
    },
    {
        "text": "interaction with ddrug0 : ddrug1 { i , e , , ddrug2 , ddrug3 , ddrug4 , or DB00921 } should not be administered to patients who have received or are receiving a course of therapy with a proof HD00981 .",
        "label": "advise"
    },
    {
        "text": "HD00374 : absorption of a single dose of DB01024 was decreased when administered to # stable renal transplant patients also taking ddrug2 - ddrug3 containing ddrug4 { 30 ml } : the mean cmax and auc { 0-t } values for mpa were 25 % and 37 % lower , respectively , than when ddrug5 was administered alone under fasting conditions .",
        "label": "NA"
    },
    {
        "text": "HD00374 : absorption of a single dose of ddrug1 was decreased when administered to # stable renal transplant patients also taking DB14513 - ddrug3 containing ddrug4 { 30 ml } : the mean cmax and auc { 0-t } values for mpa were 25 % and 37 % lower , respectively , than when ddrug5 was administered alone under fasting conditions .",
        "label": "NA"
    },
    {
        "text": "HD00374 : absorption of a single dose of ddrug1 was decreased when administered to # stable renal transplant patients also taking ddrug2 - DB01370 containing ddrug4 { 30 ml } : the mean cmax and auc { 0-t } values for mpa were 25 % and 37 % lower , respectively , than when ddrug5 was administered alone under fasting conditions .",
        "label": "NA"
    },
    {
        "text": "HD00374 : absorption of a single dose of ddrug1 was decreased when administered to # stable renal transplant patients also taking ddrug2 - ddrug3 containing ddrug4 { 30 ml } : the mean cmax and auc { 0-t } values for mpa were 25 % and 37 % lower , respectively , than when DB01024 was administered alone under fasting conditions .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : absorption of a single dose of DB01024 was decreased when administered to # stable renal transplant patients also taking DB14513 - ddrug3 containing ddrug4 { 30 ml } : the mean cmax and auc { 0-t } values for mpa were 25 % and 37 % lower , respectively , than when ddrug5 was administered alone under fasting conditions .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 : absorption of a single dose of DB01024 was decreased when administered to # stable renal transplant patients also taking ddrug2 - DB01370 containing ddrug4 { 30 ml } : the mean cmax and auc { 0-t } values for mpa were 25 % and 37 % lower , respectively , than when ddrug5 was administered alone under fasting conditions .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 : absorption of a single dose of DB01024 was decreased when administered to # stable renal transplant patients also taking ddrug2 - ddrug3 containing HD00374 { 30 ml } : the mean cmax and auc { 0-t } values for mpa were 25 % and 37 % lower , respectively , than when ddrug5 was administered alone under fasting conditions .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : absorption of a single dose of ddrug1 was decreased when administered to # stable renal transplant patients also taking DB14513 - DB01370 containing ddrug4 { 30 ml } : the mean cmax and auc { 0-t } values for mpa were 25 % and 37 % lower , respectively , than when ddrug5 was administered alone under fasting conditions .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : absorption of a single dose of ddrug1 was decreased when administered to # stable renal transplant patients also taking DB14513 - ddrug3 containing HD00374 { 30 ml } : the mean cmax and auc { 0-t } values for mpa were 25 % and 37 % lower , respectively , than when ddrug5 was administered alone under fasting conditions .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : absorption of a single dose of ddrug1 was decreased when administered to # stable renal transplant patients also taking DB14513 - ddrug3 containing ddrug4 { 30 ml } : the mean cmax and auc { 0-t } values for mpa were 25 % and 37 % lower , respectively , than when DB01024 was administered alone under fasting conditions .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : absorption of a single dose of ddrug1 was decreased when administered to # stable renal transplant patients also taking ddrug2 - DB01370 containing HD00374 { 30 ml } : the mean cmax and auc { 0-t } values for mpa were 25 % and 37 % lower , respectively , than when ddrug5 was administered alone under fasting conditions .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : absorption of a single dose of ddrug1 was decreased when administered to # stable renal transplant patients also taking ddrug2 - DB01370 containing ddrug4 { 30 ml } : the mean cmax and auc { 0-t } values for mpa were 25 % and 37 % lower , respectively , than when DB01024 was administered alone under fasting conditions .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : absorption of a single dose of ddrug1 was decreased when administered to # stable renal transplant patients also taking ddrug2 - ddrug3 containing HD00374 { 30 ml } : the mean cmax and auc { 0-t } values for mpa were 25 % and 37 % lower , respectively , than when DB01024 was administered alone under fasting conditions .",
        "label": "NA"
    },
    {
        "text": "it is recommended that DB01024 and HD00374 not be administered simultaneously .",
        "label": "advise"
    },
    {
        "text": "ddrug0 : when studied in stable renal transplant patients , DB00091 , usp { modified } pharmacokinetics were unaffected by steady state dosing of DB01024 .",
        "label": "NA"
    },
    {
        "text": "DB00787 / DB01004 : may be taken with ddrug2 ;",
        "label": "NA"
    },
    {
        "text": "DB00787 / ddrug1 : may be taken with DB01024 ;",
        "label": "NA"
    },
    {
        "text": "ddrug0 / DB01004 : may be taken with DB01024 ;",
        "label": "NA"
    },
    {
        "text": "both DB00787 / ddrug1 and HD00982 concentrations are increased in the presence of renal impairment , their coexistence may compete for tubular secretion and further increase in the concentrations of the two .",
        "label": "NA"
    },
    {
        "text": "both ddrug0 / DB01004 and HD00982 concentrations are increased in the presence of renal impairment , their coexistence may compete for tubular secretion and further increase in the concentrations of the two .",
        "label": "NA"
    },
    {
        "text": "DB00993 / DB00688 : given that ddrug2 and ddrug3 inhibit purine metabolism , it is recommended that ddrug4 not be administered concomitantly with ddrug5 or ddrug6 .",
        "label": "NA"
    },
    {
        "text": "DB00993 / ddrug1 : given that ddrug2 and DB00688 inhibit purine metabolism , it is recommended that ddrug4 not be administered concomitantly with ddrug5 or ddrug6 .",
        "label": "NA"
    },
    {
        "text": "DB00993 / ddrug1 : given that ddrug2 and ddrug3 inhibit purine metabolism , it is recommended that DB01024 not be administered concomitantly with ddrug5 or ddrug6 .",
        "label": "NA"
    },
    {
        "text": "DB00993 / ddrug1 : given that ddrug2 and ddrug3 inhibit purine metabolism , it is recommended that ddrug4 not be administered concomitantly with ddrug5 or DB00688 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 / DB00688 : given that DB00993 and ddrug3 inhibit purine metabolism , it is recommended that ddrug4 not be administered concomitantly with ddrug5 or ddrug6 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 / DB00688 : given that ddrug2 and ddrug3 inhibit purine metabolism , it is recommended that DB01024 not be administered concomitantly with ddrug5 or ddrug6 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 / DB00688 : given that ddrug2 and ddrug3 inhibit purine metabolism , it is recommended that ddrug4 not be administered concomitantly with DB00993 or ddrug6 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 / ddrug1 : given that DB00993 and DB00688 inhibit purine metabolism , it is recommended that ddrug4 not be administered concomitantly with ddrug5 or ddrug6 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 / ddrug1 : given that DB00993 and ddrug3 inhibit purine metabolism , it is recommended that DB01024 not be administered concomitantly with ddrug5 or ddrug6 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 / ddrug1 : given that DB00993 and ddrug3 inhibit purine metabolism , it is recommended that ddrug4 not be administered concomitantly with ddrug5 or DB00688 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 / ddrug1 : given that ddrug2 and DB00688 inhibit purine metabolism , it is recommended that DB01024 not be administered concomitantly with ddrug5 or ddrug6 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 / ddrug1 : given that ddrug2 and DB00688 inhibit purine metabolism , it is recommended that ddrug4 not be administered concomitantly with DB00993 or ddrug6 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 / ddrug1 : given that ddrug2 and ddrug3 inhibit purine metabolism , it is recommended that DB01024 not be administered concomitantly with DB00993 or ddrug6 .",
        "label": "advise"
    },
    {
        "text": "ddrug0 / ddrug1 : given that ddrug2 and ddrug3 inhibit purine metabolism , it is recommended that DB01024 not be administered concomitantly with ddrug5 or DB00688 .",
        "label": "advise"
    },
    {
        "text": "ddrug0 / ddrug1 : given that ddrug2 and ddrug3 inhibit purine metabolism , it is recommended that ddrug4 not be administered concomitantly with DB00993 or DB00688 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 and drugs that bind bile acids : these drugs interrupt enterohepatic recirculation and reduce DB00603 exposure when coadministered with DB00688 .",
        "label": "NA"
    },
    {
        "text": "therefore , do not administer DB01024 with DB01432 or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids , for example bile_acid sequestrates or oral ddrug2 , because of the potential to reduce the efficacy of ddrug3 .",
        "label": "advise"
    },
    {
        "text": "therefore , do not administer DB01024 with ddrug1 or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids , for example bile_acid sequestrates or oral DB09278 , because of the potential to reduce the efficacy of ddrug3 .",
        "label": "advise"
    },
    {
        "text": "therefore , do not administer ddrug0 with DB01432 or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids , for example bile_acid sequestrates or oral DB09278 , because of the potential to reduce the efficacy of ddrug3 .",
        "label": "NA"
    },
    {
        "text": "therefore , do not administer ddrug0 with DB01432 or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids , for example bile_acid sequestrates or oral ddrug2 , because of the potential to reduce the efficacy of DB01024 .",
        "label": "NA"
    },
    {
        "text": "therefore , do not administer ddrug0 with ddrug1 or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids , for example bile_acid sequestrates or oral DB09278 , because of the potential to reduce the efficacy of DB01024 .",
        "label": "NA"
    },
    {
        "text": "oral HD00283 : given the different metabolism of DB01024 and oral ddrug2 , no drug interaction between these two classes of drug is expected .",
        "label": "NA"
    },
    {
        "text": "oral ddrug0 : given the different metabolism of DB01024 and oral HD00283 , no drug interaction between these two classes of drug is expected .",
        "label": "NA"
    },
    {
        "text": "however , in a drug-drug interaction study , mean HD00983 auc was decreased by 15 % when coadministered with DB00688 .",
        "label": "mechanism"
    },
    {
        "text": "therefore , it is recommended that oral HD00283 are co - administered with DB01024 with caution and additional birth control methods be considered .",
        "label": "advise"
    },
    {
        "text": "HD00599 : during treatment with DB01024 , the use of ddrug2 should be avoided and patients should be advised that vaccinations may be less effective .",
        "label": "NA"
    },
    {
        "text": "HD00599 : during treatment with ddrug1 , the use of HD00601 should be avoided and patients should be advised that vaccinations may be less effective .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : during treatment with DB01024 , the use of HD00601 should be avoided and patients should be advised that vaccinations may be less effective .",
        "label": "advise"
    },
    {
        "text": "ddrug0 , ddrug1 , and ddrug2 : in patients treated with potent inducers of cyp3a4 { i , e , , DB00252 , ddrug4 , and ddrug5 } , the clearance of DB00904 was significantly increased and ddrug7 blood concentrations were decreased .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 , ddrug1 , and ddrug2 : in patients treated with potent inducers of cyp3a4 { i , e , , DB00252 , ddrug4 , and ddrug5 } , the clearance of ddrug6 was significantly increased and DB00904 blood concentrations were decreased .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 , ddrug1 , and ddrug2 : in patients treated with potent inducers of cyp3a4 { i , e , , ddrug3 , DB00564 , and ddrug5 } , the clearance of DB00904 was significantly increased and ddrug7 blood concentrations were decreased .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 , ddrug1 , and ddrug2 : in patients treated with potent inducers of cyp3a4 { i , e , , ddrug3 , DB00564 , and ddrug5 } , the clearance of ddrug6 was significantly increased and DB00904 blood concentrations were decreased .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 , ddrug1 , and ddrug2 : in patients treated with potent inducers of cyp3a4 { i , e , , ddrug3 , ddrug4 , and DB01045 } , the clearance of DB00904 was significantly increased and ddrug7 blood concentrations were decreased .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 , ddrug1 , and ddrug2 : in patients treated with potent inducers of cyp3a4 { i , e , , ddrug3 , ddrug4 , and DB01045 } , the clearance of ddrug6 was significantly increased and DB00904 blood concentrations were decreased .",
        "label": "mechanism"
    },
    {
        "text": "however , on the basis of available data , no dosage adjustment for DB00904 is recommended for patients on these drugs # , 3 DB00193 : although no pharmacokinetic drug interaction between ddrug2 and ddrug3 has been observed , data from # small studies indicate that ddrug4 may be associated with an increase in patient controlled administration of ddrug5 # , 5 chemotherapy : tumor response to chemotherapy in the p # mouse leukemia model is not affected by ddrug6 .",
        "label": "NA"
    },
    {
        "text": "however , on the basis of available data , no dosage adjustment for ddrug0 is recommended for patients on these drugs # , 3 ddrug1 : although no pharmacokinetic drug interaction between DB00904 and DB00193 has been observed , data from # small studies indicate that ddrug4 may be associated with an increase in patient controlled administration of ddrug5 # , 5 chemotherapy : tumor response to chemotherapy in the p # mouse leukemia model is not affected by ddrug6 .",
        "label": "NA"
    },
    {
        "text": "however , on the basis of available data , no dosage adjustment for ddrug0 is recommended for patients on these drugs # , 3 ddrug1 : although no pharmacokinetic drug interaction between DB00904 and ddrug3 has been observed , data from # small studies indicate that ddrug4 may be associated with an increase in patient controlled administration of DB00193 # , 5 chemotherapy : tumor response to chemotherapy in the p # mouse leukemia model is not affected by ddrug6 .",
        "label": "NA"
    },
    {
        "text": "however , on the basis of available data , no dosage adjustment for ddrug0 is recommended for patients on these drugs # , 3 ddrug1 : although no pharmacokinetic drug interaction between ddrug2 and DB00193 has been observed , data from # small studies indicate that DB00904 may be associated with an increase in patient controlled administration of ddrug5 # , 5 chemotherapy : tumor response to chemotherapy in the p # mouse leukemia model is not affected by ddrug6 .",
        "label": "NA"
    },
    {
        "text": "however , on the basis of available data , no dosage adjustment for ddrug0 is recommended for patients on these drugs # , 3 ddrug1 : although no pharmacokinetic drug interaction between ddrug2 and ddrug3 has been observed , data from # small studies indicate that DB00904 may be associated with an increase in patient controlled administration of DB00193 # , 5 chemotherapy : tumor response to chemotherapy in the p # mouse leukemia model is not affected by ddrug6 .",
        "label": "effect"
    },
    {
        "text": "in humans , DB00262 , ddrug1 , and ddrug2 do not affect the pharmacokinetics of DB00904 .",
        "label": "NA"
    },
    {
        "text": "in humans , ddrug0 , DB00773 , and ddrug2 do not affect the pharmacokinetics of DB00904 .",
        "label": "NA"
    },
    {
        "text": "in humans , ddrug0 , ddrug1 , and DB00515 do not affect the pharmacokinetics of DB00904 .",
        "label": "NA"
    },
    {
        "text": "DB00904 did not increase blood levels of high-dose DB00563 .",
        "label": "NA"
    },
    {
        "text": "other HD00984 should not be used concomitantly with DB00816 { ddrug2 usp } because they may have additive effects .",
        "label": "advise"
    },
    {
        "text": "other HD00984 should not be used concomitantly with ddrug1 { DB00816 usp } because they may have additive effects .",
        "label": "advise"
    },
    {
        "text": "HD00985 should be administered with caution to patients being treated with HD00275 or ddrug2 , since the action of ddrug3 on the vascular system may be potentiated .",
        "label": "advise"
    },
    {
        "text": "HD00985 should be administered with caution to patients being treated with ddrug1 or HD00043 , since the action of ddrug3 on the vascular system may be potentiated .",
        "label": "advise"
    },
    {
        "text": "ddrug0 should be administered with caution to patients being treated with HD00275 or HD00043 , since the action of ddrug3 on the vascular system may be potentiated .",
        "label": "NA"
    },
    {
        "text": "ddrug0 should be administered with caution to patients being treated with HD00275 or ddrug2 , since the action of HD00985 on the vascular system may be potentiated .",
        "label": "NA"
    },
    {
        "text": "ddrug0 should be administered with caution to patients being treated with ddrug1 or HD00043 , since the action of HD00985 on the vascular system may be potentiated .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : in a multiple-dose study in # normal weight subjects , coadministration of DB01083 and # grams of DB02325 { e , g , , approximately # glasses of wine } did not result in alteration of ddrug3 pharmacokinetics , ddrug4 pharmacodynamics { fecal fat excretion } , or systemic exposure to ddrug5 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : in a multiple-dose study in # normal weight subjects , coadministration of DB01083 and # grams of ddrug2 { e , g , , approximately # glasses of wine } did not result in alteration of DB02325 pharmacokinetics , ddrug4 pharmacodynamics { fecal fat excretion } , or systemic exposure to ddrug5 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : in a multiple-dose study in # normal weight subjects , coadministration of DB01083 and # grams of ddrug2 { e , g , , approximately # glasses of wine } did not result in alteration of ddrug3 pharmacokinetics , DB01083 pharmacodynamics { fecal fat excretion } , or systemic exposure to ddrug5 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : in a multiple-dose study in # normal weight subjects , coadministration of DB01083 and # grams of ddrug2 { e , g , , approximately # glasses of wine } did not result in alteration of ddrug3 pharmacokinetics , ddrug4 pharmacodynamics { fecal fat excretion } , or systemic exposure to DB01083 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : in a multiple-dose study in # normal weight subjects , coadministration of ddrug1 and # grams of DB02325 { e , g , , approximately # glasses of wine } did not result in alteration of ddrug3 pharmacokinetics , DB01083 pharmacodynamics { fecal fat excretion } , or systemic exposure to ddrug5 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : in a multiple-dose study in # normal weight subjects , coadministration of ddrug1 and # grams of DB02325 { e , g , , approximately # glasses of wine } did not result in alteration of ddrug3 pharmacokinetics , ddrug4 pharmacodynamics { fecal fat excretion } , or systemic exposure to DB01083 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : in a multiple-dose study in # normal weight subjects , coadministration of ddrug1 and # grams of ddrug2 { e , g , , approximately # glasses of wine } did not result in alteration of DB02325 pharmacokinetics , DB01083 pharmacodynamics { fecal fat excretion } , or systemic exposure to ddrug5 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : in a multiple-dose study in # normal weight subjects , coadministration of ddrug1 and # grams of ddrug2 { e , g , , approximately # glasses of wine } did not result in alteration of DB02325 pharmacokinetics , ddrug4 pharmacodynamics { fecal fat excretion } , or systemic exposure to DB01083 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : preliminary data from a DB01083 and DB00091 drug interaction study indicate a reduction in ddrug3 plasma levels when ddrug4 was coadministered with ddrug5 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : preliminary data from a DB01083 and ddrug2 drug interaction study indicate a reduction in DB00091 plasma levels when ddrug4 was coadministered with ddrug5 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : preliminary data from a DB01083 and ddrug2 drug interaction study indicate a reduction in ddrug3 plasma levels when ddrug4 was coadministered with DB00091 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : preliminary data from a ddrug1 and DB00091 drug interaction study indicate a reduction in ddrug3 plasma levels when DB01083 was coadministered with ddrug5 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : preliminary data from a ddrug1 and ddrug2 drug interaction study indicate a reduction in DB00091 plasma levels when DB01083 was coadministered with ddrug5 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : preliminary data from a ddrug1 and ddrug2 drug interaction study indicate a reduction in ddrug3 plasma levels when DB01083 was coadministered with DB00091 .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 : in # normal-weight subjects receiving DB01083 # mg three times a day for # days , ddrug2 did not alter the pharmacokinetics of a single dose of DB00390 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : in # normal-weight subjects receiving ddrug1 # mg three times a day for # days , DB01083 did not alter the pharmacokinetics of a single dose of DB00390 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 and analogues : a pharmacokinetic interaction study showed a 30 % reduction in DB06755 supplement absorption when concomitantly administered with DB01083 .",
        "label": "mechanism"
    },
    {
        "text": "DB01083 inhibited absorption of a DB14003 supplement by approximately 60 % .",
        "label": "mechanism"
    },
    {
        "text": "the effect of DB01083 on the absorption of supplemental DB11094 , ddrug2 , and nutritionally-derived ddrug3 is not known at this time .",
        "label": "NA"
    },
    {
        "text": "the effect of DB01083 on the absorption of supplemental ddrug1 , DB00162 , and nutritionally-derived ddrug3 is not known at this time .",
        "label": "NA"
    },
    {
        "text": "the effect of DB01083 on the absorption of supplemental ddrug1 , ddrug2 , and nutritionally-derived DB01022 is not known at this time .",
        "label": "NA"
    },
    {
        "text": "the effect of ddrug0 on the absorption of supplemental DB11094 , DB00162 , and nutritionally-derived ddrug3 is not known at this time .",
        "label": "NA"
    },
    {
        "text": "the effect of ddrug0 on the absorption of supplemental DB11094 , ddrug2 , and nutritionally-derived DB01022 is not known at this time .",
        "label": "NA"
    },
    {
        "text": "the effect of ddrug0 on the absorption of supplemental ddrug1 , DB00162 , and nutritionally-derived DB01022 is not known at this time .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : in # normal-weight subjects receiving DB01083 # mg three times a day for # days , ddrug2 did not alter the pharmacokinetics or pharmacodynamics { blood glucose-lowering } of DB01016 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : in # normal-weight subjects receiving ddrug1 # mg three times a day for # days , DB01083 did not alter the pharmacokinetics or pharmacodynamics { blood glucose-lowering } of DB01016 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 { extended-release tablets } : in # normal-weight subjects receiving DB01083 # mg three times a day for # days , ddrug2 did not alter the bioavailability of DB01115 { extended-release tablets } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 { extended-release tablets } : in # normal-weight subjects receiving ddrug1 # mg three times a day for # days , DB01083 did not alter the bioavailability of DB01115 { extended-release tablets } .",
        "label": "NA"
    },
    {
        "text": "oral ddrug0 : in # normal-weight female subjects , the treatment of DB01083 # mg three times a day for # days resulted in no changes in the ovulation-suppressing action of oral HD00283 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : in # normal-weight subjects receiving DB01083 # mg three times a day for # days , ddrug2 did not alter the pharmacokinetics of a single 300-mg dose of DB00252 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : in # normal-weight subjects receiving ddrug1 # mg three times a day for # days , DB01083 did not alter the pharmacokinetics of a single 300-mg dose of DB00252 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : in a 2-way crossover study of # normal-weight , mildly hypercholesterolemic patients receiving DB01083 # mg three times a day for # days , ddrug2 did not affect the pharmacokinetics of DB00175 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : in a 2-way crossover study of # normal-weight , mildly hypercholesterolemic patients receiving ddrug1 # mg three times a day for # days , DB01083 did not affect the pharmacokinetics of DB00175 .",
        "label": "NA"
    },
    {
        "text": "DB00682 : in # normal-weight subjects , administration of DB01083 # mg three times a day for # days did not result in any change in either ddrug2 pharmacokinetics { both r - and s-enantiomers } or pharmacodynamics { prothrombin time and serum factor vii } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : in # normal-weight subjects , administration of DB01083 # mg three times a day for # days did not result in any change in either DB00682 pharmacokinetics { both r - and s-enantiomers } or pharmacodynamics { prothrombin time and serum factor vii } .",
        "label": "NA"
    },
    {
        "text": "therefore , as DB01022 absorption may be decreased with DB01083 , patients on chronic stable doses of ddrug2 who are prescribed ddrug3 should be monitored closely for changes in coagulation parameters .",
        "label": "mechanism"
    },
    {
        "text": "therefore , as DB01022 absorption may be decreased with ddrug1 , patients on chronic stable doses of DB00682 who are prescribed ddrug3 should be monitored closely for changes in coagulation parameters .",
        "label": "NA"
    },
    {
        "text": "therefore , as DB01022 absorption may be decreased with ddrug1 , patients on chronic stable doses of ddrug2 who are prescribed DB01083 should be monitored closely for changes in coagulation parameters .",
        "label": "NA"
    },
    {
        "text": "therefore , as ddrug0 absorption may be decreased with DB01083 , patients on chronic stable doses of DB00682 who are prescribed ddrug3 should be monitored closely for changes in coagulation parameters .",
        "label": "NA"
    },
    {
        "text": "therefore , as ddrug0 absorption may be decreased with ddrug1 , patients on chronic stable doses of DB00682 who are prescribed DB01083 should be monitored closely for changes in coagulation parameters .",
        "label": "advise"
    },
    {
        "text": "DB00759 , a bacteriostatic DB09345 , may antagonize the bactericidal effect of ddrug2 and concurrent use of these drugs should be avoided .",
        "label": "NA"
    },
    {
        "text": "DB00759 , a bacteriostatic ddrug1 , may antagonize the bactericidal effect of HD00284 and concurrent use of these drugs should be avoided .",
        "label": "effect"
    },
    {
        "text": "ddrug0 , a bacteriostatic DB09345 , may antagonize the bactericidal effect of HD00284 and concurrent use of these drugs should be avoided .",
        "label": "NA"
    },
    {
        "text": "no pharmacokinetic interaction between # mg/m2 DB00526 and infusional DB00544 has been observed in patients treated every # weeks .",
        "label": "NA"
    },
    {
        "text": "increases of DB00544 plasma concentrations by approximately 20 % have been observed with doses of # mg/m2 DB00526 dosed every # weeks .",
        "label": "mechanism"
    },
    {
        "text": "HD00326 HD00986 may increase sensitivity to oral ddrug2 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 HD00986 may increase sensitivity to oral HD00326 .",
        "label": "effect"
    },
    {
        "text": "ddrug0 : a multidose study of DB00621 , given as # or # mg bid in # healthy subjects concurrently treated with DB00682 , resulted in a mean increase in ddrug3 half-life from # to # hours and auc from # to # ng * hr/ml : similar increases in ddrug4 half-life and auc were also detected .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 : a multidose study of DB00621 , given as # or # mg bid in # healthy subjects concurrently treated with ddrug2 , resulted in a mean increase in DB14055 half-life from # to # hours and auc from # to # ng * hr/ml : similar increases in ddrug4 half-life and auc were also detected .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : a multidose study of DB00621 , given as # or # mg bid in # healthy subjects concurrently treated with ddrug2 , resulted in a mean increase in ddrug3 half-life from # to # hours and auc from # to # ng * hr/ml : similar increases in DB08496 half-life and auc were also detected .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : a multidose study of ddrug1 , given as # or # mg bid in # healthy subjects concurrently treated with ddrug2 , resulted in a mean increase in DB14055 half-life from # to # hours and auc from # to # ng * hr/ml : similar increases in DB08496 half-life and auc were also detected .",
        "label": "NA"
    },
    {
        "text": "when DB00621 therapy is initiated in a patient already receiving treatment with DB00682 , the inr or prothrombin time { pt } should be monitored closely and the dose of ddrug2 adjusted as necessary until a stable target inr or pt has been achieved .",
        "label": "advise"
    },
    {
        "text": "when DB00621 therapy is initiated in a patient already receiving treatment with ddrug1 , the inr or prothrombin time { pt } should be monitored closely and the dose of DB00682 adjusted as necessary until a stable target inr or pt has been achieved .",
        "label": "NA"
    },
    {
        "text": "furthermore , in patients receiving both drugs , careful monitoring of the inr or pt , and adjustment of the DB00682 dosage if indicated are recommended when the DB00621 dose is changed or discontinued .",
        "label": "advise"
    },
    {
        "text": "oral HD00062 DB00621 may inhibit the metabolism of oral ddrug2 .",
        "label": "NA"
    },
    {
        "text": "oral ddrug0 DB00621 may inhibit the metabolism of oral HD00062 .",
        "label": "mechanism"
    },
    {
        "text": "HD00987 or DB01285 in patients with edema , concomitant administration with ddrug2 or ddrug3 may increase the edema .",
        "label": "NA"
    },
    {
        "text": "HD00987 or ddrug1 in patients with edema , concomitant administration with HD00988 or ddrug3 may increase the edema .",
        "label": "NA"
    },
    {
        "text": "HD00987 or ddrug1 in patients with edema , concomitant administration with ddrug2 or DB01285 may increase the edema .",
        "label": "NA"
    },
    {
        "text": "ddrug0 or DB01285 in patients with edema , concomitant administration with HD00988 or ddrug3 may increase the edema .",
        "label": "NA"
    },
    {
        "text": "ddrug0 or ddrug1 in patients with edema , concomitant administration with HD00988 or DB01285 may increase the edema .",
        "label": "NA"
    },
    {
        "text": "the concomitant use of DB01062 with other HD00522 or with other agents which produce dry mouth , constipation , somnolence { drowsiness } , and/or other anticholinergic-like effects may increase the frequency and/or severity of such effects .",
        "label": "effect"
    },
    {
        "text": "mean DB01062 plasma concentrations were approximately # fold higher when DB01062 was administered with ddrug2 , a potent cyp3a4 inhibitor .",
        "label": "NA"
    },
    {
        "text": "mean DB01062 plasma concentrations were approximately # fold higher when ddrug1 was administered with DB01026 , a potent cyp3a4 inhibitor .",
        "label": "NA"
    },
    {
        "text": "mean ddrug0 plasma concentrations were approximately # fold higher when DB01062 was administered with DB01026 , a potent cyp3a4 inhibitor .",
        "label": "mechanism"
    },
    {
        "text": "other inhibitors of the cytochrome p450 3a4 enzyme system , such as HD00989 { e , g , , ddrug1 and ddrug2 } or HD00093 { e , g , , ddrug4 and ddrug5 } , may alter ddrug6 mean pharmacokinetic parameters { i , e , , cmax and auc } .",
        "label": "NA"
    },
    {
        "text": "other inhibitors of the cytochrome p450 3a4 enzyme system , such as HD00989 { e , g , , ddrug1 and ddrug2 } or ddrug3 { e , g , , DB00199 and ddrug5 } , may alter ddrug6 mean pharmacokinetic parameters { i , e , , cmax and auc } .",
        "label": "NA"
    },
    {
        "text": "other inhibitors of the cytochrome p450 3a4 enzyme system , such as HD00989 { e , g , , ddrug1 and ddrug2 } or ddrug3 { e , g , , ddrug4 and DB01211 } , may alter ddrug6 mean pharmacokinetic parameters { i , e , , cmax and auc } .",
        "label": "NA"
    },
    {
        "text": "other inhibitors of the cytochrome p450 3a4 enzyme system , such as HD00989 { e , g , , ddrug1 and ddrug2 } or ddrug3 { e , g , , ddrug4 and ddrug5 } , may alter DB01062 mean pharmacokinetic parameters { i , e , , cmax and auc } .",
        "label": "mechanism"
    },
    {
        "text": "other inhibitors of the cytochrome p450 3a4 enzyme system , such as ddrug0 { e , g , , DB01167 and ddrug2 } or HD00093 { e , g , , ddrug4 and ddrug5 } , may alter ddrug6 mean pharmacokinetic parameters { i , e , , cmax and auc } .",
        "label": "NA"
    },
    {
        "text": "other inhibitors of the cytochrome p450 3a4 enzyme system , such as ddrug0 { e , g , , DB01167 and ddrug2 } or ddrug3 { e , g , , DB00199 and ddrug5 } , may alter ddrug6 mean pharmacokinetic parameters { i , e , , cmax and auc } .",
        "label": "NA"
    },
    {
        "text": "other inhibitors of the cytochrome p450 3a4 enzyme system , such as ddrug0 { e , g , , DB01167 and ddrug2 } or ddrug3 { e , g , , ddrug4 and DB01211 } , may alter ddrug6 mean pharmacokinetic parameters { i , e , , cmax and auc } .",
        "label": "NA"
    },
    {
        "text": "other inhibitors of the cytochrome p450 3a4 enzyme system , such as ddrug0 { e , g , , DB01167 and ddrug2 } or ddrug3 { e , g , , ddrug4 and ddrug5 } , may alter DB01062 mean pharmacokinetic parameters { i , e , , cmax and auc } .",
        "label": "mechanism"
    },
    {
        "text": "other inhibitors of the cytochrome p450 3a4 enzyme system , such as ddrug0 { e , g , , ddrug1 and DB01110 } or HD00093 { e , g , , ddrug4 and ddrug5 } , may alter ddrug6 mean pharmacokinetic parameters { i , e , , cmax and auc } .",
        "label": "NA"
    },
    {
        "text": "other inhibitors of the cytochrome p450 3a4 enzyme system , such as ddrug0 { e , g , , ddrug1 and DB01110 } or ddrug3 { e , g , , DB00199 and ddrug5 } , may alter ddrug6 mean pharmacokinetic parameters { i , e , , cmax and auc } .",
        "label": "NA"
    },
    {
        "text": "other inhibitors of the cytochrome p450 3a4 enzyme system , such as ddrug0 { e , g , , ddrug1 and DB01110 } or ddrug3 { e , g , , ddrug4 and DB01211 } , may alter ddrug6 mean pharmacokinetic parameters { i , e , , cmax and auc } .",
        "label": "NA"
    },
    {
        "text": "other inhibitors of the cytochrome p450 3a4 enzyme system , such as ddrug0 { e , g , , ddrug1 and DB01110 } or ddrug3 { e , g , , ddrug4 and ddrug5 } , may alter DB01062 mean pharmacokinetic parameters { i , e , , cmax and auc } .",
        "label": "mechanism"
    },
    {
        "text": "other inhibitors of the cytochrome p450 3a4 enzyme system , such as ddrug0 { e , g , , ddrug1 and ddrug2 } or HD00093 { e , g , , ddrug4 and ddrug5 } , may alter DB01062 mean pharmacokinetic parameters { i , e , , cmax and auc } .",
        "label": "mechanism"
    },
    {
        "text": "other inhibitors of the cytochrome p450 3a4 enzyme system , such as ddrug0 { e , g , , ddrug1 and ddrug2 } or ddrug3 { e , g , , DB00199 and ddrug5 } , may alter DB01062 mean pharmacokinetic parameters { i , e , , cmax and auc } .",
        "label": "mechanism"
    },
    {
        "text": "other inhibitors of the cytochrome p450 3a4 enzyme system , such as ddrug0 { e , g , , ddrug1 and ddrug2 } or ddrug3 { e , g , , ddrug4 and DB01211 } , may alter DB01062 mean pharmacokinetic parameters { i , e , , cmax and auc } .",
        "label": "mechanism"
    },
    {
        "text": "concurrent ingestion of DB06724 { 20 ml of ddrug1 containing ddrug2 , ddrug3 , and ddrug4 } did not significantly affect the exposure of DB01062 or ddrug6 .",
        "label": "NA"
    },
    {
        "text": "concurrent ingestion of DB06724 { 20 ml of ddrug1 containing ddrug2 , ddrug3 , and ddrug4 } did not significantly affect the exposure of ddrug5 or HD00990 .",
        "label": "NA"
    },
    {
        "text": "concurrent ingestion of ddrug0 { 20 ml of DB06724 containing ddrug2 , ddrug3 , and ddrug4 } did not significantly affect the exposure of DB01062 or ddrug6 .",
        "label": "NA"
    },
    {
        "text": "concurrent ingestion of ddrug0 { 20 ml of DB06724 containing ddrug2 , ddrug3 , and ddrug4 } did not significantly affect the exposure of ddrug5 or HD00990 .",
        "label": "NA"
    },
    {
        "text": "concurrent ingestion of ddrug0 { 20 ml of ddrug1 containing DB06723 , ddrug3 , and ddrug4 } did not significantly affect the exposure of DB01062 or ddrug6 .",
        "label": "NA"
    },
    {
        "text": "concurrent ingestion of ddrug0 { 20 ml of ddrug1 containing DB06723 , ddrug3 , and ddrug4 } did not significantly affect the exposure of ddrug5 or HD00990 .",
        "label": "NA"
    },
    {
        "text": "concurrent ingestion of ddrug0 { 20 ml of ddrug1 containing ddrug2 , DB09104 , and ddrug4 } did not significantly affect the exposure of DB01062 or ddrug6 .",
        "label": "NA"
    },
    {
        "text": "concurrent ingestion of ddrug0 { 20 ml of ddrug1 containing ddrug2 , DB09104 , and ddrug4 } did not significantly affect the exposure of ddrug5 or HD00990 .",
        "label": "NA"
    },
    {
        "text": "concurrent ingestion of ddrug0 { 20 ml of ddrug1 containing ddrug2 , ddrug3 , and DB11074 } did not significantly affect the exposure of DB01062 or ddrug6 .",
        "label": "NA"
    },
    {
        "text": "concurrent ingestion of ddrug0 { 20 ml of ddrug1 containing ddrug2 , ddrug3 , and DB11074 } did not significantly affect the exposure of ddrug5 or HD00990 .",
        "label": "NA"
    },
    {
        "text": "the cns depressant effects of DB00497 may be additive with that of other HD00261 , .",
        "label": "effect"
    },
    {
        "text": "the concomitant use of other HD00261 including HD00024 , ddrug2 , ddrug3 , general ddrug4 , ddrug5 , other ddrug6 , ddrug7 , ddrug8 , and ddrug9 may produce additive cns depressant effects .",
        "label": "NA"
    },
    {
        "text": "the concomitant use of other HD00261 including ddrug1 , HD00214 , ddrug3 , general ddrug4 , ddrug5 , other ddrug6 , ddrug7 , ddrug8 , and ddrug9 may produce additive cns depressant effects .",
        "label": "NA"
    },
    {
        "text": "the concomitant use of other HD00261 including ddrug1 , ddrug2 , HD00262 , general ddrug4 , ddrug5 , other ddrug6 , ddrug7 , ddrug8 , and ddrug9 may produce additive cns depressant effects .",
        "label": "NA"
    },
    {
        "text": "the concomitant use of other HD00261 including ddrug1 , ddrug2 , ddrug3 , general HD00264 , ddrug5 , other ddrug6 , ddrug7 , ddrug8 , and ddrug9 may produce additive cns depressant effects .",
        "label": "NA"
    },
    {
        "text": "the concomitant use of other HD00261 including ddrug1 , ddrug2 , ddrug3 , general ddrug4 , HD00219 , other ddrug6 , ddrug7 , ddrug8 , and ddrug9 may produce additive cns depressant effects .",
        "label": "NA"
    },
    {
        "text": "the concomitant use of other HD00261 including ddrug1 , ddrug2 , ddrug3 , general ddrug4 , ddrug5 , other HD00263 , ddrug7 , ddrug8 , and ddrug9 may produce additive cns depressant effects .",
        "label": "NA"
    },
    {
        "text": "the concomitant use of other HD00261 including ddrug1 , ddrug2 , ddrug3 , general ddrug4 , ddrug5 , other ddrug6 , HD00043 , ddrug8 , and ddrug9 may produce additive cns depressant effects .",
        "label": "NA"
    },
    {
        "text": "the concomitant use of other HD00261 including ddrug1 , ddrug2 , ddrug3 , general ddrug4 , ddrug5 , other ddrug6 , ddrug7 , HD00445 , and ddrug9 may produce additive cns depressant effects .",
        "label": "NA"
    },
    {
        "text": "the concomitant use of other HD00261 including ddrug1 , ddrug2 , ddrug3 , general ddrug4 , ddrug5 , other ddrug6 , ddrug7 , ddrug8 , and DB02325 may produce additive cns depressant effects .",
        "label": "NA"
    },
    {
        "text": "the concomitant use of other ddrug0 including ddrug1 , HD00214 , HD00262 , general ddrug4 , ddrug5 , other ddrug6 , ddrug7 , ddrug8 , and ddrug9 may produce additive cns depressant effects .",
        "label": "NA"
    },
    {
        "text": "HD00444 or other medications with anticholinergic activity when used concurrently with HD00726 may result in increased risk of urinary retention and/or severe constipation , which may lead to paralytic ileus .",
        "label": "effect"
    },
    {
        "text": "it has been reported that the incidence of bradycardia was increased when DB01192 was combined with DB00818 for induction of anesthesia .",
        "label": "effect"
    },
    {
        "text": "in addition , cns toxicity has been reported { confusion , disorientation , respiratory depression , apnea , seizures } following coadministration of DB00501 with HD00726 ;",
        "label": "effect"
    },
    {
        "text": "potential for DB01267 to affect other drugs DB01267 is not expected to cause clinically important pharmacokinetic interactions with drugs that are metabolized by cytochrome cyp2b6 isozymes .",
        "label": "NA"
    },
    {
        "text": "given the primary cns effects of DB01267 , DB01267 should be used with caution in combination with other ddrug2 and ddrug3 .",
        "label": "NA"
    },
    {
        "text": "given the primary cns effects of DB01267 , ddrug1 should be used with caution in combination with other HD00365 and ddrug3 .",
        "label": "advise"
    },
    {
        "text": "given the primary cns effects of DB01267 , ddrug1 should be used with caution in combination with other ddrug2 and DB02325 .",
        "label": "advise"
    },
    {
        "text": "given the primary cns effects of ddrug0 , DB01267 should be used with caution in combination with other HD00365 and ddrug3 .",
        "label": "advise"
    },
    {
        "text": "given the primary cns effects of ddrug0 , DB01267 should be used with caution in combination with other ddrug2 and DB02325 .",
        "label": "advise"
    },
    {
        "text": "given the primary cns effects of ddrug0 , ddrug1 should be used with caution in combination with other HD00365 and DB02325 .",
        "label": "NA"
    },
    {
        "text": "DB01267 may antagonize the effect of DB01235 and other ddrug2 .",
        "label": "effect"
    },
    {
        "text": "DB01267 may antagonize the effect of ddrug1 and other HD00342 .",
        "label": "effect"
    },
    {
        "text": "ddrug0 may antagonize the effect of DB01235 and other HD00342 .",
        "label": "NA"
    },
    {
        "text": "potential for other drugs to affect DB01267 DB01267 is not a substrate of cyp1a2 , cyp2a6 , cyp2c9 , and cyp2c19 , so that an interaction with inhibitors or inducers of these isozymes is unlikely .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : DB00277 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , DB00604 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , DB01435 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , DB00201 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00564 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB00829 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , DB14028 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , DB00586 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , DB00788 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , DB00554 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , DB00390 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , DB00898 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , DB01016 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral HD00349 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { DB00367 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / DB00977 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , DB00264 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , DB01115 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , DB00252 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , DB00682 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , DB00683 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , DB01211 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , DB00916 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of DB00213 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or DB01060 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DB00277 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral HD00349 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DB00277 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { DB00367 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DB00277 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / DB00977 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DB00277 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , DB00264 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DB00277 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , DB01115 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DB00277 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , DB00252 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DB00277 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , DB00682 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DB00277 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , DB00683 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DB00277 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , DB01211 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DB00277 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , DB00916 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DB00277 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or DB01060 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , DB00604 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral HD00349 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , DB00604 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { DB00367 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , DB00604 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / DB00977 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , DB00604 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , DB00264 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , DB00604 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , DB01115 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , DB00604 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , DB00252 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , DB00604 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , DB00682 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , DB00604 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , DB00683 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , DB00604 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , DB01211 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , DB00604 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , DB00916 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , DB00604 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or DB01060 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , DB01435 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral HD00349 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , DB01435 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { DB00367 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , DB01435 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / DB00977 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , DB01435 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , DB00264 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , DB01435 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , DB01115 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , DB01435 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , DB00252 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , DB01435 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , DB00682 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , DB01435 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , DB00683 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , DB01435 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , DB01211 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , DB01435 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , DB00916 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , DB01435 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or DB01060 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , DB00201 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral HD00349 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , DB00201 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { DB00367 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , DB00201 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / DB00977 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , DB00201 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , DB00264 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , DB00201 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , DB01115 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , DB00201 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , DB00252 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , DB00201 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , DB00682 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , DB00201 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , DB00683 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , DB00201 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , DB01211 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , DB00201 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , DB00916 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , DB00201 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or DB01060 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00564 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral HD00349 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00564 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { DB00367 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00564 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / DB00977 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00564 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , DB00264 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00564 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , DB01115 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00564 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , DB00252 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00564 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , DB00682 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00564 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , DB00683 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00564 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , DB01211 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00564 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , DB00916 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00564 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or DB01060 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB00829 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral HD00349 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB00829 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { DB00367 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB00829 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / DB00977 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB00829 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , DB00264 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB00829 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , DB01115 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB00829 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , DB00252 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB00829 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , DB00682 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB00829 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , DB00683 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB00829 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , DB01211 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB00829 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , DB00916 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB00829 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or DB01060 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , DB14028 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral HD00349 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , DB14028 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { DB00367 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , DB14028 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / DB00977 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , DB14028 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , DB00264 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , DB14028 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , DB01115 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , DB14028 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , DB00252 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , DB14028 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , DB00682 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , DB14028 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , DB00683 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , DB14028 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , DB01211 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , DB14028 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , DB00916 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , DB14028 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or DB01060 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , DB00586 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral HD00349 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , DB00586 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { DB00367 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , DB00586 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / DB00977 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , DB00586 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , DB00264 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , DB00586 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , DB01115 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , DB00586 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , DB00252 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , DB00586 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , DB00682 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , DB00586 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , DB00683 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , DB00586 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , DB01211 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , DB00586 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , DB00916 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , DB00586 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or DB01060 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , DB00788 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral HD00349 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , DB00788 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { DB00367 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , DB00788 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / DB00977 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , DB00788 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , DB00264 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , DB00788 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , DB01115 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , DB00788 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , DB00252 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , DB00788 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , DB00682 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , DB00788 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , DB00683 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , DB00788 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , DB01211 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , DB00788 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , DB00916 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , DB00788 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or DB01060 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , DB00554 , ddrug11 , ddrug12 , ddrug13 , an oral HD00349 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , DB00554 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { DB00367 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , DB00554 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / DB00977 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , DB00554 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , DB00264 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , DB00554 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , DB01115 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , DB00554 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , DB00252 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , DB00554 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , DB00682 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , DB00554 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , DB00683 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , DB00554 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , DB01211 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , DB00554 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , DB00916 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , DB00554 , ddrug11 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or DB01060 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , DB00390 , ddrug12 , ddrug13 , an oral HD00349 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , DB00390 , ddrug12 , ddrug13 , an oral ddrug14 { DB00367 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , DB00390 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / DB00977 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , DB00390 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , DB00264 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , DB00390 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , DB01115 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , DB00390 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , DB00252 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , DB00390 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , DB00682 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , DB00390 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , DB00683 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , DB00390 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , DB01211 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , DB00390 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , DB00916 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , DB00390 , ddrug12 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or DB01060 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , DB00898 , ddrug13 , an oral HD00349 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , DB00898 , ddrug13 , an oral ddrug14 { DB00367 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , DB00898 , ddrug13 , an oral ddrug14 { ddrug15 / DB00977 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , DB00898 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , DB00264 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , DB00898 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , DB01115 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , DB00898 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , DB00252 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , DB00898 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , DB00682 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , DB00898 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , DB00683 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , DB00898 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , DB01211 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , DB00898 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , DB00916 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , DB00898 , ddrug13 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or DB01060 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , DB01016 , an oral HD00349 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , DB01016 , an oral ddrug14 { DB00367 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , DB01016 , an oral ddrug14 { ddrug15 / DB00977 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , DB01016 , an oral ddrug14 { ddrug15 / ddrug16 } , DB00264 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , DB01016 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , DB01115 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , DB01016 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , DB00252 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , DB01016 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , DB00682 , ddrug21 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , DB01016 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , DB00683 , ddrug22 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , DB01016 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , DB01211 , ddrug23 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , DB01016 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , DB00916 , or ddrug24 .",
        "label": "NA"
    },
    {
        "text": "based on studies evaluating possible interactions of ddrug0 with other drugs , no dosage adjustment is needed with concomitant use of the following : ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 { and its active metabolite , ddrug7 } , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , DB01016 , an oral ddrug14 { ddrug15 / ddrug16 } , ddrug17 , ddrug18 , ddrug19 , ddrug20 , ddrug21 , ddrug22 , ddrug23 , or DB01060 .",
        "label": "NA"
    },
    {
        "text": "there have been postmarketing reports of increased inr and prothrombin time in patients receiving HD00587 , including DB00213 , and ddrug2 concomitantly .",
        "label": "NA"
    },
    {
        "text": "there have been postmarketing reports of increased inr and prothrombin time in patients receiving HD00587 , including ddrug1 , and DB00682 concomitantly .",
        "label": "effect"
    },
    {
        "text": "there have been postmarketing reports of increased inr and prothrombin time in patients receiving ddrug0 , including DB00213 , and DB00682 concomitantly .",
        "label": "effect"
    },
    {
        "text": "patients treated with HD00587 and DB00682 concomitantly should be monitored for increases in inr and prothrombin time .",
        "label": "advise"
    },
    {
        "text": "because of profound and long lasting inhibition of gastric acid secretion , DB00213 may interfere with absorption of drugs where gastric ph is an important determinant of their bioavailability { eg , DB01026 , ddrug2 esters , and ddrug3 salts } .",
        "label": "mechanism"
    },
    {
        "text": "because of profound and long lasting inhibition of gastric acid secretion , DB00213 may interfere with absorption of drugs where gastric ph is an important determinant of their bioavailability { eg , ddrug1 , DB00415 esters , and ddrug3 salts } .",
        "label": "mechanism"
    },
    {
        "text": "because of profound and long lasting inhibition of gastric acid secretion , DB00213 may interfere with absorption of drugs where gastric ph is an important determinant of their bioavailability { eg , ddrug1 , ddrug2 esters , and DB01592 salts } .",
        "label": "mechanism"
    },
    {
        "text": "laboratory tests there have been reports of false-positive urine screening tests for DB00470 { ddrug1 } in patients receiving most HD00587 , including ddrug3 .",
        "label": "NA"
    },
    {
        "text": "laboratory tests there have been reports of false-positive urine screening tests for DB00470 { ddrug1 } in patients receiving most ddrug2 , including DB00213 .",
        "label": "NA"
    },
    {
        "text": "laboratory tests there have been reports of false-positive urine screening tests for ddrug0 { HD00991 } in patients receiving most HD00587 , including ddrug3 .",
        "label": "NA"
    },
    {
        "text": "laboratory tests there have been reports of false-positive urine screening tests for ddrug0 { HD00991 } in patients receiving most ddrug2 , including DB00213 .",
        "label": "NA"
    },
    {
        "text": "laboratory tests there have been reports of false-positive urine screening tests for ddrug0 { ddrug1 } in patients receiving most HD00587 , including DB00213 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that DB01026 approximately doubled DB00910 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "mechanism"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since DB00910 is partially metabolized by cytochrome_p450_family_3_subfamily_a and DB01026 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since DB00910 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with DB01026 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since DB00910 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including DB01072 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since DB00910 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , DB01211 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since DB00910 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , DB00224 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since DB00910 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , DB01167 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since DB00910 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , DB01149 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since DB00910 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , DB00220 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since DB00910 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , DB00503 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since DB00910 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , DB01232 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since DB00910 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , DB00976 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since DB00910 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or DB00582 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and DB01026 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing DB00910 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and DB01026 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including DB01072 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and DB01026 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , DB01211 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and DB01026 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , DB00224 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and DB01026 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , DB01167 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and DB01026 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , DB01149 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and DB01026 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , DB00220 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and DB01026 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , DB00503 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and DB01026 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , DB01232 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and DB01026 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , DB00976 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and DB01026 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or DB00582 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing DB00910 with DB01026 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "advise"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing DB00910 with ddrug5 and other strong cyp2b6 3a inhibitors including DB01072 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "advise"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing DB00910 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , DB01211 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "advise"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing DB00910 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , DB00224 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "advise"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing DB00910 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , DB01167 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "advise"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing DB00910 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , DB01149 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "advise"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing DB00910 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , DB00220 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "advise"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing DB00910 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , DB00503 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "advise"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing DB00910 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , DB01232 , ddrug14 or ddrug15 .",
        "label": "advise"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing DB00910 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , DB00976 or ddrug15 .",
        "label": "advise"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing DB00910 with ddrug5 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or DB00582 .",
        "label": "advise"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with DB01026 and other strong cyp2b6 3a inhibitors including DB01072 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with DB01026 and other strong cyp2b6 3a inhibitors including ddrug6 , DB01211 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with DB01026 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , DB00224 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with DB01026 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , DB01167 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with DB01026 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , DB01149 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with DB01026 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , DB00220 , ddrug12 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with DB01026 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , DB00503 , ddrug13 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with DB01026 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , DB01232 , ddrug14 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with DB01026 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , DB00976 or ddrug15 .",
        "label": "NA"
    },
    {
        "text": "a multiple dose drug-drug interaction study demonstrated that ddrug0 approximately doubled ddrug1 auc0 - , since ddrug2 is partially metabolized by cytochrome_p450_family_3_subfamily_a and ddrug3 le is known to be a strong inhibitor of cytochrome cyp2b6 3a enzyme , care should be taken while dosing ddrug4 with DB01026 and other strong cyp2b6 3a inhibitors including ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , ddrug12 , ddrug13 , ddrug14 or DB00582 .",
        "label": "NA"
    },
    {
        "text": "dose adjustment of DB00910 capsules may be required , and ipth and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong cyp3a4 inhibitor such as DB01026 .",
        "label": "advise"
    },
    {
        "text": "drugs that impair intestinal absorption of HD00527 , such as DB01432 , may interfere with the absorption of ddrug2 capsules .",
        "label": "mechanism"
    },
    {
        "text": "drugs that impair intestinal absorption of HD00527 , such as ddrug1 , may interfere with the absorption of DB00910 capsules .",
        "label": "NA"
    },
    {
        "text": "drugs that impair intestinal absorption of ddrug0 , such as DB01432 , may interfere with the absorption of DB00910 capsules .",
        "label": "mechanism"
    },
    {
        "text": "patients receiving DB14507 and DB00019 should have more frequent monitoring of neutrophil counts .",
        "label": "advise"
    },
    {
        "text": "in a pharmacokinetic study of # chronic hepatitis c patients concomitantly receiving DB00333 , treatment with HD00992 once weekly for # weeks was associated with a mean increase of 16 % in ddrug2 auc ;",
        "label": "mechanism"
    },
    {
        "text": "in a pharmacokinetic study of # chronic hepatitis c patients concomitantly receiving ddrug0 , treatment with HD00992 once weekly for # weeks was associated with a mean increase of 16 % in DB00333 auc ;",
        "label": "NA"
    },
    {
        "text": "acromegalic patients with diabetes mellitus being treated with HD00071 and/or oral HD00854 agents may require dose reductions of these therapeutic agents after the initiation of therapy with ddrug2 .",
        "label": "NA"
    },
    {
        "text": "acromegalic patients with diabetes mellitus being treated with HD00071 and/or oral ddrug1 agents may require dose reductions of these therapeutic agents after the initiation of therapy with DB00082 .",
        "label": "advise"
    },
    {
        "text": "acromegalic patients with diabetes mellitus being treated with ddrug0 and/or oral HD00854 agents may require dose reductions of these therapeutic agents after the initiation of therapy with DB00082 .",
        "label": "advise"
    },
    {
        "text": "in clinical studies , patients on HD00263 often needed higher serum DB00082 concentrations to achieve appropriate igf1 suppression compared with patients not receiving ddrug2 .",
        "label": "mechanism"
    },
    {
        "text": "in clinical studies , patients on ddrug0 often needed higher serum DB00082 concentrations to achieve appropriate igf1 suppression compared with patients not receiving HD00263 .",
        "label": "NA"
    },
    {
        "text": "concomitant administration of substances that are also tubularly secreted { e , g , , DB01032 } could potentially result in delayed clearance of DB00642 .",
        "label": "mechanism"
    },
    {
        "text": "although DB01050 { 400 mg qid } can be administered with DB00642 in patients with normal renal function { creatinine clearance # ml/min } , caution should be used when administering ddrug2 concurrently with ddrug3 to patients with mild to moderate renal insufficiency { creatinine clearance from # to # ml/min } .",
        "label": "NA"
    },
    {
        "text": "although DB01050 { 400 mg qid } can be administered with ddrug1 in patients with normal renal function { creatinine clearance # ml/min } , caution should be used when administering ddrug2 concurrently with DB00642 to patients with mild to moderate renal insufficiency { creatinine clearance from # to # ml/min } .",
        "label": "NA"
    },
    {
        "text": "although ddrug0 { 400 mg qid } can be administered with DB00642 in patients with normal renal function { creatinine clearance # ml/min } , caution should be used when administering DB01050 concurrently with ddrug3 to patients with mild to moderate renal insufficiency { creatinine clearance from # to # ml/min } .",
        "label": "NA"
    },
    {
        "text": "although ddrug0 { 400 mg qid } can be administered with ddrug1 in patients with normal renal function { creatinine clearance # ml/min } , caution should be used when administering DB01050 concurrently with DB00642 to patients with mild to moderate renal insufficiency { creatinine clearance from # to # ml/min } .",
        "label": "advise"
    },
    {
        "text": "patients with mild to moderate renal insufficiency should avoid taking HD00203 with short elimination half-lives for a period of # days before , the day of , and # days following administration of DB00642 .",
        "label": "advise"
    },
    {
        "text": "in the absence of data regarding potential interaction between DB00642 and HD00203 with longer half-lives , all patients taking these ddrug2 should interrupt dosing for at least # days before , the day of , and # days following ddrug3 administration .",
        "label": "NA"
    },
    {
        "text": "in the absence of data regarding potential interaction between DB00642 and ddrug1 with longer half-lives , all patients taking these HD00203 should interrupt dosing for at least # days before , the day of , and # days following ddrug3 administration .",
        "label": "NA"
    },
    {
        "text": "in the absence of data regarding potential interaction between ddrug0 and HD00203 with longer half-lives , all patients taking these ddrug2 should interrupt dosing for at least # days before , the day of , and # days following DB00642 administration .",
        "label": "NA"
    },
    {
        "text": "in the absence of data regarding potential interaction between ddrug0 and ddrug1 with longer half-lives , all patients taking these HD00203 should interrupt dosing for at least # days before , the day of , and # days following DB00642 administration .",
        "label": "advise"
    },
    {
        "text": "decreased seizure threshold has been reported in patients receiving DB01230 concomitantly with HD00993 .",
        "label": "effect"
    },
    {
        "text": "concurrent administration of HD00322 { e , g , , ddrug1 , ddrug2 } may diminish the bactericidal effects of HD00124 by slowing the rate of bacterial growth .",
        "label": "effect"
    },
    {
        "text": "concurrent administration of ddrug0 { e , g , , DB00199 , ddrug2 } may diminish the bactericidal effects of HD00124 by slowing the rate of bacterial growth .",
        "label": "effect"
    },
    {
        "text": "concurrent administration of ddrug0 { e , g , , ddrug1 , DB00759 } may diminish the bactericidal effects of HD00124 by slowing the rate of bacterial growth .",
        "label": "effect"
    },
    {
        "text": "HD00284 blood levels may be prolonged by concurrent administration of DB01032 which blocks the renal tubular secretion of ddrug2 .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 blood levels may be prolonged by concurrent administration of DB01032 which blocks the renal tubular secretion of HD00124 .",
        "label": "NA"
    },
    {
        "text": "usage with ddrug0 : due to the potential for increased cns depressants effects , DB02325 should be used with caution in patients who are currently receiving DB00652 .",
        "label": "advise"
    },
    {
        "text": "although a causal relationship has not been established , there have been reports of bleeding and/or prolonged prothrombin time in patients treated with DB00806 with and without HD00326 or ddrug2 .",
        "label": "effect"
    },
    {
        "text": "although a causal relationship has not been established , there have been reports of bleeding and/or prolonged prothrombin time in patients treated with DB00806 with and without ddrug1 or HD00353 .",
        "label": "effect"
    },
    {
        "text": "although a causal relationship has not been established , there have been reports of bleeding and/or prolonged prothrombin time in patients treated with ddrug0 with and without HD00326 or HD00353 .",
        "label": "NA"
    },
    {
        "text": "concomitant administration of DB00806 and DB00277 - containing drugs leads to increased ddrug2 levels and ddrug3 toxicity in some individuals .",
        "label": "mechanism"
    },
    {
        "text": "concomitant administration of DB00806 and ddrug1 - containing drugs leads to increased DB00277 levels and ddrug3 toxicity in some individuals .",
        "label": "NA"
    },
    {
        "text": "concomitant administration of DB00806 and ddrug1 - containing drugs leads to increased ddrug2 levels and DB00277 toxicity in some individuals .",
        "label": "NA"
    },
    {
        "text": "DB00806 has been used concurrently with HD00448 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 , without observed problems .",
        "label": "NA"
    },
    {
        "text": "DB00806 has been used concurrently with ddrug1 , HD00378 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 , without observed problems .",
        "label": "NA"
    },
    {
        "text": "DB00806 has been used concurrently with ddrug1 , ddrug2 , HD00118 , ddrug4 , ddrug5 , and ddrug6 , without observed problems .",
        "label": "NA"
    },
    {
        "text": "DB00806 has been used concurrently with ddrug1 , ddrug2 , ddrug3 , HD00218 , ddrug5 , and ddrug6 , without observed problems .",
        "label": "NA"
    },
    {
        "text": "DB00806 has been used concurrently with ddrug1 , ddrug2 , ddrug3 , ddrug4 , HD00075 , and ddrug6 , without observed problems .",
        "label": "NA"
    },
    {
        "text": "DB00806 has been used concurrently with ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and HD00303 , without observed problems .",
        "label": "NA"
    },
    {
        "text": "HD00339 , such as the HD00137 { ddrug2 , ddrug3 , ddrug4 } or ddrug5 , ordinarily should not be administered concurrently with ddrug6 { a ddrug7 } ;",
        "label": "NA"
    },
    {
        "text": "HD00339 , such as the ddrug1 { HD00219 , ddrug3 , ddrug4 } or ddrug5 , ordinarily should not be administered concurrently with ddrug6 { a ddrug7 } ;",
        "label": "NA"
    },
    {
        "text": "HD00339 , such as the ddrug1 { ddrug2 , HD00340 , ddrug4 } or ddrug5 , ordinarily should not be administered concurrently with ddrug6 { a ddrug7 } ;",
        "label": "NA"
    },
    {
        "text": "HD00339 , such as the ddrug1 { ddrug2 , ddrug3 , HD00463 } or ddrug5 , ordinarily should not be administered concurrently with ddrug6 { a ddrug7 } ;",
        "label": "NA"
    },
    {
        "text": "HD00339 , such as the ddrug1 { ddrug2 , ddrug3 , ddrug4 } or DB01233 , ordinarily should not be administered concurrently with ddrug6 { a ddrug7 } ;",
        "label": "NA"
    },
    {
        "text": "HD00339 , such as the ddrug1 { ddrug2 , ddrug3 , ddrug4 } or ddrug5 , ordinarily should not be administered concurrently with DB01186 { a ddrug7 } ;",
        "label": "advise"
    },
    {
        "text": "HD00339 , such as the ddrug1 { ddrug2 , ddrug3 , ddrug4 } or ddrug5 , ordinarily should not be administered concurrently with ddrug6 { a HD00338 } ;",
        "label": "NA"
    },
    {
        "text": "ddrug0 , such as the HD00137 { ddrug2 , ddrug3 , ddrug4 } or DB01233 , ordinarily should not be administered concurrently with ddrug6 { a ddrug7 } ;",
        "label": "NA"
    },
    {
        "text": "ddrug0 , such as the HD00137 { ddrug2 , ddrug3 , ddrug4 } or ddrug5 , ordinarily should not be administered concurrently with DB01186 { a ddrug7 } ;",
        "label": "advise"
    },
    {
        "text": "ddrug0 , such as the HD00137 { ddrug2 , ddrug3 , ddrug4 } or ddrug5 , ordinarily should not be administered concurrently with ddrug6 { a HD00338 } ;",
        "label": "NA"
    },
    {
        "text": "ddrug0 , such as the ddrug1 { HD00219 , ddrug3 , ddrug4 } or DB01233 , ordinarily should not be administered concurrently with ddrug6 { a ddrug7 } ;",
        "label": "NA"
    },
    {
        "text": "ddrug0 , such as the ddrug1 { HD00219 , ddrug3 , ddrug4 } or ddrug5 , ordinarily should not be administered concurrently with DB01186 { a ddrug7 } ;",
        "label": "advise"
    },
    {
        "text": "ddrug0 , such as the ddrug1 { HD00219 , ddrug3 , ddrug4 } or ddrug5 , ordinarily should not be administered concurrently with ddrug6 { a HD00338 } ;",
        "label": "NA"
    },
    {
        "text": "ddrug0 , such as the ddrug1 { ddrug2 , HD00340 , ddrug4 } or DB01233 , ordinarily should not be administered concurrently with ddrug6 { a ddrug7 } ;",
        "label": "NA"
    },
    {
        "text": "ddrug0 , such as the ddrug1 { ddrug2 , HD00340 , ddrug4 } or ddrug5 , ordinarily should not be administered concurrently with DB01186 { a ddrug7 } ;",
        "label": "advise"
    },
    {
        "text": "ddrug0 , such as the ddrug1 { ddrug2 , HD00340 , ddrug4 } or ddrug5 , ordinarily should not be administered concurrently with ddrug6 { a HD00338 } ;",
        "label": "NA"
    },
    {
        "text": "ddrug0 , such as the ddrug1 { ddrug2 , ddrug3 , HD00463 } or DB01233 , ordinarily should not be administered concurrently with ddrug6 { a ddrug7 } ;",
        "label": "NA"
    },
    {
        "text": "ddrug0 , such as the ddrug1 { ddrug2 , ddrug3 , HD00463 } or ddrug5 , ordinarily should not be administered concurrently with DB01186 { a ddrug7 } ;",
        "label": "advise"
    },
    {
        "text": "ddrug0 , such as the ddrug1 { ddrug2 , ddrug3 , HD00463 } or ddrug5 , ordinarily should not be administered concurrently with ddrug6 { a HD00338 } ;",
        "label": "NA"
    },
    {
        "text": "ddrug0 , such as the ddrug1 { ddrug2 , ddrug3 , ddrug4 } or DB01233 , ordinarily should not be administered concurrently with DB01186 { a ddrug7 } ;",
        "label": "advise"
    },
    {
        "text": "ddrug0 , such as the ddrug1 { ddrug2 , ddrug3 , ddrug4 } or DB01233 , ordinarily should not be administered concurrently with ddrug6 { a HD00338 } ;",
        "label": "NA"
    },
    {
        "text": "HD00218 : patients on ddrug1 , and especially those started recently , may occasionally experience an excessive reduction of blood pressure after initiation of DB00790 tablets therapy .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : patients on HD00218 , and especially those started recently , may occasionally experience an excessive reduction of blood pressure after initiation of DB00790 tablets therapy .",
        "label": "effect"
    },
    {
        "text": "the possibility of hypotensive effects can be minimized by either discontinuing the HD00295 or increasing the salt intake prior to initiation of treatment with DB00790 .",
        "label": "effect"
    },
    {
        "text": "if HD00218 can not be interrupted , close medical supervision should be provided with the first dose of DB00790 tablets , for at least two hours and until blood pressure has stabilized for another hour .",
        "label": "advise"
    },
    {
        "text": "the rate and extent of DB00790 absorption and elimination are not affected by concomitant HD00218 .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of DB14213 was reduced by HD00218 , however , and this was associated with a decrease in plasma ace inhibition .",
        "label": "NA"
    },
    {
        "text": "DB14500 supplements and ddrug1 : DB00790 tablets may increase serum potassium because of its potential to decrease aldosterone production .",
        "label": "NA"
    },
    {
        "text": "ddrug0 supplements and HD00293 : DB00790 tablets may increase serum potassium because of its potential to decrease aldosterone production .",
        "label": "NA"
    },
    {
        "text": "use of HD00293 { ddrug1 , ddrug2 , ddrug3 and others } , ddrug4 supplements or other drugs capable of increasing serum potassium { DB00328 , ddrug6 , ddrug7 and others } can increase the risk of hyperkalemia .",
        "label": "NA"
    },
    {
        "text": "use of HD00293 { ddrug1 , ddrug2 , ddrug3 and others } , ddrug4 supplements or other drugs capable of increasing serum potassium { ddrug5 , DB01109 , ddrug7 and others } can increase the risk of hyperkalemia .",
        "label": "NA"
    },
    {
        "text": "use of HD00293 { ddrug1 , ddrug2 , ddrug3 and others } , ddrug4 supplements or other drugs capable of increasing serum potassium { ddrug5 , ddrug6 , DB00091 and others } can increase the risk of hyperkalemia .",
        "label": "NA"
    },
    {
        "text": "use of ddrug0 { DB00421 , ddrug2 , ddrug3 and others } , ddrug4 supplements or other drugs capable of increasing serum potassium { DB00328 , ddrug6 , ddrug7 and others } can increase the risk of hyperkalemia .",
        "label": "NA"
    },
    {
        "text": "use of ddrug0 { DB00421 , ddrug2 , ddrug3 and others } , ddrug4 supplements or other drugs capable of increasing serum potassium { ddrug5 , DB01109 , ddrug7 and others } can increase the risk of hyperkalemia .",
        "label": "NA"
    },
    {
        "text": "use of ddrug0 { DB00421 , ddrug2 , ddrug3 and others } , ddrug4 supplements or other drugs capable of increasing serum potassium { ddrug5 , ddrug6 , DB00091 and others } can increase the risk of hyperkalemia .",
        "label": "NA"
    },
    {
        "text": "use of ddrug0 { ddrug1 , DB00594 , ddrug3 and others } , ddrug4 supplements or other drugs capable of increasing serum potassium { DB00328 , ddrug6 , ddrug7 and others } can increase the risk of hyperkalemia .",
        "label": "NA"
    },
    {
        "text": "use of ddrug0 { ddrug1 , DB00594 , ddrug3 and others } , ddrug4 supplements or other drugs capable of increasing serum potassium { ddrug5 , DB01109 , ddrug7 and others } can increase the risk of hyperkalemia .",
        "label": "NA"
    },
    {
        "text": "use of ddrug0 { ddrug1 , DB00594 , ddrug3 and others } , ddrug4 supplements or other drugs capable of increasing serum potassium { ddrug5 , ddrug6 , DB00091 and others } can increase the risk of hyperkalemia .",
        "label": "NA"
    },
    {
        "text": "use of ddrug0 { ddrug1 , ddrug2 , DB00384 and others } , ddrug4 supplements or other drugs capable of increasing serum potassium { DB00328 , ddrug6 , ddrug7 and others } can increase the risk of hyperkalemia .",
        "label": "NA"
    },
    {
        "text": "use of ddrug0 { ddrug1 , ddrug2 , DB00384 and others } , ddrug4 supplements or other drugs capable of increasing serum potassium { ddrug5 , DB01109 , ddrug7 and others } can increase the risk of hyperkalemia .",
        "label": "NA"
    },
    {
        "text": "use of ddrug0 { ddrug1 , ddrug2 , DB00384 and others } , ddrug4 supplements or other drugs capable of increasing serum potassium { ddrug5 , ddrug6 , DB00091 and others } can increase the risk of hyperkalemia .",
        "label": "NA"
    },
    {
        "text": "use of ddrug0 { ddrug1 , ddrug2 , ddrug3 and others } , DB14500 supplements or other drugs capable of increasing serum potassium { DB00328 , ddrug6 , ddrug7 and others } can increase the risk of hyperkalemia .",
        "label": "NA"
    },
    {
        "text": "use of ddrug0 { ddrug1 , ddrug2 , ddrug3 and others } , DB14500 supplements or other drugs capable of increasing serum potassium { ddrug5 , DB01109 , ddrug7 and others } can increase the risk of hyperkalemia .",
        "label": "NA"
    },
    {
        "text": "use of ddrug0 { ddrug1 , ddrug2 , ddrug3 and others } , DB14500 supplements or other drugs capable of increasing serum potassium { ddrug5 , ddrug6 , DB00091 and others } can increase the risk of hyperkalemia .",
        "label": "NA"
    },
    {
        "text": "use of a HD00295 may further increase the risk of DB14507 toxicity .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : a controlled pharmacokinetic study has shown no effect on plasma DB00390 concentrations when coadministered with DB00790 tablets , but an effect of ddrug3 on the plasma concentration of ddrug4 / ddrug5 has not been excluded .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : a controlled pharmacokinetic study has shown no effect on plasma DB00390 concentrations when coadministered with ddrug2 tablets , but an effect of ddrug3 on the plasma concentration of DB00790 / ddrug5 has not been excluded .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : a controlled pharmacokinetic study has shown no effect on plasma DB00390 concentrations when coadministered with ddrug2 tablets , but an effect of ddrug3 on the plasma concentration of ddrug4 / DB14213 has not been excluded .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : a controlled pharmacokinetic study has shown no effect on plasma ddrug1 concentrations when coadministered with DB00790 tablets , but an effect of DB00390 on the plasma concentration of ddrug4 / ddrug5 has not been excluded .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : a controlled pharmacokinetic study has shown no effect on plasma ddrug1 concentrations when coadministered with DB00790 tablets , but an effect of ddrug3 on the plasma concentration of DB00790 / ddrug5 has not been excluded .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : a controlled pharmacokinetic study has shown no effect on plasma ddrug1 concentrations when coadministered with DB00790 tablets , but an effect of ddrug3 on the plasma concentration of ddrug4 / DB14213 has not been excluded .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : a controlled pharmacokinetic study has shown no effect on plasma ddrug1 concentrations when coadministered with ddrug2 tablets , but an effect of DB00390 on the plasma concentration of DB00790 / ddrug5 has not been excluded .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 : a controlled pharmacokinetic study has shown no effect on plasma ddrug1 concentrations when coadministered with ddrug2 tablets , but an effect of DB00390 on the plasma concentration of ddrug4 / DB14213 has not been excluded .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 : animal data have suggested the possibility of interaction between DB00790 and DB00798 .",
        "label": "int"
    },
    {
        "text": "food interaction : oral administration of DB00790 tablets with food does not significantly lower the rate or extent of DB00790 absorption relative to the fasted state .",
        "label": "NA"
    },
    {
        "text": "concomitant use of DB02325 with DB00191 may result in an adverse drug interaction .",
        "label": "int"
    },
    {
        "text": "HD00285 , particularly DB00610 , may cause serious cardiac arrhythmias during ddrug2 anesthesia and therefore should be used only with great caution or not at all .",
        "label": "NA"
    },
    {
        "text": "HD00285 , particularly ddrug1 , may cause serious cardiac arrhythmias during DB01159 anesthesia and therefore should be used only with great caution or not at all .",
        "label": "effect"
    },
    {
        "text": "ddrug0 , particularly DB00610 , may cause serious cardiac arrhythmias during DB01159 anesthesia and therefore should be used only with great caution or not at all .",
        "label": "effect"
    },
    {
        "text": "ddrug0 : the pressor effect of HD00994 is markedly potentiated in patients receiving HD00275 { ddrug3 } .",
        "label": "effect"
    },
    {
        "text": "ddrug0 : the pressor effect of HD00994 is markedly potentiated in patients receiving ddrug2 { HD00725 } .",
        "label": "effect"
    },
    {
        "text": "the pressor response of HD00852 may also be potentiated by HD00043 .",
        "label": "effect"
    },
    {
        "text": "HD00285 , particularly DB00610 , may cause serious cardiac arrhythmias during ddrug2 anesthesia and therefore should be used only with great caution or not at all .",
        "label": "NA"
    },
    {
        "text": "HD00285 , particularly ddrug1 , may cause serious cardiac arrhythmias during DB01159 anesthesia and therefore should be used only with great caution or not at all .",
        "label": "effect"
    },
    {
        "text": "ddrug0 , particularly DB00610 , may cause serious cardiac arrhythmias during DB01159 anesthesia and therefore should be used only with great caution or not at all .",
        "label": "effect"
    },
    {
        "text": "HD00343 - the pressor effect of HD00994 is markedly potentiated in patients receiving ddrug2 { ddrug3 } .",
        "label": "NA"
    },
    {
        "text": "HD00343 - the pressor effect of ddrug1 is markedly potentiated in patients receiving HD00275 { ddrug3 } .",
        "label": "NA"
    },
    {
        "text": "HD00343 - the pressor effect of ddrug1 is markedly potentiated in patients receiving ddrug2 { HD00725 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 - the pressor effect of HD00994 is markedly potentiated in patients receiving HD00275 { ddrug3 } .",
        "label": "effect"
    },
    {
        "text": "ddrug0 - the pressor effect of HD00994 is markedly potentiated in patients receiving ddrug2 { HD00725 } .",
        "label": "effect"
    },
    {
        "text": "the pressor response of HD00852 may also be potentiated by HD00043 .",
        "label": "effect"
    },
    {
        "text": "DB01085 should be administered with caution to patients taking HD00507 because of the possibility of conduction disturbances .",
        "label": "advise"
    },
    {
        "text": "while no formal drug interaction studies have been performed , the following concomitant drugs were used in at least 10 % of patients in either or both sj grens efficacy studies : DB00945 , artificial tears , DB01373 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 .",
        "label": "NA"
    },
    {
        "text": "while no formal drug interaction studies have been performed , the following concomitant drugs were used in at least 10 % of patients in either or both sj grens efficacy studies : DB00945 , artificial tears , ddrug1 , ddrug2 , DB01611 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 .",
        "label": "NA"
    },
    {
        "text": "while no formal drug interaction studies have been performed , the following concomitant drugs were used in at least 10 % of patients in either or both sj grens efficacy studies : DB00945 , artificial tears , ddrug1 , ddrug2 , ddrug3 , DB01050 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 .",
        "label": "NA"
    },
    {
        "text": "while no formal drug interaction studies have been performed , the following concomitant drugs were used in at least 10 % of patients in either or both sj grens efficacy studies : DB00945 , artificial tears , ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00451 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 .",
        "label": "NA"
    },
    {
        "text": "while no formal drug interaction studies have been performed , the following concomitant drugs were used in at least 10 % of patients in either or both sj grens efficacy studies : DB00945 , artificial tears , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB00603 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 .",
        "label": "NA"
    },
    {
        "text": "while no formal drug interaction studies have been performed , the following concomitant drugs were used in at least 10 % of patients in either or both sj grens efficacy studies : DB00945 , artificial tears , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , DB00563 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 .",
        "label": "NA"
    },
    {
        "text": "while no formal drug interaction studies have been performed , the following concomitant drugs were used in at least 10 % of patients in either or both sj grens efficacy studies : DB00945 , artificial tears , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , DB00788 , ddrug10 , ddrug11 , and ddrug12 .",
        "label": "NA"
    },
    {
        "text": "while no formal drug interaction studies have been performed , the following concomitant drugs were used in at least 10 % of patients in either or both sj grens efficacy studies : DB00945 , artificial tears , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , DB00338 , ddrug11 , and ddrug12 .",
        "label": "NA"
    },
    {
        "text": "while no formal drug interaction studies have been performed , the following concomitant drugs were used in at least 10 % of patients in either or both sj grens efficacy studies : DB00945 , artificial tears , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , DB00316 , and ddrug12 .",
        "label": "NA"
    },
    {
        "text": "while no formal drug interaction studies have been performed , the following concomitant drugs were used in at least 10 % of patients in either or both sj grens efficacy studies : DB00945 , artificial tears , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and DB00898 .",
        "label": "NA"
    },
    {
        "text": "catecholamine-depleting drugs { e , g , , DB00206 } may have an additive effect when given with HD00228 .",
        "label": "effect"
    },
    {
        "text": "DB00960 has been used with a variety of HD00366 , including ddrug2 , ddrug3 , and ddrug4 without unexpected adverse interactions .",
        "label": "NA"
    },
    {
        "text": "DB00960 has been used with a variety of ddrug1 , including DB00999 , ddrug3 , and ddrug4 without unexpected adverse interactions .",
        "label": "NA"
    },
    {
        "text": "DB00960 has been used with a variety of ddrug1 , including ddrug2 , DB01275 , and ddrug4 without unexpected adverse interactions .",
        "label": "NA"
    },
    {
        "text": "DB00960 has been used with a variety of ddrug1 , including ddrug2 , ddrug3 , and DB01170 without unexpected adverse interactions .",
        "label": "NA"
    },
    {
        "text": "ddrug0 has been used with a variety of HD00366 , including DB00999 , ddrug3 , and ddrug4 without unexpected adverse interactions .",
        "label": "NA"
    },
    {
        "text": "ddrug0 has been used with a variety of HD00366 , including ddrug2 , DB01275 , and ddrug4 without unexpected adverse interactions .",
        "label": "NA"
    },
    {
        "text": "ddrug0 has been used with a variety of HD00366 , including ddrug2 , ddrug3 , and DB01170 without unexpected adverse interactions .",
        "label": "NA"
    },
    {
        "text": "DB00960 has been shown to increase serum DB00679 levels when both drugs are co-administered .",
        "label": "mechanism"
    },
    {
        "text": "other HD00995 should not be used concomitantly with DB01291 because they may have additive effects .",
        "label": "advise"
    },
    {
        "text": "although this has not occurred in in vitro studies with HD00724 , interactions with ddrug1 have been reported with DB00554 since marketing , therefore , physicians should closely monitor patients for a change in dosage requirements when administering ddrug3 to patients on ddrug4 and other highly protein-bound drugs .",
        "label": "NA"
    },
    {
        "text": "although this has not occurred in in vitro studies with HD00724 , interactions with ddrug1 have been reported with ddrug2 since marketing , therefore , physicians should closely monitor patients for a change in dosage requirements when administering DB00554 to patients on ddrug4 and other highly protein-bound drugs .",
        "label": "NA"
    },
    {
        "text": "although this has not occurred in in vitro studies with ddrug0 , interactions with HD00724 have been reported with DB00554 since marketing , therefore , physicians should closely monitor patients for a change in dosage requirements when administering ddrug3 to patients on ddrug4 and other highly protein-bound drugs .",
        "label": "int"
    },
    {
        "text": "although this has not occurred in in vitro studies with ddrug0 , interactions with HD00724 have been reported with ddrug2 since marketing , therefore , physicians should closely monitor patients for a change in dosage requirements when administering DB00554 to patients on ddrug4 and other highly protein-bound drugs .",
        "label": "NA"
    },
    {
        "text": "although this has not occurred in in vitro studies with ddrug0 , interactions with ddrug1 have been reported with DB00554 since marketing , therefore , physicians should closely monitor patients for a change in dosage requirements when administering ddrug3 to patients on HD00724 and other highly protein-bound drugs .",
        "label": "NA"
    },
    {
        "text": "although this has not occurred in in vitro studies with ddrug0 , interactions with ddrug1 have been reported with ddrug2 since marketing , therefore , physicians should closely monitor patients for a change in dosage requirements when administering DB00554 to patients on HD00724 and other highly protein-bound drugs .",
        "label": "advise"
    },
    {
        "text": "plasma levels of DB00554 are depressed to approximately 80 % of their normal values when DB00554 is administered in conjunction with ddrug2 { 3900 mg/day } , but concomitant administration of ddrug3 has no effect on ddrug4 plasma levels , ddrug5 , including ddrug6 , have been reported to increase steady state plasma ddrug7 levels .",
        "label": "NA"
    },
    {
        "text": "plasma levels of DB00554 are depressed to approximately 80 % of their normal values when ddrug1 is administered in conjunction with DB00945 { 3900 mg/day } , but concomitant administration of ddrug3 has no effect on ddrug4 plasma levels , ddrug5 , including ddrug6 , have been reported to increase steady state plasma ddrug7 levels .",
        "label": "NA"
    },
    {
        "text": "plasma levels of DB00554 are depressed to approximately 80 % of their normal values when ddrug1 is administered in conjunction with ddrug2 { 3900 mg/day } , but concomitant administration of HD00374 has no effect on ddrug4 plasma levels , ddrug5 , including ddrug6 , have been reported to increase steady state plasma ddrug7 levels .",
        "label": "NA"
    },
    {
        "text": "plasma levels of DB00554 are depressed to approximately 80 % of their normal values when ddrug1 is administered in conjunction with ddrug2 { 3900 mg/day } , but concomitant administration of ddrug3 has no effect on ddrug4 plasma levels , HD00518 , including ddrug6 , have been reported to increase steady state plasma ddrug7 levels .",
        "label": "NA"
    },
    {
        "text": "plasma levels of DB00554 are depressed to approximately 80 % of their normal values when ddrug1 is administered in conjunction with ddrug2 { 3900 mg/day } , but concomitant administration of ddrug3 has no effect on ddrug4 plasma levels , ddrug5 , including DB00554 , have been reported to increase steady state plasma ddrug7 levels .",
        "label": "NA"
    },
    {
        "text": "plasma levels of DB00554 are depressed to approximately 80 % of their normal values when ddrug1 is administered in conjunction with ddrug2 { 3900 mg/day } , but concomitant administration of ddrug3 has no effect on ddrug4 plasma levels , ddrug5 , including ddrug6 , have been reported to increase steady state plasma DB14507 levels .",
        "label": "NA"
    },
    {
        "text": "plasma levels of ddrug0 are depressed to approximately 80 % of their normal values when DB00554 is administered in conjunction with DB00945 { 3900 mg/day } , but concomitant administration of ddrug3 has no effect on ddrug4 plasma levels , ddrug5 , including ddrug6 , have been reported to increase steady state plasma ddrug7 levels .",
        "label": "mechanism"
    },
    {
        "text": "plasma levels of ddrug0 are depressed to approximately 80 % of their normal values when DB00554 is administered in conjunction with ddrug2 { 3900 mg/day } , but concomitant administration of HD00374 has no effect on ddrug4 plasma levels , ddrug5 , including ddrug6 , have been reported to increase steady state plasma ddrug7 levels .",
        "label": "NA"
    },
    {
        "text": "plasma levels of ddrug0 are depressed to approximately 80 % of their normal values when DB00554 is administered in conjunction with ddrug2 { 3900 mg/day } , but concomitant administration of ddrug3 has no effect on DB00554 plasma levels , ddrug5 , including ddrug6 , have been reported to increase steady state plasma ddrug7 levels .",
        "label": "NA"
    },
    {
        "text": "plasma levels of ddrug0 are depressed to approximately 80 % of their normal values when DB00554 is administered in conjunction with ddrug2 { 3900 mg/day } , but concomitant administration of ddrug3 has no effect on ddrug4 plasma levels , HD00518 , including ddrug6 , have been reported to increase steady state plasma ddrug7 levels .",
        "label": "NA"
    },
    {
        "text": "plasma levels of ddrug0 are depressed to approximately 80 % of their normal values when DB00554 is administered in conjunction with ddrug2 { 3900 mg/day } , but concomitant administration of ddrug3 has no effect on ddrug4 plasma levels , ddrug5 , including ddrug6 , have been reported to increase steady state plasma DB14507 levels .",
        "label": "NA"
    },
    {
        "text": "plasma levels of ddrug0 are depressed to approximately 80 % of their normal values when ddrug1 is administered in conjunction with DB00945 { 3900 mg/day } , but concomitant administration of HD00374 has no effect on ddrug4 plasma levels , ddrug5 , including ddrug6 , have been reported to increase steady state plasma ddrug7 levels .",
        "label": "NA"
    },
    {
        "text": "plasma levels of ddrug0 are depressed to approximately 80 % of their normal values when ddrug1 is administered in conjunction with DB00945 { 3900 mg/day } , but concomitant administration of ddrug3 has no effect on DB00554 plasma levels , ddrug5 , including ddrug6 , have been reported to increase steady state plasma ddrug7 levels .",
        "label": "NA"
    },
    {
        "text": "plasma levels of ddrug0 are depressed to approximately 80 % of their normal values when ddrug1 is administered in conjunction with DB00945 { 3900 mg/day } , but concomitant administration of ddrug3 has no effect on ddrug4 plasma levels , HD00518 , including ddrug6 , have been reported to increase steady state plasma ddrug7 levels .",
        "label": "NA"
    },
    {
        "text": "plasma levels of ddrug0 are depressed to approximately 80 % of their normal values when ddrug1 is administered in conjunction with DB00945 { 3900 mg/day } , but concomitant administration of ddrug3 has no effect on ddrug4 plasma levels , ddrug5 , including DB00554 , have been reported to increase steady state plasma ddrug7 levels .",
        "label": "NA"
    },
    {
        "text": "plasma levels of ddrug0 are depressed to approximately 80 % of their normal values when ddrug1 is administered in conjunction with DB00945 { 3900 mg/day } , but concomitant administration of ddrug3 has no effect on ddrug4 plasma levels , ddrug5 , including ddrug6 , have been reported to increase steady state plasma DB14507 levels .",
        "label": "NA"
    },
    {
        "text": "plasma levels of ddrug0 are depressed to approximately 80 % of their normal values when ddrug1 is administered in conjunction with ddrug2 { 3900 mg/day } , but concomitant administration of HD00374 has no effect on DB00554 plasma levels , ddrug5 , including ddrug6 , have been reported to increase steady state plasma ddrug7 levels .",
        "label": "NA"
    },
    {
        "text": "plasma levels of ddrug0 are depressed to approximately 80 % of their normal values when ddrug1 is administered in conjunction with ddrug2 { 3900 mg/day } , but concomitant administration of HD00374 has no effect on ddrug4 plasma levels , HD00518 , including ddrug6 , have been reported to increase steady state plasma ddrug7 levels .",
        "label": "NA"
    },
    {
        "text": "plasma levels of ddrug0 are depressed to approximately 80 % of their normal values when ddrug1 is administered in conjunction with ddrug2 { 3900 mg/day } , but concomitant administration of HD00374 has no effect on ddrug4 plasma levels , ddrug5 , including DB00554 , have been reported to increase steady state plasma ddrug7 levels .",
        "label": "NA"
    },
    {
        "text": "plasma levels of ddrug0 are depressed to approximately 80 % of their normal values when ddrug1 is administered in conjunction with ddrug2 { 3900 mg/day } , but concomitant administration of HD00374 has no effect on ddrug4 plasma levels , ddrug5 , including ddrug6 , have been reported to increase steady state plasma DB14507 levels .",
        "label": "NA"
    },
    {
        "text": "plasma levels of ddrug0 are depressed to approximately 80 % of their normal values when ddrug1 is administered in conjunction with ddrug2 { 3900 mg/day } , but concomitant administration of ddrug3 has no effect on DB00554 plasma levels , HD00518 , including ddrug6 , have been reported to increase steady state plasma ddrug7 levels .",
        "label": "NA"
    },
    {
        "text": "plasma levels of ddrug0 are depressed to approximately 80 % of their normal values when ddrug1 is administered in conjunction with ddrug2 { 3900 mg/day } , but concomitant administration of ddrug3 has no effect on DB00554 plasma levels , ddrug5 , including DB00554 , have been reported to increase steady state plasma ddrug7 levels .",
        "label": "NA"
    },
    {
        "text": "plasma levels of ddrug0 are depressed to approximately 80 % of their normal values when ddrug1 is administered in conjunction with ddrug2 { 3900 mg/day } , but concomitant administration of ddrug3 has no effect on DB00554 plasma levels , ddrug5 , including ddrug6 , have been reported to increase steady state plasma DB14507 levels .",
        "label": "NA"
    },
    {
        "text": "plasma levels of ddrug0 are depressed to approximately 80 % of their normal values when ddrug1 is administered in conjunction with ddrug2 { 3900 mg/day } , but concomitant administration of ddrug3 has no effect on ddrug4 plasma levels , HD00518 , including DB00554 , have been reported to increase steady state plasma ddrug7 levels .",
        "label": "NA"
    },
    {
        "text": "plasma levels of ddrug0 are depressed to approximately 80 % of their normal values when ddrug1 is administered in conjunction with ddrug2 { 3900 mg/day } , but concomitant administration of ddrug3 has no effect on ddrug4 plasma levels , HD00518 , including ddrug6 , have been reported to increase steady state plasma DB14507 levels .",
        "label": "mechanism"
    },
    {
        "text": "plasma levels of ddrug0 are depressed to approximately 80 % of their normal values when ddrug1 is administered in conjunction with ddrug2 { 3900 mg/day } , but concomitant administration of ddrug3 has no effect on ddrug4 plasma levels , ddrug5 , including DB00554 , have been reported to increase steady state plasma DB14507 levels .",
        "label": "mechanism"
    },
    {
        "text": "it is recommended that plasma DB14507 levels be monitored when initiating , adjusting and discontinuing DB00554 .",
        "label": "advise"
    },
    {
        "text": "when DB00572 and DB00733 are used together , the signs of atropinization { flushing , mydriasis , tachycardia , dryness of the mouth and nose } may occur earlier than might be expected when ddrug2 is used alone .",
        "label": "effect"
    },
    {
        "text": "when ddrug0 and DB00733 are used together , the signs of atropinization { flushing , mydriasis , tachycardia , dryness of the mouth and nose } may occur earlier than might be expected when DB00572 is used alone .",
        "label": "NA"
    },
    {
        "text": "this is especially true if the total dose of DB00572 has been large and the administration of DB00733 has been delayed .",
        "label": "NA"
    },
    {
        "text": "2 - # the following precautions should be kept in mind in the treatment of anticholinesterase poisoning , although they do not bear directly on the use of DB00733 : since HD00026 are potentiated by the ddrug2 , they should be used cautiously in the treatment of convulsions ;",
        "label": "NA"
    },
    {
        "text": "2 - # the following precautions should be kept in mind in the treatment of anticholinesterase poisoning , although they do not bear directly on the use of DB00733 : since ddrug1 are potentiated by the HD00385 , they should be used cautiously in the treatment of convulsions ;",
        "label": "NA"
    },
    {
        "text": "2 - # the following precautions should be kept in mind in the treatment of anticholinesterase poisoning , although they do not bear directly on the use of ddrug0 : since HD00026 are potentiated by the HD00385 , they should be used cautiously in the treatment of convulsions ;",
        "label": "effect"
    },
    {
        "text": "DB00190 / DB01235 : ddrug2 / ddrug3 does not influence the pharmacokinetics of ddrug4 in healthy volunteers { n = 10 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 / ddrug1 : DB00190 / ddrug3 does not influence the pharmacokinetics of DB00413 in healthy volunteers { n = 10 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 / ddrug1 : ddrug2 / DB01235 does not influence the pharmacokinetics of DB00413 in healthy volunteers { n = 10 } .",
        "label": "NA"
    },
    {
        "text": "DB01037 : in healthy volunteers { n = 11 } , ddrug1 did not influence the pharmacokinetics of DB00413 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : in healthy volunteers { n = 11 } , DB01037 did not influence the pharmacokinetics of DB00413 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : population pharmacokinetic analysis suggests that DB00915 is unlikely to alter the oral clearance of DB00413 { n = 54 } .",
        "label": "NA"
    },
    {
        "text": "DB00501 : ddrug1 , a known inhibitor of renal tubular secretion of organic bases via the cationic transport system , caused a 50 % increase in DB00413 auc and a 40 % increase in half-life { n = 12 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : DB00501 , a known inhibitor of renal tubular secretion of organic bases via the cationic transport system , caused a 50 % increase in DB00413 auc and a 40 % increase in half-life { n = 12 } .",
        "label": "mechanism"
    },
    {
        "text": "DB01032 : ddrug1 , a known inhibitor of renal tubular secretion of organic acids via the aruonic transporter , did not noticeably influence DB00413 pharmacokinetics { n = 12 } .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : DB01032 , a known inhibitor of renal tubular secretion of organic acids via the aruonic transporter , did not noticeably influence DB00413 pharmacokinetics { n = 12 } .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , DB00501 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of DB00413 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "mechanism"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , DB00501 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , HD00485 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , DB00501 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , HD00124 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , DB00501 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , DB00328 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , DB00501 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , DB00999 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , DB00501 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and DB00672 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , DB00501 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of DB00413 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , DB00863 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of DB00413 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "mechanism"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , DB00863 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , HD00485 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , DB00863 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , HD00124 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , DB00863 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , DB00328 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , DB00863 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , DB00999 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , DB00863 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and DB00672 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , DB00863 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of DB00413 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , DB00343 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of DB00413 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "mechanism"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , DB00343 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , HD00485 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , DB00343 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , HD00124 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , DB00343 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , DB00328 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , DB00343 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , DB00999 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , DB00343 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and DB00672 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , DB00343 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of DB00413 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , DB00384 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of DB00413 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "mechanism"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , DB00384 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , HD00485 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , DB00384 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , HD00124 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , DB00384 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , DB00328 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , DB00384 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , DB00999 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , DB00384 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and DB00672 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , DB00384 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of DB00413 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , DB00661 , ddrug5 , and ddrug6 } decreases the oral clearance of DB00413 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "mechanism"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , DB00661 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , HD00485 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , DB00661 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , HD00124 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , DB00661 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , DB00328 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , DB00661 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , DB00999 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , DB00661 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and DB00672 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , DB00661 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of DB00413 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00908 , and ddrug6 } decreases the oral clearance of DB00413 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "mechanism"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00908 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , HD00485 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00908 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , HD00124 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00908 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , DB00328 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00908 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , DB00999 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00908 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and DB00672 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00908 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of DB00413 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and DB00468 } decreases the oral clearance of DB00413 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "mechanism"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and DB00468 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , HD00485 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and DB00468 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , HD00124 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and DB00468 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , DB00328 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and DB00468 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , DB00999 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and DB00468 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and DB00672 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and DB00468 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of DB00413 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of DB00413 by about 20 % , while those secreted by the anionic transport system { e , g , , HD00485 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of DB00413 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , HD00124 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of DB00413 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , DB00328 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of DB00413 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , DB00999 , and ddrug12 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of DB00413 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and DB00672 } are likely to have little effect on the oral clearance of ddrug13 .",
        "label": "NA"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , HD00485 , ddrug9 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of DB00413 .",
        "label": "mechanism"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , HD00124 , ddrug10 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of DB00413 .",
        "label": "mechanism"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , DB00328 , ddrug11 , and ddrug12 } are likely to have little effect on the oral clearance of DB00413 .",
        "label": "mechanism"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , DB00999 , and ddrug12 } are likely to have little effect on the oral clearance of DB00413 .",
        "label": "mechanism"
    },
    {
        "text": "other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system { e , g , , ddrug0 , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 } decreases the oral clearance of ddrug7 by about 20 % , while those secreted by the anionic transport system { e , g , , ddrug8 , ddrug9 , ddrug10 , ddrug11 , and DB00672 } are likely to have little effect on the oral clearance of DB00413 .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 : since DB00413 is a HD00338 , it is possible that ddrug3 , such as the ddrug4 { ddrug5 , ddrug6 , ddrug7 } or ddrug8 , may diminish the effectiveness of ddrug9 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since DB00413 is a ddrug2 , it is possible that HD00339 , such as the ddrug4 { ddrug5 , ddrug6 , ddrug7 } or ddrug8 , may diminish the effectiveness of ddrug9 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since DB00413 is a ddrug2 , it is possible that ddrug3 , such as the HD00137 { ddrug5 , ddrug6 , ddrug7 } or ddrug8 , may diminish the effectiveness of ddrug9 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since DB00413 is a ddrug2 , it is possible that ddrug3 , such as the ddrug4 { HD00219 , ddrug6 , ddrug7 } or ddrug8 , may diminish the effectiveness of ddrug9 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since DB00413 is a ddrug2 , it is possible that ddrug3 , such as the ddrug4 { ddrug5 , HD00340 , ddrug7 } or ddrug8 , may diminish the effectiveness of ddrug9 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since DB00413 is a ddrug2 , it is possible that ddrug3 , such as the ddrug4 { ddrug5 , ddrug6 , HD00341 } or ddrug8 , may diminish the effectiveness of ddrug9 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since DB00413 is a ddrug2 , it is possible that ddrug3 , such as the ddrug4 { ddrug5 , ddrug6 , ddrug7 } or DB01233 , may diminish the effectiveness of ddrug9 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since DB00413 is a ddrug2 , it is possible that ddrug3 , such as the ddrug4 { ddrug5 , ddrug6 , ddrug7 } or ddrug8 , may diminish the effectiveness of DB00413 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since ddrug1 is a HD00338 , it is possible that HD00339 , such as the ddrug4 { ddrug5 , ddrug6 , ddrug7 } or ddrug8 , may diminish the effectiveness of ddrug9 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since ddrug1 is a HD00338 , it is possible that ddrug3 , such as the HD00137 { ddrug5 , ddrug6 , ddrug7 } or ddrug8 , may diminish the effectiveness of ddrug9 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since ddrug1 is a HD00338 , it is possible that ddrug3 , such as the ddrug4 { HD00219 , ddrug6 , ddrug7 } or ddrug8 , may diminish the effectiveness of ddrug9 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since ddrug1 is a HD00338 , it is possible that ddrug3 , such as the ddrug4 { ddrug5 , HD00340 , ddrug7 } or ddrug8 , may diminish the effectiveness of ddrug9 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since ddrug1 is a HD00338 , it is possible that ddrug3 , such as the ddrug4 { ddrug5 , ddrug6 , HD00341 } or ddrug8 , may diminish the effectiveness of ddrug9 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since ddrug1 is a HD00338 , it is possible that ddrug3 , such as the ddrug4 { ddrug5 , ddrug6 , ddrug7 } or DB01233 , may diminish the effectiveness of ddrug9 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since ddrug1 is a HD00338 , it is possible that ddrug3 , such as the ddrug4 { ddrug5 , ddrug6 , ddrug7 } or ddrug8 , may diminish the effectiveness of DB00413 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since ddrug1 is a ddrug2 , it is possible that HD00339 , such as the HD00137 { ddrug5 , ddrug6 , ddrug7 } or ddrug8 , may diminish the effectiveness of ddrug9 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since ddrug1 is a ddrug2 , it is possible that HD00339 , such as the ddrug4 { HD00219 , ddrug6 , ddrug7 } or ddrug8 , may diminish the effectiveness of ddrug9 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since ddrug1 is a ddrug2 , it is possible that HD00339 , such as the ddrug4 { ddrug5 , HD00340 , ddrug7 } or ddrug8 , may diminish the effectiveness of ddrug9 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since ddrug1 is a ddrug2 , it is possible that HD00339 , such as the ddrug4 { ddrug5 , ddrug6 , HD00341 } or ddrug8 , may diminish the effectiveness of ddrug9 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since ddrug1 is a ddrug2 , it is possible that HD00339 , such as the ddrug4 { ddrug5 , ddrug6 , ddrug7 } or DB01233 , may diminish the effectiveness of ddrug9 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since ddrug1 is a ddrug2 , it is possible that HD00339 , such as the ddrug4 { ddrug5 , ddrug6 , ddrug7 } or ddrug8 , may diminish the effectiveness of DB00413 .",
        "label": "effect"
    },
    {
        "text": "ddrug0 : since ddrug1 is a ddrug2 , it is possible that ddrug3 , such as the HD00137 { ddrug5 , ddrug6 , ddrug7 } or DB01233 , may diminish the effectiveness of ddrug9 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since ddrug1 is a ddrug2 , it is possible that ddrug3 , such as the HD00137 { ddrug5 , ddrug6 , ddrug7 } or ddrug8 , may diminish the effectiveness of DB00413 .",
        "label": "effect"
    },
    {
        "text": "ddrug0 : since ddrug1 is a ddrug2 , it is possible that ddrug3 , such as the ddrug4 { HD00219 , ddrug6 , ddrug7 } or DB01233 , may diminish the effectiveness of ddrug9 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since ddrug1 is a ddrug2 , it is possible that ddrug3 , such as the ddrug4 { HD00219 , ddrug6 , ddrug7 } or ddrug8 , may diminish the effectiveness of DB00413 .",
        "label": "effect"
    },
    {
        "text": "ddrug0 : since ddrug1 is a ddrug2 , it is possible that ddrug3 , such as the ddrug4 { ddrug5 , HD00340 , ddrug7 } or DB01233 , may diminish the effectiveness of ddrug9 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since ddrug1 is a ddrug2 , it is possible that ddrug3 , such as the ddrug4 { ddrug5 , HD00340 , ddrug7 } or ddrug8 , may diminish the effectiveness of DB00413 .",
        "label": "effect"
    },
    {
        "text": "ddrug0 : since ddrug1 is a ddrug2 , it is possible that ddrug3 , such as the ddrug4 { ddrug5 , ddrug6 , HD00341 } or DB01233 , may diminish the effectiveness of ddrug9 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : since ddrug1 is a ddrug2 , it is possible that ddrug3 , such as the ddrug4 { ddrug5 , ddrug6 , HD00341 } or ddrug8 , may diminish the effectiveness of DB00413 .",
        "label": "effect"
    },
    {
        "text": "ddrug0 : since ddrug1 is a ddrug2 , it is possible that ddrug3 , such as the ddrug4 { ddrug5 , ddrug6 , ddrug7 } or DB01233 , may diminish the effectiveness of DB00413 .",
        "label": "effect"
    },
    {
        "text": "due to its effects on gastric emptying , DB01278 therapy should not be considered for patients taking drugs that alter gastrointestinal motility { e , g , , HD00352 such as ddrug2 } and agents that slow the intestinal absorption of nutrients { e , g , , ddrug3 } .",
        "label": "advise"
    },
    {
        "text": "due to its effects on gastric emptying , DB01278 therapy should not be considered for patients taking drugs that alter gastrointestinal motility { e , g , , ddrug1 such as DB00572 } and agents that slow the intestinal absorption of nutrients { e , g , , ddrug3 } .",
        "label": "advise"
    },
    {
        "text": "due to its effects on gastric emptying , DB01278 therapy should not be considered for patients taking drugs that alter gastrointestinal motility { e , g , , ddrug1 such as ddrug2 } and agents that slow the intestinal absorption of nutrients { e , g , , HD00996 } .",
        "label": "advise"
    },
    {
        "text": "due to its effects on gastric emptying , ddrug0 therapy should not be considered for patients taking drugs that alter gastrointestinal motility { e , g , , HD00352 such as ddrug2 } and agents that slow the intestinal absorption of nutrients { e , g , , HD00996 } .",
        "label": "NA"
    },
    {
        "text": "due to its effects on gastric emptying , ddrug0 therapy should not be considered for patients taking drugs that alter gastrointestinal motility { e , g , , ddrug1 such as DB00572 } and agents that slow the intestinal absorption of nutrients { e , g , , HD00996 } .",
        "label": "NA"
    },
    {
        "text": "when the rapid onset of a concomitant orally administered agent is a critical determinant of effectiveness { such as HD00651 } , the agent should be administered at least # hour prior to or # hours after DB01278 injection .",
        "label": "advise"
    },
    {
        "text": "in clinical trials , the concomitant use of HD00222 or HD00997 did not alter the adverse event profile of ddrug2 .",
        "label": "NA"
    },
    {
        "text": "in clinical trials , the concomitant use of HD00222 or ddrug1 did not alter the adverse event profile of DB01278 .",
        "label": "NA"
    },
    {
        "text": "in clinical trials , the concomitant use of ddrug0 or HD00997 did not alter the adverse event profile of DB01278 .",
        "label": "NA"
    },
    {
        "text": "no formal interaction studies have been performed to assess the effect of DB01278 on the kinetics of oral HD00075 .",
        "label": "NA"
    },
    {
        "text": "mixing DB01278 and HD00071 the pharmacokinetic parameters of ddrug2 were altered when mixed with regular , nph , and 70/30 premixed formulations of recombinant ddrug3 immediately prior to injection .",
        "label": "NA"
    },
    {
        "text": "mixing DB01278 and ddrug1 the pharmacokinetic parameters of ddrug2 were altered when mixed with regular , nph , and 70/30 premixed formulations of recombinant DB00030 immediately prior to injection .",
        "label": "NA"
    },
    {
        "text": "mixing ddrug0 and HD00071 the pharmacokinetic parameters of DB01278 were altered when mixed with regular , nph , and 70/30 premixed formulations of recombinant ddrug3 immediately prior to injection .",
        "label": "NA"
    },
    {
        "text": "mixing ddrug0 and ddrug1 the pharmacokinetic parameters of DB01278 were altered when mixed with regular , nph , and 70/30 premixed formulations of recombinant DB00030 immediately prior to injection .",
        "label": "mechanism"
    },
    {
        "text": "thus , DB01278 and HD00071 should not be mixed and must be administered separately .",
        "label": "NA"
    },
    {
        "text": "drugs that induce hepatic enzymes such as DB01174 , ddrug1 and ddrug2 may increase the clearance of HD00175 and may require increases in ddrug4 dose to achieve the desired response .",
        "label": "mechanism"
    },
    {
        "text": "drugs that induce hepatic enzymes such as DB01174 , ddrug1 and ddrug2 may increase the clearance of ddrug3 and may require increases in HD00579 dose to achieve the desired response .",
        "label": "mechanism"
    },
    {
        "text": "drugs that induce hepatic enzymes such as ddrug0 , DB00252 and ddrug2 may increase the clearance of HD00175 and may require increases in ddrug4 dose to achieve the desired response .",
        "label": "mechanism"
    },
    {
        "text": "drugs that induce hepatic enzymes such as ddrug0 , DB00252 and ddrug2 may increase the clearance of ddrug3 and may require increases in HD00579 dose to achieve the desired response .",
        "label": "mechanism"
    },
    {
        "text": "drugs that induce hepatic enzymes such as ddrug0 , ddrug1 and DB01045 may increase the clearance of HD00175 and may require increases in ddrug4 dose to achieve the desired response .",
        "label": "mechanism"
    },
    {
        "text": "drugs that induce hepatic enzymes such as ddrug0 , ddrug1 and DB01045 may increase the clearance of ddrug3 and may require increases in HD00579 dose to achieve the desired response .",
        "label": "mechanism"
    },
    {
        "text": "drugs such as DB13179 and DB01026 may inhibit the metabolism of ddrug2 and thus decrease their clearance .",
        "label": "NA"
    },
    {
        "text": "drugs such as DB13179 and ddrug1 may inhibit the metabolism of HD00175 and thus decrease their clearance .",
        "label": "mechanism"
    },
    {
        "text": "drugs such as ddrug0 and DB01026 may inhibit the metabolism of HD00175 and thus decrease their clearance .",
        "label": "mechanism"
    },
    {
        "text": "HD00175 may increase the clearance of chronic high dose DB00945 .",
        "label": "mechanism"
    },
    {
        "text": "this could lead to decreased HD00372 serum levels or increase the risk of ddrug1 toxicity when HD00579 is withdrawn .",
        "label": "NA"
    },
    {
        "text": "this could lead to decreased ddrug0 serum levels or increase the risk of HD00372 toxicity when HD00579 is withdrawn .",
        "label": "effect"
    },
    {
        "text": "DB00945 should be used cautiously in conjunction with HD00175 in patients suffering from hypoprothrombinemia .",
        "label": "advise"
    },
    {
        "text": "the effect of HD00175 on oral HD00326 is variable .",
        "label": "effect"
    },
    {
        "text": "there are reports of enhanced as well as diminished effects of HD00326 when given concurrently with HD00175 .",
        "label": "effect"
    },
    {
        "text": "HD00385 : concurrent use of HD00998 and ddrug2 may result in increased systemic toxicity since ddrug3 inhibit the breakdown of ddrug4 .",
        "label": "NA"
    },
    {
        "text": "HD00385 : concurrent use of ddrug1 and HD00591 may result in increased systemic toxicity since ddrug3 inhibit the breakdown of ddrug4 .",
        "label": "NA"
    },
    {
        "text": "HD00385 : concurrent use of ddrug1 and ddrug2 may result in increased systemic toxicity since ddrug3 inhibit the breakdown of HD00998 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : concurrent use of HD00998 and HD00591 may result in increased systemic toxicity since ddrug3 inhibit the breakdown of ddrug4 .",
        "label": "effect"
    },
    {
        "text": "ddrug0 : concurrent use of HD00998 and ddrug2 may result in increased systemic toxicity since HD00385 inhibit the breakdown of ddrug4 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : concurrent use of ddrug1 and HD00591 may result in increased systemic toxicity since HD00385 inhibit the breakdown of ddrug4 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : concurrent use of ddrug1 and HD00591 may result in increased systemic toxicity since ddrug3 inhibit the breakdown of HD00998 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : concurrent use of ddrug1 and ddrug2 may result in increased systemic toxicity since HD00385 inhibit the breakdown of HD00998 .",
        "label": "mechanism"
    },
    {
        "text": "HD00957 medications : concurrent use of HD00998 and ddrug2 may result in additive depressant effects .",
        "label": "NA"
    },
    {
        "text": "ddrug0 medications : concurrent use of HD00998 and HD00999 may result in additive depressant effects .",
        "label": "effect"
    },
    {
        "text": "ddrug0 : DB00070 may increase the diffusion rate of HD00998 , resulting in a decreased time of onset , but an increase in systemic toxicity .",
        "label": "mechanism"
    },
    {
        "text": "HD00547 { such as ddrug1 } : concurrent use of HD00998 and ddrug3 may result in prolongation or enhancement of the neuromuscular blockade .",
        "label": "NA"
    },
    {
        "text": "ddrug0 { such as HD01000 } : concurrent use of HD00998 and ddrug3 may result in prolongation or enhancement of the neuromuscular blockade .",
        "label": "NA"
    },
    {
        "text": "ddrug0 { such as HD01000 } : concurrent use of ddrug2 and HD00547 may result in prolongation or enhancement of the neuromuscular blockade .",
        "label": "NA"
    },
    {
        "text": "ddrug0 { such as ddrug1 } : concurrent use of HD00998 and HD00547 may result in prolongation or enhancement of the neuromuscular blockade .",
        "label": "effect"
    },
    {
        "text": "HD00297 : concurrent use of HD00998 and ddrug2 may result in a reduction of the antibacterial action of the ddrug3 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : concurrent use of HD00998 and HD00297 may result in a reduction of the antibacterial action of the ddrug3 .",
        "label": "effect"
    },
    {
        "text": "ddrug0 : concurrent use of HD00998 and ddrug2 may result in a reduction of the antibacterial action of the HD01001 .",
        "label": "NA"
    },
    {
        "text": "DB00819 : concurrent use of ddrug1 and HD00998 may extend the plasma half-life of ddrug3 .",
        "label": "NA"
    },
    {
        "text": "DB00819 : concurrent use of ddrug1 and ddrug2 may extend the plasma half-life of DB00721 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : concurrent use of DB00819 and HD00998 may extend the plasma half-life of ddrug3 .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 : concurrent use of DB00819 and ddrug2 may extend the plasma half-life of DB00721 .",
        "label": "NA"
    },
    {
        "text": "to minimize cns depression and possible potentiation , ddrug0 , ddrug1 , ddrug2 , HD01002 or HD00219 should be used with caution .",
        "label": "NA"
    },
    {
        "text": "because DB01168 exhibits some maoa inhibitory activity , HD00390 , ddrug2 drugs { e , g , , ddrug3 , ddrug4 } and other drugs and foods with known high ddrug5 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .",
        "label": "advise"
    },
    {
        "text": "because DB01168 exhibits some maoa inhibitory activity , ddrug1 , HD00042 drugs { e , g , , ddrug3 , ddrug4 } and other drugs and foods with known high ddrug5 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .",
        "label": "advise"
    },
    {
        "text": "because DB01168 exhibits some maoa inhibitory activity , ddrug1 , ddrug2 drugs { e , g , , HD00314 , ddrug4 } and other drugs and foods with known high ddrug5 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .",
        "label": "advise"
    },
    {
        "text": "because DB01168 exhibits some maoa inhibitory activity , ddrug1 , ddrug2 drugs { e , g , , ddrug3 , HD01003 } and other drugs and foods with known high ddrug5 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .",
        "label": "advise"
    },
    {
        "text": "because DB01168 exhibits some maoa inhibitory activity , ddrug1 , ddrug2 drugs { e , g , , ddrug3 , ddrug4 } and other drugs and foods with known high DB08841 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .",
        "label": "advise"
    },
    {
        "text": "because ddrug0 exhibits some maoa inhibitory activity , HD00390 , HD00042 drugs { e , g , , ddrug3 , ddrug4 } and other drugs and foods with known high ddrug5 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .",
        "label": "NA"
    },
    {
        "text": "because ddrug0 exhibits some maoa inhibitory activity , HD00390 , ddrug2 drugs { e , g , , HD00314 , ddrug4 } and other drugs and foods with known high ddrug5 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .",
        "label": "NA"
    },
    {
        "text": "because ddrug0 exhibits some maoa inhibitory activity , HD00390 , ddrug2 drugs { e , g , , ddrug3 , HD01003 } and other drugs and foods with known high ddrug5 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .",
        "label": "NA"
    },
    {
        "text": "because ddrug0 exhibits some maoa inhibitory activity , HD00390 , ddrug2 drugs { e , g , , ddrug3 , ddrug4 } and other drugs and foods with known high DB08841 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .",
        "label": "NA"
    },
    {
        "text": "because ddrug0 exhibits some maoa inhibitory activity , ddrug1 , HD00042 drugs { e , g , , HD00314 , ddrug4 } and other drugs and foods with known high ddrug5 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .",
        "label": "NA"
    },
    {
        "text": "because ddrug0 exhibits some maoa inhibitory activity , ddrug1 , HD00042 drugs { e , g , , ddrug3 , HD01003 } and other drugs and foods with known high ddrug5 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .",
        "label": "NA"
    },
    {
        "text": "because ddrug0 exhibits some maoa inhibitory activity , ddrug1 , HD00042 drugs { e , g , , ddrug3 , ddrug4 } and other drugs and foods with known high DB08841 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .",
        "label": "NA"
    },
    {
        "text": "because ddrug0 exhibits some maoa inhibitory activity , ddrug1 , ddrug2 drugs { e , g , , HD00314 , ddrug4 } and other drugs and foods with known high DB08841 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .",
        "label": "NA"
    },
    {
        "text": "because ddrug0 exhibits some maoa inhibitory activity , ddrug1 , ddrug2 drugs { e , g , , ddrug3 , HD01003 } and other drugs and foods with known high DB08841 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .",
        "label": "NA"
    },
    {
        "text": "HD00029 may accentuate the orthostatic hypotension that may occur with HD00219 .",
        "label": "effect"
    },
    {
        "text": "antihypertensive effects of DB01170 and related compounds may be counteracted when HD00219 are used concomitantly .",
        "label": "effect"
    },
    {
        "text": "concomitant administration of DB00571 with HD00219 results in increased plasma levels of both drugs .",
        "label": "mechanism"
    },
    {
        "text": "the induction dose requirements of DB00818 injectable emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with HD00543 { eg , ddrug2 , ddrug3 , and ddrug4 , etc . .",
        "label": "effect"
    },
    {
        "text": "the induction dose requirements of DB00818 injectable emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with ddrug1 { eg , DB00295 , ddrug3 , and ddrug4 , etc . .",
        "label": "effect"
    },
    {
        "text": "the induction dose requirements of DB00818 injectable emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with ddrug1 { eg , ddrug2 , DB00454 , and ddrug4 , etc . .",
        "label": "effect"
    },
    {
        "text": "the induction dose requirements of DB00818 injectable emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with ddrug1 { eg , ddrug2 , ddrug3 , and DB00813 , etc . .",
        "label": "effect"
    },
    {
        "text": "and combinations of HD00263 and HD00024 { eg , ddrug2 , ddrug3 , ddrug4 , ddrug5 , etc , } .",
        "label": "NA"
    },
    {
        "text": "and combinations of HD00263 and ddrug1 { eg , HD00100 , ddrug3 , ddrug4 , ddrug5 , etc , } .",
        "label": "NA"
    },
    {
        "text": "and combinations of HD00263 and ddrug1 { eg , ddrug2 , HD00026 , ddrug4 , ddrug5 , etc , } .",
        "label": "NA"
    },
    {
        "text": "and combinations of HD00263 and ddrug1 { eg , ddrug2 , ddrug3 , DB01563 , ddrug5 , etc , } .",
        "label": "NA"
    },
    {
        "text": "and combinations of HD00263 and ddrug1 { eg , ddrug2 , ddrug3 , ddrug4 , DB00450 , etc , } .",
        "label": "NA"
    },
    {
        "text": "during maintenance of anesthesia or sedation , the rate of DB00818 injectable emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental HD00131 { eg , ddrug2 or ddrug3 } .",
        "label": "advise"
    },
    {
        "text": "during maintenance of anesthesia or sedation , the rate of DB00818 injectable emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental ddrug1 { eg , DB06690 or ddrug3 } .",
        "label": "advise"
    },
    {
        "text": "during maintenance of anesthesia or sedation , the rate of DB00818 injectable emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental ddrug1 { eg , ddrug2 or HD00263 } .",
        "label": "advise"
    },
    {
        "text": "the concurrent administration of potent inhalational agents { eg , DB00753 , ddrug1 , and ddrug2 } during maintenance with DB00818 injectable emulsion has not been extensively evaluated .",
        "label": "NA"
    },
    {
        "text": "the concurrent administration of potent inhalational agents { eg , ddrug0 , DB00228 , and ddrug2 } during maintenance with DB00818 injectable emulsion has not been extensively evaluated .",
        "label": "NA"
    },
    {
        "text": "the concurrent administration of potent inhalational agents { eg , ddrug0 , ddrug1 , and DB01159 } during maintenance with DB00818 injectable emulsion has not been extensively evaluated .",
        "label": "NA"
    },
    {
        "text": "DB00818 injectable emulsion does not cause a clinically significant change in onset , intensity , or duration of action of the commonly used HD00547 { eg , ddrug2 and ddrug3 } .",
        "label": "NA"
    },
    {
        "text": "DB00818 injectable emulsion does not cause a clinically significant change in onset , intensity , or duration of action of the commonly used ddrug1 { eg , DB00202 and ddrug3 } .",
        "label": "NA"
    },
    {
        "text": "DB00818 injectable emulsion does not cause a clinically significant change in onset , intensity , or duration of action of the commonly used ddrug1 { eg , ddrug2 and HD00816 } .",
        "label": "NA"
    },
    {
        "text": "the cns-depressant effect of DB00647 is additive with that of other HD00261 , including ddrug2 .",
        "label": "effect"
    },
    {
        "text": "the cns-depressant effect of DB00647 is additive with that of other ddrug1 , including DB02325 .",
        "label": "effect"
    },
    {
        "text": "the cns-depressant effect of ddrug0 is additive with that of other HD00261 , including DB02325 .",
        "label": "NA"
    },
    {
        "text": "such occurrences have been reported when DB00647 was administered to patients on HD00216 , ddrug2 , or ddrug3 - like drugs .",
        "label": "NA"
    },
    {
        "text": "such occurrences have been reported when DB00647 was administered to patients on ddrug1 , HD00282 , or ddrug3 - like drugs .",
        "label": "NA"
    },
    {
        "text": "such occurrences have been reported when DB00647 was administered to patients on ddrug1 , ddrug2 , or DB00682 - like drugs .",
        "label": "NA"
    },
    {
        "text": "such occurrences have been reported when ddrug0 was administered to patients on HD00216 , HD00282 , or ddrug3 - like drugs .",
        "label": "NA"
    },
    {
        "text": "such occurrences have been reported when ddrug0 was administered to patients on HD00216 , ddrug2 , or DB00682 - like drugs .",
        "label": "NA"
    },
    {
        "text": "such occurrences have been reported when ddrug0 was administered to patients on ddrug1 , HD00282 , or DB00682 - like drugs .",
        "label": "NA"
    },
    {
        "text": "HD00343 and HD00479 increase the effects of ddrug2 .",
        "label": "NA"
    },
    {
        "text": "HD00343 and ddrug1 increase the effects of DB00852 .",
        "label": "effect"
    },
    {
        "text": "ddrug0 and HD00479 increase the effects of DB00852 .",
        "label": "effect"
    },
    {
        "text": "HD00391 may reduce the antihypertensive effects of DB00968 , ddrug2 , ddrug3 and ddrug4 .",
        "label": "effect"
    },
    {
        "text": "HD00391 may reduce the antihypertensive effects of ddrug1 , DB00657 , ddrug3 and ddrug4 .",
        "label": "effect"
    },
    {
        "text": "HD00391 may reduce the antihypertensive effects of ddrug1 , ddrug2 , DB00206 and ddrug4 .",
        "label": "effect"
    },
    {
        "text": "HD00391 may reduce the antihypertensive effects of ddrug1 , ddrug2 , ddrug3 and HD00392 .",
        "label": "effect"
    },
    {
        "text": "DB00205 may be used with HD00297 , ddrug2 and other ddrug3 , and with other ddrug4 .",
        "label": "NA"
    },
    {
        "text": "DB00205 may be used with ddrug1 , DB00468 and other ddrug3 , and with other ddrug4 .",
        "label": "NA"
    },
    {
        "text": "DB00205 may be used with ddrug1 , ddrug2 and other HD01004 , and with other ddrug4 .",
        "label": "NA"
    },
    {
        "text": "DB00205 may be used with ddrug1 , ddrug2 and other ddrug3 , and with other HD00002 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may be used with HD00297 , ddrug2 and other ddrug3 , and with other HD00002 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may be used with ddrug1 , DB00468 and other ddrug3 , and with other HD00002 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may be used with ddrug1 , ddrug2 and other HD01004 , and with other HD00002 .",
        "label": "NA"
    },
    {
        "text": "mild hepatotoxicity has been reported in some patients when DB00186 and DB00205 were administered concomitantly .",
        "label": "effect"
    },
    {
        "text": "DB01432 : ddrug1 causes a 60 % reduction in the absorption and enterohepatic cycling of DB00481 and should not be coadministered with ddrug3 .",
        "label": "NA"
    },
    {
        "text": "DB01432 : ddrug1 causes a 60 % reduction in the absorption and enterohepatic cycling of ddrug2 and should not be coadministered with DB00481 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : DB01432 causes a 60 % reduction in the absorption and enterohepatic cycling of DB00481 and should not be coadministered with ddrug3 .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 : DB01432 causes a 60 % reduction in the absorption and enterohepatic cycling of ddrug2 and should not be coadministered with DB00481 .",
        "label": "advise"
    },
    {
        "text": "ddrug0 : ddrug1 causes a 60 % reduction in the absorption and enterohepatic cycling of DB00481 and should not be coadministered with DB00481 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : the coadministration of DB00481 and DB00682 has not been assessed under chronic conditions .",
        "label": "NA"
    },
    {
        "text": "if DB00481 is given concurrently with DB00682 , prothrombin time should be monitored .",
        "label": "advise"
    },
    {
        "text": "in vitro , DB00481 did not affect the binding of DB00682 , ddrug2 , or ddrug3 .",
        "label": "NA"
    },
    {
        "text": "in vitro , DB00481 did not affect the binding of ddrug1 , DB00252 , or ddrug3 .",
        "label": "NA"
    },
    {
        "text": "in vitro , DB00481 did not affect the binding of ddrug1 , ddrug2 , or DB00675 .",
        "label": "NA"
    },
    {
        "text": "caution should be used when DB00481 is coadministered with other highly protein-bound drugs , such as DB00636 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 .",
        "label": "advise"
    },
    {
        "text": "caution should be used when DB00481 is coadministered with other highly protein-bound drugs , such as ddrug1 , DB00328 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 .",
        "label": "advise"
    },
    {
        "text": "caution should be used when DB00481 is coadministered with other highly protein-bound drugs , such as ddrug1 , ddrug2 , DB00788 , ddrug4 , ddrug5 , and ddrug6 .",
        "label": "advise"
    },
    {
        "text": "caution should be used when DB00481 is coadministered with other highly protein-bound drugs , such as ddrug1 , ddrug2 , ddrug3 , DB01050 , ddrug5 , and ddrug6 .",
        "label": "advise"
    },
    {
        "text": "caution should be used when DB00481 is coadministered with other highly protein-bound drugs , such as ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00829 , and ddrug6 .",
        "label": "advise"
    },
    {
        "text": "caution should be used when DB00481 is coadministered with other highly protein-bound drugs , such as ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and DB01119 .",
        "label": "advise"
    },
    {
        "text": "coadministration of HD01005 with DB01211 resulted in increased plasma ddrug2 concentrations { 57 % } , increased plasma bismuth trough concentrations { 48 % } , and increased ddrug3 plasma concentrations { 31 % } .",
        "label": "mechanism"
    },
    {
        "text": "coadministration of HD01005 with ddrug1 resulted in increased plasma DB00863 concentrations { 57 % } , increased plasma bismuth trough concentrations { 48 % } , and increased ddrug3 plasma concentrations { 31 % } .",
        "label": "NA"
    },
    {
        "text": "coadministration of HD01005 with ddrug1 resulted in increased plasma ddrug2 concentrations { 57 % } , increased plasma bismuth trough concentrations { 48 % } , and increased HD01006 plasma concentrations { 31 % } .",
        "label": "NA"
    },
    {
        "text": "coadministration of ddrug0 with DB01211 resulted in increased plasma DB00863 concentrations { 57 % } , increased plasma bismuth trough concentrations { 48 % } , and increased ddrug3 plasma concentrations { 31 % } .",
        "label": "NA"
    },
    {
        "text": "coadministration of ddrug0 with ddrug1 resulted in increased plasma DB00863 concentrations { 57 % } , increased plasma bismuth trough concentrations { 48 % } , and increased HD01006 plasma concentrations { 31 % } .",
        "label": "NA"
    },
    {
        "text": "coadministration with DB00945 results in a slight decrease in the rate of HD00372 absorption that is clinically unimportant .",
        "label": "NA"
    },
    {
        "text": "coadministration with a high dose of DB06724 { 170 meq } results in a 28 % decrease in plasma concentrations of DB00863 and may decrease plasma concentrations of bismuth from ddrug2 .",
        "label": "mechanism"
    },
    {
        "text": "coadministration with a high dose of DB06724 { 170 meq } results in a 28 % decrease in plasma concentrations of ddrug1 and may decrease plasma concentrations of bismuth from HD01005 .",
        "label": "mechanism"
    },
    {
        "text": "coadministration with a high dose of ddrug0 { 170 meq } results in a 28 % decrease in plasma concentrations of DB00863 and may decrease plasma concentrations of bismuth from HD01005 .",
        "label": "NA"
    },
    {
        "text": "for information on drug interactions associated with DB00863 , refer to the DB00863 package insert .",
        "label": "NA"
    },
    {
        "text": "co-administration of oral DB01026 # mg twice daily increased DB01256 geometric mean auc { 0 - 24 } and cmax by 81 % after topical application of ddrug2 ointment , 1 % on the abraded skin of healthy adult males .",
        "label": "NA"
    },
    {
        "text": "co-administration of oral DB01026 # mg twice daily increased ddrug1 geometric mean auc { 0 - 24 } and cmax by 81 % after topical application of DB01256 ointment , 1 % on the abraded skin of healthy adult males .",
        "label": "mechanism"
    },
    {
        "text": "due to low systemic exposure to DB01256 following topical application in patients , dosage adjustments for ddrug1 are unnecessary when co-administered with cyp3a4 inhibitors , such as DB01026 .",
        "label": "NA"
    },
    {
        "text": "due to low systemic exposure to ddrug0 following topical application in patients , dosage adjustments for DB01256 are unnecessary when co-administered with cyp3a4 inhibitors , such as DB01026 .",
        "label": "NA"
    },
    {
        "text": "based on in vitro p450 inhibition studies and the low systemic exposure observed following topical application of DB01256 , DB01256 is unlikely to affect the metabolism of other cyp2b6 substrates .",
        "label": "NA"
    },
    {
        "text": "in addition to bleeding associated with DB01109 and HD00286 , drugs that alter platelet function { such as ddrug2 , ddrug3 , and ddrug4 } may increase the risk of bleeding if administered prior to or after ddrug5 therapy .",
        "label": "NA"
    },
    {
        "text": "in addition to bleeding associated with DB01109 and ddrug1 , drugs that alter platelet function { such as DB00945 , ddrug3 , and ddrug4 } may increase the risk of bleeding if administered prior to or after ddrug5 therapy .",
        "label": "NA"
    },
    {
        "text": "in addition to bleeding associated with DB01109 and ddrug1 , drugs that alter platelet function { such as ddrug2 , DB00975 , and ddrug4 } may increase the risk of bleeding if administered prior to or after ddrug5 therapy .",
        "label": "NA"
    },
    {
        "text": "in addition to bleeding associated with DB01109 and ddrug1 , drugs that alter platelet function { such as ddrug2 , ddrug3 , and DB00054 } may increase the risk of bleeding if administered prior to or after ddrug5 therapy .",
        "label": "NA"
    },
    {
        "text": "in addition to bleeding associated with DB01109 and ddrug1 , drugs that alter platelet function { such as ddrug2 , ddrug3 , and ddrug4 } may increase the risk of bleeding if administered prior to or after DB00015 therapy .",
        "label": "effect"
    },
    {
        "text": "in addition to bleeding associated with ddrug0 and HD00286 , drugs that alter platelet function { such as DB00945 , ddrug3 , and ddrug4 } may increase the risk of bleeding if administered prior to or after ddrug5 therapy .",
        "label": "NA"
    },
    {
        "text": "in addition to bleeding associated with ddrug0 and HD00286 , drugs that alter platelet function { such as ddrug2 , DB00975 , and ddrug4 } may increase the risk of bleeding if administered prior to or after ddrug5 therapy .",
        "label": "NA"
    },
    {
        "text": "in addition to bleeding associated with ddrug0 and HD00286 , drugs that alter platelet function { such as ddrug2 , ddrug3 , and DB00054 } may increase the risk of bleeding if administered prior to or after ddrug5 therapy .",
        "label": "NA"
    },
    {
        "text": "in addition to bleeding associated with ddrug0 and HD00286 , drugs that alter platelet function { such as ddrug2 , ddrug3 , and ddrug4 } may increase the risk of bleeding if administered prior to or after DB00015 therapy .",
        "label": "effect"
    },
    {
        "text": "in addition to bleeding associated with ddrug0 and ddrug1 , drugs that alter platelet function { such as DB00945 , ddrug3 , and ddrug4 } may increase the risk of bleeding if administered prior to or after DB00015 therapy .",
        "label": "effect"
    },
    {
        "text": "in addition to bleeding associated with ddrug0 and ddrug1 , drugs that alter platelet function { such as ddrug2 , DB00975 , and ddrug4 } may increase the risk of bleeding if administered prior to or after DB00015 therapy .",
        "label": "effect"
    },
    {
        "text": "in addition to bleeding associated with ddrug0 and ddrug1 , drugs that alter platelet function { such as ddrug2 , ddrug3 , and DB00054 } may increase the risk of bleeding if administered prior to or after DB00015 therapy .",
        "label": "effect"
    },
    {
        "text": "interactions for DB00140 { ddrug1 } : DB02325 - impairs the intestinal absorption of ddrug3",
        "label": "NA"
    },
    {
        "text": "interactions for ddrug0 { DB00140 } : DB02325 - impairs the intestinal absorption of ddrug3",
        "label": "NA"
    },
    {
        "text": "interactions for ddrug0 { ddrug1 } : DB02325 - impairs the intestinal absorption of DB00140",
        "label": "mechanism"
    },
    {
        "text": "DB01032 - concurrent use decreases gastrointestinal absorption of DB00140 ;",
        "label": "mechanism"
    },
    {
        "text": "requirements for DB00140 may be increased in patients receiving DB01032 .",
        "label": "effect"
    },
    {
        "text": "ddrug0 : the effects of chronic DB00501 use on the metabolism of DB00478 are not known .",
        "label": "NA"
    },
    {
        "text": "when a single # mg dose of HD01007 was administered one hour after the initiation of DB00501 { 300 mg four times a day } , the apparent total ddrug2 clearance of this single dose in normal healthy adults was reduced by 18 % { compared to the apparent total ddrug3 clearance in the same subjects in the absence of ddrug4 } .",
        "label": "mechanism"
    },
    {
        "text": "when a single # mg dose of HD01007 was administered one hour after the initiation of ddrug1 { 300 mg four times a day } , the apparent total ddrug2 clearance of this single dose in normal healthy adults was reduced by 18 % { compared to the apparent total ddrug3 clearance in the same subjects in the absence of DB00501 } .",
        "label": "NA"
    },
    {
        "text": "when a single # mg dose of ddrug0 was administered one hour after the initiation of DB00501 { 300 mg four times a day } , the apparent total DB00478 clearance of this single dose in normal healthy adults was reduced by 18 % { compared to the apparent total ddrug3 clearance in the same subjects in the absence of ddrug4 } .",
        "label": "NA"
    },
    {
        "text": "when a single # mg dose of ddrug0 was administered one hour after the initiation of DB00501 { 300 mg four times a day } , the apparent total ddrug2 clearance of this single dose in normal healthy adults was reduced by 18 % { compared to the apparent total DB00478 clearance in the same subjects in the absence of ddrug4 } .",
        "label": "NA"
    },
    {
        "text": "when a single # mg dose of ddrug0 was administered one hour after the initiation of ddrug1 { 300 mg four times a day } , the apparent total DB00478 clearance of this single dose in normal healthy adults was reduced by 18 % { compared to the apparent total ddrug3 clearance in the same subjects in the absence of DB00501 } .",
        "label": "NA"
    },
    {
        "text": "when a single # mg dose of ddrug0 was administered one hour after the initiation of ddrug1 { 300 mg four times a day } , the apparent total ddrug2 clearance of this single dose in normal healthy adults was reduced by 18 % { compared to the apparent total DB00478 clearance in the same subjects in the absence of DB00501 } .",
        "label": "NA"
    },
    {
        "text": "DB00316 : HD01007 , # mg , was given twice daily for # days to # healthy volunteers .",
        "label": "NA"
    },
    {
        "text": "coadministration with DB00316 reduced the peak concentration and auc values for DB00478 by approximately 11 % .",
        "label": "mechanism"
    },
    {
        "text": "DB00945 : HD01007 , # mg , was given twice daily fro # days to # healthy volunteers .",
        "label": "NA"
    },
    {
        "text": "peak plasma concentrations and auc of DB00478 were reduced approximately 10 % in the presence of DB00945 .",
        "label": "mechanism"
    },
    {
        "text": "the elevation of prothrombin time induced by DB00682 is not affected by administration of DB00989 .",
        "label": "NA"
    },
    {
        "text": "single dose pharmacokinetic studies demonstrated that the metabolism of DB00989 is not significantly affected by concurrent administration of DB00390 , ddrug2 , ddrug3 , or ddrug4 .",
        "label": "NA"
    },
    {
        "text": "single dose pharmacokinetic studies demonstrated that the metabolism of DB00989 is not significantly affected by concurrent administration of ddrug1 , DB00682 , ddrug3 , or ddrug4 .",
        "label": "NA"
    },
    {
        "text": "single dose pharmacokinetic studies demonstrated that the metabolism of DB00989 is not significantly affected by concurrent administration of ddrug1 , ddrug2 , DB00829 , or ddrug4 .",
        "label": "NA"
    },
    {
        "text": "single dose pharmacokinetic studies demonstrated that the metabolism of DB00989 is not significantly affected by concurrent administration of ddrug1 , ddrug2 , ddrug3 , or DB00472 .",
        "label": "NA"
    },
    {
        "text": "population pk analysis with a database of # patients showed that the pharmacokinetics of DB00989 were not influenced by commonly prescribed medications such as HD00374 { n = 77 } , ddrug2 { n = 72 } , ddrug3 { n = 75 } , ddrug4 { n = 21 } , ddrug5 { n = 79 } , ddrug6 { n = 70 } , ddrug7 { n = 177 } , ddrug8 { n = 35 } , and ddrug9 { n = 15 } .",
        "label": "NA"
    },
    {
        "text": "population pk analysis with a database of # patients showed that the pharmacokinetics of DB00989 were not influenced by commonly prescribed medications such as ddrug1 { n = 77 } , HD00255 { n = 72 } , ddrug3 { n = 75 } , ddrug4 { n = 21 } , ddrug5 { n = 79 } , ddrug6 { n = 70 } , ddrug7 { n = 177 } , ddrug8 { n = 35 } , and ddrug9 { n = 15 } .",
        "label": "NA"
    },
    {
        "text": "population pk analysis with a database of # patients showed that the pharmacokinetics of DB00989 were not influenced by commonly prescribed medications such as ddrug1 { n = 77 } , ddrug2 { n = 72 } , HD00377 { n = 75 } , ddrug4 { n = 21 } , ddrug5 { n = 79 } , ddrug6 { n = 70 } , ddrug7 { n = 177 } , ddrug8 { n = 35 } , and ddrug9 { n = 15 } .",
        "label": "NA"
    },
    {
        "text": "population pk analysis with a database of # patients showed that the pharmacokinetics of DB00989 were not influenced by commonly prescribed medications such as ddrug1 { n = 77 } , ddrug2 { n = 72 } , ddrug3 { n = 75 } , HD00899 { n = 21 } , ddrug5 { n = 79 } , ddrug6 { n = 70 } , ddrug7 { n = 177 } , ddrug8 { n = 35 } , and ddrug9 { n = 15 } .",
        "label": "NA"
    },
    {
        "text": "population pk analysis with a database of # patients showed that the pharmacokinetics of DB00989 were not influenced by commonly prescribed medications such as ddrug1 { n = 77 } , ddrug2 { n = 72 } , ddrug3 { n = 75 } , ddrug4 { n = 21 } , HD00233 { n = 79 } , ddrug6 { n = 70 } , ddrug7 { n = 177 } , ddrug8 { n = 35 } , and ddrug9 { n = 15 } .",
        "label": "NA"
    },
    {
        "text": "population pk analysis with a database of # patients showed that the pharmacokinetics of DB00989 were not influenced by commonly prescribed medications such as ddrug1 { n = 77 } , ddrug2 { n = 72 } , ddrug3 { n = 75 } , ddrug4 { n = 21 } , ddrug5 { n = 79 } , HD00220 { n = 70 } , ddrug7 { n = 177 } , ddrug8 { n = 35 } , and ddrug9 { n = 15 } .",
        "label": "NA"
    },
    {
        "text": "population pk analysis with a database of # patients showed that the pharmacokinetics of DB00989 were not influenced by commonly prescribed medications such as ddrug1 { n = 77 } , ddrug2 { n = 72 } , ddrug3 { n = 75 } , ddrug4 { n = 21 } , ddrug5 { n = 79 } , ddrug6 { n = 70 } , HD01008 { n = 177 } , ddrug8 { n = 35 } , and ddrug9 { n = 15 } .",
        "label": "NA"
    },
    {
        "text": "population pk analysis with a database of # patients showed that the pharmacokinetics of DB00989 were not influenced by commonly prescribed medications such as ddrug1 { n = 77 } , ddrug2 { n = 72 } , ddrug3 { n = 75 } , ddrug4 { n = 21 } , ddrug5 { n = 79 } , ddrug6 { n = 70 } , ddrug7 { n = 177 } , HD01009 { n = 35 } , and ddrug9 { n = 15 } .",
        "label": "NA"
    },
    {
        "text": "population pk analysis with a database of # patients showed that the pharmacokinetics of DB00989 were not influenced by commonly prescribed medications such as ddrug1 { n = 77 } , ddrug2 { n = 72 } , ddrug3 { n = 75 } , ddrug4 { n = 21 } , ddrug5 { n = 79 } , ddrug6 { n = 70 } , ddrug7 { n = 177 } , ddrug8 { n = 35 } , and HD00388 { n = 15 } .",
        "label": "NA"
    },
    {
        "text": "population pk analysis with a database of # patients showed that the pharmacokinetics of ddrug0 were not influenced by commonly prescribed medications such as HD00374 { n = 77 } , ddrug2 { n = 72 } , ddrug3 { n = 75 } , ddrug4 { n = 21 } , ddrug5 { n = 79 } , HD00220 { n = 70 } , ddrug7 { n = 177 } , ddrug8 { n = 35 } , and ddrug9 { n = 15 } .",
        "label": "NA"
    },
    {
        "text": "population pk analysis with a database of # patients showed that the pharmacokinetics of ddrug0 were not influenced by commonly prescribed medications such as HD00374 { n = 77 } , ddrug2 { n = 72 } , ddrug3 { n = 75 } , ddrug4 { n = 21 } , ddrug5 { n = 79 } , ddrug6 { n = 70 } , HD01008 { n = 177 } , ddrug8 { n = 35 } , and ddrug9 { n = 15 } .",
        "label": "NA"
    },
    {
        "text": "population pk analysis with a database of # patients showed that the pharmacokinetics of ddrug0 were not influenced by commonly prescribed medications such as HD00374 { n = 77 } , ddrug2 { n = 72 } , ddrug3 { n = 75 } , ddrug4 { n = 21 } , ddrug5 { n = 79 } , ddrug6 { n = 70 } , ddrug7 { n = 177 } , HD01009 { n = 35 } , and ddrug9 { n = 15 } .",
        "label": "NA"
    },
    {
        "text": "population pk analysis with a database of # patients showed that the pharmacokinetics of ddrug0 were not influenced by commonly prescribed medications such as HD00374 { n = 77 } , ddrug2 { n = 72 } , ddrug3 { n = 75 } , ddrug4 { n = 21 } , ddrug5 { n = 79 } , ddrug6 { n = 70 } , ddrug7 { n = 177 } , ddrug8 { n = 35 } , and HD00388 { n = 15 } .",
        "label": "NA"
    },
    {
        "text": "population pk analysis with a database of # patients showed that the pharmacokinetics of ddrug0 were not influenced by commonly prescribed medications such as ddrug1 { n = 77 } , ddrug2 { n = 72 } , HD00377 { n = 75 } , ddrug4 { n = 21 } , HD00233 { n = 79 } , ddrug6 { n = 70 } , ddrug7 { n = 177 } , ddrug8 { n = 35 } , and ddrug9 { n = 15 } .",
        "label": "NA"
    },
    {
        "text": "use with ddrug0 : because of their mechanism of action , HD00632 have the potential to interfere with the activity of HD00814 .",
        "label": "int"
    },
    {
        "text": "use with HD01010 and other HD00632 : a synergistic effect may be expected when ddrug2 are given concurrently with ddrug3 , similar ddrug4 or ddrug5 such as ddrug6 .",
        "label": "NA"
    },
    {
        "text": "use with ddrug0 and other ddrug1 : a synergistic effect may be expected when HD00632 are given concurrently with DB00202 , similar ddrug4 or ddrug5 such as ddrug6 .",
        "label": "effect"
    },
    {
        "text": "use with ddrug0 and other ddrug1 : a synergistic effect may be expected when HD00632 are given concurrently with ddrug3 , similar HD00547 or ddrug5 such as ddrug6 .",
        "label": "effect"
    },
    {
        "text": "use with ddrug0 and other ddrug1 : a synergistic effect may be expected when HD00632 are given concurrently with ddrug3 , similar ddrug4 or HD01011 such as ddrug6 .",
        "label": "effect"
    },
    {
        "text": "use with ddrug0 and other ddrug1 : a synergistic effect may be expected when HD00632 are given concurrently with ddrug3 , similar ddrug4 or ddrug5 such as DB01019 .",
        "label": "effect"
    },
    {
        "text": "use with ddrug0 and other ddrug1 : a synergistic effect may be expected when ddrug2 are given concurrently with DB00202 , similar ddrug4 or ddrug5 such as DB01019 .",
        "label": "NA"
    },
    {
        "text": "use with ddrug0 and other ddrug1 : a synergistic effect may be expected when ddrug2 are given concurrently with ddrug3 , similar HD00547 or ddrug5 such as DB01019 .",
        "label": "NA"
    },
    {
        "text": "use with ddrug0 and other ddrug1 : a synergistic effect may be expected when ddrug2 are given concurrently with ddrug3 , similar ddrug4 or HD01011 such as DB01019 .",
        "label": "NA"
    },
    {
        "text": "drug interactions : the use of DB00728 { ddrug1 } injection before DB00202 , for the purpose of attenuating some of the side effects of ddrug3 , has not been studied .",
        "label": "NA"
    },
    {
        "text": "drug interactions : the use of DB00728 { ddrug1 } injection before ddrug2 , for the purpose of attenuating some of the side effects of DB00202 , has not been studied .",
        "label": "NA"
    },
    {
        "text": "drug interactions : the use of ddrug0 { DB00728 } injection before DB00202 , for the purpose of attenuating some of the side effects of ddrug3 , has not been studied .",
        "label": "NA"
    },
    {
        "text": "drug interactions : the use of ddrug0 { DB00728 } injection before ddrug2 , for the purpose of attenuating some of the side effects of DB00202 , has not been studied .",
        "label": "NA"
    },
    {
        "text": "if DB00728 is administered following administration of DB00202 , it should not be given until recovery from ddrug2 has been observed .",
        "label": "advise"
    },
    {
        "text": "if DB00728 is administered following administration of ddrug1 , it should not be given until recovery from DB00202 has been observed .",
        "label": "NA"
    },
    {
        "text": "the median duration of action of DB00728 # mg/kg administered after a # mg/kg dose of DB00202 when t # returned to 75 % of control was # minutes { range 14 - 57 , n = 12 } vs.",
        "label": "NA"
    },
    {
        "text": "there are no controlled studies documenting the use of DB00728 before or after other HD00816 .",
        "label": "NA"
    },
    {
        "text": "DB00296 should be used with caution in patients receiving other local HD00264 or agents structurally related to ddrug2 , since the toxic effects of these drugs are additive .",
        "label": "advise"
    },
    {
        "text": "DB00296 should be used with caution in patients receiving other local ddrug1 or agents structurally related to HD01012 , since the toxic effects of these drugs are additive .",
        "label": "NA"
    },
    {
        "text": "in vivo , the plasma clearance of DB00296 was reduced by 70 % during coadministration of DB00176 { 25 mg bid for # days } , a selective and potent cyp1a2 inhibitor .",
        "label": "mechanism"
    },
    {
        "text": "thus strong inhibitors of cytochrome p4501a2 , such as DB00176 , given concomitantly during administration of DB00296 , can interact with ddrug2 leading to increased ddrug3 plasma levels .",
        "label": "int"
    },
    {
        "text": "thus strong inhibitors of cytochrome p4501a2 , such as DB00176 , given concomitantly during administration of ddrug1 , can interact with DB00296 leading to increased ddrug3 plasma levels .",
        "label": "NA"
    },
    {
        "text": "thus strong inhibitors of cytochrome p4501a2 , such as DB00176 , given concomitantly during administration of ddrug1 , can interact with ddrug2 leading to increased DB00296 plasma levels .",
        "label": "NA"
    },
    {
        "text": "possible interactions with drugs known to be metabolized by cyp1a2 via competitive inhibition such as DB00277 and DB00458 may also occur .",
        "label": "NA"
    },
    {
        "text": "coadministration of a selective and potent inhibitor of cyp3a4 , DB01026 { 100 mg bid for # days with DB00296 infusion administered # hour after ddrug2 } caused a 15 % reduction in in-vivo plasma clearance of ddrug3 .",
        "label": "NA"
    },
    {
        "text": "coadministration of a selective and potent inhibitor of cyp3a4 , DB01026 { 100 mg bid for # days with ddrug1 infusion administered # hour after ddrug2 } caused a 15 % reduction in in-vivo plasma clearance of DB00296 .",
        "label": "mechanism"
    },
    {
        "text": "coadministration of a selective and potent inhibitor of cyp3a4 , ddrug0 { 100 mg bid for # days with DB00296 infusion administered # hour after DB01026 } caused a 15 % reduction in in-vivo plasma clearance of ddrug3 .",
        "label": "NA"
    },
    {
        "text": "coadministration of a selective and potent inhibitor of cyp3a4 , ddrug0 { 100 mg bid for # days with ddrug1 infusion administered # hour after DB01026 } caused a 15 % reduction in in-vivo plasma clearance of DB00296 .",
        "label": "NA"
    },
    {
        "text": "an inhibitor of cyp2c8 { such as DB01241 } may increase the auc of DB00412 and an inducer of cyp2c8 { such as ddrug2 } may decrease the auc of ddrug3 .",
        "label": "mechanism"
    },
    {
        "text": "an inhibitor of cyp2c8 { such as DB01241 } may increase the auc of ddrug1 and an inducer of cyp2c8 { such as DB01045 } may decrease the auc of ddrug3 .",
        "label": "NA"
    },
    {
        "text": "an inhibitor of cyp2c8 { such as DB01241 } may increase the auc of ddrug1 and an inducer of cyp2c8 { such as ddrug2 } may decrease the auc of DB00412 .",
        "label": "NA"
    },
    {
        "text": "an inhibitor of cyp2c8 { such as ddrug0 } may increase the auc of DB00412 and an inducer of cyp2c8 { such as DB01045 } may decrease the auc of ddrug3 .",
        "label": "NA"
    },
    {
        "text": "an inhibitor of cyp2c8 { such as ddrug0 } may increase the auc of ddrug1 and an inducer of cyp2c8 { such as DB01045 } may decrease the auc of DB00412 .",
        "label": "mechanism"
    },
    {
        "text": "concomitant administrations not recommended : - DB00342 and DB00637 : certain ddrug2 interact with ddrug3 and ddrug4 leading to increased serum concentrations of the latter .",
        "label": "NA"
    },
    {
        "text": "concomitant administrations not recommended : - ddrug0 and ddrug1 : certain HD00375 interact with DB00342 and ddrug4 leading to increased serum concentrations of the latter .",
        "label": "int"
    },
    {
        "text": "concomitant administrations not recommended : - ddrug0 and ddrug1 : certain HD00375 interact with ddrug3 and DB00637 leading to increased serum concentrations of the latter .",
        "label": "int"
    },
    {
        "text": "concomitant administrations not recommended : - ddrug0 and ddrug1 : certain ddrug2 interact with DB00342 and DB00637 leading to increased serum concentrations of the latter .",
        "label": "NA"
    },
    {
        "text": "although such a reaction has not been demonstrated with DB00778 , concomitant administration of ddrug1 with DB00342 or ddrug3 is not recommended .",
        "label": "NA"
    },
    {
        "text": "although such a reaction has not been demonstrated with DB00778 , concomitant administration of ddrug1 with ddrug2 or DB00637 is not recommended .",
        "label": "NA"
    },
    {
        "text": "although such a reaction has not been demonstrated with ddrug0 , concomitant administration of DB00778 with DB00342 or ddrug3 is not recommended .",
        "label": "advise"
    },
    {
        "text": "although such a reaction has not been demonstrated with ddrug0 , concomitant administration of DB00778 with ddrug2 or DB00637 is not recommended .",
        "label": "advise"
    },
    {
        "text": "although such a reaction has not been demonstrated with ddrug0 , concomitant administration of ddrug1 with DB00342 or DB00637 is not recommended .",
        "label": "NA"
    },
    {
        "text": "- DB00604 , DB01100 : other drugs such as ddrug2 or ddrug3 , which are metabolised by hepatic cytochrome_p450_family_3_subfamily_a isozymes have been associated with qt interval prolongation and/or cardiac arrythmias { typically torsades de pointe } as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme , including some ddrug4 .",
        "label": "NA"
    },
    {
        "text": "- ddrug0 , ddrug1 : other drugs such as DB00604 or DB01100 , which are metabolised by hepatic cytochrome_p450_family_3_subfamily_a isozymes have been associated with qt interval prolongation and/or cardiac arrythmias { typically torsades de pointe } as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme , including some ddrug4 .",
        "label": "NA"
    },
    {
        "text": "- ddrug0 , ddrug1 : other drugs such as DB00604 or ddrug3 , which are metabolised by hepatic cytochrome_p450_family_3_subfamily_a isozymes have been associated with qt interval prolongation and/or cardiac arrythmias { typically torsades de pointe } as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme , including some HD01013 .",
        "label": "mechanism"
    },
    {
        "text": "- ddrug0 , ddrug1 : other drugs such as ddrug2 or DB01100 , which are metabolised by hepatic cytochrome_p450_family_3_subfamily_a isozymes have been associated with qt interval prolongation and/or cardiac arrythmias { typically torsades de pointe } as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme , including some HD01013 .",
        "label": "NA"
    },
    {
        "text": "however , in patients with paget 's disease prior HD01014 use appears to reduce the anti-resorptive response to HD01015 nasal spray .",
        "label": "effect"
    },
    {
        "text": "DB00945 and other HD01016 will be additive to ddrug2 and may increase plasma concentrations of ddrug3 to toxic levels .",
        "label": "NA"
    },
    {
        "text": "DB00945 and other ddrug1 will be additive to DB01399 and may increase plasma concentrations of ddrug3 to toxic levels .",
        "label": "effect"
    },
    {
        "text": "DB00945 and other ddrug1 will be additive to ddrug2 and may increase plasma concentrations of DB00645 to toxic levels .",
        "label": "NA"
    },
    {
        "text": "ddrug0 and other HD01016 will be additive to DB01399 and may increase plasma concentrations of ddrug3 to toxic levels .",
        "label": "effect"
    },
    {
        "text": "ddrug0 and other HD01016 will be additive to ddrug2 and may increase plasma concentrations of DB00645 to toxic levels .",
        "label": "NA"
    },
    {
        "text": "ddrug0 and other ddrug1 will be additive to DB01399 and may increase plasma concentrations of DB00645 to toxic levels .",
        "label": "NA"
    },
    {
        "text": "HD00328 given concomitantly with HD00974 may predispose to systemic bleeding .",
        "label": "effect"
    },
    {
        "text": "HD00328 may enhance the hypoglycemic effect of oral HD00394 of the sulfonylurea class .",
        "label": "effect"
    },
    {
        "text": "HD00372 competes with a number of drugs for protein binding sites , notably HD00284 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and possibly ddrug10 .",
        "label": "mechanism"
    },
    {
        "text": "HD00372 competes with a number of drugs for protein binding sites , notably ddrug1 , DB00599 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and possibly ddrug10 .",
        "label": "mechanism"
    },
    {
        "text": "HD00372 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , HD00525 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and possibly ddrug10 .",
        "label": "mechanism"
    },
    {
        "text": "HD00372 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , ddrug3 , DB00279 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and possibly ddrug10 .",
        "label": "mechanism"
    },
    {
        "text": "HD00372 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00252 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and possibly ddrug10 .",
        "label": "mechanism"
    },
    {
        "text": "HD00372 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB01138 , ddrug7 , ddrug8 , ddrug9 , and possibly ddrug10 .",
        "label": "mechanism"
    },
    {
        "text": "HD00372 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , DB00788 , ddrug8 , ddrug9 , and possibly ddrug10 .",
        "label": "mechanism"
    },
    {
        "text": "HD00372 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , DB00682 , ddrug9 , and possibly ddrug10 .",
        "label": "mechanism"
    },
    {
        "text": "HD00372 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , DB00563 , and possibly ddrug10 .",
        "label": "mechanism"
    },
    {
        "text": "HD00372 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and possibly HD00175 .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 competes with a number of drugs for protein binding sites , notably HD00284 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and possibly HD00175 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 competes with a number of drugs for protein binding sites , notably ddrug1 , DB00599 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and possibly HD00175 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , HD00525 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and possibly HD00175 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , ddrug3 , DB00279 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and possibly HD00175 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00252 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , and possibly HD00175 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB01138 , ddrug7 , ddrug8 , ddrug9 , and possibly HD00175 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , DB00788 , ddrug8 , ddrug9 , and possibly HD00175 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , DB00682 , ddrug9 , and possibly HD00175 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 competes with a number of drugs for protein binding sites , notably ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , DB00563 , and possibly HD00175 .",
        "label": "NA"
    },
    {
        "text": "drugs which may potentiate the myeloproliferative effects of DB00020 , such as DB14507 and ddrug2 , should be used with caution .",
        "label": "effect"
    },
    {
        "text": "drugs which may potentiate the myeloproliferative effects of DB00020 , such as ddrug1 and HD00175 , should be used with caution .",
        "label": "effect"
    },
    {
        "text": "drugs which may potentiate the myeloproliferative effects of ddrug0 , such as DB14507 and HD00175 , should be used with caution .",
        "label": "NA"
    },
    {
        "text": "DB00747 should be used with care in patients taking other drugs that are capable of causing cns effects such as HD00024 , ddrug2 , or ddrug3 .",
        "label": "advise"
    },
    {
        "text": "DB00747 should be used with care in patients taking other drugs that are capable of causing cns effects such as ddrug1 , HD00262 , or ddrug3 .",
        "label": "advise"
    },
    {
        "text": "DB00747 should be used with care in patients taking other drugs that are capable of causing cns effects such as ddrug1 , ddrug2 , or DB02325 .",
        "label": "advise"
    },
    {
        "text": "HD00026 may decrease the effectiveness of oral HD00283 , certain ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , and ddrug7 .",
        "label": "int"
    },
    {
        "text": "HD00026 may decrease the effectiveness of oral ddrug1 , certain HD00002 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , and ddrug7 .",
        "label": "int"
    },
    {
        "text": "HD00026 may decrease the effectiveness of oral ddrug1 , certain ddrug2 , DB00908 , ddrug4 , ddrug5 , ddrug6 , and ddrug7 .",
        "label": "int"
    },
    {
        "text": "HD00026 may decrease the effectiveness of oral ddrug1 , certain ddrug2 , ddrug3 , DB00277 , ddrug5 , ddrug6 , and ddrug7 .",
        "label": "int"
    },
    {
        "text": "HD00026 may decrease the effectiveness of oral ddrug1 , certain ddrug2 , ddrug3 , ddrug4 , HD00175 , ddrug6 , and ddrug7 .",
        "label": "int"
    },
    {
        "text": "HD00026 may decrease the effectiveness of oral ddrug1 , certain ddrug2 , ddrug3 , ddrug4 , ddrug5 , HD00326 , and ddrug7 .",
        "label": "int"
    },
    {
        "text": "HD00026 may decrease the effectiveness of oral ddrug1 , certain ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , and HD00378 .",
        "label": "int"
    },
    {
        "text": "the occurrence of stupor , muscular rigidity , severe agitation , and elevated temperature has been reported in some patients receiving the combination of DB01037 and DB00454 .",
        "label": "effect"
    },
    {
        "text": "this is typical of the interaction of DB00454 and HD00546 .",
        "label": "int"
    },
    {
        "text": "severe toxicity has also been reported in patients receiving the combination of HD00043 and DB01037 and ddrug2 and ddrug3 .",
        "label": "effect"
    },
    {
        "text": "severe toxicity has also been reported in patients receiving the combination of HD00043 and ddrug1 and HD00113 and ddrug3 .",
        "label": "NA"
    },
    {
        "text": "severe toxicity has also been reported in patients receiving the combination of HD00043 and ddrug1 and ddrug2 and DB01037 .",
        "label": "NA"
    },
    {
        "text": "one case of hypertensive crisis has been reported in a patient taking the recommended doses of DB01037 and a HD01017 { ddrug2 } .",
        "label": "effect"
    },
    {
        "text": "one case of hypertensive crisis has been reported in a patient taking the recommended doses of DB01037 and a ddrug1 { DB01364 } .",
        "label": "effect"
    },
    {
        "text": "ddrug0 : there was a slight increase in the area under the curve { auc , 11 % } and mean peak drug concentration { cmax , 18 % } of DB00390 with the co-administration of # mg DB01261 for # days .",
        "label": "mechanism"
    },
    {
        "text": "no dosage adjustment of DB00390 or DB01261 is recommended .",
        "label": "NA"
    },
    {
        "text": "DB00368 and DB00841 are incompatible with ddrug2 solution .",
        "label": "NA"
    },
    {
        "text": "DB00368 and ddrug1 are incompatible with DB01390 solution .",
        "label": "int"
    },
    {
        "text": "ddrug0 and DB00841 are incompatible with DB01390 solution .",
        "label": "int"
    },
    {
        "text": "the addition of DB01390 to parenteral solutions containing DB01373 should be avoided , except where compatibility has been previously established .",
        "label": "NA"
    },
    {
        "text": "do not exceed a # mg daily dose of DB01591 when administered with therapeutic doses of DB01026 or other potent cyp3a4 inhibitors .",
        "label": "advise"
    },
    {
        "text": "patients with congenital or acquired qt prolongation in a study of the effect of DB01591 on the qt interval in # healthy women , the qt prolonging effect appeared less with ddrug1 # mg than with # mg { three times the maximum recommended dose } , and the effect of ddrug2 # mg did not appear as large as that of the positive control DB00218 at its therapeutic dose .",
        "label": "NA"
    },
    {
        "text": "patients with congenital or acquired qt prolongation in a study of the effect of ddrug0 on the qt interval in # healthy women , the qt prolonging effect appeared less with DB01591 # mg than with # mg { three times the maximum recommended dose } , and the effect of ddrug2 # mg did not appear as large as that of the positive control DB00218 at its therapeutic dose .",
        "label": "NA"
    },
    {
        "text": "patients with congenital or acquired qt prolongation in a study of the effect of ddrug0 on the qt interval in # healthy women , the qt prolonging effect appeared less with ddrug1 # mg than with # mg { three times the maximum recommended dose } , and the effect of DB01591 # mg did not appear as large as that of the positive control DB00218 at its therapeutic dose .",
        "label": "NA"
    },
    {
        "text": "limited published data indicate that HD01018 treatment increases cytochrome cyp2b6 { cp450 } mediated DB01435 clearance in man .",
        "label": "mechanism"
    },
    {
        "text": "these data suggest that HD01018 administration may alter the clearance of compounds known to be metabolized by cp450 liver enzymes { e , g , , HD00175 , ddrug2 , ddrug3 , ddrug4 } .",
        "label": "mechanism"
    },
    {
        "text": "these data suggest that HD01018 administration may alter the clearance of compounds known to be metabolized by cp450 liver enzymes { e , g , , ddrug1 , HD00578 , ddrug3 , ddrug4 } .",
        "label": "mechanism"
    },
    {
        "text": "these data suggest that HD01018 administration may alter the clearance of compounds known to be metabolized by cp450 liver enzymes { e , g , , ddrug1 , ddrug2 , HD00282 , ddrug4 } .",
        "label": "mechanism"
    },
    {
        "text": "these data suggest that HD01018 administration may alter the clearance of compounds known to be metabolized by cp450 liver enzymes { e , g , , ddrug1 , ddrug2 , ddrug3 , DB00091 } .",
        "label": "mechanism"
    },
    {
        "text": "caution is recommended when administering DB00398 with compounds that are metabolized/eliminated predominantly by the ugt1a1 pathway { e , g , DB00762 } .",
        "label": "advise"
    },
    {
        "text": "concomitant treatment with DB00398 resulted in a 21 % increase in the auc of DB00997 .",
        "label": "mechanism"
    },
    {
        "text": "caution is recommended when administering DB00997 with DB00398 .",
        "label": "advise"
    },
    {
        "text": "DB00495 competitively inhibits the intracellular phosphorylation of DB00649 .",
        "label": "effect"
    },
    {
        "text": "therefore , use of DB00495 in combination with DB00649 should be avoided .",
        "label": "advise"
    },
    {
        "text": "in vitro data indicate that the phosphorylation of DB00649 is also inhibited at relevant concentrations by DB00997 and ddrug2 .",
        "label": "effect"
    },
    {
        "text": "in vitro data indicate that the phosphorylation of DB00649 is also inhibited at relevant concentrations by ddrug1 and DB00811 .",
        "label": "effect"
    },
    {
        "text": "in vitro data indicate that the phosphorylation of ddrug0 is also inhibited at relevant concentrations by DB00997 and DB00811 .",
        "label": "NA"
    },
    {
        "text": "the interaction of DB00086 , DB00086 , with other drugs has not been well studied .",
        "label": "NA"
    },
    {
        "text": "use of HD00326 and HD00363 -- ddrug2 , ddrug3 , alone or in combination with ddrug4 and ddrug5 , may cause bleeding complications .",
        "label": "NA"
    },
    {
        "text": "use of HD00326 and ddrug1 -- DB00086 , ddrug3 , alone or in combination with ddrug4 and ddrug5 , may cause bleeding complications .",
        "label": "NA"
    },
    {
        "text": "use of HD00326 and ddrug1 -- ddrug2 , DB00086 , alone or in combination with ddrug4 and ddrug5 , may cause bleeding complications .",
        "label": "NA"
    },
    {
        "text": "use of HD00326 and ddrug1 -- ddrug2 , ddrug3 , alone or in combination with HD00363 and ddrug5 , may cause bleeding complications .",
        "label": "NA"
    },
    {
        "text": "use of ddrug0 and HD00363 -- DB00086 , ddrug3 , alone or in combination with ddrug4 and ddrug5 , may cause bleeding complications .",
        "label": "NA"
    },
    {
        "text": "use of ddrug0 and HD00363 -- ddrug2 , DB00086 , alone or in combination with ddrug4 and ddrug5 , may cause bleeding complications .",
        "label": "NA"
    },
    {
        "text": "use of ddrug0 and HD00363 -- ddrug2 , ddrug3 , alone or in combination with ddrug4 and HD00326 , may cause bleeding complications .",
        "label": "NA"
    },
    {
        "text": "use of ddrug0 and ddrug1 -- DB00086 , DB00086 , alone or in combination with ddrug4 and ddrug5 , may cause bleeding complications .",
        "label": "NA"
    },
    {
        "text": "use of ddrug0 and ddrug1 -- DB00086 , ddrug3 , alone or in combination with HD00363 and ddrug5 , may cause bleeding complications .",
        "label": "effect"
    },
    {
        "text": "use of ddrug0 and ddrug1 -- DB00086 , ddrug3 , alone or in combination with ddrug4 and HD00326 , may cause bleeding complications .",
        "label": "effect"
    },
    {
        "text": "use of ddrug0 and ddrug1 -- ddrug2 , DB00086 , alone or in combination with HD00363 and ddrug5 , may cause bleeding complications .",
        "label": "effect"
    },
    {
        "text": "use of ddrug0 and ddrug1 -- ddrug2 , DB00086 , alone or in combination with ddrug4 and HD00326 , may cause bleeding complications .",
        "label": "effect"
    },
    {
        "text": "use of ddrug0 and ddrug1 -- ddrug2 , ddrug3 , alone or in combination with HD00363 and HD00326 , may cause bleeding complications .",
        "label": "NA"
    },
    {
        "text": "in the treatment of acute mi , DB00945 , when not otherwise contraindicated , should be administered with DB00086 { see below } .",
        "label": "NA"
    },
    {
        "text": "anticoagulation and HD01019 after treatment for myocardial infarction -- in the treatment of acute myocardial infarction , the use of DB00945 has been shown to reduce the incidence of reinfarction and stroke .",
        "label": "NA"
    },
    {
        "text": "the addition of DB00945 to DB00086 causes a minimal increase in the risk of minor bleeding { # % vs , # % } , but does not appear to increase the incidence of major bleeding { see",
        "label": "effect"
    },
    {
        "text": "DB00428 has been reported to prolong the elimination half-life of DB00997 and may lead to severe bone marrow suppression ;",
        "label": "mechanism"
    },
    {
        "text": "a reduction of the DB00997 dosage should be considered in patients receiving DB00428 concurrently .",
        "label": "advise"
    },
    {
        "text": "the concurrent use of DB00428 and DB00252 has been reported in one case to result in reduced ddrug2 cytotoxicity .",
        "label": "effect"
    },
    {
        "text": "the concurrent use of ddrug0 and DB00252 has been reported in one case to result in reduced DB00428 cytotoxicity .",
        "label": "NA"
    },
    {
        "text": "DB00566 is not known to interact with other drugs including DB01592 supplements ;",
        "label": "NA"
    },
    {
        "text": "concomitant administration of DB00566 with other chelation therapy , such as HD01020 is not recommended .",
        "label": "advise"
    },
    {
        "text": "DB00576 may increase the effects of HD00026 , ddrug2 , and ddrug3 .",
        "label": "effect"
    },
    {
        "text": "DB00576 may increase the effects of ddrug1 , DB01124 , and ddrug3 .",
        "label": "effect"
    },
    {
        "text": "DB00576 may increase the effects of ddrug1 , ddrug2 , and HD01021 .",
        "label": "effect"
    },
    {
        "text": "it may also interact with HD00217 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of DB00563 } , ddrug6 { decreased hepatic clearance of ddrug7 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with HD00217 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of ddrug5 } , ddrug6 { decreased hepatic clearance of DB00252 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , DB00091 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of DB00563 } , ddrug6 { decreased hepatic clearance of ddrug7 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , DB00091 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of ddrug5 } , DB00252 { decreased hepatic clearance of ddrug7 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , DB00091 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of ddrug5 } , ddrug6 { decreased hepatic clearance of DB00252 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , HD01022 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of DB00563 } , ddrug6 { decreased hepatic clearance of ddrug7 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , HD01022 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of ddrug5 } , DB00252 { decreased hepatic clearance of ddrug7 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , HD01022 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of ddrug5 } , ddrug6 { decreased hepatic clearance of DB00252 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , DB00682 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of DB00563 } , ddrug6 { decreased hepatic clearance of ddrug7 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , DB00682 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of ddrug5 } , DB00252 { decreased hepatic clearance of ddrug7 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , DB00682 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of ddrug5 } , ddrug6 { decreased hepatic clearance of DB00252 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , DB00563 { decreased renal excretion of ddrug5 } , DB00252 { decreased hepatic clearance of ddrug7 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , DB00563 { decreased renal excretion of ddrug5 } , ddrug6 { decreased hepatic clearance of DB00252 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of DB00563 } , DB00252 { decreased hepatic clearance of ddrug7 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of DB00563 } , ddrug6 { decreased hepatic clearance of DB00252 } .",
        "label": "NA"
    },
    {
        "text": "in elderly patients concurrently receiving certain HD00218 , primarily HD00217 , an increased incidence of thrombopenia with purpura has been reported .",
        "label": "NA"
    },
    {
        "text": "it has been reported that DB01015 may prolong the prothrombin time in patients who are receiving the HD00025 ddrug2 .",
        "label": "NA"
    },
    {
        "text": "it has been reported that DB01015 may prolong the prothrombin time in patients who are receiving the ddrug1 DB00682 .",
        "label": "effect"
    },
    {
        "text": "it has been reported that ddrug0 may prolong the prothrombin time in patients who are receiving the HD00025 DB00682 .",
        "label": "NA"
    },
    {
        "text": "DB01015 may inhibit the hepatic metabolism of DB00252 .",
        "label": "mechanism"
    },
    {
        "text": "at a # - g dose , DB01015 produced a slight but significant increase in the half-life of DB00252 but did not produce a corresponding decrease in the metabolic clearance rate .",
        "label": "mechanism"
    },
    {
        "text": "HD00297 can also displace DB00563 from plasma protein-binding sites , thus increasing free ddrug2 concentrations .",
        "label": "mechanism"
    },
    {
        "text": "HD00297 can also displace ddrug1 from plasma protein-binding sites , thus increasing free DB00563 concentrations .",
        "label": "NA"
    },
    {
        "text": "reduced absorption of DB00158 and DB00390 have been reported when those agents were administered concomitantly with ddrug2 .",
        "label": "NA"
    },
    {
        "text": "reduced absorption of DB00158 and ddrug1 have been reported when those agents were administered concomitantly with DB00795 .",
        "label": "mechanism"
    },
    {
        "text": "reduced absorption of ddrug0 and DB00390 have been reported when those agents were administered concomitantly with DB00795 .",
        "label": "mechanism"
    },
    {
        "text": "when daily doses of DB00795 # g and weekly doses of DB00563 # mg were coadministered to # rheumatoid_arthritis patients in a drug-drug interaction study , the pharmacokinetic disposition of the drugs was not altered .",
        "label": "NA"
    },
    {
        "text": "daily doses of DB00795 # g { maximum # g } and weekly doses of DB00563 # mg { maximum # mg } were administered alone or in combination to # rheumatoid_arthritis patients in two controlled 52-week clinical studies .",
        "label": "NA"
    },
    {
        "text": "DB01145 may increase the effects of HD00026 , ddrug2 , and ddrug3 .",
        "label": "effect"
    },
    {
        "text": "DB01145 may increase the effects of ddrug1 , DB01124 , and ddrug3 .",
        "label": "effect"
    },
    {
        "text": "DB01145 may increase the effects of ddrug1 , ddrug2 , and HD01021 .",
        "label": "effect"
    },
    {
        "text": "it may also interact with HD00217 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of DB00563 } , ddrug6 { decreased hepatic clearance of ddrug7 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with HD00217 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of ddrug5 } , ddrug6 { decreased hepatic clearance of DB00252 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , DB00091 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of DB00563 } , ddrug6 { decreased hepatic clearance of ddrug7 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , DB00091 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of ddrug5 } , DB00252 { decreased hepatic clearance of ddrug7 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , DB00091 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of ddrug5 } , ddrug6 { decreased hepatic clearance of DB00252 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , HD01022 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of DB00563 } , ddrug6 { decreased hepatic clearance of ddrug7 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , HD01022 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of ddrug5 } , DB00252 { decreased hepatic clearance of ddrug7 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , HD01022 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of ddrug5 } , ddrug6 { decreased hepatic clearance of DB00252 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , DB00682 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of DB00563 } , ddrug6 { decreased hepatic clearance of ddrug7 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , DB00682 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of ddrug5 } , DB00252 { decreased hepatic clearance of ddrug7 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , DB00682 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of ddrug5 } , ddrug6 { decreased hepatic clearance of DB00252 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , DB00563 { decreased renal excretion of ddrug5 } , DB00252 { decreased hepatic clearance of ddrug7 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , DB00563 { decreased renal excretion of ddrug5 } , ddrug6 { decreased hepatic clearance of DB00252 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of DB00563 } , DB00252 { decreased hepatic clearance of ddrug7 } .",
        "label": "NA"
    },
    {
        "text": "it may also interact with ddrug0 { increased thrombocytopenia } , ddrug1 { increased nephrotoxicity } , ddrug2 { increased hypoglycemic response } , ddrug3 { increased anticoagulant effect } , ddrug4 { decreased renal excretion of DB00563 } , ddrug6 { decreased hepatic clearance of DB00252 } .",
        "label": "NA"
    },
    {
        "text": "because there is a theoretical basis that these effects may be additive , use of DB00201 - containing or HD00274 { like ddrug2 or ddrug3 } and ddrug4 within # hours of each other should be avoided .",
        "label": "NA"
    },
    {
        "text": "because there is a theoretical basis that these effects may be additive , use of DB00201 - containing or ddrug1 { like ddrug2 or DB00247 } and ddrug4 within # hours of each other should be avoided .",
        "label": "NA"
    },
    {
        "text": "because there is a theoretical basis that these effects may be additive , use of DB00201 - containing or ddrug1 { like ddrug2 or ddrug3 } and DB00669 within # hours of each other should be avoided .",
        "label": "advise"
    },
    {
        "text": "because there is a theoretical basis that these effects may be additive , use of ddrug0 - containing or HD00274 { like ddrug2 or ddrug3 } and DB00669 within # hours of each other should be avoided .",
        "label": "advise"
    },
    {
        "text": "because there is a theoretical basis that these effects may be additive , use of ddrug0 - containing or ddrug1 { like DB00320 or ddrug3 } and DB00669 within # hours of each other should be avoided .",
        "label": "advise"
    },
    {
        "text": "because there is a theoretical basis that these effects may be additive , use of ddrug0 - containing or ddrug1 { like ddrug2 or DB00247 } and DB00669 within # hours of each other should be avoided .",
        "label": "advise"
    },
    {
        "text": "HD01023 reduce DB00669 clearance , significantly increasing systemic exposure .",
        "label": "mechanism"
    },
    {
        "text": "therefore , the use of DB00669 tablets in patients receiving HD01023 is contraindicated , ddrug2 { ddrug3 } { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with ddrug8 .",
        "label": "advise"
    },
    {
        "text": "therefore , the use of DB00669 tablets in patients receiving ddrug1 is contraindicated , HD00113 { ddrug3 } { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with ddrug8 .",
        "label": "NA"
    },
    {
        "text": "therefore , the use of DB00669 tablets in patients receiving ddrug1 is contraindicated , ddrug2 { HD00114 } { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with ddrug8 .",
        "label": "NA"
    },
    {
        "text": "therefore , the use of DB00669 tablets in patients receiving ddrug1 is contraindicated , ddrug2 { ddrug3 } { e , g , , DB00472 , ddrug5 , ddrug6 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with ddrug8 .",
        "label": "NA"
    },
    {
        "text": "therefore , the use of DB00669 tablets in patients receiving ddrug1 is contraindicated , ddrug2 { ddrug3 } { e , g , , ddrug4 , DB00176 , ddrug6 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with ddrug8 .",
        "label": "NA"
    },
    {
        "text": "therefore , the use of DB00669 tablets in patients receiving ddrug1 is contraindicated , ddrug2 { ddrug3 } { e , g , , ddrug4 , ddrug5 , DB00715 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with ddrug8 .",
        "label": "NA"
    },
    {
        "text": "therefore , the use of DB00669 tablets in patients receiving ddrug1 is contraindicated , ddrug2 { ddrug3 } { e , g , , ddrug4 , ddrug5 , ddrug6 , DB01104 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with ddrug8 .",
        "label": "NA"
    },
    {
        "text": "therefore , the use of ddrug0 tablets in patients receiving HD01023 is contraindicated , HD00113 { ddrug3 } { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with ddrug8 .",
        "label": "NA"
    },
    {
        "text": "therefore , the use of ddrug0 tablets in patients receiving HD01023 is contraindicated , ddrug2 { HD00114 } { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with ddrug8 .",
        "label": "NA"
    },
    {
        "text": "therefore , the use of ddrug0 tablets in patients receiving HD01023 is contraindicated , ddrug2 { ddrug3 } { e , g , , DB00472 , ddrug5 , ddrug6 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with ddrug8 .",
        "label": "NA"
    },
    {
        "text": "therefore , the use of ddrug0 tablets in patients receiving HD01023 is contraindicated , ddrug2 { ddrug3 } { e , g , , ddrug4 , DB00176 , ddrug6 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with ddrug8 .",
        "label": "NA"
    },
    {
        "text": "therefore , the use of ddrug0 tablets in patients receiving HD01023 is contraindicated , ddrug2 { ddrug3 } { e , g , , ddrug4 , ddrug5 , DB00715 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with ddrug8 .",
        "label": "NA"
    },
    {
        "text": "therefore , the use of ddrug0 tablets in patients receiving HD01023 is contraindicated , ddrug2 { ddrug3 } { e , g , , ddrug4 , ddrug5 , ddrug6 , DB01104 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with ddrug8 .",
        "label": "NA"
    },
    {
        "text": "therefore , the use of ddrug0 tablets in patients receiving HD01023 is contraindicated , ddrug2 { ddrug3 } { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DB00669 .",
        "label": "NA"
    },
    {
        "text": "therefore , the use of ddrug0 tablets in patients receiving ddrug1 is contraindicated , HD00113 { ddrug3 } { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DB00669 .",
        "label": "effect"
    },
    {
        "text": "therefore , the use of ddrug0 tablets in patients receiving ddrug1 is contraindicated , ddrug2 { HD00114 } { e , g , , ddrug4 , ddrug5 , ddrug6 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DB00669 .",
        "label": "effect"
    },
    {
        "text": "therefore , the use of ddrug0 tablets in patients receiving ddrug1 is contraindicated , ddrug2 { ddrug3 } { e , g , , DB00472 , ddrug5 , ddrug6 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DB00669 .",
        "label": "effect"
    },
    {
        "text": "therefore , the use of ddrug0 tablets in patients receiving ddrug1 is contraindicated , ddrug2 { ddrug3 } { e , g , , ddrug4 , DB00176 , ddrug6 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DB00669 .",
        "label": "effect"
    },
    {
        "text": "therefore , the use of ddrug0 tablets in patients receiving ddrug1 is contraindicated , ddrug2 { ddrug3 } { e , g , , ddrug4 , ddrug5 , DB00715 , ddrug7 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DB00669 .",
        "label": "effect"
    },
    {
        "text": "therefore , the use of ddrug0 tablets in patients receiving ddrug1 is contraindicated , ddrug2 { ddrug3 } { e , g , , ddrug4 , ddrug5 , ddrug6 , DB01104 } have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DB00669 .",
        "label": "effect"
    },
    {
        "text": "if concomitant treatment with DB00669 and an HD00278 is clinically warranted , appropriate observation of the patient is advised .",
        "label": "advise"
    },
    {
        "text": "co-administration of DB01268 with strong inhibitors of the cyp3a4 family { e , g , , DB01026 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases ddrug12 concentrations .",
        "label": "mechanism"
    },
    {
        "text": "co-administration of DB01268 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , DB01167 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases ddrug12 concentrations .",
        "label": "mechanism"
    },
    {
        "text": "co-administration of DB01268 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , DB01211 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases ddrug12 concentrations .",
        "label": "mechanism"
    },
    {
        "text": "co-administration of DB01268 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , DB01072 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases ddrug12 concentrations .",
        "label": "mechanism"
    },
    {
        "text": "co-administration of DB01268 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00224 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases ddrug12 concentrations .",
        "label": "mechanism"
    },
    {
        "text": "co-administration of DB01268 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB01149 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases ddrug12 concentrations .",
        "label": "mechanism"
    },
    {
        "text": "co-administration of DB01268 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , DB00220 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases ddrug12 concentrations .",
        "label": "mechanism"
    },
    {
        "text": "co-administration of DB01268 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , DB00503 , ddrug9 , ddrug10 , ddrug11 } may increases ddrug12 concentrations .",
        "label": "mechanism"
    },
    {
        "text": "co-administration of DB01268 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , DB01232 , ddrug10 , ddrug11 } may increases ddrug12 concentrations .",
        "label": "mechanism"
    },
    {
        "text": "co-administration of DB01268 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , DB00976 , ddrug11 } may increases ddrug12 concentrations .",
        "label": "mechanism"
    },
    {
        "text": "co-administration of DB01268 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , HD01024 } may increases ddrug12 concentrations .",
        "label": "mechanism"
    },
    {
        "text": "co-administration of DB01268 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases DB01268 concentrations .",
        "label": "NA"
    },
    {
        "text": "co-administration of ddrug0 with strong inhibitors of the cyp3a4 family { e , g , , DB01026 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases DB01268 concentrations .",
        "label": "NA"
    },
    {
        "text": "co-administration of ddrug0 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , DB01167 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases DB01268 concentrations .",
        "label": "NA"
    },
    {
        "text": "co-administration of ddrug0 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , DB01211 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases DB01268 concentrations .",
        "label": "NA"
    },
    {
        "text": "co-administration of ddrug0 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , DB01072 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases DB01268 concentrations .",
        "label": "NA"
    },
    {
        "text": "co-administration of ddrug0 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00224 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases DB01268 concentrations .",
        "label": "NA"
    },
    {
        "text": "co-administration of ddrug0 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB01149 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases DB01268 concentrations .",
        "label": "NA"
    },
    {
        "text": "co-administration of ddrug0 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , DB00220 , ddrug8 , ddrug9 , ddrug10 , ddrug11 } may increases DB01268 concentrations .",
        "label": "NA"
    },
    {
        "text": "co-administration of ddrug0 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , DB00503 , ddrug9 , ddrug10 , ddrug11 } may increases DB01268 concentrations .",
        "label": "NA"
    },
    {
        "text": "co-administration of ddrug0 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , DB01232 , ddrug10 , ddrug11 } may increases DB01268 concentrations .",
        "label": "NA"
    },
    {
        "text": "co-administration of ddrug0 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , DB00976 , ddrug11 } may increases DB01268 concentrations .",
        "label": "NA"
    },
    {
        "text": "co-administration of ddrug0 with strong inhibitors of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , ddrug10 , HD01024 } may increases DB01268 concentrations .",
        "label": "NA"
    },
    {
        "text": "co-administration of DB01268 with inducers of the cyp3a4 family { e , g , , DB01234 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , st , johns wort } may decrease ddrug8 concentrations .",
        "label": "mechanism"
    },
    {
        "text": "co-administration of DB01268 with inducers of the cyp3a4 family { e , g , , ddrug1 , DB00252 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , st , johns wort } may decrease ddrug8 concentrations .",
        "label": "mechanism"
    },
    {
        "text": "co-administration of DB01268 with inducers of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , DB00564 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , st , johns wort } may decrease ddrug8 concentrations .",
        "label": "mechanism"
    },
    {
        "text": "co-administration of DB01268 with inducers of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , DB01045 , ddrug5 , ddrug6 , ddrug7 , st , johns wort } may decrease ddrug8 concentrations .",
        "label": "mechanism"
    },
    {
        "text": "co-administration of DB01268 with inducers of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00615 , ddrug6 , ddrug7 , st , johns wort } may decrease ddrug8 concentrations .",
        "label": "mechanism"
    },
    {
        "text": "co-administration of DB01268 with inducers of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB01201 , ddrug7 , st , johns wort } may decrease ddrug8 concentrations .",
        "label": "mechanism"
    },
    {
        "text": "co-administration of DB01268 with inducers of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , DB01174 , st , johns wort } may decrease ddrug8 concentrations .",
        "label": "mechanism"
    },
    {
        "text": "co-administration of DB01268 with inducers of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , st , johns wort } may decrease DB01268 concentrations .",
        "label": "NA"
    },
    {
        "text": "co-administration of ddrug0 with inducers of the cyp3a4 family { e , g , , DB01234 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , st , johns wort } may decrease DB01268 concentrations .",
        "label": "NA"
    },
    {
        "text": "co-administration of ddrug0 with inducers of the cyp3a4 family { e , g , , ddrug1 , DB00252 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , st , johns wort } may decrease DB01268 concentrations .",
        "label": "NA"
    },
    {
        "text": "co-administration of ddrug0 with inducers of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , DB00564 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , st , johns wort } may decrease DB01268 concentrations .",
        "label": "NA"
    },
    {
        "text": "co-administration of ddrug0 with inducers of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , DB01045 , ddrug5 , ddrug6 , ddrug7 , st , johns wort } may decrease DB01268 concentrations .",
        "label": "NA"
    },
    {
        "text": "co-administration of ddrug0 with inducers of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , DB00615 , ddrug6 , ddrug7 , st , johns wort } may decrease DB01268 concentrations .",
        "label": "NA"
    },
    {
        "text": "co-administration of ddrug0 with inducers of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB01201 , ddrug7 , st , johns wort } may decrease DB01268 concentrations .",
        "label": "NA"
    },
    {
        "text": "co-administration of ddrug0 with inducers of the cyp3a4 family { e , g , , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , DB01174 , st , johns wort } may decrease DB01268 concentrations .",
        "label": "NA"
    },
    {
        "text": "other eye drops or medications such as HD01025 { ddrug1 } and DB00411 { ddrug3 , ddrug4 } may decrease the effects of ddrug5 ophthalmic .",
        "label": "NA"
    },
    {
        "text": "other eye drops or medications such as HD01025 { ddrug1 } and ddrug2 { HD01026 , ddrug4 } may decrease the effects of ddrug5 ophthalmic .",
        "label": "NA"
    },
    {
        "text": "other eye drops or medications such as HD01025 { ddrug1 } and ddrug2 { ddrug3 , DB00411 } may decrease the effects of ddrug5 ophthalmic .",
        "label": "NA"
    },
    {
        "text": "other eye drops or medications such as HD01025 { ddrug1 } and ddrug2 { ddrug3 , ddrug4 } may decrease the effects of DB00870 ophthalmic .",
        "label": "effect"
    },
    {
        "text": "other eye drops or medications such as ddrug0 { HD01027 } and DB00411 { ddrug3 , ddrug4 } may decrease the effects of ddrug5 ophthalmic .",
        "label": "NA"
    },
    {
        "text": "other eye drops or medications such as ddrug0 { HD01027 } and ddrug2 { HD01026 , ddrug4 } may decrease the effects of ddrug5 ophthalmic .",
        "label": "NA"
    },
    {
        "text": "other eye drops or medications such as ddrug0 { HD01027 } and ddrug2 { ddrug3 , DB00411 } may decrease the effects of ddrug5 ophthalmic .",
        "label": "NA"
    },
    {
        "text": "other eye drops or medications such as ddrug0 { HD01027 } and ddrug2 { ddrug3 , ddrug4 } may decrease the effects of DB00870 ophthalmic .",
        "label": "effect"
    },
    {
        "text": "other eye drops or medications such as ddrug0 { ddrug1 } and DB00411 { ddrug3 , ddrug4 } may decrease the effects of DB00870 ophthalmic .",
        "label": "effect"
    },
    {
        "text": "other eye drops or medications such as ddrug0 { ddrug1 } and ddrug2 { HD01026 , ddrug4 } may decrease the effects of DB00870 ophthalmic .",
        "label": "effect"
    },
    {
        "text": "other eye drops or medications such as ddrug0 { ddrug1 } and ddrug2 { ddrug3 , DB00411 } may decrease the effects of DB00870 ophthalmic .",
        "label": "effect"
    },
    {
        "text": "drug-drug interactions : the pharmacokinetic and pharmacodynamic interactions between DB00706 capsules and other HD00647 have not been determined .",
        "label": "NA"
    },
    {
        "text": "however , interactions may be expected and DB00706 capsules should not be used in combination with other HD00647 .",
        "label": "advise"
    },
    {
        "text": "the pharmacokinetic interaction between DB00501 and DB00706 capsules was investigated .",
        "label": "NA"
    },
    {
        "text": "therefore , DB00706 capsules should be used with caution in combination with DB00501 , particularly at doses higher than # mg .",
        "label": "advise"
    },
    {
        "text": "results from limited in vitro and in vivo drug-drug interaction studies between HD01028 and DB00682 are inconclusive .",
        "label": "NA"
    },
    {
        "text": "therefore , caution should be exercised with concomitant administration of DB00682 and DB00706 capsules .",
        "label": "advise"
    },
    {
        "text": "administration of DB00313 decreases oral clearance of DB00853 by about 5 % .",
        "label": "mechanism"
    },
    {
        "text": "patients studied in clinical trials of DB02325 were routinely treated with DB01109 and ddrug2 .",
        "label": "NA"
    },
    {
        "text": "patients studied in clinical trials of DB02325 were routinely treated with ddrug1 and DB00945 .",
        "label": "NA"
    },
    {
        "text": "patients studied in clinical trials of ddrug0 were routinely treated with DB01109 and DB00945 .",
        "label": "NA"
    },
    {
        "text": "HD00326 { such as ddrug1 and ddrug2 } and drugs that alter platelet function { such as DB00945 , ddrug4 , and gp iib/iiia inhibitors } may increase the risk of bleeding if administered prior to , during , or after ddrug5 therapy .",
        "label": "NA"
    },
    {
        "text": "HD00326 { such as ddrug1 and ddrug2 } and drugs that alter platelet function { such as ddrug3 , DB00975 , and gp iib/iiia inhibitors } may increase the risk of bleeding if administered prior to , during , or after ddrug5 therapy .",
        "label": "NA"
    },
    {
        "text": "HD00326 { such as ddrug1 and ddrug2 } and drugs that alter platelet function { such as ddrug3 , ddrug4 , and gp iib/iiia inhibitors } may increase the risk of bleeding if administered prior to , during , or after DB02325 therapy .",
        "label": "effect"
    },
    {
        "text": "ddrug0 { such as DB01109 and ddrug2 } and drugs that alter platelet function { such as DB00945 , ddrug4 , and gp iib/iiia inhibitors } may increase the risk of bleeding if administered prior to , during , or after ddrug5 therapy .",
        "label": "NA"
    },
    {
        "text": "ddrug0 { such as DB01109 and ddrug2 } and drugs that alter platelet function { such as ddrug3 , DB00975 , and gp iib/iiia inhibitors } may increase the risk of bleeding if administered prior to , during , or after ddrug5 therapy .",
        "label": "NA"
    },
    {
        "text": "ddrug0 { such as DB01109 and ddrug2 } and drugs that alter platelet function { such as ddrug3 , ddrug4 , and gp iib/iiia inhibitors } may increase the risk of bleeding if administered prior to , during , or after DB02325 therapy .",
        "label": "effect"
    },
    {
        "text": "ddrug0 { such as ddrug1 and HD00286 } and drugs that alter platelet function { such as DB00945 , ddrug4 , and gp iib/iiia inhibitors } may increase the risk of bleeding if administered prior to , during , or after ddrug5 therapy .",
        "label": "NA"
    },
    {
        "text": "ddrug0 { such as ddrug1 and HD00286 } and drugs that alter platelet function { such as ddrug3 , DB00975 , and gp iib/iiia inhibitors } may increase the risk of bleeding if administered prior to , during , or after ddrug5 therapy .",
        "label": "NA"
    },
    {
        "text": "ddrug0 { such as ddrug1 and HD00286 } and drugs that alter platelet function { such as ddrug3 , ddrug4 , and gp iib/iiia inhibitors } may increase the risk of bleeding if administered prior to , during , or after DB02325 therapy .",
        "label": "effect"
    },
    {
        "text": "ddrug0 { such as ddrug1 and ddrug2 } and drugs that alter platelet function { such as DB00945 , ddrug4 , and gp iib/iiia inhibitors } may increase the risk of bleeding if administered prior to , during , or after DB02325 therapy .",
        "label": "effect"
    },
    {
        "text": "ddrug0 { such as ddrug1 and ddrug2 } and drugs that alter platelet function { such as ddrug3 , DB00975 , and gp iib/iiia inhibitors } may increase the risk of bleeding if administered prior to , during , or after DB02325 therapy .",
        "label": "effect"
    },
    {
        "text": "in a study in which # different drugs were tested , therapeutically relevant concentrations of DB01124 , ddrug1 and ddrug2 displaced protein-bound DB00444 in fresh human serum to a small but significant extent .",
        "label": "mechanism"
    },
    {
        "text": "in a study in which # different drugs were tested , therapeutically relevant concentrations of ddrug0 , HD01029 and ddrug2 displaced protein-bound DB00444 in fresh human serum to a small but significant extent .",
        "label": "mechanism"
    },
    {
        "text": "in a study in which # different drugs were tested , therapeutically relevant concentrations of ddrug0 , ddrug1 and DB00576 displaced protein-bound DB00444 in fresh human serum to a small but significant extent .",
        "label": "mechanism"
    },
    {
        "text": "there was no change in the plasma kinetics of DB00444 when coadministered with DB00563 .",
        "label": "NA"
    },
    {
        "text": "an increase in intracellular levels of DB00563 was observed in vitro in the presence of DB00444 .",
        "label": "mechanism"
    },
    {
        "text": "in vitro studies with human liver microsomes showed that DB00857 does not inhibit the metabolism of DB01124 , ddrug2 , ddrug3 , and ddrug4 .",
        "label": "NA"
    },
    {
        "text": "in vitro studies with human liver microsomes showed that DB00857 does not inhibit the metabolism of ddrug1 , DB00977 , ddrug3 , and ddrug4 .",
        "label": "NA"
    },
    {
        "text": "in vitro studies with human liver microsomes showed that DB00857 does not inhibit the metabolism of ddrug1 , ddrug2 , HD01030 , and ddrug4 .",
        "label": "NA"
    },
    {
        "text": "in vitro studies with human liver microsomes showed that DB00857 does not inhibit the metabolism of ddrug1 , ddrug2 , ddrug3 , and DB00091 .",
        "label": "NA"
    },
    {
        "text": "in vivo drug-drug interaction studies conducted in normal volunteer subjects showed that DB00857 does not affect the clearance of DB01435 or ddrug2 .",
        "label": "NA"
    },
    {
        "text": "in vivo drug-drug interaction studies conducted in normal volunteer subjects showed that DB00857 does not affect the clearance of ddrug1 or DB00390 .",
        "label": "NA"
    },
    {
        "text": "in vivo drug-drug interaction studies conducted in normal volunteer subjects showed that ddrug0 does not affect the clearance of DB01435 or DB00390 .",
        "label": "NA"
    },
    {
        "text": "DB00857 decreases the clearance of DB00201 by 19 % .",
        "label": "mechanism"
    },
    {
        "text": "DB00857 increases the clearance of DB00091 by 15 % .",
        "label": "mechanism"
    },
    {
        "text": "there have been spontaneous reports of increase or decrease in prothrombin times in patients concomitantly taking oral DB00857 and DB00682 , however , a causal relationship between ddrug2 tablets and these changes has not been established .",
        "label": "effect"
    },
    {
        "text": "there have been spontaneous reports of increase or decrease in prothrombin times in patients concomitantly taking oral DB00857 and ddrug1 , however , a causal relationship between DB00857 tablets and these changes has not been established .",
        "label": "NA"
    },
    {
        "text": "there have been spontaneous reports of increase or decrease in prothrombin times in patients concomitantly taking oral ddrug0 and DB00682 , however , a causal relationship between DB00857 tablets and these changes has not been established .",
        "label": "NA"
    },
    {
        "text": "DB00857 clearance is increased 100 % by DB01045 , a cyp450 enzyme inducer , and decreased 33 % by ddrug2 , a cyp450 enzyme inhibitor .",
        "label": "mechanism"
    },
    {
        "text": "DB00857 clearance is increased 100 % by ddrug1 , a cyp450 enzyme inducer , and decreased 33 % by DB00501 , a cyp450 enzyme inhibitor .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 clearance is increased 100 % by DB01045 , a cyp450 enzyme inducer , and decreased 33 % by DB00501 , a cyp450 enzyme inhibitor .",
        "label": "NA"
    },
    {
        "text": "DB00857 clearance is unaffected by DB00091 .",
        "label": "NA"
    },
    {
        "text": "there is no information available from adequate drug-drug interaction studies with the following classes of drugs : oral HD00283 , hormone replacement therapies , HD00484 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 .",
        "label": "NA"
    },
    {
        "text": "there is no information available from adequate drug-drug interaction studies with the following classes of drugs : oral HD00283 , hormone replacement therapies , ddrug1 , HD01031 , ddrug3 , ddrug4 , ddrug5 , and ddrug6 .",
        "label": "NA"
    },
    {
        "text": "there is no information available from adequate drug-drug interaction studies with the following classes of drugs : oral HD00283 , hormone replacement therapies , ddrug1 , ddrug2 , HD01032 , ddrug4 , ddrug5 , and ddrug6 .",
        "label": "NA"
    },
    {
        "text": "there is no information available from adequate drug-drug interaction studies with the following classes of drugs : oral HD00283 , hormone replacement therapies , ddrug1 , ddrug2 , ddrug3 , HD00029 , ddrug5 , and ddrug6 .",
        "label": "NA"
    },
    {
        "text": "there is no information available from adequate drug-drug interaction studies with the following classes of drugs : oral HD00283 , hormone replacement therapies , ddrug1 , ddrug2 , ddrug3 , ddrug4 , HD00378 , and ddrug6 .",
        "label": "NA"
    },
    {
        "text": "there is no information available from adequate drug-drug interaction studies with the following classes of drugs : oral HD00283 , hormone replacement therapies , ddrug1 , ddrug2 , ddrug3 , ddrug4 , ddrug5 , and HD00377 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : spontaneous adverse reaction reports of patients taking concomitant DB01026 with recommended doses of DB00342 demonstrate qt interval prolongation and rare serious cardiac events , e , g.",
        "label": "effect"
    },
    {
        "text": "pharmacokinetic data indicate that DB01026 markedly inhibits the metabolism of DB00342 , resulting in elevated plasma ddrug2 levels .",
        "label": "mechanism"
    },
    {
        "text": "pharmacokinetic data indicate that DB01026 markedly inhibits the metabolism of ddrug1 , resulting in elevated plasma DB00342 levels .",
        "label": "NA"
    },
    {
        "text": "concomitant administration of DB01026 and DB00342 is contraindicated .",
        "label": "advise"
    },
    {
        "text": "ddrug0 : torsades de pointes and elevated parent DB00342 levels have been reported during concomitant use of ddrug2 and DB01167 in clinical trials of ddrug4 and from foreign post-marketing sources .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : torsades de pointes and elevated parent DB00342 levels have been reported during concomitant use of ddrug2 and ddrug3 in clinical trials of DB01167 and from foreign post-marketing sources .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : torsades de pointes and elevated parent ddrug1 levels have been reported during concomitant use of DB00342 and DB01167 in clinical trials of ddrug4 and from foreign post-marketing sources .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 : torsades de pointes and elevated parent ddrug1 levels have been reported during concomitant use of DB00342 and ddrug3 in clinical trials of DB01167 and from foreign post-marketing sources .",
        "label": "NA"
    },
    {
        "text": "concomitant administration of DB01167 and DB00342 is contraindicated .",
        "label": "advise"
    },
    {
        "text": "due to the chemical similarity of other HD01033 { including ddrug1 , ddrug2 , and ddrug3 } to DB01026 , and ddrug5 , concomitant use of these products with ddrug6 is not recommended pending full examination of potential interactions .",
        "label": "NA"
    },
    {
        "text": "due to the chemical similarity of other HD01033 { including ddrug1 , ddrug2 , and ddrug3 } to ddrug4 , and DB01167 , concomitant use of these products with ddrug6 is not recommended pending full examination of potential interactions .",
        "label": "NA"
    },
    {
        "text": "due to the chemical similarity of other HD01033 { including ddrug1 , ddrug2 , and ddrug3 } to ddrug4 , and ddrug5 , concomitant use of these products with DB00342 is not recommended pending full examination of potential interactions .",
        "label": "advise"
    },
    {
        "text": "due to the chemical similarity of other ddrug0 { including DB00196 , ddrug2 , and ddrug3 } to DB01026 , and ddrug5 , concomitant use of these products with ddrug6 is not recommended pending full examination of potential interactions .",
        "label": "NA"
    },
    {
        "text": "due to the chemical similarity of other ddrug0 { including DB00196 , ddrug2 , and ddrug3 } to ddrug4 , and DB01167 , concomitant use of these products with ddrug6 is not recommended pending full examination of potential interactions .",
        "label": "NA"
    },
    {
        "text": "due to the chemical similarity of other ddrug0 { including DB00196 , ddrug2 , and ddrug3 } to ddrug4 , and ddrug5 , concomitant use of these products with DB00342 is not recommended pending full examination of potential interactions .",
        "label": "advise"
    },
    {
        "text": "due to the chemical similarity of other ddrug0 { including ddrug1 , DB00916 , and ddrug3 } to DB01026 , and ddrug5 , concomitant use of these products with ddrug6 is not recommended pending full examination of potential interactions .",
        "label": "NA"
    },
    {
        "text": "due to the chemical similarity of other ddrug0 { including ddrug1 , DB00916 , and ddrug3 } to ddrug4 , and DB01167 , concomitant use of these products with ddrug6 is not recommended pending full examination of potential interactions .",
        "label": "NA"
    },
    {
        "text": "due to the chemical similarity of other ddrug0 { including ddrug1 , DB00916 , and ddrug3 } to ddrug4 , and ddrug5 , concomitant use of these products with DB00342 is not recommended pending full examination of potential interactions .",
        "label": "advise"
    },
    {
        "text": "due to the chemical similarity of other ddrug0 { including ddrug1 , ddrug2 , and DB01110 } to DB01026 , and ddrug5 , concomitant use of these products with ddrug6 is not recommended pending full examination of potential interactions .",
        "label": "NA"
    },
    {
        "text": "due to the chemical similarity of other ddrug0 { including ddrug1 , ddrug2 , and DB01110 } to ddrug4 , and DB01167 , concomitant use of these products with ddrug6 is not recommended pending full examination of potential interactions .",
        "label": "NA"
    },
    {
        "text": "due to the chemical similarity of other ddrug0 { including ddrug1 , ddrug2 , and DB01110 } to ddrug4 , and ddrug5 , concomitant use of these products with DB00342 is not recommended pending full examination of potential interactions .",
        "label": "advise"
    },
    {
        "text": "due to the chemical similarity of other ddrug0 { including ddrug1 , ddrug2 , and ddrug3 } to DB01026 , and DB01167 , concomitant use of these products with ddrug6 is not recommended pending full examination of potential interactions .",
        "label": "NA"
    },
    {
        "text": "due to the chemical similarity of other ddrug0 { including ddrug1 , ddrug2 , and ddrug3 } to DB01026 , and ddrug5 , concomitant use of these products with DB00342 is not recommended pending full examination of potential interactions .",
        "label": "NA"
    },
    {
        "text": "due to the chemical similarity of other ddrug0 { including ddrug1 , ddrug2 , and ddrug3 } to ddrug4 , and DB01167 , concomitant use of these products with DB00342 is not recommended pending full examination of potential interactions .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : clinical drug interaction studies indicate that DB00199 and DB01211 can exert an effect on ddrug3 metabolism by a mechanism which may be similar to that of ddrug4 , but to a lesser extent .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : clinical drug interaction studies indicate that DB00199 and ddrug2 can exert an effect on DB00342 metabolism by a mechanism which may be similar to that of ddrug4 , but to a lesser extent .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 : clinical drug interaction studies indicate that DB00199 and ddrug2 can exert an effect on ddrug3 metabolism by a mechanism which may be similar to that of DB01026 , but to a lesser extent .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : clinical drug interaction studies indicate that ddrug1 and DB01211 can exert an effect on DB00342 metabolism by a mechanism which may be similar to that of ddrug4 , but to a lesser extent .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 : clinical drug interaction studies indicate that ddrug1 and DB01211 can exert an effect on ddrug3 metabolism by a mechanism which may be similar to that of DB01026 , but to a lesser extent .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : clinical drug interaction studies indicate that ddrug1 and ddrug2 can exert an effect on DB00342 metabolism by a mechanism which may be similar to that of DB01026 , but to a lesser extent .",
        "label": "NA"
    },
    {
        "text": "a few spontaneous accounts of qt interval prolongation with ventricular arrhythmia including torsades de pointes , have been reported in patients receiving DB00199 or DB13179 .",
        "label": "NA"
    },
    {
        "text": "concomitant administration of DB00342 with DB01211 , ddrug2 , or ddrug3 is contraindicated : pending full characterization of potential interactions , concomitant administration of ddrug4 with other ddrug5 , including ddrug6 , is not recommended .",
        "label": "advise"
    },
    {
        "text": "concomitant administration of DB00342 with ddrug1 , DB00199 , or ddrug3 is contraindicated : pending full characterization of potential interactions , concomitant administration of ddrug4 with other ddrug5 , including ddrug6 , is not recommended .",
        "label": "advise"
    },
    {
        "text": "concomitant administration of DB00342 with ddrug1 , ddrug2 , or DB13179 is contraindicated : pending full characterization of potential interactions , concomitant administration of ddrug4 with other ddrug5 , including ddrug6 , is not recommended .",
        "label": "advise"
    },
    {
        "text": "concomitant administration of ddrug0 with ddrug1 , ddrug2 , or ddrug3 is contraindicated : pending full characterization of potential interactions , concomitant administration of DB00342 with other HD00093 , including ddrug6 , is not recommended .",
        "label": "advise"
    },
    {
        "text": "concomitant administration of ddrug0 with ddrug1 , ddrug2 , or ddrug3 is contraindicated : pending full characterization of potential interactions , concomitant administration of DB00342 with other ddrug5 , including DB00207 , is not recommended .",
        "label": "advise"
    },
    {
        "text": "concomitant administration of ddrug0 with ddrug1 , ddrug2 , or ddrug3 is contraindicated : pending full characterization of potential interactions , concomitant administration of ddrug4 with other HD00093 , including DB00207 , is not recommended .",
        "label": "NA"
    },
    {
        "text": "studies to evaluate potential interactions of DB00342 with DB00207 are in progress .",
        "label": "NA"
    },
    {
        "text": "when administered concurrently , DB00894 may increase the effects of oral HD00326 ;",
        "label": "effect"
    },
    {
        "text": "DB01041 has been reported to enhance the sedative activity of HD00026 , ddrug2 , ddrug3 , and ddrug4 .",
        "label": "effect"
    },
    {
        "text": "DB01041 has been reported to enhance the sedative activity of ddrug1 , DB02325 , ddrug3 , and ddrug4 .",
        "label": "NA"
    },
    {
        "text": "DB01041 has been reported to enhance the sedative activity of ddrug1 , ddrug2 , DB00477 , and ddrug4 .",
        "label": "NA"
    },
    {
        "text": "DB01041 has been reported to enhance the sedative activity of ddrug1 , ddrug2 , ddrug3 , and DB00206 .",
        "label": "NA"
    },
    {
        "text": "oral HD00283 : in # healthy women , the pharmacokinetic profiles of DB00717 and ddrug2 following administration of a single dose containing # mg of ddrug3 and # g of ddrug4 were studied .",
        "label": "NA"
    },
    {
        "text": "oral HD00283 : in # healthy women , the pharmacokinetic profiles of ddrug1 and DB00977 following administration of a single dose containing # mg of ddrug3 and # g of ddrug4 were studied .",
        "label": "NA"
    },
    {
        "text": "oral HD00283 : in # healthy women , the pharmacokinetic profiles of ddrug1 and ddrug2 following administration of a single dose containing # mg of DB00717 and # g of ddrug4 were studied .",
        "label": "NA"
    },
    {
        "text": "oral HD00283 : in # healthy women , the pharmacokinetic profiles of ddrug1 and ddrug2 following administration of a single dose containing # mg of ddrug3 and # g of DB00977 were studied .",
        "label": "NA"
    },
    {
        "text": "oral ddrug0 : in # healthy women , the pharmacokinetic profiles of DB00717 and DB00977 following administration of a single dose containing # mg of ddrug3 and # g of ddrug4 were studied .",
        "label": "NA"
    },
    {
        "text": "oral ddrug0 : in # healthy women , the pharmacokinetic profiles of DB00717 and ddrug2 following administration of a single dose containing # mg of ddrug3 and # g of DB00977 were studied .",
        "label": "NA"
    },
    {
        "text": "oral ddrug0 : in # healthy women , the pharmacokinetic profiles of ddrug1 and DB00977 following administration of a single dose containing # mg of DB00717 and # g of ddrug4 were studied .",
        "label": "NA"
    },
    {
        "text": "oral ddrug0 : in # healthy women , the pharmacokinetic profiles of ddrug1 and ddrug2 following administration of a single dose containing # mg of DB00717 and # g of DB00977 were studied .",
        "label": "NA"
    },
    {
        "text": "important non - DB01041 drug interactions drugs that interfere with HD00432 : concomitant use of ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , or certain herbal supplements such as st .",
        "label": "NA"
    },
    {
        "text": "important non - DB01041 drug interactions drugs that interfere with ddrug1 : concomitant use of HD01034 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , or certain herbal supplements such as st .",
        "label": "NA"
    },
    {
        "text": "important non - DB01041 drug interactions drugs that interfere with ddrug1 : concomitant use of ddrug2 , DB00400 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , or certain herbal supplements such as st .",
        "label": "NA"
    },
    {
        "text": "important non - DB01041 drug interactions drugs that interfere with ddrug1 : concomitant use of ddrug2 , ddrug3 , DB00745 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , or certain herbal supplements such as st .",
        "label": "NA"
    },
    {
        "text": "important non - DB01041 drug interactions drugs that interfere with ddrug1 : concomitant use of ddrug2 , ddrug3 , ddrug4 , HD00124 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , or certain herbal supplements such as st .",
        "label": "NA"
    },
    {
        "text": "important non - DB01041 drug interactions drugs that interfere with ddrug1 : concomitant use of ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB01045 , ddrug7 , ddrug8 , ddrug9 , or certain herbal supplements such as st .",
        "label": "NA"
    },
    {
        "text": "important non - DB01041 drug interactions drugs that interfere with ddrug1 : concomitant use of ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , DB00615 , ddrug8 , ddrug9 , or certain herbal supplements such as st .",
        "label": "NA"
    },
    {
        "text": "important non - DB01041 drug interactions drugs that interfere with ddrug1 : concomitant use of ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , DB00252 , ddrug9 , or certain herbal supplements such as st .",
        "label": "NA"
    },
    {
        "text": "important non - DB01041 drug interactions drugs that interfere with ddrug1 : concomitant use of ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , DB00564 , or certain herbal supplements such as st .",
        "label": "NA"
    },
    {
        "text": "important non - ddrug0 drug interactions drugs that interfere with HD00432 : concomitant use of HD01034 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , or certain herbal supplements such as st .",
        "label": "NA"
    },
    {
        "text": "important non - ddrug0 drug interactions drugs that interfere with HD00432 : concomitant use of ddrug2 , DB00400 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , or certain herbal supplements such as st .",
        "label": "NA"
    },
    {
        "text": "important non - ddrug0 drug interactions drugs that interfere with HD00432 : concomitant use of ddrug2 , ddrug3 , DB00745 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , or certain herbal supplements such as st .",
        "label": "NA"
    },
    {
        "text": "important non - ddrug0 drug interactions drugs that interfere with HD00432 : concomitant use of ddrug2 , ddrug3 , ddrug4 , HD00124 , ddrug6 , ddrug7 , ddrug8 , ddrug9 , or certain herbal supplements such as st .",
        "label": "NA"
    },
    {
        "text": "important non - ddrug0 drug interactions drugs that interfere with HD00432 : concomitant use of ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB01045 , ddrug7 , ddrug8 , ddrug9 , or certain herbal supplements such as st .",
        "label": "NA"
    },
    {
        "text": "important non - ddrug0 drug interactions drugs that interfere with HD00432 : concomitant use of ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , DB00615 , ddrug8 , ddrug9 , or certain herbal supplements such as st .",
        "label": "NA"
    },
    {
        "text": "important non - ddrug0 drug interactions drugs that interfere with HD00432 : concomitant use of ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , DB00252 , ddrug9 , or certain herbal supplements such as st .",
        "label": "NA"
    },
    {
        "text": "important non - ddrug0 drug interactions drugs that interfere with HD00432 : concomitant use of ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 , ddrug8 , DB00564 , or certain herbal supplements such as st .",
        "label": "NA"
    },
    {
        "text": "HD01035 with HD01036 may reduce the effectiveness of the contraception and up to one month after discontinuation of these concomitant therapies .",
        "label": "effect"
    },
    {
        "text": "DB00730 may compete with other drugs , such as DB00277 , for sites of metabolism in the liver , thus elevating the serum levels of such compounds to potentially toxic levels .",
        "label": "mechanism"
    },
    {
        "text": "therefore , when concomitant use of DB00730 and HD00741 is anticipated , it may be necessary to monitor blood levels and/or reduce the dosage of such compounds .",
        "label": "advise"
    },
    {
        "text": "interactions for DB00152 { ddrug1 } : HD00105 , oral ddrug3 , ddrug4 , ddrug5",
        "label": "int"
    },
    {
        "text": "interactions for DB00152 { ddrug1 } : ddrug2 , oral HD00283 , ddrug4 , ddrug5",
        "label": "int"
    },
    {
        "text": "interactions for DB00152 { ddrug1 } : ddrug2 , oral ddrug3 , DB00649 , ddrug5",
        "label": "int"
    },
    {
        "text": "interactions for DB00152 { ddrug1 } : ddrug2 , oral ddrug3 , ddrug4 , HD00043",
        "label": "int"
    },
    {
        "text": "interactions for ddrug0 { DB00152 } : HD00105 , oral ddrug3 , ddrug4 , ddrug5",
        "label": "int"
    },
    {
        "text": "interactions for ddrug0 { DB00152 } : ddrug2 , oral HD00283 , ddrug4 , ddrug5",
        "label": "int"
    },
    {
        "text": "interactions for ddrug0 { DB00152 } : ddrug2 , oral ddrug3 , DB00649 , ddrug5",
        "label": "int"
    },
    {
        "text": "interactions for ddrug0 { DB00152 } : ddrug2 , oral ddrug3 , ddrug4 , HD00043",
        "label": "int"
    },
    {
        "text": "interactions for ddrug0 { ddrug1 } : HD00105 , oral HD00283 , ddrug4 , ddrug5",
        "label": "NA"
    },
    {
        "text": "interactions for ddrug0 { ddrug1 } : HD00105 , oral ddrug3 , DB00649 , ddrug5",
        "label": "NA"
    },
    {
        "text": "interactions for ddrug0 { ddrug1 } : HD00105 , oral ddrug3 , ddrug4 , HD00043",
        "label": "NA"
    },
    {
        "text": "interactions for ddrug0 { ddrug1 } : ddrug2 , oral HD00283 , DB00649 , ddrug5",
        "label": "NA"
    },
    {
        "text": "interactions for ddrug0 { ddrug1 } : ddrug2 , oral HD00283 , ddrug4 , HD00043",
        "label": "NA"
    },
    {
        "text": "interactions for ddrug0 { ddrug1 } : ddrug2 , oral ddrug3 , DB00649 , HD00043",
        "label": "NA"
    },
    {
        "text": "HD00219 are capable of potentiating HD00261 { e , g , , ddrug2 , ddrug3 , ddrug4 , ddrug5 , etc . .",
        "label": "effect"
    },
    {
        "text": "HD00219 are capable of potentiating ddrug1 { e , g , , HD00026 , ddrug3 , ddrug4 , ddrug5 , etc . .",
        "label": "effect"
    },
    {
        "text": "HD00219 are capable of potentiating ddrug1 { e , g , , ddrug2 , HD00264 , ddrug4 , ddrug5 , etc . .",
        "label": "effect"
    },
    {
        "text": "HD00219 are capable of potentiating ddrug1 { e , g , , ddrug2 , ddrug3 , HD00344 , ddrug5 , etc . .",
        "label": "effect"
    },
    {
        "text": "HD00219 are capable of potentiating ddrug1 { e , g , , ddrug2 , ddrug3 , ddrug4 , DB02325 , etc . .",
        "label": "effect"
    },
    {
        "text": "as well as DB00572 and HD01037 .",
        "label": "NA"
    },
    {
        "text": "there is usually complete cross-resistance between DB01033 { ddrug1 } and DB00352 brand ddrug3 .",
        "label": "effect"
    },
    {
        "text": "there is usually complete cross-resistance between DB01033 { ddrug1 } and ddrug2 brand DB00352 .",
        "label": "effect"
    },
    {
        "text": "there is usually complete cross-resistance between ddrug0 { DB01033 } and DB00352 brand ddrug3 .",
        "label": "effect"
    },
    {
        "text": "there is usually complete cross-resistance between ddrug0 { DB01033 } and ddrug2 brand DB00352 .",
        "label": "effect"
    },
    {
        "text": "there is usually complete cross-resistance between ddrug0 { ddrug1 } and DB00352 brand DB00352 .",
        "label": "NA"
    },
    {
        "text": "as there is in vitro evidence that HD01038 { e , g , , ddrug1 , ddrug2 , or ddrug3 } inhibit the tpmt enzyme , they should be administered with caution to patients receiving concurrent DB00352 therapy .",
        "label": "mechanism"
    },
    {
        "text": "as there is in vitro evidence that ddrug0 { e , g , , DB01250 , ddrug2 , or ddrug3 } inhibit the tpmt enzyme , they should be administered with caution to patients receiving concurrent DB00352 therapy .",
        "label": "mechanism"
    },
    {
        "text": "as there is in vitro evidence that ddrug0 { e , g , , ddrug1 , DB00244 , or ddrug3 } inhibit the tpmt enzyme , they should be administered with caution to patients receiving concurrent DB00352 therapy .",
        "label": "mechanism"
    },
    {
        "text": "as there is in vitro evidence that ddrug0 { e , g , , ddrug1 , ddrug2 , or HD01039 } inhibit the tpmt enzyme , they should be administered with caution to patients receiving concurrent DB00352 therapy .",
        "label": "mechanism"
    },
    {
        "text": "caution should be exercised when administering HD01040 therapy in combination with other HD01041 .",
        "label": "advise"
    },
    {
        "text": "prothrombin time or other suitable anticoagulation test should be monitored if DB00560 is administered with DB00682 .",
        "label": "advise"
    },
    {
        "text": "concurrent use of HD01042 with oral HD00283 may render oral ddrug2 less effective .",
        "label": "effect"
    },
    {
        "text": "concurrent use of HD01042 with oral ddrug1 may render oral HD00283 less effective .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of DB01133 is decreased 80 % by DB01373 , when ddrug2 and ddrug3 are administered at the same time , and 60 % by some ddrug4 - or ddrug5 - containing ddrug6 , when administered # hour before ddrug7 .",
        "label": "mechanism"
    },
    {
        "text": "the bioavailability of DB01133 is decreased 80 % by ddrug1 , when DB01373 and ddrug3 are administered at the same time , and 60 % by some ddrug4 - or ddrug5 - containing ddrug6 , when administered # hour before ddrug7 .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of DB01133 is decreased 80 % by ddrug1 , when ddrug2 and ddrug3 are administered at the same time , and 60 % by some DB01370 - or ddrug5 - containing ddrug6 , when administered # hour before ddrug7 .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of DB01133 is decreased 80 % by ddrug1 , when ddrug2 and ddrug3 are administered at the same time , and 60 % by some ddrug4 - or DB14513 - containing ddrug6 , when administered # hour before ddrug7 .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of DB01133 is decreased 80 % by ddrug1 , when ddrug2 and ddrug3 are administered at the same time , and 60 % by some ddrug4 - or ddrug5 - containing HD00374 , when administered # hour before ddrug7 .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of ddrug0 is decreased 80 % by DB01373 , when ddrug2 and DB01133 are administered at the same time , and 60 % by some ddrug4 - or ddrug5 - containing ddrug6 , when administered # hour before ddrug7 .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of ddrug0 is decreased 80 % by DB01373 , when ddrug2 and ddrug3 are administered at the same time , and 60 % by some DB01370 - or ddrug5 - containing ddrug6 , when administered # hour before ddrug7 .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of ddrug0 is decreased 80 % by DB01373 , when ddrug2 and ddrug3 are administered at the same time , and 60 % by some ddrug4 - or DB14513 - containing ddrug6 , when administered # hour before ddrug7 .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of ddrug0 is decreased 80 % by DB01373 , when ddrug2 and ddrug3 are administered at the same time , and 60 % by some ddrug4 - or ddrug5 - containing HD00374 , when administered # hour before ddrug7 .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of ddrug0 is decreased 80 % by DB01373 , when ddrug2 and ddrug3 are administered at the same time , and 60 % by some ddrug4 - or ddrug5 - containing ddrug6 , when administered # hour before DB01133 .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of ddrug0 is decreased 80 % by ddrug1 , when DB01373 and DB01133 are administered at the same time , and 60 % by some ddrug4 - or ddrug5 - containing ddrug6 , when administered # hour before ddrug7 .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of ddrug0 is decreased 80 % by ddrug1 , when DB01373 and ddrug3 are administered at the same time , and 60 % by some DB01370 - or ddrug5 - containing ddrug6 , when administered # hour before ddrug7 .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of ddrug0 is decreased 80 % by ddrug1 , when DB01373 and ddrug3 are administered at the same time , and 60 % by some ddrug4 - or DB14513 - containing ddrug6 , when administered # hour before ddrug7 .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of ddrug0 is decreased 80 % by ddrug1 , when DB01373 and ddrug3 are administered at the same time , and 60 % by some ddrug4 - or ddrug5 - containing HD00374 , when administered # hour before ddrug7 .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of ddrug0 is decreased 80 % by ddrug1 , when DB01373 and ddrug3 are administered at the same time , and 60 % by some ddrug4 - or ddrug5 - containing ddrug6 , when administered # hour before DB01133 .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of ddrug0 is decreased 80 % by ddrug1 , when ddrug2 and DB01133 are administered at the same time , and 60 % by some DB01370 - or ddrug5 - containing ddrug6 , when administered # hour before ddrug7 .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of ddrug0 is decreased 80 % by ddrug1 , when ddrug2 and DB01133 are administered at the same time , and 60 % by some ddrug4 - or DB14513 - containing ddrug6 , when administered # hour before ddrug7 .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of ddrug0 is decreased 80 % by ddrug1 , when ddrug2 and DB01133 are administered at the same time , and 60 % by some ddrug4 - or ddrug5 - containing HD00374 , when administered # hour before ddrug7 .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of ddrug0 is decreased 80 % by ddrug1 , when ddrug2 and ddrug3 are administered at the same time , and 60 % by some DB01370 - or DB14513 - containing ddrug6 , when administered # hour before ddrug7 .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of ddrug0 is decreased 80 % by ddrug1 , when ddrug2 and ddrug3 are administered at the same time , and 60 % by some DB01370 - or ddrug5 - containing HD00374 , when administered # hour before ddrug7 .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of ddrug0 is decreased 80 % by ddrug1 , when ddrug2 and ddrug3 are administered at the same time , and 60 % by some DB01370 - or ddrug5 - containing ddrug6 , when administered # hour before DB01133 .",
        "label": "mechanism"
    },
    {
        "text": "the bioavailability of ddrug0 is decreased 80 % by ddrug1 , when ddrug2 and ddrug3 are administered at the same time , and 60 % by some ddrug4 - or DB14513 - containing HD00374 , when administered # hour before ddrug7 .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of ddrug0 is decreased 80 % by ddrug1 , when ddrug2 and ddrug3 are administered at the same time , and 60 % by some ddrug4 - or DB14513 - containing ddrug6 , when administered # hour before DB01133 .",
        "label": "mechanism"
    },
    {
        "text": "the bioavailability of ddrug0 is decreased 80 % by ddrug1 , when ddrug2 and ddrug3 are administered at the same time , and 60 % by some ddrug4 - or ddrug5 - containing HD00374 , when administered # hour before DB01133 .",
        "label": "NA"
    },
    {
        "text": "DB00945 may decrease bioavailability of DB01133 by up to 50 % when taken # hours after ddrug2 .",
        "label": "mechanism"
    },
    {
        "text": "DB00945 may decrease bioavailability of ddrug1 by up to 50 % when taken # hours after DB01133 .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of DB01133 is increased 2 - 4 fold by DB00328 but is not significantly altered by coadministration of ddrug2 .",
        "label": "mechanism"
    },
    {
        "text": "the bioavailability of DB01133 is increased 2 - 4 fold by ddrug1 but is not significantly altered by coadministration of DB00586 .",
        "label": "NA"
    },
    {
        "text": "the bioavailability of ddrug0 is increased 2 - 4 fold by DB00328 but is not significantly altered by coadministration of DB00586 .",
        "label": "NA"
    },
    {
        "text": "the pharmacokinetic parameters of DB00390 are not significantly modified by DB01133 coadministration .",
        "label": "NA"
    },
    {
        "text": "in vitro studies show that DB01133 does not displace DB00682 from its binding site on protein .",
        "label": "NA"
    },
    {
        "text": "these include HD00660 , ddrug1 , and oral and inhaled HD00356 .",
        "label": "NA"
    },
    {
        "text": "these include ddrug0 , HD00246 , and oral and inhaled HD00356 .",
        "label": "NA"
    },
    {
        "text": "however , the co administration of DB01409 with other HD00315 containing drugs { e , g , , ddrug2 } has not been studied and is therefore not recommended .",
        "label": "advise"
    },
    {
        "text": "however , the co administration of DB01409 with other ddrug1 containing drugs { e , g , , DB00332 } has not been studied and is therefore not recommended .",
        "label": "advise"
    },
    {
        "text": "however , the co administration of ddrug0 with other HD00315 containing drugs { e , g , , DB00332 } has not been studied and is therefore not recommended .",
        "label": "NA"
    },
    {
        "text": "DB00775 has been studied on a background of DB00945 and ddrug2 .",
        "label": "NA"
    },
    {
        "text": "DB00775 has been studied on a background of ddrug1 and DB01109 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 has been studied on a background of DB00945 and DB01109 .",
        "label": "NA"
    },
    {
        "text": "the use of DB00775 , in combination with DB01109 and ddrug2 , has been associated with an increase in bleeding compared to ddrug3 and ddrug4 alone { see",
        "label": "effect"
    },
    {
        "text": "the use of DB00775 , in combination with ddrug1 and DB00945 , has been associated with an increase in bleeding compared to ddrug3 and ddrug4 alone { see",
        "label": "effect"
    },
    {
        "text": "the use of DB00775 , in combination with ddrug1 and ddrug2 , has been associated with an increase in bleeding compared to DB01109 and ddrug4 alone { see",
        "label": "NA"
    },
    {
        "text": "the use of DB00775 , in combination with ddrug1 and ddrug2 , has been associated with an increase in bleeding compared to ddrug3 and DB00945 alone { see",
        "label": "NA"
    },
    {
        "text": "the use of ddrug0 , in combination with DB01109 and DB00945 , has been associated with an increase in bleeding compared to ddrug3 and ddrug4 alone { see",
        "label": "NA"
    },
    {
        "text": "the use of ddrug0 , in combination with DB01109 and ddrug2 , has been associated with an increase in bleeding compared to ddrug3 and DB00945 alone { see",
        "label": "NA"
    },
    {
        "text": "the use of ddrug0 , in combination with ddrug1 and DB00945 , has been associated with an increase in bleeding compared to DB01109 and ddrug4 alone { see",
        "label": "NA"
    },
    {
        "text": "the use of ddrug0 , in combination with ddrug1 and ddrug2 , has been associated with an increase in bleeding compared to DB01109 and DB00945 alone { see",
        "label": "NA"
    },
    {
        "text": "in clinical studies of DB00684 , patients taking ddrug1 concomitantly with DB00003 { ddrug3 , genentech } , ddrug4 , inhaled ddrug5 , other ddrug6 , or parenteral ddrug7 demonstrated adverse experience profiles similar to the study population as a whole .",
        "label": "NA"
    },
    {
        "text": "in clinical studies of DB00684 , patients taking ddrug1 concomitantly with ddrug2 { DB00003 , genentech } , ddrug4 , inhaled ddrug5 , other ddrug6 , or parenteral ddrug7 demonstrated adverse experience profiles similar to the study population as a whole .",
        "label": "NA"
    },
    {
        "text": "in clinical studies of DB00684 , patients taking ddrug1 concomitantly with ddrug2 { ddrug3 , genentech } , HD01043 , inhaled ddrug5 , other ddrug6 , or parenteral ddrug7 demonstrated adverse experience profiles similar to the study population as a whole .",
        "label": "NA"
    },
    {
        "text": "in clinical studies of DB00684 , patients taking ddrug1 concomitantly with ddrug2 { ddrug3 , genentech } , ddrug4 , inhaled HD00175 , other ddrug6 , or parenteral ddrug7 demonstrated adverse experience profiles similar to the study population as a whole .",
        "label": "NA"
    },
    {
        "text": "in clinical studies of DB00684 , patients taking ddrug1 concomitantly with ddrug2 { ddrug3 , genentech } , ddrug4 , inhaled ddrug5 , other HD01044 , or parenteral ddrug7 demonstrated adverse experience profiles similar to the study population as a whole .",
        "label": "NA"
    },
    {
        "text": "in clinical studies of DB00684 , patients taking ddrug1 concomitantly with ddrug2 { ddrug3 , genentech } , ddrug4 , inhaled ddrug5 , other ddrug6 , or parenteral HD00249 demonstrated adverse experience profiles similar to the study population as a whole .",
        "label": "NA"
    },
    {
        "text": "in clinical studies of ddrug0 , patients taking DB00684 concomitantly with DB00003 { ddrug3 , genentech } , ddrug4 , inhaled ddrug5 , other ddrug6 , or parenteral ddrug7 demonstrated adverse experience profiles similar to the study population as a whole .",
        "label": "effect"
    },
    {
        "text": "in clinical studies of ddrug0 , patients taking DB00684 concomitantly with ddrug2 { DB00003 , genentech } , ddrug4 , inhaled ddrug5 , other ddrug6 , or parenteral ddrug7 demonstrated adverse experience profiles similar to the study population as a whole .",
        "label": "effect"
    },
    {
        "text": "in clinical studies of ddrug0 , patients taking DB00684 concomitantly with ddrug2 { ddrug3 , genentech } , HD01043 , inhaled ddrug5 , other ddrug6 , or parenteral ddrug7 demonstrated adverse experience profiles similar to the study population as a whole .",
        "label": "effect"
    },
    {
        "text": "in clinical studies of ddrug0 , patients taking DB00684 concomitantly with ddrug2 { ddrug3 , genentech } , ddrug4 , inhaled HD00175 , other ddrug6 , or parenteral ddrug7 demonstrated adverse experience profiles similar to the study population as a whole .",
        "label": "effect"
    },
    {
        "text": "in clinical studies of ddrug0 , patients taking DB00684 concomitantly with ddrug2 { ddrug3 , genentech } , ddrug4 , inhaled ddrug5 , other HD01044 , or parenteral ddrug7 demonstrated adverse experience profiles similar to the study population as a whole .",
        "label": "effect"
    },
    {
        "text": "in clinical studies of ddrug0 , patients taking DB00684 concomitantly with ddrug2 { ddrug3 , genentech } , ddrug4 , inhaled ddrug5 , other ddrug6 , or parenteral HD00249 demonstrated adverse experience profiles similar to the study population as a whole .",
        "label": "effect"
    },
    {
        "text": "in clinical studies of ddrug0 , patients taking ddrug1 concomitantly with DB00003 { ddrug3 , genentech } , HD01043 , inhaled ddrug5 , other ddrug6 , or parenteral ddrug7 demonstrated adverse experience profiles similar to the study population as a whole .",
        "label": "NA"
    },
    {
        "text": "in clinical studies of ddrug0 , patients taking ddrug1 concomitantly with DB00003 { ddrug3 , genentech } , ddrug4 , inhaled ddrug5 , other ddrug6 , or parenteral HD00249 demonstrated adverse experience profiles similar to the study population as a whole .",
        "label": "NA"
    },
    {
        "text": "in clinical studies of ddrug0 , patients taking ddrug1 concomitantly with ddrug2 { DB00003 , genentech } , HD01043 , inhaled ddrug5 , other ddrug6 , or parenteral ddrug7 demonstrated adverse experience profiles similar to the study population as a whole .",
        "label": "NA"
    },
    {
        "text": "in clinical studies of ddrug0 , patients taking ddrug1 concomitantly with ddrug2 { DB00003 , genentech } , ddrug4 , inhaled ddrug5 , other ddrug6 , or parenteral HD00249 demonstrated adverse experience profiles similar to the study population as a whole .",
        "label": "NA"
    },
    {
        "text": "in clinical studies of ddrug0 , patients taking ddrug1 concomitantly with ddrug2 { ddrug3 , genentech } , HD01043 , inhaled HD00175 , other ddrug6 , or parenteral ddrug7 demonstrated adverse experience profiles similar to the study population as a whole .",
        "label": "NA"
    },
    {
        "text": "in clinical studies of ddrug0 , patients taking ddrug1 concomitantly with ddrug2 { ddrug3 , genentech } , HD01043 , inhaled ddrug5 , other HD01044 , or parenteral ddrug7 demonstrated adverse experience profiles similar to the study population as a whole .",
        "label": "NA"
    },
    {
        "text": "in clinical studies of ddrug0 , patients taking ddrug1 concomitantly with ddrug2 { ddrug3 , genentech } , HD01043 , inhaled ddrug5 , other ddrug6 , or parenteral HD00249 demonstrated adverse experience profiles similar to the study population as a whole .",
        "label": "NA"
    },
    {
        "text": "in clinical studies of ddrug0 , patients taking ddrug1 concomitantly with ddrug2 { ddrug3 , genentech } , ddrug4 , inhaled HD00175 , other ddrug6 , or parenteral HD00249 demonstrated adverse experience profiles similar to the study population as a whole .",
        "label": "NA"
    },
    {
        "text": "in clinical studies of ddrug0 , patients taking ddrug1 concomitantly with ddrug2 { ddrug3 , genentech } , ddrug4 , inhaled ddrug5 , other HD01044 , or parenteral HD00249 demonstrated adverse experience profiles similar to the study population as a whole .",
        "label": "NA"
    },
    {
        "text": "some HD00218 can enhance HD00494 toxicity by altering ddrug2 concentrations in serum and tissue .",
        "label": "effect"
    },
    {
        "text": "some HD00218 can enhance ddrug1 toxicity by altering DB09345 concentrations in serum and tissue .",
        "label": "NA"
    },
    {
        "text": "some ddrug0 can enhance HD00494 toxicity by altering DB09345 concentrations in serum and tissue .",
        "label": "NA"
    },
    {
        "text": "DB00684 should not be administered concomitantly with DB00903 , ddrug2 , ddrug3 , or ddrug4 .",
        "label": "advise"
    },
    {
        "text": "DB00684 should not be administered concomitantly with ddrug1 , DB00695 , ddrug3 , or ddrug4 .",
        "label": "advise"
    },
    {
        "text": "DB00684 should not be administered concomitantly with ddrug1 , ddrug2 , DB03904 , or ddrug4 .",
        "label": "advise"
    },
    {
        "text": "DB00684 should not be administered concomitantly with ddrug1 , ddrug2 , ddrug3 , or DB00742 .",
        "label": "advise"
    },
    {
        "text": "the in vitro binding of DB00682 to human plasma proteins is unaffected by DB00500 , and ddrug2 does not alter the prothrombin time of normal volunteers .",
        "label": "NA"
    },
    {
        "text": "the in vitro binding of DB00682 to human plasma proteins is unaffected by ddrug1 , and DB00500 does not alter the prothrombin time of normal volunteers .",
        "label": "NA"
    },
    {
        "text": "however , increased prothrombin time and bleeding have been reported in patients on concomitant HD01045 and DB00682 therapy .",
        "label": "effect"
    },
    {
        "text": "therefore , caution should be exercised when administering HD01045 to patients on HD00326 .",
        "label": "advise"
    },
    {
        "text": "in adult diabetic patients under treatment with either HD00222 or HD00071 there is no change in the clinical effects of either ddrug2 or the ddrug3 .",
        "label": "NA"
    },
    {
        "text": "in adult diabetic patients under treatment with either HD00222 or ddrug1 there is no change in the clinical effects of either HD01045 or the ddrug3 .",
        "label": "NA"
    },
    {
        "text": "in adult diabetic patients under treatment with either HD00222 or ddrug1 there is no change in the clinical effects of either ddrug2 or the HD00062 .",
        "label": "NA"
    },
    {
        "text": "in adult diabetic patients under treatment with either ddrug0 or HD00071 there is no change in the clinical effects of either HD01045 or the ddrug3 .",
        "label": "NA"
    },
    {
        "text": "in adult diabetic patients under treatment with either ddrug0 or HD00071 there is no change in the clinical effects of either ddrug2 or the HD00062 .",
        "label": "NA"
    },
    {
        "text": "in adult diabetic patients under treatment with either ddrug0 or ddrug1 there is no change in the clinical effects of either HD01045 or the HD00062 .",
        "label": "NA"
    },
    {
        "text": "caution should be used if HD01045 is administered concomitantly with DB00563 .",
        "label": "advise"
    },
    {
        "text": "HD01045 and other HD00233 have been reported to reduce the tubular secretion of ddrug2 in an animal model , possibly enhancing the toxicity of ddrug3 .",
        "label": "NA"
    },
    {
        "text": "HD01045 and other ddrug1 have been reported to reduce the tubular secretion of DB00563 in an animal model , possibly enhancing the toxicity of ddrug3 .",
        "label": "mechanism"
    },
    {
        "text": "HD01045 and other ddrug1 have been reported to reduce the tubular secretion of ddrug2 in an animal model , possibly enhancing the toxicity of DB00563 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 and other HD00233 have been reported to reduce the tubular secretion of DB00563 in an animal model , possibly enhancing the toxicity of ddrug3 .",
        "label": "mechanism"
    },
    {
        "text": "ddrug0 and other HD00233 have been reported to reduce the tubular secretion of ddrug2 in an animal model , possibly enhancing the toxicity of DB00563 .",
        "label": "NA"
    },
    {
        "text": "cyp3a4 inhibitors : DB01026 , an inhibitor of the drug metabolizing enzyme cyp3a4 , significantly increased plasma concentrations of DB01036 when coadministered to subjects who were poor metabolizers { see clinical pharmacology , variability in metabolism and drug-drug interactions } .",
        "label": "mechanism"
    },
    {
        "text": "for patients receiving DB01026 or other potent cyp3a4 inhibitors such as other HD00270 { eg , ddrug2 , ddrug3 } or ddrug4 { eg , ddrug5 , ddrug6 } or ddrug7 or ddrug8 , the recommended dose of ddrug9 is # mg daily .",
        "label": "NA"
    },
    {
        "text": "for patients receiving DB01026 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , DB01167 , ddrug3 } or ddrug4 { eg , ddrug5 , ddrug6 } or ddrug7 or ddrug8 , the recommended dose of ddrug9 is # mg daily .",
        "label": "NA"
    },
    {
        "text": "for patients receiving DB01026 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , ddrug2 , DB01110 } or ddrug4 { eg , ddrug5 , ddrug6 } or ddrug7 or ddrug8 , the recommended dose of ddrug9 is # mg daily .",
        "label": "NA"
    },
    {
        "text": "for patients receiving DB01026 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , ddrug2 , ddrug3 } or HD00093 { eg , ddrug5 , ddrug6 } or ddrug7 or ddrug8 , the recommended dose of ddrug9 is # mg daily .",
        "label": "NA"
    },
    {
        "text": "for patients receiving DB01026 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , ddrug2 , ddrug3 } or ddrug4 { eg , DB00199 , ddrug6 } or ddrug7 or ddrug8 , the recommended dose of ddrug9 is # mg daily .",
        "label": "NA"
    },
    {
        "text": "for patients receiving DB01026 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , ddrug2 , ddrug3 } or ddrug4 { eg , ddrug5 , DB01211 } or ddrug7 or ddrug8 , the recommended dose of ddrug9 is # mg daily .",
        "label": "NA"
    },
    {
        "text": "for patients receiving DB01026 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , ddrug2 , ddrug3 } or ddrug4 { eg , ddrug5 , ddrug6 } or DB00091 or ddrug8 , the recommended dose of ddrug9 is # mg daily .",
        "label": "NA"
    },
    {
        "text": "for patients receiving DB01026 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , ddrug2 , ddrug3 } or ddrug4 { eg , ddrug5 , ddrug6 } or ddrug7 or DB00570 , the recommended dose of ddrug9 is # mg daily .",
        "label": "NA"
    },
    {
        "text": "for patients receiving DB01026 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , ddrug2 , ddrug3 } or ddrug4 { eg , ddrug5 , ddrug6 } or ddrug7 or ddrug8 , the recommended dose of DB01036 is # mg daily .",
        "label": "advise"
    },
    {
        "text": "for patients receiving ddrug0 or other potent cyp3a4 inhibitors such as other HD00270 { eg , ddrug2 , ddrug3 } or ddrug4 { eg , ddrug5 , ddrug6 } or ddrug7 or ddrug8 , the recommended dose of DB01036 is # mg daily .",
        "label": "advise"
    },
    {
        "text": "for patients receiving ddrug0 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , DB01167 , ddrug3 } or ddrug4 { eg , ddrug5 , ddrug6 } or ddrug7 or ddrug8 , the recommended dose of DB01036 is # mg daily .",
        "label": "advise"
    },
    {
        "text": "for patients receiving ddrug0 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , ddrug2 , DB01110 } or ddrug4 { eg , ddrug5 , ddrug6 } or ddrug7 or ddrug8 , the recommended dose of DB01036 is # mg daily .",
        "label": "advise"
    },
    {
        "text": "for patients receiving ddrug0 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , ddrug2 , ddrug3 } or HD00093 { eg , ddrug5 , ddrug6 } or ddrug7 or ddrug8 , the recommended dose of DB01036 is # mg daily .",
        "label": "advise"
    },
    {
        "text": "for patients receiving ddrug0 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , ddrug2 , ddrug3 } or ddrug4 { eg , DB00199 , ddrug6 } or ddrug7 or ddrug8 , the recommended dose of DB01036 is # mg daily .",
        "label": "advise"
    },
    {
        "text": "for patients receiving ddrug0 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , ddrug2 , ddrug3 } or ddrug4 { eg , ddrug5 , DB01211 } or ddrug7 or ddrug8 , the recommended dose of DB01036 is # mg daily .",
        "label": "advise"
    },
    {
        "text": "for patients receiving ddrug0 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , ddrug2 , ddrug3 } or ddrug4 { eg , ddrug5 , ddrug6 } or DB00091 or DB00570 , the recommended dose of ddrug9 is # mg daily .",
        "label": "NA"
    },
    {
        "text": "for patients receiving ddrug0 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , ddrug2 , ddrug3 } or ddrug4 { eg , ddrug5 , ddrug6 } or DB00091 or ddrug8 , the recommended dose of DB01036 is # mg daily .",
        "label": "advise"
    },
    {
        "text": "for patients receiving ddrug0 or other potent cyp3a4 inhibitors such as other ddrug1 { eg , ddrug2 , ddrug3 } or ddrug4 { eg , ddrug5 , ddrug6 } or ddrug7 or DB00570 , the recommended dose of DB01036 is # mg daily .",
        "label": "advise"
    },
    {
        "text": "administration of DB01229 in combination with DB00072 resulted in a two-fold decrease in ddrug2 clearance in a non-human primate study and in a # - fold increase in ddrug3 serum levels in clinical studies .",
        "label": "mechanism"
    },
    {
        "text": "administration of DB01229 in combination with ddrug1 resulted in a two-fold decrease in DB00072 clearance in a non-human primate study and in a # - fold increase in ddrug3 serum levels in clinical studies .",
        "label": "NA"
    },
    {
        "text": "administration of DB01229 in combination with ddrug1 resulted in a two-fold decrease in ddrug2 clearance in a non-human primate study and in a # - fold increase in DB00072 serum levels in clinical studies .",
        "label": "NA"
    },
    {
        "text": "DB01108 may interact with DB00357 or ddrug2 { causing too great a decrease in adrenal function } .",
        "label": "int"
    },
    {
        "text": "DB01108 may interact with ddrug1 or DB00648 { causing too great a decrease in adrenal function } .",
        "label": "int"
    },
    {
        "text": "ddrug0 may interact with DB00357 or DB00648 { causing too great a decrease in adrenal function } .",
        "label": "NA"
    },
    {
        "text": "DB00440 may inhibit the hepatic metabolism of DB00252 .",
        "label": "mechanism"
    },
    {
        "text": "DB00440 , given at a common clinical dosage , increased the DB00252 half-life by 51 % and decreased the ddrug2 metabolic clearance rate by 30 % .",
        "label": "mechanism"
    },
    {
        "text": "DB00440 , given at a common clinical dosage , increased the ddrug1 half-life by 51 % and decreased the DB00252 metabolic clearance rate by 30 % .",
        "label": "mechanism"
    },
    {
        "text": "agents that might be coadministered with DB01157 in acquired_immune_deficiency_syndrome patients for other indications that could elicit this activity include DB00199 , ddrug2 , ddrug3 , ddrug4 , and ddrug5 .",
        "label": "effect"
    },
    {
        "text": "agents that might be coadministered with DB01157 in acquired_immune_deficiency_syndrome patients for other indications that could elicit this activity include ddrug1 , DB01045 , ddrug3 , ddrug4 , and ddrug5 .",
        "label": "effect"
    },
    {
        "text": "agents that might be coadministered with DB01157 in acquired_immune_deficiency_syndrome patients for other indications that could elicit this activity include ddrug1 , ddrug2 , DB00615 , ddrug4 , and ddrug5 .",
        "label": "effect"
    },
    {
        "text": "agents that might be coadministered with DB01157 in acquired_immune_deficiency_syndrome patients for other indications that could elicit this activity include ddrug1 , ddrug2 , ddrug3 , DB01026 , and ddrug5 .",
        "label": "effect"
    },
    {
        "text": "agents that might be coadministered with DB01157 in acquired_immune_deficiency_syndrome patients for other indications that could elicit this activity include ddrug1 , ddrug2 , ddrug3 , ddrug4 , and DB00196 .",
        "label": "effect"
    },
    {
        "text": "in vitro perfusion of isolated rat liver has shown that DB00501 caused a significant reduction in DB01157 metabolism and that ddrug2 altered the relative concentration of tmq metabolites possibly by competing for sulfate metabolites .",
        "label": "mechanism"
    },
    {
        "text": "in vitro perfusion of isolated rat liver has shown that DB00501 caused a significant reduction in ddrug1 metabolism and that DB00316 altered the relative concentration of tmq metabolites possibly by competing for sulfate metabolites .",
        "label": "NA"
    },
    {
        "text": "in vitro perfusion of isolated rat liver has shown that ddrug0 caused a significant reduction in DB01157 metabolism and that DB00316 altered the relative concentration of tmq metabolites possibly by competing for sulfate metabolites .",
        "label": "NA"
    },
    {
        "text": "based on an in vitro rat liver model , nitrogen substituted HD00825 { ddrug1 , ddrug2 , ddrug3 } were potent , non-competitive inhibitors of DB01157 metabolism .",
        "label": "mechanism"
    },
    {
        "text": "based on an in vitro rat liver model , nitrogen substituted ddrug0 { DB00257 , ddrug2 , ddrug3 } were potent , non-competitive inhibitors of DB01157 metabolism .",
        "label": "mechanism"
    },
    {
        "text": "based on an in vitro rat liver model , nitrogen substituted ddrug0 { ddrug1 , DB01026 , ddrug3 } were potent , non-competitive inhibitors of DB01157 metabolism .",
        "label": "mechanism"
    },
    {
        "text": "based on an in vitro rat liver model , nitrogen substituted ddrug0 { ddrug1 , ddrug2 , DB01110 } were potent , non-competitive inhibitors of DB01157 metabolism .",
        "label": "mechanism"
    },
    {
        "text": "DB00427 may enhance the sedative effects of HD00389 including ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , and ddrug7 .",
        "label": "effect"
    },
    {
        "text": "DB00427 may enhance the sedative effects of ddrug1 including DB02325 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , and ddrug7 .",
        "label": "effect"
    },
    {
        "text": "DB00427 may enhance the sedative effects of ddrug1 including ddrug2 , HD00026 , ddrug4 , ddrug5 , ddrug6 , and ddrug7 .",
        "label": "effect"
    },
    {
        "text": "DB00427 may enhance the sedative effects of ddrug1 including ddrug2 , ddrug3 , HD00214 , ddrug5 , ddrug6 , and ddrug7 .",
        "label": "effect"
    },
    {
        "text": "DB00427 may enhance the sedative effects of ddrug1 including ddrug2 , ddrug3 , ddrug4 , HD00424 , ddrug6 , and ddrug7 .",
        "label": "effect"
    },
    {
        "text": "DB00427 may enhance the sedative effects of ddrug1 including ddrug2 , ddrug3 , ddrug4 , ddrug5 , HD00024 , and ddrug7 .",
        "label": "effect"
    },
    {
        "text": "DB00427 may enhance the sedative effects of ddrug1 including ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , and HD01046 .",
        "label": "effect"
    },
    {
        "text": "ddrug0 may enhance the sedative effects of HD00389 including DB02325 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , and ddrug7 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may enhance the sedative effects of HD00389 including ddrug2 , HD00026 , ddrug4 , ddrug5 , ddrug6 , and ddrug7 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may enhance the sedative effects of HD00389 including ddrug2 , ddrug3 , HD00214 , ddrug5 , ddrug6 , and ddrug7 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may enhance the sedative effects of HD00389 including ddrug2 , ddrug3 , ddrug4 , HD00424 , ddrug6 , and ddrug7 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may enhance the sedative effects of HD00389 including ddrug2 , ddrug3 , ddrug4 , ddrug5 , HD00024 , and ddrug7 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 may enhance the sedative effects of HD00389 including ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , and HD01046 .",
        "label": "NA"
    },
    {
        "text": "the effects of HD00522 , such as DB00572 and ddrug2 may be enhanced by the concomitant administration of ddrug3 .",
        "label": "NA"
    },
    {
        "text": "the effects of HD00522 , such as ddrug1 and HD00043 may be enhanced by the concomitant administration of ddrug3 .",
        "label": "NA"
    },
    {
        "text": "the effects of HD00522 , such as ddrug1 and ddrug2 may be enhanced by the concomitant administration of DB00427 .",
        "label": "effect"
    },
    {
        "text": "the effects of ddrug0 , such as DB00572 and HD00043 may be enhanced by the concomitant administration of ddrug3 .",
        "label": "NA"
    },
    {
        "text": "the effects of ddrug0 , such as DB00572 and ddrug2 may be enhanced by the concomitant administration of DB00427 .",
        "label": "effect"
    },
    {
        "text": "the effects of ddrug0 , such as ddrug1 and HD00043 may be enhanced by the concomitant administration of DB00427 .",
        "label": "effect"
    },
    {
        "text": "the concomitant use of DB00209 with other HD00352 that produce dry mouth , constipation , and other anticholinergic pharmacological effects may increase the frequency and/or severity of such effects .",
        "label": "effect"
    },
    {
        "text": "drugs eliminated by active tubular secretion : although studies to assess drug-drug interactions with DB00209 have not been conducted , ddrug1 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion { e , g , DB00390 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 and ddrug8 } .",
        "label": "NA"
    },
    {
        "text": "drugs eliminated by active tubular secretion : although studies to assess drug-drug interactions with DB00209 have not been conducted , ddrug1 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion { e , g , ddrug2 , DB01035 , ddrug4 , ddrug5 , ddrug6 , ddrug7 and ddrug8 } .",
        "label": "NA"
    },
    {
        "text": "drugs eliminated by active tubular secretion : although studies to assess drug-drug interactions with DB00209 have not been conducted , ddrug1 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion { e , g , ddrug2 , ddrug3 , DB01337 , ddrug5 , ddrug6 , ddrug7 and ddrug8 } .",
        "label": "NA"
    },
    {
        "text": "drugs eliminated by active tubular secretion : although studies to assess drug-drug interactions with DB00209 have not been conducted , ddrug1 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion { e , g , ddrug2 , ddrug3 , ddrug4 , DB00295 , ddrug6 , ddrug7 and ddrug8 } .",
        "label": "NA"
    },
    {
        "text": "drugs eliminated by active tubular secretion : although studies to assess drug-drug interactions with DB00209 have not been conducted , ddrug1 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion { e , g , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB00512 , ddrug7 and ddrug8 } .",
        "label": "NA"
    },
    {
        "text": "drugs eliminated by active tubular secretion : although studies to assess drug-drug interactions with DB00209 have not been conducted , ddrug1 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion { e , g , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , DB00331 and ddrug8 } .",
        "label": "NA"
    },
    {
        "text": "drugs eliminated by active tubular secretion : although studies to assess drug-drug interactions with DB00209 have not been conducted , ddrug1 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion { e , g , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 and DB14126 } .",
        "label": "NA"
    },
    {
        "text": "drugs eliminated by active tubular secretion : although studies to assess drug-drug interactions with ddrug0 have not been conducted , DB00209 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion { e , g , DB00390 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 and ddrug8 } .",
        "label": "mechanism"
    },
    {
        "text": "drugs eliminated by active tubular secretion : although studies to assess drug-drug interactions with ddrug0 have not been conducted , DB00209 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion { e , g , ddrug2 , DB01035 , ddrug4 , ddrug5 , ddrug6 , ddrug7 and ddrug8 } .",
        "label": "mechanism"
    },
    {
        "text": "drugs eliminated by active tubular secretion : although studies to assess drug-drug interactions with ddrug0 have not been conducted , DB00209 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion { e , g , ddrug2 , ddrug3 , DB01337 , ddrug5 , ddrug6 , ddrug7 and ddrug8 } .",
        "label": "mechanism"
    },
    {
        "text": "drugs eliminated by active tubular secretion : although studies to assess drug-drug interactions with ddrug0 have not been conducted , DB00209 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion { e , g , ddrug2 , ddrug3 , ddrug4 , DB00295 , ddrug6 , ddrug7 and ddrug8 } .",
        "label": "mechanism"
    },
    {
        "text": "drugs eliminated by active tubular secretion : although studies to assess drug-drug interactions with ddrug0 have not been conducted , DB00209 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion { e , g , ddrug2 , ddrug3 , ddrug4 , ddrug5 , DB00512 , ddrug7 and ddrug8 } .",
        "label": "mechanism"
    },
    {
        "text": "drugs eliminated by active tubular secretion : although studies to assess drug-drug interactions with ddrug0 have not been conducted , DB00209 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion { e , g , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , DB00331 and ddrug8 } .",
        "label": "mechanism"
    },
    {
        "text": "drugs eliminated by active tubular secretion : although studies to assess drug-drug interactions with ddrug0 have not been conducted , DB00209 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion { e , g , ddrug2 , ddrug3 , ddrug4 , ddrug5 , ddrug6 , ddrug7 and DB14126 } .",
        "label": "mechanism"
    },
    {
        "text": "concomitant administration of DB00512 and HD00822 has been associated with erythema and histamine-like flushing and anaphylactoid reactions .",
        "label": "effect"
    },
    {
        "text": "a study published in # found that DB01080 causes a statistically significant increase in plasma clearance of DB00564 .",
        "label": "mechanism"
    },
    {
        "text": "in 1984 , drs rimmer and richens at the university of wales reported that administering DB01080 with DB00252 lowered the serum ddrug2 concentration in patients with treatment-resistant epilepsy .",
        "label": "mechanism"
    },
    {
        "text": "in 1984 , drs rimmer and richens at the university of wales reported that administering DB01080 with ddrug1 lowered the serum DB00252 concentration in patients with treatment-resistant epilepsy .",
        "label": "NA"
    },
    {
        "text": "drug interactions : women on oral HD00283 have shown a significant increase in plasma DB00162 levels .",
        "label": "mechanism"
    },
    {
        "text": "limited evidence suggests that DB00126 may influence the intensity and duration of action of HD00159 .",
        "label": "mechanism"
    },
    {
        "text": "HD00469 : prolongation of prothrombin time { pt } and international normalized ratio { inr } were observed in patients receiving DB02546 concomitantly with ddrug2 .",
        "label": "NA"
    },
    {
        "text": "ddrug0 : prolongation of prothrombin time { pt } and international normalized ratio { inr } were observed in patients receiving DB02546 concomitantly with HD00469 .",
        "label": "effect"
    },
    {
        "text": "physicians should carefully monitor pt and inr in patients concurrently administered DB02546 and HD00708 .",
        "label": "advise"
    },
    {
        "text": "other HD01047 severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of DB02546 and other ddrug2 { e , g , , ddrug3 } .",
        "label": "NA"
    },
    {
        "text": "other HD01047 severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of ddrug1 and other ddrug2 { e , g , , DB00313 } .",
        "label": "NA"
    },
    {
        "text": "other ddrug0 severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of DB02546 and other HD01047 { e , g , , ddrug3 } .",
        "label": "effect"
    },
    {
        "text": "other ddrug0 severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of DB02546 and other ddrug2 { e , g , , DB00313 } .",
        "label": "effect"
    }
]